data_2kl3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.742 0.306 . . . . 74.34 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 71.23 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 64.3 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 74.25 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.14 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 73.51 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 72.41 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 75.35 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 71.2 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 55.44 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 73.33 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.583 HD23 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 71.52 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 63.15 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.496 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 74.42 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 75.4 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.496 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.44 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 73.1 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.618 ' HE3' ' HE2' ' A' ' 43' ' ' MET . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.618 ' HE2' ' HE3' ' A' ' 41' ' ' MET . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 74.33 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 74.13 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 60.25 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 74.41 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 73.31 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 74.12 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 74.51 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 61.52 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.583 HD11 HD23 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 72.44 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 75.21 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 74.14 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.52 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 74.33 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 72.55 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 73.01 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 71.14 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 65.43 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 75.44 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 72.02 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 74.24 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 63.34 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 75.42 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.3 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.44 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.414 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 63.41 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.22 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.5 HG12 HG11 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.45 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.45 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.629 HD13 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 62.41 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 70.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 73.44 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.31 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 63.43 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 63.5 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 61.35 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.5 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 63.04 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 74.1 111.789 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 120.801 0.334 . . . . 55.34 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 72.13 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 71.24 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 74.15 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 74.34 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 73.31 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 64.41 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 72.25 110.815 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 72.04 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 55.43 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 72.23 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 75.03 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 74.32 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 74.34 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 73.43 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 74.52 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 74.12 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 74.25 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 75.05 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 HD11 HD23 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 71.15 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 82' ' ' ALA . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 75.03 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 75.2 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 74.43 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 73.23 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 74.11 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 75.5 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 74.11 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.9 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 75.31 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.599 HH21 HG11 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 74.45 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 73.13 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 72.33 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 75.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 61.31 111.263 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 71.42 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 61.52 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 72.22 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 70.21 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 73.32 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 53.31 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 74.42 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 72.43 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 72.44 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 72.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 62.25 112.149 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.966 0.413 . . . . 74.42 111.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' HD13 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 70.23 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 74.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 65.1 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.1 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 75.34 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 73.35 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 75.43 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 75.01 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 73.44 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD21 HD12 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 74.12 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 72.11 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 75.32 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.42 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.469 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.61 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 73.31 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.31 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 62.25 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.54 ' HB2' HD22 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.451 ' HE2' ' HB3' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 74.14 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 75.24 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 75.43 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 72.13 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.451 ' HB3' ' HE2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 74.5 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 74.15 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 71.11 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.67 HD12 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.22 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 74.23 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 74.03 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.628 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 72.33 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 73.5 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 74.31 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HB3' HD22 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 74.41 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 65.35 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 72.41 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 72.24 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 73.4 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 58' ' ' LYS . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 60.25 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 75.22 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 72.11 111.647 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 61.31 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 70.43 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 75.21 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.801 ' HG2' HG23 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 70.24 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 73.24 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 65.11 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.801 HG23 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 73.31 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 70.2 110.579 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.411 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 74.25 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.55 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 6' ' ' ASP . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 72.42 110.133 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 HD13 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 75.42 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 75.14 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 70.24 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HD2' HD13 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 75.34 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 65.04 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 74.0 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 74.23 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 72.11 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.43 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 73.25 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 75.05 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 74.12 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 61.25 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 74.53 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.803 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 73.43 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 53.31 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 72.3 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.718 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 75.05 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 75.21 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 71.33 113.647 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 72.34 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 74.34 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 73.43 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 64.34 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 75.42 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 63.44 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 74.33 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 41.03 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 75.31 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 53.13 111.36 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 70.13 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 73.13 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 60.01 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 74.4 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 73.04 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.58 HG11 HG11 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 61.41 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 75.33 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.75 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 64.33 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 74.43 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 73.12 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.764 ' HG2' HG23 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 73.11 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 74.0 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.803 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.42 112.693 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.764 HG23 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 73.24 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 74.13 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.13 111.617 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 72.34 111.963 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.471 ' O ' HD13 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 73.3 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.532 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 74.54 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 75.44 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 73.45 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 74.45 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 72.31 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 73.13 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 75.44 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.502 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 75.44 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 74.42 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 74.02 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 73.33 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 73.42 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 71.15 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 73.13 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 71.04 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 74.31 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 44.24 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.457 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 74.43 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.41 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.423 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 75.31 112.13 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.604 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 74.41 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 74.32 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 74.51 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 74.13 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 74.35 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.631 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 70.35 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.24 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 73.03 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 74.23 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.52 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 63.01 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 73.04 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 74.11 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 70.31 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.42 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 73.01 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 75.05 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 73.24 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 71.01 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 74.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.672 ' HB3' HG22 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 74.32 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 74.32 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 74.33 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 64.44 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 73.31 112.295 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 74.41 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 75.22 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 65.32 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 72.15 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 65.04 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 73.41 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 74.4 111.736 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.837 0.351 . . . . 74.05 111.704 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 73.2 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 62.43 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 74.21 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 73.14 112.093 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 73.15 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.523 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 75.34 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 73.41 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.523 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 75.13 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 61.23 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 74.23 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 74.14 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 72.54 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 74.23 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 75.04 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 71.12 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 74.44 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.446 ' HB2' HD23 ' A' ' 24' ' ' LEU . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 74.12 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 74.12 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 64.52 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 74.3 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 71.24 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 74.4 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 74.21 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 73.31 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 74.55 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.663 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 74.1 112.443 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 64.31 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG22 HD11 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 73.41 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 71.03 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 73.12 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 65.55 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 74.45 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.43 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 74.32 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 73.21 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 64.32 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 71.53 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 74.43 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.498 HD12 HD11 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 74.21 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 73.51 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.54 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 74.02 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.614 HG12 HG12 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 70.12 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 75.33 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 62.23 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 74.15 111.743 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 73.23 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 74.42 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' HG23 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 73.12 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 73.31 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.41 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 74.25 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 73.24 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 75.35 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.445 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.34 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 62.13 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 72.55 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 75.51 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 74.03 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 74.02 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 74.03 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.69 HD21 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 75.23 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.644 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 75.45 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.639 ' NH1' HG21 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 74.54 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 74.15 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 64.44 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 73.13 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 75.42 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 74.55 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 73.03 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.43 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 74.12 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 71.12 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.536 ' HE2' ' HE1' ' A' ' 43' ' ' MET . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.69 ' SD ' HD21 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 75.45 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.644 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.45 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 74.13 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 73.35 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 71.41 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 74.1 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.35 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 73.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 73.4 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 75.42 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 73.15 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 74.21 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 61.15 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.483 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 71.4 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 74.4 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 73.43 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 75.31 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 71.45 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD11 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 71.25 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 75.43 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.54 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 74.43 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 73.43 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 HG11 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.607 ' HB3' HG22 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.23 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 73.34 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.708 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.45 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.409 HD23 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.439 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 44.02 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 74.32 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 74.45 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 74.15 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.501 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 65.4 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 75.22 112.34 176.189 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 64.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.556 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 73.4 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 74.41 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 70.13 110.609 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 73.33 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 74.43 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 75.33 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 74.22 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 74.11 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.456 HG23 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD22 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 75.32 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.13 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' A' ' 75' ' ' ALA . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 73.4 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 73.12 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 72.22 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.433 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.683 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 71.42 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 74.33 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 HG23 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 74.55 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 55.21 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.476 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 72.05 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 74.24 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.692 ' SD ' HD21 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 73.1 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 75.15 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 71.33 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 75' ' ' ALA . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 75.2 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 62.25 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.602 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 74.01 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 71.04 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.31 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 73.14 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD11 HD22 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.43 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 74.14 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 71.21 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 71.21 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 74.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 72.1 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 71.14 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 74.33 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 75.34 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 75.32 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 73.12 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.45 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 75.11 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 74.43 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.43 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 75.43 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.706 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 75.01 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 75.11 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 71.43 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 74.31 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 74.14 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' HG23 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 74.13 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 64.1 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 61.32 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 74.41 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.54 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.4 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 73.25 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.591 ' HB2' HG23 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.13 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 74.55 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 74.51 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 64.23 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.497 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 64.33 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 63.55 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.11 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 75.44 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 72.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.497 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 71.13 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 HG21 HD22 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 75.4 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 74.1 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.45 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 74.24 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 62.51 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 74.02 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 75.22 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 55.31 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 74.54 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 61.41 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.54 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 65.11 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.3 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 74.2 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.514 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 74.23 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 73.43 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 72.02 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' HD22 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.33 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.431 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 73.04 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 71.2 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 71.45 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG21 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 74.22 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 75.4 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 65.23 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 71.25 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 73.31 111.332 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 73.13 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 72.03 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.44 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.41 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 75.43 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.54 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 75.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.54 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 72.45 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 73.52 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 45.44 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 74.33 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 72.34 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 74.13 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 74.44 110.984 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.964 0.411 . . . . 75.53 111.062 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 71.14 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 74.34 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 75.14 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 75.41 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 74.11 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 73.4 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 75.11 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 71.04 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 70.31 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 53.52 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.522 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.53 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 73.44 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 74.43 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 61.01 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 73.32 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 74.31 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.436 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 64.35 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 74.35 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 72.42 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.41 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 72.21 111.143 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 HG13 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 74.1 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 74.14 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.2 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 41.12 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 73.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD13 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 74.22 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 74.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.694 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 73.04 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 74.12 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 72.43 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 75.34 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 74.52 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' HD22 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 52.22 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 74.4 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 63.12 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 75.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 74.15 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 55.31 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.431 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.04 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.767 ' HG2' HG23 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 61.12 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 62.21 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 64.31 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 74.02 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 74.41 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 75.54 111.637 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 73.43 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.43 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.665 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 74.03 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 75.14 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.51 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 75.31 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 73.32 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 74.22 112.414 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 65.22 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 62.21 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.678 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 73.03 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.517 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 74.0 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 74.35 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 73.15 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 65.14 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 75.44 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 65.41 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 74.54 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 65.43 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.678 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 74.22 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 64.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 73.32 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.43 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 65.24 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 74.21 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 74.14 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 74.4 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 71.3 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.2 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.576 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 63.24 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 70.04 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.5 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 74.44 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 75.23 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 74.23 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 75.04 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 72.01 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 74.12 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 63.42 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 75.11 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 70.31 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 74.3 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 75.51 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 72.2 110.775 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HB3' HG22 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 72.02 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 72.45 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 70.55 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 74.34 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 74.52 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 75.43 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 61.13 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 72.24 111.597 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.801 -0.444 . . . . 65.33 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 64.44 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.681 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 62.1 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 73.4 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 74.53 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 73.14 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 52.43 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.52 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 74.34 111.658 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 62.52 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 75.5 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' NH1' HD21 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.633 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 73.22 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 73.32 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 71.53 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 74.52 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.435 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 63.04 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.523 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 74.54 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 70.21 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.497 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 74.13 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 75.53 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 73.12 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 63.31 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.702 HD12 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 74.22 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.662 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.662 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 74.44 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 74.24 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 74.22 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 74.13 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 74.14 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 73.12 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 74.22 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 71.14 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 72.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 76' ' ' VAL . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 51.14 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 75.15 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 72.31 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 74.33 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 74.34 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 63.35 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 72.21 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.527 HG23 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 72.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.577 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 74.0 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 74.31 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 75.1 112.274 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.755 0.312 . . . . 74.23 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 73.43 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 74.44 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 74.41 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 71.42 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 73.25 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' ALA . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 74.01 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 73.42 112.298 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 73.43 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 74.23 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.594 HD21 HD13 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 65.42 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 64.24 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.576 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.576 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 74.41 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.35 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 53.33 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' HA ' HD11 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 74.31 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 75.21 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 71.23 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 64.33 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.62 ' HE2' ' HE2' ' A' ' 43' ' ' MET . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.62 ' HE2' ' HE2' ' A' ' 41' ' ' MET . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 64.43 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 60.12 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 HG13 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 74.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 72.11 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 74.5 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 73.21 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 74.05 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD13 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 75.22 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.45 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 72.34 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 72.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 HG23 HD11 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.503 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 74.42 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.542 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 72.33 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 61.15 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 70.04 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 73.03 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 74.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 75.54 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 71.22 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 75.21 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 60.44 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 72.54 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.43 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.21 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 75.41 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 71.13 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 72.1 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 63.02 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 75.01 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 72.21 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 75.35 111.265 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HG2' HG22 ' A' ' 104' ' ' THR . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 73.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 75.14 111.518 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 72.41 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.43 HG22 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 75.14 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 71.5 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 65.22 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 64.1 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 74.03 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 74.21 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 73.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 72.11 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 74.43 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 HD23 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 72.53 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 72.24 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 74.22 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 71.42 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.571 ' HB2' HD21 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 75.34 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.546 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 74.44 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.42 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 75.02 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 75' ' ' ALA . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 73.14 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 72.44 111.795 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 74.41 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 72.5 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 63.35 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 72.33 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 64.52 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 74.21 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 73.51 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 73.41 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 75.53 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 71.44 111.412 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 75.25 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.663 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' A' ' 64' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.24 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.663 HD13 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 73.24 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.404 HD11 HG22 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 73.22 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 72.02 112.085 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 75.13 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 74.13 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.414 HG12 HG11 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 71.02 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 74.4 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 75.11 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 74.23 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.13 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 73.25 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 74.31 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 73.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 62.33 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 73.21 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.14 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.11 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 73.1 111.649 179.104 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.786 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 74.02 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 75.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 75.2 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 72.21 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 75.43 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.731 HD23 HD12 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 73.44 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 65.32 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' NH1' HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 75.13 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 74.35 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 63.12 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 75.1 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.24 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 72.02 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 64.41 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.647 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 74.21 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 75.02 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 63.01 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 74.14 111.99 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.582 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 72.51 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 73.11 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 54.34 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 71.24 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 75.14 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.731 HD12 HD23 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 74.4 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 56' ' ' LEU . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 72.35 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 75.33 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 64.04 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 74.22 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 72.33 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 72.12 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 73.42 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 74.35 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 75.4 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.54 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 75.25 111.796 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.53 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 75.23 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 62.41 111.604 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.786 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.704 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 71.13 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 62.01 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.466 HD22 ' NH1' ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 74.21 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 73.11 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 44.13 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.463 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 73.33 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.511 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 74.11 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.21 -0.293 . . . . 75.22 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 64.53 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.436 ' HA ' HD11 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 74.32 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 74.32 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 74.03 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 64.12 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.514 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 74.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.32 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.514 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 72.22 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.659 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 73.31 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 73.15 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.54 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 74.22 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 74.21 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.528 HG22 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 72.53 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 75.42 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.536 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 75.42 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 75.21 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 75.31 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 72.33 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 70.34 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.659 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 74.45 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.52 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 55.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 72.03 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 70.21 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.622 HD11 HD23 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 74.23 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 74.13 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 74.21 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 73.41 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 70.35 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 72.42 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 75.03 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.3 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.572 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 71.4 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 73.23 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 64.13 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 74.35 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 74.15 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 74.3 111.653 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 71.02 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 74.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 61.13 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.32 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 75.41 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.557 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 64.12 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 72.03 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 72.11 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 74.01 111.506 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.53 0.205 . . . . 74.22 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 60.13 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 73.32 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 62.23 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 70.31 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 73.41 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 74.23 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 73.12 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.33 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 75.12 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 62.45 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 75.22 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 70.14 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.628 HD21 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HB2' ' HH ' ' A' ' 65' ' ' TYR . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 74.2 110.623 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.495 HG11 HD12 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 74.44 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 64.34 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 60.25 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 74.14 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.472 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.556 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.474 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.737 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 HG11 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.34 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.737 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 71.32 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 75.33 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 73.51 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 74.24 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 73.13 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.484 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 73.3 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 70.3 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.8 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.608 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG11 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 74.24 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 75.51 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 73.43 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 70.34 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 52.01 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 70.44 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 72.51 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HZ1' ' CG ' ' A' ' 69' ' ' ASP . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 73.12 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 74.13 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG21 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 70.14 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 74.33 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 74.45 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 74.31 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 74.1 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 65.23 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 74.22 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 75.31 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 54.02 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 72.4 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.77 0.319 . . . . 75.21 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 74.14 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 71.11 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 74.02 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 74.33 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 75.2 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 74.31 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 71.43 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.42 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 73.03 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 74.41 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 HD21 HD12 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 70.21 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 73.41 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 64.42 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.51 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 65.31 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 74.3 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 71.44 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 75.51 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.46 ' HG2' HD13 ' A' ' 48' ' ' LEU . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 70.02 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 73.12 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 75.5 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 71.24 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' HB1' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 74.51 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.439 ' HB1' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 73.11 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 72.0 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 74.14 111.38 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.521 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 62' ' ' ILE . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 75.22 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 55.55 111.589 -174.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.4 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 71.4 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.31 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 74.32 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 4.4 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 61.14 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 62.24 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 73.33 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 75.22 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 72.1 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 61.32 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.534 ' HB3' HG22 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 73.02 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 73.34 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 62.24 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 72.54 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 74.05 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG23 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 63.42 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 72.55 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 74.03 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 74.3 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.802 HG23 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 73.02 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 71.3 111.345 174.494 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.81 0.338 . . . . 74.11 111.609 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 75.4 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 72.41 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 71.41 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 74.34 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 74.31 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 74.03 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 73.42 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 73.41 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.4 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 75.34 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG13 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 72.12 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.537 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 64.21 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 61.34 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 74.11 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 72.05 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 74.3 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 75.35 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 73.11 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.12 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD13 HG13 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.21 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 73.05 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 73.31 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 75.34 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 74.21 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 70.31 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 72.33 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 74.42 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 65.41 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 73.12 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 74.13 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.43 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 73.31 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 65.04 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 72.24 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 HG11 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 73.21 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.491 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG22 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 72.52 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 72.2 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 51.33 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.413 HD23 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 74.52 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 75.31 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.44 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 75.33 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 71.05 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 40.23 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.413 HG23 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 75.42 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 72.41 112.319 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 73.12 111.971 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 65.14 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.559 ' HA ' HD13 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 65.3 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.41 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 73.43 111.184 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 73.52 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 74.34 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 75.22 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 62.03 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 73.24 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.908 HD21 HD12 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 64.01 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 72.42 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 72.34 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 74.42 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.51 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.552 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 108' ' ' ILE . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 42.54 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 74.22 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.508 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 75.22 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 62.03 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 75.31 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 73.14 112.555 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 71.5 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 64.54 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 75.35 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.23 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 74.25 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 73.23 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.908 HD12 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 71.1 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 75.1 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 75.11 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.495 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 73.54 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 73.03 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 74.41 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 72.53 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 75.2 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 53.25 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 71.22 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 75.32 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 65.12 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 71.52 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 71.03 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.23 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 63.25 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.454 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 74.23 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 75.0 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.735 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 75.5 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 75.25 113.761 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 73.22 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 74.21 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 75.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 73.21 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 74.45 111.13 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.971 0.415 . . . . 73.25 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.72 154.43 45.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.28 -0.418 . . . . 71.24 111.669 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.66 -26.84 13.72 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.38 2.72 . . . . 73.42 115.066 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -129.07 115.19 17.37 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.023 -0.423 . . . . 74.34 111.704 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 71.23 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 64.3 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 74.12 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 74.25 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.14 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 73.51 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 72.41 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 75.35 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 71.2 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 55.44 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 73.33 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.583 HD23 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 71.52 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 63.15 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.496 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 74.42 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 75.4 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.496 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.44 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 73.1 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.618 ' HE3' ' HE2' ' A' ' 43' ' ' MET . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.618 ' HE2' ' HE3' ' A' ' 41' ' ' MET . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 75.31 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 74.33 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 74.13 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 60.25 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD22 ' HB3' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 74.41 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 73.31 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 74.12 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 74.51 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 61.52 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.583 HD11 HD23 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 72.44 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 75.21 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 74.14 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.52 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 74.33 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 72.55 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 73.01 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 71.14 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 65.43 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 75.44 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 72.02 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 74.24 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 63.34 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 75.42 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.3 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.44 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.414 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 63.41 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.22 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.5 HG12 HG11 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.45 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.45 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.629 HD13 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 62.41 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 70.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.47 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 73.44 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.31 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 63.43 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 63.5 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.401 HG23 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 61.35 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.5 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 63.04 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.38 -27.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 74.1 111.789 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -57.67 -17.22 13.61 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.289 0.566 . . . . 61.55 110.641 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.1 m -99.81 -59.67 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.705 -0.68 . . . . 75.34 111.003 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -92.67 127.93 38.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.21 0.529 . . . . 74.34 111.755 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.9 p -123.27 151.39 62.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 116.269 -0.423 . . . . 74.41 111.625 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.43 97.46 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.527 2.151 . . . . 65.45 112.552 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.69 159.42 44.01 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.95 -0.568 . . . . 70.23 111.55 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.63 90.65 0.8 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.33 -0.462 . . . . 65.12 112.732 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.29 122.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.552 0.575 . . . . 71.44 112.552 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -168.05 121.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.092 0.557 . . . . 65.12 109.922 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -143.98 108.74 4.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.651 0.611 . . . . 75.35 112.651 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -150.76 86.4 1.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.23 0.538 . . . . 75.13 110.916 168.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -120.34 75.83 1.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.227 0.537 . . . . 75.0 110.098 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.4 t -136.6 115.84 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.908 -0.587 . . . . 74.54 111.344 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 m -101.61 125.93 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.293 -0.412 . . . . 75.43 110.794 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.0 t -110.37 101.16 9.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.002 0.371 . . . . 44.01 112.002 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -167.56 111.46 0.67 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.397 -0.365 . . . . 72.21 110.365 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.5 tp -110.88 159.66 17.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.728 -0.214 . . . . 71.14 110.819 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.98 133.56 37.66 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 122.305 -0.247 . . . . 74.43 110.807 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -138.87 69.66 1.37 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.366 0.603 . . . . 71.3 112.51 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -69.53 144.43 53.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.598 0.592 . . . . 75.25 112.598 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -145.1 179.69 7.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.016 -0.538 . . . . 71.14 110.798 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 67.88 102.56 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.61 0.596 . . . . 72.4 112.61 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -148.0 151.84 36.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.92 0.39 . . . . 71.31 111.24 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.391 0.615 . . . . 75.34 110.745 177.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 22.8 ptp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.531 0.205 . . . . 75.23 110.906 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.41 143.04 98.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 120.743 0.306 . . . . 63.43 111.741 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.8 -60.43 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.888 2.392 . . . . 72.41 112.977 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.1 110.96 21.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.373 -0.376 . . . . 55.34 110.833 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 72.13 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 71.24 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.601 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 74.15 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.528 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 74.34 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 73.31 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 64.41 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.512 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.585 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 72.25 110.815 175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 72.04 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.478 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 55.43 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 72.23 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 75.03 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 74.32 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 74.34 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 73.43 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 74.52 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.45 HD23 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 74.12 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 74.25 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.607 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 75.05 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 HD11 HD23 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 71.15 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.488 ' NZ ' ' O ' ' A' ' 82' ' ' ALA . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 75.03 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HG2' HD23 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 75.2 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 74.43 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 73.23 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 74.11 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 75.5 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.585 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 74.11 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.9 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 75.31 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.599 HH21 HG11 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 74.45 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 73.13 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 72.33 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 75.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.501 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.405 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 61.31 111.263 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 71.42 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 61.52 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 72.22 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 70.21 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 73.32 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 53.31 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 74.42 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 72.43 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 72.44 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 72.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm -85.11 -36.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 62.25 112.149 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.46 86.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 73.15 111.005 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.5 t -159.35 -58.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.652 -0.703 . . . . 74.52 111.631 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.582 ' HD3' ' H ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.6 151.71 23.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.961 0.41 . . . . 74.42 111.453 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 m -140.3 35.17 0.22 Allowed Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.25 0.833 . . . . 74.12 113.25 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 112' ' ' THR . 32.0 Cg_endo -65.03 83.99 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.247 2.631 . . . . 75.13 113.532 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.868 -0.605 . . . . 72.13 110.823 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.62 -13.73 2.7 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.74 -0.743 . . . . 72.24 113.899 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.78 116.64 15.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.098 0.449 . . . . 71.12 111.297 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -175.11 124.6 0.25 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.613 0.227 . . . . 74.11 111.613 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -166.33 146.64 6.19 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.325 0.584 . . . . 73.14 112.482 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.3 t80 179.36 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.163 -0.926 . . . . 75.13 110.047 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -133.15 11.94 4.23 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.049 -0.523 . . . . 71.12 111.666 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.9 110.87 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.001 0.429 . . . . 73.24 111.704 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.92 144.58 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.163 -0.471 . . . . 75.53 110.865 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -128.49 110.02 11.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.77 0.319 . . . . 74.31 111.766 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.99 155.73 28.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.837 0.351 . . . . 72.44 110.936 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 tp -145.83 144.45 30.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.749 0.309 . . . . 73.42 111.219 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -151.13 137.18 18.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.63 0.252 . . . . 73.11 111.622 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.34 115.21 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.989 0.423 . . . . 74.34 111.449 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -145.36 110.46 5.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.338 0.59 . . . . 73.41 111.352 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -166.44 119.96 1.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.914 -0.585 . . . . 71.22 110.607 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -146.96 21.33 1.25 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.036 0.384 . . . . 75.23 112.036 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -73.55 82.95 1.51 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.13 0.491 . . . . 72.41 110.825 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.137 0.494 . . . . 75.45 111.067 -178.101 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' HE1' ' HB2' ' A' ' 88' ' ' SER . 23.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.642 -0.133 . . . . 74.1 110.642 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -60.38 147.79 81.44 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 112.098 0.407 . . . . 70.15 112.098 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.61 -53.59 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.841 2.361 . . . . 73.54 112.206 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -121.07 118.76 30.58 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.719 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' HD13 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 70.23 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 74.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.602 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 65.1 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.1 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 75.34 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 73.35 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 75.43 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 75.01 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 73.44 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD21 HD12 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 74.12 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 72.11 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 75.32 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.42 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.469 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.61 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 73.31 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.31 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 62.25 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.54 ' HB2' HD22 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.451 ' HE2' ' HB3' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 74.14 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 75.24 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 75.43 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 72.13 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.451 ' HB3' ' HE2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 74.5 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 74.15 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 71.11 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.67 HD12 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.22 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 74.23 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 74.03 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.628 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 72.33 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 73.5 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 74.31 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HB3' HD22 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 74.41 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 65.35 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 72.41 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 72.24 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 73.4 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 58' ' ' LYS . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 60.25 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG12 HG11 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 75.22 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 72.11 111.647 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 61.31 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 70.43 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 75.21 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.801 ' HG2' HG23 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 70.24 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 73.1 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 73.24 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 65.11 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.801 HG23 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 73.31 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 110' ' ' SER . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp -70.92 -33.6 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 70.2 110.579 173.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -71.15 -5.98 35.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.486 -1.234 . . . . 63.21 111.269 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 16.4 t -67.99 -37.71 81.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.752 -0.658 . . . . 70.12 111.981 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -160.12 151.32 19.36 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.068 0.461 . . . . 74.45 111.972 -177.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.6 p -120.7 167.45 12.87 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.843 -0.617 . . . . 75.42 111.329 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 6.7 Cg_exo -75.24 -125.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.592 2.194 . . . . 73.44 111.032 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 176.47 160.62 0.35 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.992 0.368 . . . . 74.24 111.992 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 122.68 0.69 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.873 -0.68 . . . . 73.23 113.389 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.4 148.28 33.17 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.55 -0.382 . . . . 74.2 111.49 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -155.67 157.77 37.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.993 0.425 . . . . 75.4 111.622 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -131.56 139.89 49.33 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.923 0.392 . . . . 74.22 111.505 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -90.03 127.68 36.11 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.902 0.382 . . . . 72.14 111.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.78 90.75 0.6 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.017 0.437 . . . . 72.22 111.591 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.27 75.28 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.476 0.655 . . . . 71.01 112.244 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.06 104.66 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.655 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -174.44 104.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.831 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.86 113.24 1.93 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.8 0.333 . . . . 74.45 111.352 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.08 157.6 39.23 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.027 0.442 . . . . 65.52 111.882 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.28 150.01 34.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.086 0.469 . . . . 53.4 112.228 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -131.68 83.43 2.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.329 -0.396 . . . . 75.13 111.227 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -124.0 120.13 31.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.75 0.309 . . . . 75.55 111.285 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -153.86 104.24 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.473 -0.33 . . . . 71.23 111.025 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -125.73 12.64 7.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.92 0.39 . . . . 74.23 111.803 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -62.97 116.74 5.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.655 0.264 . . . . 75.22 111.375 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.987 0.422 . . . . 75.11 111.848 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.451 0.167 . . . . 75.41 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 68.07 153.33 0.13 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.097 0.559 . . . . 72.55 112.282 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.35 -54.46 2.14 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.91 2.406 . . . . 71.25 113.687 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -118.53 124.31 47.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 74.25 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.55 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' HB3' ' A' ' 6' ' ' ASP . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 72.42 110.133 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 HD13 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 75.42 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 75.14 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 70.24 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HD2' HD13 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 75.34 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 65.04 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 74.0 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 74.23 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 72.11 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.43 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 73.25 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 75.05 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 74.12 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 61.25 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.547 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 74.53 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 72.01 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.803 ' HE1' ' HB2' ' A' ' 103' ' ' PRO . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 73.43 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 53.31 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 72.3 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.718 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 75.05 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 75.21 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 71.33 113.647 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 75.14 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 72.34 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD12 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 74.34 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 73.43 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 64.34 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 75.42 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 63.44 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 74.33 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 41.03 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 75.31 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 53.13 111.36 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 126' ' ' GLU . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 70.13 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 73.13 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.633 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 60.01 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 HD12 HD13 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 74.4 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 73.04 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.58 HG11 HG11 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 61.41 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 75.33 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.75 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 64.33 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 74.43 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 73.12 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.764 ' HG2' HG23 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 73.11 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 74.0 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.803 ' HB2' ' HE1' ' A' ' 38' ' ' MET . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.42 112.693 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.764 HG23 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 73.24 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 74.13 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 108' ' ' ILE . 1.9 mp -91.83 -43.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.13 111.617 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.97 -5.39 34.56 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.4 -0.818 . . . . 64.42 112.572 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.1 t -53.35 -30.89 41.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.51 . . . . 72.33 110.869 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.599 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -149.77 106.68 3.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.359 0.6 . . . . 73.41 110.368 177.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -85.52 124.14 71.82 Favored Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 122.017 -0.427 . . . . 75.2 111.329 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -85.34 -4.53 9.39 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.612 2.208 . . . . 73.22 113.301 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -156.68 128.56 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.38 0.511 . . . . 63.31 112.38 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.86 80.9 0.71 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.255 -0.738 . . . . 72.04 111.255 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.44 24.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.019 0.748 . . . . 74.32 113.019 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.13 141.9 28.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.872 -0.603 . . . . 75.03 110.546 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -94.87 158.74 15.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.314 0.578 . . . . 73.14 112.102 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -54.35 -34.34 60.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.524 -0.762 . . . . 73.24 110.287 167.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 46.07 63.58 1.79 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.826 -1.079 . . . . 62.41 112.16 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.48 127.36 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.334 -0.394 . . . . 71.3 110.606 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.87 89.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.281 0.562 . . . . 74.22 111.043 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.5 p -71.52 -75.68 0.12 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.795 -0.639 . . . . 71.33 110.673 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 124' ' ' ARG . 1.7 tmm_? 58.42 103.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.249 0.547 . . . . 72.42 112.115 174.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 tp -115.6 6.18 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.912 0.863 . . . . 75.04 109.815 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.416 ' HG3' ' OG ' ' A' ' 73' ' ' SER . 4.4 mp0 -74.98 112.24 11.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.037 -0.983 . . . . 71.22 112.039 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -67.55 134.22 50.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.809 -0.812 . . . . 74.45 108.809 165.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -55.38 166.66 0.58 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.17 0.804 . . . . 71.02 113.17 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -47.98 145.9 2.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.793 1.034 . . . . 74.14 113.793 -170.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -93.93 -156.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.406 -0.815 . . . . 75.23 109.739 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -75.69 163.16 27.58 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.143 -0.348 . . . . 63.33 110.552 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 N--CA 1.471 0.625 0 N-CA-C 112.092 0.404 . . . . 72.33 112.092 -173.556 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.822 0.344 . . . . 75.52 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.09 154.12 86.51 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.377 -0.374 . . . . 74.4 111.498 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.61 -57.13 2.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.743 2.295 . . . . 75.33 112.849 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -104.34 130.04 52.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 72.34 111.963 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.471 ' O ' HD13 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.549 ' HB3' HG22 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG22 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 73.3 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.532 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 74.54 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 75.44 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 73.45 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 74.45 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 72.31 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 73.13 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 75.44 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.502 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 75.44 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 74.42 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 74.02 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 73.33 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 73.42 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 71.15 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 73.13 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 71.04 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 74.31 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 44.24 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.457 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 64.43 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 74.43 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.41 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.423 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 75.31 112.13 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD23 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.604 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 74.41 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 74.32 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 74.51 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 74.13 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 74.35 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.631 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 70.35 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.24 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 73.03 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 74.23 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.52 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.62 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 63.01 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 73.04 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 74.11 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.664 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 70.31 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.42 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 73.01 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 75.05 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 73.24 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.448 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 71.01 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 74.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.672 ' HB3' HG22 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 74.32 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 74.32 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 74.33 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.43 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 64.44 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 73.31 112.295 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 74.41 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 75.22 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 65.32 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 72.15 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 65.04 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 73.41 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -72.4 -30.53 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 74.4 111.736 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 98' ' ' LYS . 20.5 mm-40 -59.93 -4.95 0.83 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.891 -0.595 . . . . 73.23 112.53 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.8 t -88.33 -4.99 58.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.729 0.64 . . . . 63.53 112.729 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 151.73 41.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.213 0.53 . . . . 75.5 112.222 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.6 p -105.89 144.47 28.96 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.787 -0.642 . . . . 75.0 112.022 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.3 Cg_exo -80.52 105.55 1.74 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.03 2.487 . . . . 75.41 112.018 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.91 139.37 53.73 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.505 0.557 . . . . 65.54 112.505 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.77 88.38 1.71 Allowed Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.352 -0.385 . . . . 63.32 113.792 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.94 116.42 0.45 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.183 0.438 . . . . 64.43 112.183 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -161.11 126.16 3.64 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.836 0.351 . . . . 73.0 111.696 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.74 76.66 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.101 0.477 . . . . 72.44 110.816 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.32 30.29 2.57 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.404 0.621 . . . . 71.33 111.748 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -76.92 71.45 3.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.356 0.598 . . . . 73.01 110.816 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.57 146.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.137 -0.483 . . . . 65.35 112.088 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.6 p -116.39 127.56 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.943 0.401 . . . . 70.34 110.702 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -144.81 93.69 2.44 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.958 0.409 . . . . 61.11 111.229 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -165.47 123.81 1.61 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.556 -0.293 . . . . 74.14 110.532 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.1 tp -165.9 128.26 1.99 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -172.47 134.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.1 -0.5 . . . . 72.04 111.144 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -168.23 45.91 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 74.4 111.852 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -84.39 130.75 34.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.167 -0.333 . . . . 73.35 111.312 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.26 127.17 3.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.366 . . . . 72.12 111.611 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -148.64 159.31 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.652 -0.249 . . . . 73.22 110.972 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -153.27 81.48 1.19 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.783 0.325 . . . . 64.22 111.688 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 123.076 0.55 . . . . 73.34 111.188 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 tpp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.8 0.333 . . . . 63.25 111.291 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.75 159.29 66.66 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.452 -0.34 . . . . 74.35 111.121 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -45.9 -60.06 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.716 2.278 . . . . 75.11 113.892 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -105.49 115.96 31.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.075 -0.39 . . . . 74.05 111.704 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 73.2 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 62.43 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 74.21 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 73.14 112.093 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 73.15 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.523 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 75.34 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 73.41 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 75.13 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.588 HD21 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 61.23 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 74.23 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 74.14 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 72.54 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 74.23 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 75.04 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 71.12 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 74.44 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.446 ' HB2' HD23 ' A' ' 24' ' ' LEU . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 74.12 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 74.12 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 64.52 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 74.3 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG13 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 71.24 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 74.4 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 74.21 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 73.31 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 74.55 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.663 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 74.1 112.443 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 64.31 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG22 HD11 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 73.41 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 71.03 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 73.12 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 65.55 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 74.45 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.43 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 74.32 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 73.21 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 64.32 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 71.53 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 74.43 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD12 HD11 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 74.21 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 73.51 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.54 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 74.02 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.614 HG12 HG12 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 70.12 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 75.33 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 62.23 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 74.15 111.743 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 73.23 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 74.42 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.544 ' HG2' HG23 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 73.12 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 73.31 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.41 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 74.25 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.434 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 73.24 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.01 -23.63 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -56.65 -15.56 4.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.391 0.515 . . . . 70.2 112.391 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -95.42 6.21 49.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.604 0.594 . . . . 73.51 112.604 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.415 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 35.2 ptt180 -132.05 -170.88 2.5 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.08 -0.388 . . . . 73.4 111.944 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.61 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 6.2 m 77.01 27.01 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.238 1.57 . . . . 73.1 115.238 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 112' ' ' THR . 60.0 Cg_endo -72.85 134.74 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.831 2.354 . . . . 70.31 112.907 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -158.7 173.37 16.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.55 -0.296 . . . . 74.53 111.319 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.86 88.32 0.28 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.174 -0.536 . . . . 72.33 113.057 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.71 112.88 9.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.691 0.282 . . . . 73.31 111.143 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.09 173.62 12.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.357 0.598 . . . . 64.25 112.589 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.36 173.14 13.37 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.905 -0.589 . . . . 72.35 110.995 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -140.23 127.75 21.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.953 0.406 . . . . 75.25 111.404 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.26 93.36 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.155 0.503 . . . . 70.2 110.944 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.1 104.02 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.536 0.684 . . . . 73.53 112.013 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -154.36 111.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.442 0.639 . . . . 74.33 111.514 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.6 t -155.26 104.44 2.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.005 0.431 . . . . 65.55 110.784 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.15 123.18 21.5 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.18 0.514 . . . . 75.45 110.922 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -145.88 154.18 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.139 0.495 . . . . 74.54 111.652 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -137.25 131.26 32.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.088 -0.505 . . . . 73.23 110.826 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -126.96 115.25 18.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.073 0.463 . . . . 74.14 111.183 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.75 127.66 19.41 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.293 -0.412 . . . . 75.54 110.878 -175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -163.6 122.37 1.99 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.833 0.349 . . . . 73.23 110.972 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -149.01 26.98 0.87 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.95 0.352 . . . . 73.45 111.95 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -79.99 117.47 20.86 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.964 0.412 . . . . 52.22 111.297 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.326 0.584 . . . . 64.24 111.636 179.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.804 0.335 . . . . 74.1 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.31 152.89 96.25 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.985 0.365 . . . . 64.41 111.985 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -58.29 -27.63 81.66 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.831 2.354 . . . . 72.15 113.18 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -126.44 141.78 51.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 75.35 111.798 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.34 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 62.13 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 72.55 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 75.51 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 74.03 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 74.02 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 74.03 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.69 HD21 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 75.23 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.644 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 75.45 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.639 ' NH1' HG21 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 74.54 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 74.15 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 64.44 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.639 HG21 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 73.13 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 75.42 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 74.55 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.591 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 73.03 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.43 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 74.12 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 71.12 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.536 ' HE2' ' HE1' ' A' ' 43' ' ' MET . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.69 ' SD ' HD21 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 75.45 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.644 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.45 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.654 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 74.13 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 73.35 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 71.41 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 74.1 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 74.03 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.35 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 73.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 73.4 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 75.42 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 73.15 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 74.21 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 61.15 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.483 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 71.4 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 74.4 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 73.43 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 75.31 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 71.45 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD11 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 71.25 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 75.43 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.41 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.54 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 74.43 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 73.43 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 HG11 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.607 ' HB3' HG22 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.23 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 73.34 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.708 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.45 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.439 ' HA3' ' HB3' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 HD23 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.439 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 44.02 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 74.32 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 74.45 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 74.15 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.501 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 65.4 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.85 -40.1 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 75.22 112.34 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 66.2 mm-40 -69.48 72.2 0.33 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.659 0.743 . . . . 64.31 111.703 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -161.87 -38.61 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.343 -0.844 . . . . 75.14 109.312 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.18 83.41 1.79 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.451 -0.795 . . . . 75.11 110.566 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -109.44 145.85 32.73 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.928 -0.578 . . . . 73.42 112.513 -171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -94.86 15.5 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.4 2.733 . . . . 73.41 112.922 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.66 -178.74 2.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.895 0.702 . . . . 73.32 112.895 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.02 -148.44 20.15 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.853 -0.612 . . . . 43.2 112.307 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.75 108.0 0.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.252 0.834 . . . . 75.15 113.252 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -129.21 125.58 37.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.81 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -99.8 -174.95 2.83 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.034 0.445 . . . . 74.15 111.777 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -153.66 136.51 15.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.899 0.333 . . . . 71.31 111.899 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -79.29 110.29 14.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 110.12 -0.326 . . . . 75.3 110.12 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.8 t -80.96 -27.91 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.709 0.633 . . . . 75.02 112.709 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.09 105.14 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.836 0.351 . . . . 71.14 111.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 t -167.73 14.1 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.933 0.397 . . . . 61.24 111.966 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.3 tpt85 -126.17 122.37 35.45 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.883 0.373 . . . . 75.1 111.562 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.52 169.42 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.387 -0.37 . . . . 75.42 111.604 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.47 138.51 21.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.747 0.308 . . . . 75.42 110.846 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -161.48 89.42 0.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.952 0.405 . . . . 72.22 111.878 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -131.87 121.09 23.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.114 0.483 . . . . 73.53 112.181 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -132.32 143.83 50.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.356 -0.384 . . . . 73.31 111.472 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -113.8 -77.55 0.58 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.664 -0.244 . . . . 71.24 110.91 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 55.33 96.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.718 0.636 . . . . 74.12 112.718 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.067 0.461 . . . . 75.32 111.462 178.167 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 23.3 ttt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.479 0.18 . . . . 75.12 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.62 142.17 25.45 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 111.816 0.302 . . . . 74.32 111.816 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.88 -41.83 50.5 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.956 2.437 . . . . 74.11 112.708 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -125.19 133.63 52.69 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 64.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.556 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 73.4 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 74.41 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 70.13 110.609 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 73.33 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 74.43 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 75.33 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 74.22 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 74.11 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.456 HG23 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD22 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 75.32 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.13 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' A' ' 75' ' ' ALA . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 73.4 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 73.12 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 72.22 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.433 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 73.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.683 ' HA ' HD11 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 71.42 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 74.33 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 HD12 HG23 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 74.55 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 55.21 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.476 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 72.05 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 74.24 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.692 ' SD ' HD21 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 73.1 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 75.15 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 71.33 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.492 HD23 ' HB1' ' A' ' 75' ' ' ALA . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 75.2 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 62.25 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.602 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 74.01 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 71.04 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.31 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 73.14 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD11 HD22 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.43 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 74.14 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 71.21 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 71.21 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 74.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 72.1 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 71.14 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 74.33 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 75.34 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 75.32 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 73.12 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.45 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 75.11 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 74.43 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.43 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.507 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 75.43 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HB3' HG22 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.706 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 75.01 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 75.11 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 71.43 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 74.31 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 74.14 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HG2' HG23 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 74.13 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 64.1 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 61.32 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.635 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 74.41 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.54 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -64.04 -30.35 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.15 -6.24 1.92 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.899 -0.591 . . . . 74.23 111.997 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.3 t -111.42 6.41 20.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.173 0.434 . . . . 71.5 112.173 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.49 138.48 54.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.992 0.425 . . . . 74.11 112.02 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.6 p -131.24 150.32 76.17 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.261 -0.427 . . . . 73.54 111.17 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.24 97.15 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.55 2.167 . . . . 74.33 113.118 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.74 150.76 39.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.875 0.369 . . . . 74.52 111.701 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.2 116.27 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.432 -0.413 . . . . 73.45 113.403 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.84 39.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.92 0.391 . . . . 70.23 111.9 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -159.2 149.53 19.34 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.444 -0.344 . . . . 72.33 111.719 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -171.81 -178.39 2.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.064 0.459 . . . . 73.43 112.135 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.8 t80 60.56 53.74 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.634 -0.712 . . . . 75.4 112.072 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -75.89 -28.92 58.29 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.533 0.683 . . . . 73.53 110.197 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.65 143.25 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.419 0.896 . . . . 72.13 113.419 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.44 131.32 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.508 -0.769 . . . . 75.45 110.14 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t -139.29 105.0 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.881 0.697 . . . . 63.33 112.881 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.066 -0.516 . . . . 73.1 110.815 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.3 tp -150.26 99.23 2.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.737 0.304 . . . . 71.3 111.671 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -174.31 99.75 0.1 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 61.24 111.448 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -157.07 88.04 1.01 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.377 -0.374 . . . . 65.21 110.836 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -167.92 114.92 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.572 -0.286 . . . . 73.03 110.941 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -154.02 126.85 8.22 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.973 0.416 . . . . 74.13 111.717 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -132.36 96.9 3.97 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.273 -0.422 . . . . 74.13 111.161 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -112.08 55.77 0.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.277 0.56 . . . . 71.43 111.429 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.83 177.647 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.552 0.215 . . . . 74.24 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -80.69 153.07 73.03 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 120.642 0.258 . . . . 74.01 111.328 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.31 -43.19 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.162 1.908 . . . . 71.34 111.489 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -149.61 116.88 6.05 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 73.25 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.591 ' HB2' HG23 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.13 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 74.55 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 74.51 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 64.23 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.497 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 64.33 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 63.55 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.11 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 75.44 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 72.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.497 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 71.13 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 HG21 HD22 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 72.35 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 75.4 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 74.1 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.45 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 74.24 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 62.51 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 74.02 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 75.22 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 55.31 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 74.54 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.514 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 61.41 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.54 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 65.11 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.3 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 74.2 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.514 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 74.23 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 73.43 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 72.02 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' HD22 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.33 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.431 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 73.04 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 71.2 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 71.45 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.417 ' O ' HG21 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 74.22 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 75.4 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 65.23 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG23 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 71.25 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.539 HD13 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.555 HD11 HD13 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 73.31 111.332 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 73.13 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 72.03 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.44 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.41 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.434 HG11 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 75.43 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.54 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 75.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.54 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 72.45 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.591 HG23 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 73.52 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 45.44 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 74.33 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 72.34 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 74.13 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -69.68 -23.25 25.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 74.44 110.984 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.02 80.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.46 -0.791 . . . . 74.05 109.688 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.434 ' HB3' ' HD3' ' A' ' 111' ' ' ARG . 38.6 t 176.96 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 75.54 110.13 -169.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' HD3' ' HB3' ' A' ' 110' ' ' SER . 0.0 OUTLIER -121.08 -1.16 9.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.264 -0.425 . . . . 75.03 111.188 177.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 p 63.96 148.18 0.1 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.158 0.983 . . . . 74.34 111.52 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.51 -64.7 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.531 2.154 . . . . 61.41 113.604 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -178.05 -173.13 0.36 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.367 -0.833 . . . . 75.52 111.419 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.1 -155.92 27.99 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.193 -0.527 . . . . 72.14 112.281 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.63 147.06 32.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.004 0.43 . . . . 75.31 111.76 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -160.68 128.94 4.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.095 -0.502 . . . . 72.23 110.934 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -144.67 179.98 6.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.144 -0.48 . . . . 75.31 110.763 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.46 142.49 25.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.802 0.334 . . . . 74.13 111.19 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -64.46 108.86 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.42 0.629 . . . . 64.04 111.154 175.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.67 85.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.19 0.519 . . . . 74.42 111.304 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.7 120.69 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.881 -0.6 . . . . 75.44 111.935 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.7 t 176.09 89.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.844 -0.616 . . . . 74.11 110.436 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 124' ' ' ARG . 36.8 ttt180 -138.13 142.17 40.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.997 0.427 . . . . 73.55 112.125 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.36 95.7 2.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.157 -0.474 . . . . 74.01 110.701 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -147.45 130.46 16.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 74.52 111.564 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -146.01 14.25 1.32 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.463 0.542 . . . . 63.4 112.463 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -77.41 109.66 11.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.829 -0.544 . . . . 74.34 110.93 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -161.53 110.94 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.372 -0.376 . . . . 64.51 111.071 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.75 136.18 1.96 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.908 0.336 . . . . 70.12 111.908 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -151.05 97.35 2.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.587 0.588 . . . . 61.15 112.587 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.602 0.239 . . . . 73.43 111.123 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.461 0.172 . . . . 73.52 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.36 155.65 92.58 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.837 0.351 . . . . 75.22 111.73 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.46 -32.89 97.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.574 2.182 . . . . 73.24 112.103 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -121.85 109.61 14.86 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.794 -0.639 . . . . 75.53 111.062 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 71.14 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' HG21 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 74.34 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 75.14 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 75.41 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 74.11 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 73.4 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 75.11 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 71.04 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 70.31 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 53.52 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.522 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.53 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 73.44 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 74.43 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 61.01 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 73.32 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 74.31 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.436 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 64.35 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.465 ' HB2' HD22 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 74.35 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 72.42 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.41 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 72.21 111.143 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD12 HG13 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 74.1 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 74.14 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.2 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 41.12 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 73.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD13 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 74.22 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.694 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 74.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.694 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 73.04 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 74.12 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 72.43 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 75.34 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 74.52 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' HD22 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 52.22 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 74.4 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.606 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 63.12 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 75.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 74.15 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 55.31 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.431 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.04 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.767 ' HG2' HG23 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 61.12 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.767 HG23 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 62.21 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 64.31 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 74.02 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 74.41 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp -73.87 -32.86 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 75.54 111.637 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -71.34 -1.07 11.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.156 -0.475 . . . . 71.44 112.071 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -73.39 -19.03 61.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.792 0.664 . . . . 63.33 112.792 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -154.95 160.64 41.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.076 0.465 . . . . 72.1 112.162 -178.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -99.23 140.69 21.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 115.854 -0.612 . . . . 73.44 111.832 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.01 122.13 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.93 2.42 . . . . 75.25 113.654 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.59 131.16 2.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.949 -0.568 . . . . 70.05 110.969 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.41 117.74 0.42 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.948 -0.644 . . . . 74.4 113.456 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.13 149.87 12.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.943 0.401 . . . . 75.34 111.695 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -149.11 144.79 26.87 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.32 -0.4 . . . . 71.31 110.722 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -142.1 131.09 23.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.578 0.584 . . . . 74.03 112.578 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -169.06 85.54 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.261 0.553 . . . . 73.43 111.512 170.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -119.83 70.27 0.86 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.425 0.631 . . . . 65.35 109.495 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.4 114.81 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.853 -0.612 . . . . 74.31 111.533 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.7 130.33 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.062 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -150.78 110.87 4.12 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.793 0.294 . . . . 64.22 111.793 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -129.13 137.28 51.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.779 0.323 . . . . 75.11 110.718 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.86 110.18 13.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.734 0.302 . . . . 72.41 111.451 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.64 112.47 8.95 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.52 0.676 . . . . 75.01 112.123 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -136.2 113.05 10.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.322 -0.399 . . . . 70.23 110.345 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -143.96 102.18 3.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.791 0.329 . . . . 75.53 111.085 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -130.98 121.99 26.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.706 0.289 . . . . 74.24 110.977 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -161.51 151.43 16.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.772 0.32 . . . . 72.21 111.554 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.37 152.9 42.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.694 0.283 . . . . 73.35 111.132 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.357 0.599 . . . . 72.21 111.984 -179.215 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 41.1 tpp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.671 0.248 . . . . 74.41 111.671 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 69.42 148.0 0.12 Allowed Pre-proline 0 N--CA 1.476 0.856 0 CA-C-O 121.172 0.51 . . . . 75.31 112.267 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 11.3 Cg_endo -55.7 -37.71 95.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.639 2.226 . . . . 70.14 112.583 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -133.09 131.18 40.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.285 -0.416 . . . . 73.43 111.247 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.43 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.665 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 74.03 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 75.14 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.51 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 75.31 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 73.32 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 74.22 112.414 -176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 65.22 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 62.21 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.43 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 74.51 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.498 HD11 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.678 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 73.03 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.517 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 74.0 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 74.35 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 73.15 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 65.14 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.596 ' HA ' HD11 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 75.44 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 65.41 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 74.54 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 65.43 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.678 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 74.22 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 64.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 73.32 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.43 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD21 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 65.24 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 74.21 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 74.14 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 74.4 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 71.3 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD12 HD23 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.2 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.576 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 63.24 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.486 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 70.04 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.5 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 74.44 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 75.23 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 74.23 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 75.04 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.461 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 72.01 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 74.12 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG22 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 63.42 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 75.11 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 70.31 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 74.3 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.533 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 75.51 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.428 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 72.2 110.775 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.629 ' HB3' HG22 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 72.02 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 72.45 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 70.55 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 74.34 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 74.52 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 75.43 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 61.13 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -70.47 -23.23 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 72.24 111.597 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.36 -12.07 12.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.214 -0.448 . . . . 73.33 112.143 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -89.18 -0.4 57.42 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.256 0.465 . . . . 73.41 112.256 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -141.75 159.72 41.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.145 0.497 . . . . 71.52 111.968 -176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.2 p -97.2 132.68 25.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 74.53 111.256 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.5 Cg_exo -75.52 35.75 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.977 2.452 . . . . 63.31 113.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -179.46 154.93 0.65 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.181 0.592 . . . . 75.22 110.733 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.1 132.25 1.35 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.695 -0.764 . . . . 53.34 113.815 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.02 101.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.805 0.669 . . . . 74.44 112.805 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -172.24 127.64 0.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.683 -0.69 . . . . 74.42 110.107 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.09 129.92 12.42 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.114 0.412 . . . . 74.22 112.114 -175.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -118.42 11.14 12.91 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.312 0.577 . . . . 74.14 111.346 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.07 83.83 0.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.319 0.58 . . . . 63.33 111.288 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.97 164.39 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.092 -0.504 . . . . 73.54 111.604 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.41 143.24 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.703 0.287 . . . . 73.4 111.23 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.4 t -154.88 89.97 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.211 0.449 . . . . 74.13 112.211 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -178.28 128.84 0.13 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.855 0.36 . . . . 75.21 111.567 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.8 tp -152.99 127.84 9.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.197 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 13.2 pt-20 -159.54 -147.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.496 0.554 . . . . 72.31 112.496 -170.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 32.8 m170 87.12 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.598 1.159 . . . . 75.21 113.114 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -137.67 113.68 9.89 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.027 -0.533 . . . . 70.03 110.692 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -165.68 128.08 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.716 -0.22 . . . . 74.14 111.397 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -167.64 130.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.978 0.418 . . . . 74.51 111.713 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -162.24 113.2 1.59 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.095 0.474 . . . . 73.15 111.203 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 121.271 0.557 . . . . 71.52 111.336 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.74 0.305 . . . . 71.12 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -89.13 150.72 45.64 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 75.24 112.26 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.23 -39.36 13.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.445 2.097 . . . . 73.44 110.655 168.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -131.43 109.85 10.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.141 -0.936 . . . . 65.33 109.801 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 64.44 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.681 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 62.1 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 73.4 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 74.53 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.479 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 73.14 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 52.43 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.52 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 74.34 111.658 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.504 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 62.52 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.702 HD21 HD12 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 75.5 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' NH1' HD21 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.633 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 73.22 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 73.32 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 71.53 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 74.52 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.435 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 63.04 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.523 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.604 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 74.54 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 70.21 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.497 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 74.13 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 75.53 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.604 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 73.12 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 63.31 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.702 HD12 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 74.22 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.662 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.662 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 74.44 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 74.24 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 74.22 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 74.13 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 74.14 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.559 HD11 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 73.12 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 74.22 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 71.14 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 72.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 76' ' ' VAL . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 51.14 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.606 HD21 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 73.22 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 75.15 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 72.31 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 74.33 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 74.34 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 63.35 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 72.21 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.527 HG23 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 72.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.577 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 74.0 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 74.31 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.28 -23.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 75.1 112.274 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -53.3 -23.49 9.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 112.197 0.443 . . . . 75.21 112.197 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.2 t -58.11 -32.34 68.01 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.05 0.452 . . . . 71.42 111.303 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.32 100.63 10.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.735 -0.468 . . . . 65.23 109.735 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.0 p -87.6 118.53 69.92 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 113.055 0.761 . . . . 74.23 113.055 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.25 68.77 7.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.106 2.537 . . . . 72.44 111.69 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -91.51 0.77 57.47 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.542 0.571 . . . . 74.4 112.542 -175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.24 73.02 1.12 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.22 -0.514 . . . . 50.44 113.28 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.54 146.8 29.0 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.636 -0.331 . . . . 64.32 111.434 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.09 -169.24 1.7 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.987 0.422 . . . . 63.3 111.552 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.3 125.33 32.83 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.243 0.46 . . . . 65.35 112.243 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.436 ' O ' HG21 ' A' ' 121' ' ' VAL . 73.2 t80 -74.94 -73.71 0.23 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.984 0.421 . . . . 75.04 109.876 172.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.52 11.58 1.77 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.891 1.071 . . . . 72.04 113.891 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 119' ' ' TYR . 35.2 t -88.51 109.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.108 0.48 . . . . 70.24 110.981 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.21 39.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.1 0.476 . . . . 75.34 112.097 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 m -59.37 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.856 0.687 . . . . 71.41 112.856 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 124' ' ' ARG . 19.9 ttm-85 -151.24 105.2 3.18 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.886 -0.597 . . . . 75.12 110.475 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.9 tp -164.35 97.47 0.8 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.917 0.389 . . . . 74.03 111.619 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.8 130.98 16.42 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.386 -0.37 . . . . 63.11 111.032 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -142.79 106.11 4.59 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.433 0.531 . . . . 73.35 112.433 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -147.85 135.53 20.89 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.053 0.541 . . . . 75.32 110.228 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -145.2 149.46 34.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.89 0.376 . . . . 73.12 111.814 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -121.57 141.45 51.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.32 -0.4 . . . . 71.52 111.367 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -80.02 122.93 27.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.682 0.277 . . . . 62.14 111.029 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.01 0.433 . . . . 75.5 111.496 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 25.8 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.64 0.257 . . . . 74.31 110.821 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -81.18 145.83 57.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.767 0.317 . . . . 71.43 111.781 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.86 -32.93 93.21 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.024 2.482 . . . . 74.53 112.649 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.39 130.92 53.36 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.298 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 73.43 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 74.44 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 74.41 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 71.42 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 73.25 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' ALA . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 74.01 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' GLU . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 73.42 112.298 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 73.43 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 74.23 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.594 HD21 HD13 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 65.42 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 64.24 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.576 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 74.41 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.35 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 53.33 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' HA ' HD11 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 74.31 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 75.21 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 71.23 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 64.33 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.62 ' HE2' ' HE2' ' A' ' 43' ' ' MET . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.62 ' HE2' ' HE2' ' A' ' 41' ' ' MET . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 64.43 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 60.12 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 HG13 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 74.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 72.11 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 74.5 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 73.21 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 74.05 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD13 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 75.22 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.45 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 72.34 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 72.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 HG23 HD11 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.503 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 74.42 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.542 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 72.33 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 61.15 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.422 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.503 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 70.04 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.565 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 73.03 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 74.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 75.54 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 71.22 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 75.21 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 60.44 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 72.54 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.577 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.43 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.21 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 75.41 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 71.13 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 72.1 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 63.02 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 75.01 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 72.21 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 75.35 111.265 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' HZ3' ' CD ' ' A' ' 109' ' ' GLU . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 73.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 75.14 111.518 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 72.41 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.43 HG22 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 75.14 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -79.23 -36.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' A' ' 98' ' ' LYS . 32.7 mm-40 -72.55 36.74 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 116.037 -0.529 . . . . 74.12 111.927 176.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.5 t -157.04 19.06 0.3 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.846 0.355 . . . . 75.43 111.777 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 111' ' ' ARG . 9.9 ptp180 -153.18 173.11 15.94 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.432 0.634 . . . . 75.14 112.684 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -120.84 151.12 54.24 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 115.539 -0.755 . . . . 72.23 112.16 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 85.8 Cg_endo -82.79 -129.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 122.859 2.372 . . . . 75.53 111.804 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.446 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 57.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.885 0.698 . . . . 71.04 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -162.53 41.73 0.36 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.572 -0.823 . . . . 62.33 113.39 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -176.28 132.27 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.982 0.364 . . . . 74.4 111.982 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -167.24 117.85 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.428 -0.351 . . . . 72.2 110.075 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -90.84 -176.38 4.65 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.975 0.732 . . . . 71.44 112.975 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -141.77 141.25 33.21 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.857 -0.61 . . . . 75.34 111.106 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.13 118.22 12.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.932 0.396 . . . . 75.43 111.311 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.72 117.12 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.173 0.435 . . . . 72.12 112.173 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -166.76 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.055 -0.52 . . . . 74.35 111.339 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 99.1 p -166.35 123.59 1.36 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -177.15 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.74 -0.663 . . . . 64.44 110.11 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.1 tp -95.13 126.69 40.63 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.172 0.51 . . . . 73.05 112.127 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -120.82 138.88 53.82 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.113 -0.494 . . . . 74.53 111.227 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -167.38 96.98 0.49 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.257 0.551 . . . . 74.22 111.619 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -145.81 121.91 10.78 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.33 -0.395 . . . . 54.34 110.829 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -150.34 128.73 12.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.892 0.377 . . . . 73.34 111.692 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -160.91 136.62 8.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.253 -0.431 . . . . 74.33 110.985 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -159.29 94.7 1.2 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.045 0.45 . . . . 72.44 111.211 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.272 -0.422 . . . . 74.23 111.01 -179.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.486 0.184 . . . . 75.04 110.705 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.16 144.7 82.55 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 120.5 0.191 . . . . 72.0 111.247 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.36 -45.78 17.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.262 1.974 . . . . 71.41 112.303 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.84 122.15 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 71.5 111.386 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 65.22 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.528 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 64.1 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 74.03 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 74.21 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 74.14 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 73.24 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 72.11 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 74.43 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.481 HG22 HD23 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 72.53 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 74.25 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 72.24 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 74.22 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 71.42 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.571 ' HB2' HD21 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 75.34 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.546 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 74.44 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.42 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 75.02 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 75' ' ' ALA . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 73.14 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 72.44 111.795 -175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 74.41 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 72.5 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 63.35 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 72.33 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 64.52 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 74.21 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 73.51 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 73.41 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 75.53 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 71.44 111.412 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 75.25 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.663 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG23 ' HB ' ' A' ' 64' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.24 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.663 HD13 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 73.24 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.404 HD11 HG22 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 73.22 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 72.02 112.085 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 75.13 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 74.13 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.421 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.414 HG12 HG11 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 71.02 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 74.4 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 75.11 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.468 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 74.23 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.13 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 73.25 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 74.31 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 73.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 62.33 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 73.21 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.14 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.11 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.36 -29.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 73.1 111.649 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.42 -15.98 8.13 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.295 0.569 . . . . 72.43 111.209 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 m -105.7 3.45 29.0 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 73.4 112.664 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 111' ' ' ARG . 43.5 mtp-105 -96.64 128.97 44.08 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.414 0.524 . . . . 64.13 112.414 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 121.14 56.26 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 116.126 -0.488 . . . . 73.14 112.03 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.45 107.32 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.955 2.437 . . . . 63.11 112.127 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.53 145.14 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.058 0.456 . . . . 74.54 112.19 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -106.34 -158.26 21.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.202 -0.523 . . . . 71.03 112.868 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.42 -156.78 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.41 0.284 . . . . 75.04 111.585 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.54 ' HB3' HD22 ' A' ' 120' ' ' ASN . 2.5 m-20 -54.52 160.17 1.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.34 112.501 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -99.4 -157.6 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.995 -0.548 . . . . 75.41 111.426 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.45 -38.08 68.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.201 0.445 . . . . 72.1 112.201 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.54 HD22 ' HB3' ' A' ' 117' ' ' ASP . 48.3 m-80 60.19 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.09 0.556 . . . . 73.03 111.657 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.8 t 55.05 103.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.441 0.696 . . . . 74.21 112.419 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.82 -42.39 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.853 -0.612 . . . . 75.34 112.283 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 t 59.74 -166.09 0.19 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.375 0.27 . . . . 75.53 111.384 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 66.06 -177.32 0.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.399 0.518 . . . . 74.1 112.399 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.404 ' HG ' ' CE1' ' A' ' 127' ' ' HIS . 20.1 tp 59.22 33.5 22.7 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.456 0.646 . . . . 74.11 111.836 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.08 -22.12 64.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.789 0.663 . . . . 74.12 112.789 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.404 ' CE1' ' HG ' ' A' ' 125' ' ' LEU . 40.5 m80 67.05 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.793 1.035 . . . . 73.33 113.793 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.93 113.82 8.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.575 -0.739 . . . . 63.22 109.724 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -63.81 -44.36 93.51 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.54 0.571 . . . . 74.24 112.54 -173.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 65.06 148.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.296 0.85 . . . . 64.33 113.296 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -177.89 -59.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.912 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 122.712 0.405 . . . . 74.14 111.213 -173.789 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 13.0 tmm? . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.156 -0.313 . . . . 74.24 110.156 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.47 148.66 98.16 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 112.522 0.564 . . . . 75.24 112.522 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.56 -26.16 21.58 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.443 2.762 . . . . 74.44 113.848 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.786 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -131.6 173.27 11.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 173.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 74.02 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 75.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 75.2 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.595 HG23 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 72.21 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 75.43 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.731 HD23 HD12 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 73.44 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HD11 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 65.32 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' NH1' HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 75.13 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 74.35 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 63.12 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 75.1 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.24 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 72.02 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.41 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 64.41 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.647 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 74.21 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 75.02 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 63.01 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 74.14 111.99 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.582 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 72.51 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 73.11 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 54.34 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 71.24 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 75.14 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.731 HD12 HD23 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 74.4 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 56' ' ' LEU . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 72.35 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 75.33 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 64.04 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 74.22 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 72.33 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 72.12 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 73.42 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 74.35 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 75.4 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.54 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 75.25 111.796 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.53 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 75.23 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.603 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 62.41 111.604 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.786 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.704 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 71.13 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 62.01 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.466 HD22 ' NH1' ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 74.21 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 73.11 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 44.13 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.463 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 73.33 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.511 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 74.11 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -54.02 -34.49 60.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.667 -0.697 . . . . 71.01 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.7 m -61.41 -35.12 76.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.654 -0.703 . . . . 74.21 112.364 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -105.39 135.76 46.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.356 0.598 . . . . 73.35 111.526 -175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -130.68 141.18 41.04 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 112.037 0.384 . . . . 74.42 112.037 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.34 136.35 23.97 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.839 2.359 . . . . 64.53 112.305 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.42 160.91 26.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.965 0.412 . . . . 73.44 111.605 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.06 37.07 6.1 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.26 -0.495 . . . . 63.25 113.108 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.15 123.14 36.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.857 0.361 . . . . 61.12 110.996 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -149.2 163.96 36.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.624 -0.262 . . . . 64.43 110.954 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -161.25 161.06 30.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.778 0.323 . . . . 74.34 111.245 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -152.92 135.6 15.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 73.22 111.439 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.39 94.24 0.71 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.319 -0.4 . . . . 62.21 110.964 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.92 67.1 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.745 0.783 . . . . 70.24 112.15 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.54 109.52 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.328 0.585 . . . . 72.35 111.386 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.4 t -159.7 105.13 1.6 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.293 -0.412 . . . . 72.13 111.429 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -159.66 116.18 2.55 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.361 -0.381 . . . . 75.11 110.844 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.546 ' O ' HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -142.46 138.89 31.35 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.712 0.292 . . . . 75.15 111.479 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.0 119.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.772 0.656 . . . . 75.4 112.772 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -163.46 98.98 0.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.693 -0.685 . . . . 74.42 110.354 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -134.4 34.21 3.26 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.105 -0.498 . . . . 73.44 112.148 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -110.52 88.03 2.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.204 0.526 . . . . 63.2 110.3 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -165.37 95.29 0.65 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.986 -0.552 . . . . 73.4 110.614 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -158.92 100.61 1.58 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.908 0.385 . . . . 74.23 111.043 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.738 0.78 . . . . 71.24 110.702 -178.787 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.526 -0.175 . . . . 75.41 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.83 149.99 54.74 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.341 0.256 . . . . 71.53 111.235 -177.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.47 -55.41 4.11 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.088 2.525 . . . . 74.22 113.45 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -121.7 118.2 28.53 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.473 -0.331 . . . . 75.22 110.21 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 64.53 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.436 ' HA ' HD11 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 74.32 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 74.32 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 74.03 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 64.12 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.514 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 74.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.32 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.514 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 72.22 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.659 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 73.31 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 73.15 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.54 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 74.22 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 74.21 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.528 HG22 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 72.53 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 75.42 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 75.42 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 75.21 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 75.31 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 72.33 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 70.34 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.659 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 74.45 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.52 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 55.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 72.03 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 70.21 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.622 HD11 HD23 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 74.23 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 74.13 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 74.21 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 73.41 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 70.35 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 72.42 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.652 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 75.03 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.3 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.572 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 71.4 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 73.23 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 64.13 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 74.35 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 74.15 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 74.3 111.653 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.466 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 71.02 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 74.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 61.13 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.32 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 HD11 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 75.41 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.557 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 64.12 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 72.03 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 72.11 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -74.31 -33.95 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 74.01 111.506 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.573 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 33.9 mm-40 -58.39 -27.25 64.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.683 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.1 m -63.5 -49.36 73.87 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.044 0.45 . . . . 45.43 110.784 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 2.1 ppt_? -168.32 130.18 1.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.726 -0.67 . . . . 71.53 111.236 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 p -78.63 161.97 67.39 Favored Pre-proline 0 N--CA 1.474 0.76 0 N-CA-C 112.787 0.662 . . . . 70.42 112.787 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.64 -140.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.724 2.282 . . . . 74.22 111.381 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 175.8 -174.75 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.801 0.334 . . . . 75.25 111.739 -172.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.37 111.67 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.036 -0.602 . . . . 73.53 113.502 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.08 99.94 0.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.264 0.226 . . . . 71.04 111.548 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.85 122.24 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.072 0.463 . . . . 72.3 111.505 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.29 168.02 25.28 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.092 -0.504 . . . . 75.03 110.984 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -130.56 142.59 50.47 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.98 0.419 . . . . 74.54 111.402 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.49 100.42 11.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 74.43 110.959 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.0 t -85.59 -30.27 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.162 -0.472 . . . . 74.14 111.992 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 m -62.74 84.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.734 0.778 . . . . 74.4 112.808 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 t -137.22 77.46 1.64 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.57 -0.741 . . . . 63.22 109.747 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -171.15 118.64 0.48 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.241 -0.89 . . . . 73.31 109.21 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.5 tp -128.8 131.01 47.75 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.05 0.759 . . . . 72.43 113.05 -171.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -132.29 138.68 47.94 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.647 -0.706 . . . . 74.52 110.338 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -167.4 102.43 0.51 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.147 0.499 . . . . 73.44 111.228 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -151.64 109.77 3.72 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.87 0.367 . . . . 73.15 110.667 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -148.01 162.6 39.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.967 0.358 . . . . 74.45 111.967 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.2 89.43 0.78 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.095 0.474 . . . . 74.31 112.019 177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -141.57 156.05 45.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.419 -0.355 . . . . 74.22 111.336 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.209 0.528 . . . . 73.11 111.714 178.049 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ppp? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.003 0.43 . . . . 70.32 110.632 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 88' ' ' SER . 6.4 mp0 -72.03 146.54 90.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.192 -0.458 . . . . 73.31 111.867 -172.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.64 -24.27 78.04 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.672 2.248 . . . . 75.42 112.03 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.54 120.17 5.15 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.112 -0.949 . . . . 74.22 110.492 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 60.13 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' HB2' HG21 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 73.32 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 62.23 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 70.31 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 73.41 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 74.23 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 73.12 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.33 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.452 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 75.12 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 62.45 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 75.22 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 70.14 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.628 HD21 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.467 ' HB2' ' HH ' ' A' ' 65' ' ' TYR . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 74.2 110.623 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.495 HG11 HD12 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 74.44 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.575 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 64.34 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 60.25 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 74.14 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.556 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.474 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.737 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.495 HD12 HG11 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.34 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.737 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 71.32 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 75.33 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 73.51 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 74.24 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 73.13 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.484 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 73.3 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 70.3 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.8 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.608 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 HG11 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 74.24 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 75.51 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 73.43 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 70.34 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 52.01 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 70.44 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 72.51 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.52 HG11 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HZ1' ' CG ' ' A' ' 69' ' ' ASP . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 73.12 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 74.13 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG21 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 70.14 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 74.33 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 74.45 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 74.31 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 74.1 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 65.23 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 74.22 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 75.31 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 54.02 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 72.4 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -33.79 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -60.8 -18.79 57.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.73 -0.668 . . . . 74.43 111.137 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 51.3 m -76.09 -24.54 55.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.199 -0.455 . . . . 62.52 111.441 175.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -157.07 58.51 0.52 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.388 0.613 . . . . 73.14 111.475 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.5 p -53.33 147.99 17.66 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 112.512 0.56 . . . . 74.55 112.512 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.97 -25.07 80.87 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.582 2.188 . . . . 75.22 113.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 52.96 38.23 26.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.618 . . . . 73.13 112.536 175.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.05 -175.49 40.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.18 -0.533 . . . . 74.45 113.1 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -175.59 125.33 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 122.63 0.372 . . . . 53.42 111.42 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -108.29 151.56 25.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.956 0.408 . . . . 72.33 111.722 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.98 176.55 6.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.838 0.351 . . . . 75.21 111.563 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -105.82 -83.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.223 -0.298 . . . . 75.45 111.184 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.8 m120 67.05 -7.68 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.859 1.059 . . . . 75.53 113.859 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.49 132.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 121.996 -0.44 . . . . 74.35 111.729 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.96 144.05 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.472 0.545 . . . . 72.41 112.472 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.6 m -155.41 136.76 14.02 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.249 -0.432 . . . . 65.12 111.278 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -169.41 128.98 1.02 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.67 0.272 . . . . 74.34 110.918 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 126' ' ' GLU . 3.0 tm? -158.4 139.2 12.9 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.189 -0.319 . . . . 75.43 111.334 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 125' ' ' LEU . 7.2 tp10 -165.74 122.06 1.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.566 0.58 . . . . 75.14 112.566 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -169.09 112.78 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.93 0.395 . . . . 74.41 111.647 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -148.62 143.91 26.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.655 0.613 . . . . 73.54 112.655 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -159.41 121.71 3.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 74.4 110.581 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -80.12 -12.46 59.66 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.744 0.275 . . . . 74.53 111.744 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 18.7 t60 74.58 -34.02 0.26 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.958 1.095 . . . . 74.31 113.958 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.037 0.446 . . . . 72.3 112.177 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 25.3 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.397 0.147 . . . . 73.53 111.397 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 1' ' ' MET . 45.3 mm-40 67.45 145.33 0.1 Allowed Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 121.328 0.585 . . . . 73.42 112.269 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 39.8 Cg_endo -69.22 -38.7 8.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.567 2.178 . . . . 75.14 111.809 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -131.82 109.32 10.03 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.752 -0.658 . . . . 75.21 111.117 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 74.14 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.504 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 71.11 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 74.02 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 74.33 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 75.2 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 74.31 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 71.43 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.42 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 73.03 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 74.41 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 HD21 HD12 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 70.21 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 73.41 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 64.42 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.51 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 65.31 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 74.3 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 71.44 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 75.51 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.46 ' HG2' HD13 ' A' ' 48' ' ' LEU . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 70.02 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 73.12 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 75.5 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 71.24 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD13 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' HB1' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 74.51 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.439 ' HB1' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 73.11 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 72.0 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD12 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.521 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 74.14 111.38 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.521 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.437 ' O ' HG13 ' A' ' 62' ' ' ILE . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 75.22 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 55.55 111.589 -174.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.4 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 71.4 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.31 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 74.32 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 4.4 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 61.14 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 62.24 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 73.33 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 75.22 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 72.1 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 61.32 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' HB3' HG22 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 73.02 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 73.34 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 62.24 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 72.54 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 74.05 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG23 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 63.42 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 72.55 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 74.03 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 74.3 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.802 HG23 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 73.02 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.95 -35.19 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 71.3 111.345 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 64.0 mm-40 -78.2 65.02 3.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.484 0.659 . . . . 73.4 110.357 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.1 t -179.9 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.545 -0.752 . . . . 73.4 111.298 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -75.93 172.14 13.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.202 0.525 . . . . 74.42 112.393 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.4 p -84.82 129.98 54.55 Favored Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.386 0.884 . . . . 62.43 113.386 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -96.32 115.13 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.321 2.68 . . . . 73.44 113.333 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 72.33 172.7 0.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.648 0.981 . . . . 74.23 113.648 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.21 -137.38 2.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.714 -0.676 . . . . 50.12 113.036 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.8 101.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.341 0.571 . . . . 71.42 112.205 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -133.4 129.78 37.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.315 -0.241 . . . . 71.53 111.251 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.69 169.19 24.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.331 0.586 . . . . 75.01 111.862 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 121' ' ' VAL . 34.3 t80 -108.98 -58.99 1.95 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.908 -0.587 . . . . 73.52 110.66 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.3 -71.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.57 0.748 . . . . 74.51 112.807 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -30.75 105.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.746 1.218 . . . . 73.53 113.913 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.13 130.37 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.933 -0.576 . . . . 65.11 111.357 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -144.52 131.77 20.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.048 0.452 . . . . 64.12 112.021 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -158.65 -71.18 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.101 -0.5 . . . . 75.35 110.214 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 tt 46.34 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.859 0.864 . . . . 74.12 113.058 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.46 133.43 52.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.09 -0.381 . . . . 44.24 110.181 171.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -153.61 93.51 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.067 0.461 . . . . 71.31 112.089 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -147.39 120.42 8.81 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.838 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -163.7 125.61 2.43 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.04 0.448 . . . . 74.23 111.417 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -98.1 -102.66 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.627 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -150.67 156.22 40.91 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.921 -0.487 . . . . 75.44 111.852 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.216 0.531 . . . . 75.01 110.897 176.072 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.688 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 18.4 tmm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.561 0.219 . . . . 74.02 110.618 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.517 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 11.1 pt-20 -89.91 159.14 43.57 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 112.652 0.612 . . . . 72.42 112.652 -171.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 11.1 Cg_endo -56.22 -37.54 96.5 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.224 2.616 . . . . 73.2 113.543 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.58 99.32 6.12 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.334 -0.394 . . . . 74.11 111.609 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 75.4 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 72.41 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 71.41 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD11 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 74.34 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 74.31 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 74.03 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.55 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 73.42 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 73.41 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.4 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 75.34 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.643 HD23 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG13 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 72.12 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.537 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 64.21 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.416 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 61.34 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 74.11 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 72.05 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 74.3 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 75.35 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 73.11 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.643 ' SD ' HD23 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.12 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD13 HG13 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.21 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.492 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 73.05 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 73.31 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 60' ' ' ARG . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.491 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 75.34 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 74.21 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 70.31 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 72.33 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 74.42 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 65.41 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 73.12 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG22 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 74.13 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.43 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 73.31 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 65.04 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 72.24 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG12 HG11 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 73.21 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.688 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG22 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 72.52 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 72.2 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 51.33 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.413 HD23 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 74.52 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.517 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 75.31 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.44 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 75.33 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 71.05 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 40.23 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.413 HG23 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 75.42 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 34' ' ' ASP . 1.7 mp -67.4 -40.02 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 72.41 112.319 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.78 -14.06 19.09 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 74.35 111.029 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -102.48 1.18 34.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.055 -0.52 . . . . 53.13 111.737 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' A' ' 108' ' ' ILE . 12.7 mmm180 -87.25 142.66 27.73 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.154 0.502 . . . . 74.22 111.956 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 54.7 p -95.05 142.34 24.47 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.846 -0.615 . . . . 70.33 111.499 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 16.5 Cg_exo -68.42 -75.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.042 2.495 . . . . 72.3 113.514 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 63.11 -171.3 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.929 -0.578 . . . . 70.33 112.294 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.78 108.1 3.27 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.887 -0.673 . . . . 72.51 113.454 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.01 143.54 2.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.616 0.367 . . . . 73.32 111.119 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -158.11 121.87 4.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.625 0.726 . . . . 75.54 111.818 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.78 153.07 50.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 74.22 110.847 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -151.5 145.0 24.87 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.786 0.327 . . . . 71.4 111.845 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.01 80.15 0.66 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.353 0.597 . . . . 74.24 110.978 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.28 -16.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 75.04 112.377 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.33 103.05 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.992 0.425 . . . . 73.5 111.428 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.4 t -132.83 109.5 9.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.314 -0.403 . . . . 73.54 110.799 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.61 123.88 5.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.725 0.298 . . . . 72.45 110.423 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.5 125.63 7.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.663 0.268 . . . . 74.41 111.663 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -153.0 144.65 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.926 0.393 . . . . 70.24 111.187 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.99 29.99 1.18 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.787 0.327 . . . . 71.41 111.804 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.96 114.42 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.891 0.377 . . . . 73.3 111.791 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -142.43 118.17 10.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.032 -0.531 . . . . 75.54 110.026 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -127.0 100.73 6.26 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.131 0.419 . . . . 74.33 112.131 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -155.4 135.43 12.93 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.567 0.347 . . . . 54.22 111.836 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.3 m80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.012 0.434 . . . . 73.31 111.184 173.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.637 0.256 . . . . 74.33 110.77 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.58 155.06 89.89 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.487 -0.324 . . . . 75.14 111.573 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.39 -20.58 54.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.585 2.19 . . . . 70.45 112.654 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.32 124.79 35.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 73.12 111.971 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 65.14 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.735 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.559 ' HA ' HD13 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 65.3 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.41 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HZ3' ' CD ' ' A' ' 15' ' ' GLU . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 73.43 111.184 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 73.52 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 74.34 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 75.22 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 62.03 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.529 HG23 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 73.24 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.908 HD21 HD12 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 64.01 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 72.42 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 72.34 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 74.42 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.51 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.552 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' HB2' HG21 ' A' ' 108' ' ' ILE . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 42.54 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 74.22 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.508 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 75.22 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 62.03 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 75.31 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 73.14 112.555 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 71.5 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 64.54 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 75.35 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.23 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 74.25 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 73.23 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.908 HD12 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 71.1 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 75.1 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 75.11 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.495 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 73.54 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 73.03 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 74.41 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 72.53 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 75.2 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 53.25 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 71.22 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 75.32 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 65.12 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.606 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 71.52 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 71.03 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.23 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 63.25 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.454 ' HB1' HG11 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 74.23 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.513 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 75.0 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.735 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 75.5 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 75.25 113.761 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 73.22 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 74.21 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.411 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 75.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 73.21 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.569 HG21 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp -70.73 -28.92 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 74.45 111.13 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.89 78.35 0.63 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.488 -1.233 . . . . 74.25 110.67 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.3 t -176.54 -38.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.041 -0.981 . . . . 60.01 110.596 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 2.5 mpt_? -86.11 120.29 27.33 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.167 -0.47 . . . . 75.44 111.635 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 3.3 t -88.01 130.52 46.08 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-O 120.838 0.351 . . . . 75.05 111.878 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 3.0 Cg_exo -75.64 98.5 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.811 2.341 . . . . 75.04 112.339 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.74 108.81 13.96 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.986 0.422 . . . . 74.43 111.939 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.31 109.02 0.22 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.261 -0.495 . . . . 72.22 112.913 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.8 158.6 9.1 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.877 0.37 . . . . 75.14 111.676 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -135.47 -169.85 2.48 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.768 0.318 . . . . 71.42 111.419 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.29 159.35 44.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.864 0.69 . . . . 74.34 112.864 -173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -161.97 97.1 1.03 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.973 -0.558 . . . . 73.34 111.455 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.452 HD21 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -158.04 22.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 73.11 111.401 174.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -90.23 129.33 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.723 0.638 . . . . 75.11 112.723 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.5 t 59.64 104.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 113.786 1.032 . . . . 74.53 113.786 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 t -161.12 99.26 1.2 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.987 -0.551 . . . . 64.21 110.894 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -148.6 146.09 28.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.825 0.345 . . . . 75.1 111.181 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -149.94 131.64 14.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.435 -0.348 . . . . 74.14 110.434 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.53 141.86 19.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.849 0.357 . . . . 74.41 111.352 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -165.75 112.5 0.91 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.003 0.43 . . . . 71.42 112.007 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.88 146.5 45.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 53.11 111.292 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.38 99.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.219 0.533 . . . . 74.4 111.924 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -139.62 103.59 4.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.103 0.477 . . . . 75.23 111.16 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -129.97 96.04 4.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 75.31 110.512 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.238 0.461 0 CA-C-N 116.255 -0.429 . . . . 74.45 110.991 -176.631 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.742 0.306 . . . . 72.55 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 63.32 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 62.32 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 72.53 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.03 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 70.45 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 62.42 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 71.21 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 62.31 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 42.14 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 65.12 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD21 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 64.34 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG11 ' HB1' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 51.12 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.505 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 72.11 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 74.15 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.32 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 71.13 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.583 ' SD ' HD22 ' A' ' 24' ' ' LEU . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 53.11 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 63.02 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 73.2 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 44.34 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD22 ' HB1' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 71.34 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 72.0 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 52.44 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 64.31 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 55.43 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD11 HD21 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 71.31 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 70.32 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 55.51 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.14 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 73.44 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 64.34 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 71.22 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 64.04 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 54.51 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 52.13 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 64.54 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 72.15 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG13 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 62.2 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 71.11 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.01 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.31 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 51.43 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.436 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.14 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.01 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.11 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 61.05 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 30.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 60.35 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.13 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 61.04 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 62.11 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 54.22 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.32 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 51.52 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 71.24 111.789 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 120.801 0.334 . . . . 55.34 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 90' ' ' LEU . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 71.42 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 65.45 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.597 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 71.21 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.549 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 42.33 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 72.3 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 54.22 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HE ' ' HB2' ' A' ' 29' ' ' ARG . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 65.44 110.815 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.435 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 71.12 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 53.55 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 54.11 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 65.12 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 62.2 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 71.25 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.634 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 64.41 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 73.44 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 65.32 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 73.54 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 74.22 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 70.2 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 74.43 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG2' HD22 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 72.42 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 73.44 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 52.4 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 54.0 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 71.23 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 73.45 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 20.3 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.66 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 70.53 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.625 HH21 HG12 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 72.43 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 54.4 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 63.34 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 74.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 45.31 111.263 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 65.15 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 54.45 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 65.03 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 63.13 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 61.12 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 14.53 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 63.41 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 71.52 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 65.34 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 71.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 61.25 112.149 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.966 0.413 . . . . 74.42 111.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 42.01 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 64.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 64.02 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.05 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 70.23 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 70.33 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 60.42 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 63.3 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 72.14 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 42.3 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 62.13 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 71.51 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.14 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 72.45 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.2 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 61.32 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HD23 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 73.32 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 74.3 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 74.21 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 82' ' ' ALA . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 71.33 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 42.51 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 65.12 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 70.3 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.701 HD11 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.13 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 71.44 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 72.31 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.683 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 71.13 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 72.42 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 65.41 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HB3' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 72.12 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 41.02 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 61.01 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 52.33 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 71.31 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 52' ' ' ALA . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 55.51 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 71.24 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 70.3 111.647 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 51.13 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 64.13 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 64.31 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.81 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 60.43 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 72.01 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 60.0 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.6 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 42.52 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.81 HG21 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 62.41 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.552 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 65.54 110.579 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 73.01 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.0 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 62.24 110.133 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 61.0 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 74.31 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 63.45 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HD2' HD12 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 73.24 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 54.35 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 70.4 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 71.43 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 71.51 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.24 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 70.44 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 71.01 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG11 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 73.02 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 51.42 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.544 HG22 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 72.32 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 63.13 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.454 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 70.53 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 44.34 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 71.41 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.74 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 54.43 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 73.24 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 43' ' ' MET . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 70.41 113.647 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 53.33 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.571 HD11 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 64.13 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 70.35 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 45.31 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 73.22 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 34.24 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 62.41 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 25.33 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.579 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 74.23 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 50.34 111.36 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 44.21 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 64.34 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 51.34 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 63.11 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 53.0 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 41.23 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 72.02 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 54.54 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 64.3 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 71.33 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.782 ' HG2' HG21 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 64.02 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 64.2 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.11 112.693 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.782 HG21 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 72.21 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 64.24 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 108' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.0 111.617 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 64.5 111.963 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 61.33 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 70.45 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 61.03 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 72.01 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 60.44 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 70.15 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 72.33 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 73.45 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 71.31 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 73.13 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 54.53 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 71.32 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 71.24 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.483 ' HA ' HD13 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 63.31 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 34.12 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 62.34 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 42.24 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 43.14 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.464 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 64.11 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.03 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.43 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 64.11 112.13 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 73.4 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 73.33 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 63.05 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 73.34 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 61.5 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.704 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 60' ' ' ARG . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 61.22 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.14 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 72.11 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 52.43 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.12 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 52.43 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 72.32 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 53.15 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.31 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 53.42 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 74.34 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 64.31 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 61.33 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 62.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.704 ' HB3' HG21 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 71.11 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 70.14 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 62.45 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 63.34 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 65.53 112.295 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 65.01 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 71.1 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 63.45 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 64.35 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 60.1 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 63.35 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 71.52 111.736 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.837 0.351 . . . . 74.05 111.704 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 64.02 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 60.04 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 63.54 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 102' ' ' GLY . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 71.43 112.093 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 53.4 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 73.3 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 72.34 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 73.32 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.594 HD22 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 42.24 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 71.43 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 72.44 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 71.15 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 54.54 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 72.13 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 61.1 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 72.02 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.459 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 50.01 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.664 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 71.21 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 60.22 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 65.31 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.532 HD13 HG12 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 54.22 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 65.55 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 44.55 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 65.04 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.724 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 65.15 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 63.4 112.443 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 63.33 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 71.42 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 70.21 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 62.23 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 63.44 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 71.44 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.42 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 51.42 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 45.43 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 60.14 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG13 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 70.13 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 73.13 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 53.24 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 64.33 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.22 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 44.44 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 64.24 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 74.11 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 13.0 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD22 HH12 ' A' ' 27' ' ' ARG . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 73.04 111.743 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 55.2 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 70.53 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 64.5 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 61.22 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 11' ' ' LYS . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.13 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 73.31 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 64.03 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 63.5 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.31 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 40.22 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 55.31 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 74.02 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 63.41 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 70.24 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 60.22 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 63.34 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 73.11 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.663 ' NH1' HG22 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 71.5 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 63.12 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 63.32 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.663 HG22 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 71.14 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 74.55 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 72.12 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 72.52 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.34 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 71.2 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 54.24 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 53.14 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.1 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 64.4 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 61.05 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 60.21 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 22' ' ' THR . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 52.32 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 70.12 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.32 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 53.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 63.03 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 72.34 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 62.51 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 65.04 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 60.24 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 62.34 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 73.3 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 72.13 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 71.43 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 44.03 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 61.44 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 73.13 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.3 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 73.11 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 71.41 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.05 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 63.11 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.24 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 33.0 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 73.34 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 63.31 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 60.41 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 52.1 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 63.55 112.34 176.189 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 42.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 63.55 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 61.53 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 90' ' ' LEU . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 62.11 110.609 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 61.04 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 73.2 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 73.04 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 65.43 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 61.2 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.586 HG21 HD21 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 54.41 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.1 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 48' ' ' LEU . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 53.23 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 55.35 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 65.41 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 72.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.654 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 64.53 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 63.11 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 72.13 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 25.01 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 55.33 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 71.11 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 72.35 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 72.01 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 63.4 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 71.52 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 26' ' ' VAL . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 73.43 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 53.15 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 72.45 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 64.14 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.03 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 71.02 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.32 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 64.42 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 61.55 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 70.43 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 45.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 64.23 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 65.33 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 73.52 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 74.24 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 72.42 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 72.54 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.23 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 74.3 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 44.24 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.02 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 33.13 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.666 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 60.31 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 73.14 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 54.51 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 73.01 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 73.23 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HG2' HG21 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 43.33 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 54.52 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 54.23 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 43.13 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.452 HG21 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 54.34 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.24 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 71.51 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.0 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 62.34 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 65.24 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 63.34 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 63.44 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 60.42 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.02 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 71.21 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 54.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 65.4 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.45 HG21 HD21 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 71.11 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 74.33 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 64.11 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.41 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 61.44 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 32.52 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 63.23 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 63.55 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 54.33 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 54.0 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.545 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 44.22 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.03 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 61.42 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.03 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 62.52 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 72.33 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 71.12 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.608 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 71.43 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 65.23 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 72' ' ' THR . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' HB3' HD23 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.32 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 61.4 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 64.24 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 64.44 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 52.01 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 70.51 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 52.24 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 55.14 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 64.31 111.332 176.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 51.12 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 61.21 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.42 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.02 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 71.01 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.51 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 65.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.31 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 63.12 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 70.03 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 44.24 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 73.53 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 71.23 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 44.12 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 61.42 110.984 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.964 0.411 . . . . 63.34 111.062 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 65.34 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 72.12 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 64.43 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 72.11 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 72.53 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 71.13 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 71.1 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 32.31 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 65.24 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.677 HD22 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HD13 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 51.32 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.2 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 70.31 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 73.24 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.488 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 60.54 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 71.43 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 73.51 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.747 ' HA ' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 60.21 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.49 ' HB2' HD23 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.677 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 64.23 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 70.13 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 54.12 111.143 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 52.24 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 70.31 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.05 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 34.14 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 71.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 54.24 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.742 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 62.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.742 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 60.12 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 71.01 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 70.14 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 73.12 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 64.31 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 44.25 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 17.8 m80 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 44.22 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 34.32 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 64.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 72.23 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.459 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 15.21 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.427 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.01 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG21 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 54.41 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.802 HG21 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 60.23 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 62.43 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 71.34 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 44.14 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 73.21 111.637 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 51.22 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.411 ' O ' HD12 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.33 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.689 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 72.13 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 71.32 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.1 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 73.32 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 63.21 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.534 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 73.33 112.414 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 61.11 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 55.52 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 61.54 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 72.32 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 53.41 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 72.43 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 72.04 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 63.23 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' HA ' HD13 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.462 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 54.31 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 64.42 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 62.01 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 72.53 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 51.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 72.41 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.34 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.494 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD22 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 64.4 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 63.14 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 73.03 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 64.32 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 44.04 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.03 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.637 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 53.51 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 61.3 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.34 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 73.43 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 72.31 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 61.03 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 74.43 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 54.5 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 72.21 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 61.55 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 64.5 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 63.12 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 63.24 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 64.53 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG12 HG13 ' A' ' 76' ' ' VAL . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 41.45 110.775 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 62.23 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 65.12 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 62.22 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 52.24 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 72.4 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 12.51 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 62.44 111.597 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.801 -0.444 . . . . 62.21 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 62.33 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 52.14 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 54.22 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 70.55 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.492 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 72.02 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 31.15 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.34 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 56' ' ' LEU . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 64.42 111.658 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 40.54 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.716 HD21 HD11 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 64.22 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.615 ' NH1' HD22 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.648 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 54.34 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 63.12 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 64.4 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 42.12 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 53.44 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.537 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 63.53 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 61.4 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 73.45 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 65.32 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 64.14 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 62.02 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 63.52 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.692 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 73.03 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 70.32 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 54.43 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 73.15 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 65.22 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 64.14 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 63.04 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 45.11 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 70.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 41.51 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.615 HD22 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 64.02 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 73.33 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 64.22 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 65.43 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 53.54 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 43.24 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 71.13 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.543 HG21 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 54.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 73.04 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 73.03 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 65.41 112.274 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.755 0.312 . . . . 70.23 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 64.12 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 64.41 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 73.5 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 70.33 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 72.23 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 34.44 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 72.31 112.298 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 61.34 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 73.43 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 54.1 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 55.21 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 72.44 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.15 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 52.5 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 60.25 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 64.44 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 64.21 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 62.43 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 24' ' ' LEU . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 60.03 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 40.11 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.504 HD13 HG12 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 61.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 62.1 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 70.21 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 72.34 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 61.4 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 71.13 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.13 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 64.31 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 61.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 71.45 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 54.04 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 24.34 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 53.11 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 70.5 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 62.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 73.1 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 63.54 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 73.24 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 53.32 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 60.03 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.02 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 71.25 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.11 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 74.33 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 52.24 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 64.52 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 41.41 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 44.43 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 63.25 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 74.24 111.265 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 104' ' ' THR . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 64.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 8' ' ' HIS . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 73.13 111.518 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 51.22 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.462 HG21 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 63.33 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 65.42 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 63.32 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 61.02 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 61.42 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 62.55 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 73.41 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 72.34 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 71.41 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 72.14 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.468 HG21 HD21 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 52.11 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.537 HG11 ' HB1' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 73.43 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 51.44 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 55.23 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' HH22 ' A' ' 27' ' ' ARG . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 64.33 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.566 ' HB2' HD23 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 52.31 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 62.33 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.33 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 65.22 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 43' ' ' MET . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 60.4 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 82' ' ' ALA . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 64.54 111.795 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 64.34 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 64.21 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 55.2 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 63.13 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 52.34 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 63.24 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 73.24 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 61.4 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 64.55 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 62.23 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 76' ' ' VAL . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 41.11 111.412 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 73.15 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 87' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.2 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 71.3 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 64.1 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 44.21 112.085 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 74.43 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 72.11 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 65.42 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 64.22 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 55.03 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 53.52 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.03 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 55.43 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 71.11 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 54.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 50.51 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 72.4 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.13 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.02 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 72.15 111.649 179.104 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.799 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 21' ' ' PHE . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 73.45 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 72.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 71.11 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.619 HG21 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 70.44 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 72.23 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 53.4 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 61.0 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 HH12 HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 65.44 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 72.24 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 53.34 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 63.12 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.05 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 65.04 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 62.13 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.637 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 72.12 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 53.23 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 62.03 111.99 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.632 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 71.21 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 65.42 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 40.03 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 63.0 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 55.23 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.744 HD11 HD21 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 73.41 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 64.33 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 64.42 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 33.14 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 61.13 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 71.04 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 71.44 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 61.43 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 70.01 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 62.12 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.11 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 71.1 111.796 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.01 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 73.52 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 51.14 111.604 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.799 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.709 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 63.44 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 21.23 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD22 HH12 ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 65.3 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 72.03 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 32.53 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 33.14 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 62.32 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.21 -0.293 . . . . 73.35 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 52.12 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 62.35 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 61.45 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 54.43 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 52.21 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 72.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.14 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 70.11 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 60.03 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 72.42 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 73.32 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 65.25 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 61.21 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 53.55 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 52.13 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 64.13 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 71.14 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 64.35 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 31.43 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 72.2 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 82' ' ' ALA . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.42 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 31.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 71.32 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 34.1 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.625 HD11 HD21 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 70.42 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 73.3 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 71.33 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 63.41 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 61.21 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 65.34 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 45' ' ' ILE . 22.9 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 63.52 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 71.2 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 54.2 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 72.54 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 32.44 111.653 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 62.01 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 73.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 24.24 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.13 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.56 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 45.42 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 55.12 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 61.31 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 61.45 111.506 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.53 0.205 . . . . 64.1 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 45.23 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' HG23 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 52.31 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 52.35 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 53.41 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 72.11 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 70.04 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 63.54 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.14 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 54.35 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 73.21 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.659 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 63.21 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 72.42 110.623 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 71.4 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 62.33 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 53.01 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 34.52 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.77 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD13 HG12 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.11 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.77 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 61.2 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 65.53 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 64.43 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 54.22 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 72.14 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 72' ' ' THR . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 72.1 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 65.04 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 23.7 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 73.13 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 64.15 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 72.14 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 60.43 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 43.33 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 65.22 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 53.3 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 64.04 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 62.44 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 52.34 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 53.43 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 73.0 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 52.22 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 71.23 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 55.3 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 65.33 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 65.43 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 53.22 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 62.33 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.77 0.319 . . . . 75.21 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 63.2 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.495 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 61.43 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 73.43 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 72.32 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 61.1 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 71.41 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 51.21 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.24 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 20' ' ' ALA . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 62.2 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 72.14 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 64.33 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 53.25 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 62.25 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.43 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 64.44 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 72.03 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 61.24 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 63.34 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.473 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 65.21 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 61.43 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 74.34 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 65.44 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 61.1 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 71.54 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 63.32 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 73.35 111.38 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.57 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 74.33 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 24' ' ' LEU . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 50.11 111.589 -174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.21 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 55.51 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.22 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 73.34 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 29.6 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 52.24 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 51.12 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 72.13 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 64.42 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 71.55 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 53.15 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 61.1 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 63.52 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 61.21 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 43.41 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 65.45 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 44.3 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 71.13 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 63.01 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.522 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 64.33 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.822 HG21 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.468 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 61.22 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 70.31 111.345 174.494 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.81 0.338 . . . . 61.01 111.609 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 71.44 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 43.54 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 64.42 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 72.32 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 65.51 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 61.22 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 62.41 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 62.34 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 74.41 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.653 HD22 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 71.43 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 63.24 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 53.02 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 71.25 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 62.44 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 73.21 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 33.33 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 72.35 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.653 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.03 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.55 HD13 HG12 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.2 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 52.45 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD11 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 65.51 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.673 ' HG2' ' H ' ' A' ' 59' ' ' SER . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.673 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 72.14 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 73.14 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 53.41 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 50.44 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 61.44 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 63.31 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 54.3 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 73.4 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.41 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 71.23 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 61.33 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 55.44 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 52.13 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 52.31 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 55.33 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 45.41 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD22 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 64.5 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 74.34 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 74.42 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 65.23 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.633 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 35.15 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 74.11 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 64.05 112.319 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 64.12 111.971 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 62.11 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HA ' HD12 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 62.32 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.02 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.406 ' HA ' ' HD1' ' A' ' 16' ' ' TRP . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 63.31 111.184 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 62.2 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HD1' ' HA ' ' A' ' 12' ' ' SER . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 73.25 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 71.25 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 21.4 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 52.11 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 63.41 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 53.34 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 71.24 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 63.13 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.02 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.402 ' O ' HG13 ' A' ' 107' ' ' ILE . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 31' ' ' THR . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 34.21 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 70.02 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.524 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 72.41 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 51.53 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 74.3 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 43.23 112.555 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 62.34 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 63.01 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 63.33 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.2 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 70.31 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 71.32 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.928 HD11 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 54.13 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 74.32 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 63.42 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 63.22 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 72.45 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 73.13 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 64.12 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 63.51 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 42.13 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 63.14 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 71.11 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 64.02 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 63.34 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 50.43 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.14 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 41.43 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 62.04 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 76' ' ' VAL . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 74.11 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 73.03 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 72.11 113.761 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 63.12 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 61.15 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 61.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 54.15 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 33' ' ' ASN . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 65.25 111.13 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.971 0.415 . . . . 64.33 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.72 154.43 45.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.28 -0.418 . . . . 71.24 111.669 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.66 -26.84 13.72 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.38 2.72 . . . . 73.42 115.066 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -129.07 115.19 17.37 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.023 -0.423 . . . . 72.55 111.704 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 63.32 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 62.32 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 72.53 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.03 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 70.45 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 62.42 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 71.21 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 62.31 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 42.14 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 65.12 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD21 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 64.34 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG11 ' HB1' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 51.12 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.505 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 72.11 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 74.15 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.32 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 71.13 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.583 ' SD ' HD22 ' A' ' 24' ' ' LEU . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 53.11 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 63.02 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 73.2 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 44.34 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD22 ' HB1' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 71.34 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 72.0 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 52.44 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 64.31 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 55.43 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD11 HD21 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 71.31 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 70.32 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 55.51 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.14 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 73.44 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 64.34 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 71.22 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 64.04 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 54.51 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 52.13 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 64.54 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 72.15 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG13 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 62.2 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 71.11 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.01 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.31 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 51.43 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.436 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.14 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.01 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.11 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 61.05 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 30.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 60.35 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.13 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 61.04 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 62.11 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 54.22 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.32 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 51.52 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.38 -27.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 71.24 111.789 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -57.67 -17.22 13.61 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.289 0.566 . . . . 61.55 110.641 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.1 m -99.81 -59.67 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.705 -0.68 . . . . 75.34 111.003 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -92.67 127.93 38.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.21 0.529 . . . . 41.2 111.755 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.9 p -123.27 151.39 62.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.625 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.43 97.46 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.527 2.151 . . . . 64.33 112.552 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.69 159.42 44.01 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.95 -0.568 . . . . 25.41 111.55 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.63 90.65 0.8 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.33 -0.462 . . . . 65.12 112.732 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.29 122.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.552 0.575 . . . . 71.44 112.552 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -168.05 121.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.092 0.557 . . . . 65.12 109.922 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -143.98 108.74 4.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.651 0.611 . . . . 72.12 112.651 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -150.76 86.4 1.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.23 0.538 . . . . 74.22 110.916 168.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -120.34 75.83 1.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.227 0.537 . . . . 75.0 110.098 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.4 t -136.6 115.84 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.908 -0.587 . . . . 74.54 111.344 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 m -101.61 125.93 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.293 -0.412 . . . . 73.35 110.794 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.0 t -110.37 101.16 9.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.002 0.371 . . . . 34.35 112.002 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -167.56 111.46 0.67 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.397 -0.365 . . . . 72.21 110.365 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.5 tp -110.88 159.66 17.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.728 -0.214 . . . . 71.1 110.819 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.98 133.56 37.66 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 122.305 -0.247 . . . . 74.43 110.807 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -138.87 69.66 1.37 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.366 0.603 . . . . 70.21 112.51 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -69.53 144.43 53.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.598 0.592 . . . . 75.13 112.598 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -145.1 179.69 7.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.016 -0.538 . . . . 71.14 110.798 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 67.88 102.56 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.61 0.596 . . . . 72.33 112.61 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -148.0 151.84 36.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.92 0.39 . . . . 64.51 111.24 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.391 0.615 . . . . 75.34 110.745 177.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 22.8 ptp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.531 0.205 . . . . 73.02 110.906 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.41 143.04 98.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 120.743 0.306 . . . . 63.43 111.741 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.8 -60.43 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.888 2.392 . . . . 43.43 112.977 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -112.1 110.96 21.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.373 -0.376 . . . . 55.34 110.833 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 90' ' ' LEU . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 71.42 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 65.45 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.597 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 71.21 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.549 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 42.33 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 72.3 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 54.22 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HE ' ' HB2' ' A' ' 29' ' ' ARG . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 65.44 110.815 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.435 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 71.12 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 53.55 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 54.11 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 65.12 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 62.2 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 71.25 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.634 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 64.41 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 73.44 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 65.32 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 73.54 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 74.22 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 70.2 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 74.43 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG2' HD22 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 72.42 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 73.44 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 52.4 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 54.0 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 71.23 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 73.45 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 20.3 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.66 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 70.53 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.625 HH21 HG12 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 72.43 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 54.4 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 63.34 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 74.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 45.31 111.263 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 65.15 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 54.45 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 65.03 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 63.13 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 61.12 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 14.53 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 63.41 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 71.52 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 65.34 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 71.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm -85.11 -36.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 61.25 112.149 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.46 86.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 73.15 111.005 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.5 t -159.35 -58.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.652 -0.703 . . . . 64.3 111.631 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.645 ' HD3' ' H ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.6 151.71 23.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.961 0.41 . . . . 62.45 111.453 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 m -140.3 35.17 0.22 Allowed Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.25 0.833 . . . . 74.12 113.25 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 112' ' ' THR . 32.0 Cg_endo -65.03 83.99 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.247 2.631 . . . . 71.21 113.532 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.868 -0.605 . . . . 53.03 110.823 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.62 -13.73 2.7 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.74 -0.743 . . . . 63.12 113.899 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.78 116.64 15.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.098 0.449 . . . . 71.12 111.297 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -175.11 124.6 0.25 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.613 0.227 . . . . 74.11 111.613 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -166.33 146.64 6.19 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.325 0.584 . . . . 73.14 112.482 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.3 t80 179.36 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.163 -0.926 . . . . 75.13 110.047 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -133.15 11.94 4.23 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.049 -0.523 . . . . 71.12 111.666 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.9 110.87 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.001 0.429 . . . . 64.15 111.704 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.92 144.58 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.865 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -128.49 110.02 11.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.77 0.319 . . . . 73.02 111.766 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.99 155.73 28.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.837 0.351 . . . . 63.15 110.936 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 tp -145.83 144.45 30.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.749 0.309 . . . . 73.21 111.219 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -151.13 137.18 18.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.63 0.252 . . . . 65.41 111.622 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.34 115.21 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.989 0.423 . . . . 74.34 111.449 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -145.36 110.46 5.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.338 0.59 . . . . 71.23 111.352 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -166.44 119.96 1.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.914 -0.585 . . . . 62.41 110.607 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -146.96 21.33 1.25 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.036 0.384 . . . . 74.41 112.036 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -73.55 82.95 1.51 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.13 0.491 . . . . 71.43 110.825 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.137 0.494 . . . . 75.45 111.067 -178.101 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.642 -0.133 . . . . 53.25 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -60.38 147.79 81.44 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 112.098 0.407 . . . . 70.15 112.098 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.61 -53.59 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.841 2.361 . . . . 73.54 112.206 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -121.07 118.76 30.58 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.719 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 42.01 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 64.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 64.02 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.05 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 70.23 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 70.33 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 60.42 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 63.3 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 72.14 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 42.3 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 62.13 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 71.51 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.14 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 72.45 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.2 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 61.32 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HD23 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 73.32 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 74.3 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 74.21 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 82' ' ' ALA . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 71.33 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 42.51 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 65.12 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 70.3 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.701 HD11 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.13 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 71.44 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 72.31 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.683 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 71.13 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 72.42 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 65.41 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HB3' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 72.12 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 41.02 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 61.01 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 52.33 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 71.31 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 52' ' ' ALA . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 55.51 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 71.24 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 70.3 111.647 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 51.13 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 64.13 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 64.31 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.81 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 60.43 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 72.01 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 60.0 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.6 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 42.52 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.81 HG21 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 62.41 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.552 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 110' ' ' SER . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp -70.92 -33.6 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 65.54 110.579 173.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -71.15 -5.98 35.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.486 -1.234 . . . . 54.14 111.269 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 16.4 t -67.99 -37.71 81.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.752 -0.658 . . . . 70.12 111.981 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -160.12 151.32 19.36 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.068 0.461 . . . . 74.43 111.972 -177.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.6 p -120.7 167.45 12.87 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.843 -0.617 . . . . 75.42 111.329 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 6.7 Cg_exo -75.24 -125.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.592 2.194 . . . . 73.44 111.032 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 176.47 160.62 0.35 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.992 0.368 . . . . 74.24 111.992 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 122.68 0.69 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.873 -0.68 . . . . 62.31 113.389 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.4 148.28 33.17 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.55 -0.382 . . . . 74.2 111.49 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -155.67 157.77 37.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.993 0.425 . . . . 75.4 111.622 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -131.56 139.89 49.33 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.923 0.392 . . . . 74.22 111.505 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -90.03 127.68 36.11 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.902 0.382 . . . . 63.44 111.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.78 90.75 0.6 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.017 0.437 . . . . 72.22 111.591 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.27 75.28 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.476 0.655 . . . . 71.01 112.244 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.06 104.66 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.655 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -174.44 104.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.831 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.86 113.24 1.93 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.8 0.333 . . . . 74.23 111.352 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.08 157.6 39.23 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.027 0.442 . . . . 65.52 111.882 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.28 150.01 34.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.086 0.469 . . . . 44.45 112.228 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -131.68 83.43 2.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.329 -0.396 . . . . 61.13 111.227 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -124.0 120.13 31.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.75 0.309 . . . . 75.55 111.285 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -153.86 104.24 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.473 -0.33 . . . . 71.23 111.025 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -125.73 12.64 7.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.92 0.39 . . . . 74.23 111.803 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -62.97 116.74 5.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.655 0.264 . . . . 75.22 111.375 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.987 0.422 . . . . 72.41 111.848 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.451 0.167 . . . . 70.24 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 68.07 153.33 0.13 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.097 0.559 . . . . 65.42 112.282 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.35 -54.46 2.14 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.91 2.406 . . . . 71.25 113.687 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -118.53 124.31 47.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 73.01 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.0 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 62.24 110.133 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 61.0 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 74.31 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 63.45 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HD2' HD12 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 73.24 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 54.35 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 70.4 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 71.43 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 71.51 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.24 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 70.44 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 71.01 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG11 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 73.02 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 51.42 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.544 HG22 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 72.32 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 63.13 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.454 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 70.53 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 44.34 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 71.41 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.74 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 54.43 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 73.24 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 43' ' ' MET . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 70.41 113.647 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 53.33 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.571 HD11 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 64.13 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 70.35 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 45.31 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 73.22 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 34.24 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 62.41 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 25.33 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.579 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 74.23 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 50.34 111.36 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' HG3' ' A' ' 126' ' ' GLU . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 44.21 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 64.34 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 51.34 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 63.11 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 53.0 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 41.23 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 72.02 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 54.54 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 64.3 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 71.33 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.782 ' HG2' HG21 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 64.02 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 64.2 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.11 112.693 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.782 HG21 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 72.21 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 64.24 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 108' ' ' ILE . 1.9 mp -91.83 -43.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.0 111.617 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.97 -5.39 34.56 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.4 -0.818 . . . . 61.55 112.572 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.1 t -53.35 -30.89 41.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.51 . . . . 64.02 110.869 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -149.77 106.68 3.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.359 0.6 . . . . 73.41 110.368 177.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -85.52 124.14 71.82 Favored Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 122.017 -0.427 . . . . 54.1 111.329 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -85.34 -4.53 9.39 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.612 2.208 . . . . 73.22 113.301 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -156.68 128.56 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.38 0.511 . . . . 41.2 112.38 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.86 80.9 0.71 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.255 -0.738 . . . . 64.31 111.255 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.44 24.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.019 0.748 . . . . 74.32 113.019 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.13 141.9 28.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.872 -0.603 . . . . 75.03 110.546 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -94.87 158.74 15.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.314 0.578 . . . . 73.03 112.102 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -54.35 -34.34 60.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.524 -0.762 . . . . 73.03 110.287 167.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 46.07 63.58 1.79 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.826 -1.079 . . . . 62.41 112.16 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.48 127.36 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.334 -0.394 . . . . 71.3 110.606 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.87 89.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.281 0.562 . . . . 74.22 111.043 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.5 p -71.52 -75.68 0.12 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.795 -0.639 . . . . 71.33 110.673 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 124' ' ' ARG . 1.7 tmm_? 58.42 103.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.249 0.547 . . . . 62.24 112.115 174.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 tp -115.6 6.18 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.912 0.863 . . . . 75.04 109.815 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HG3' ' OG ' ' A' ' 73' ' ' SER . 4.4 mp0 -74.98 112.24 11.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.037 -0.983 . . . . 71.22 112.039 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -67.55 134.22 50.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.809 -0.812 . . . . 74.45 108.809 165.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -55.38 166.66 0.58 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.17 0.804 . . . . 71.02 113.17 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -47.98 145.9 2.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.793 1.034 . . . . 74.14 113.793 -170.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -93.93 -156.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.406 -0.815 . . . . 74.51 109.739 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -75.69 163.16 27.58 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.143 -0.348 . . . . 63.33 110.552 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 N--CA 1.471 0.625 0 N-CA-C 112.092 0.404 . . . . 62.51 112.092 -173.556 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.822 0.344 . . . . 61.52 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.09 154.12 86.51 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.377 -0.374 . . . . 74.4 111.498 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.61 -57.13 2.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.743 2.295 . . . . 75.22 112.849 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -104.34 130.04 52.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 64.5 111.963 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 61.33 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 70.45 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 61.03 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 72.01 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 60.44 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 70.15 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 72.33 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 73.45 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 71.31 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 73.13 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 54.53 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 71.32 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 71.24 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.483 ' HA ' HD13 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 63.31 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 34.12 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 62.34 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 42.24 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 43.14 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.464 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 64.11 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.03 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.43 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 64.11 112.13 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 73.4 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 73.33 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 63.05 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 73.34 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 61.5 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.704 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 60' ' ' ARG . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 61.22 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.14 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 72.11 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 52.43 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.12 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 52.43 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 72.32 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 53.15 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.31 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 53.42 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 74.34 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 64.31 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 61.33 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 62.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.704 ' HB3' HG21 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 71.11 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 70.14 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 62.45 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 63.34 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 65.53 112.295 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 65.01 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 71.1 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 63.45 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 64.35 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 60.1 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 63.35 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -72.4 -30.53 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 71.52 111.736 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -59.93 -4.95 0.83 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.891 -0.595 . . . . 73.23 112.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.8 t -88.33 -4.99 58.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.729 0.64 . . . . 63.53 112.729 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 151.73 41.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.213 0.53 . . . . 75.11 112.222 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.6 p -105.89 144.47 28.96 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.787 -0.642 . . . . 75.0 112.022 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.3 Cg_exo -80.52 105.55 1.74 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.03 2.487 . . . . 72.32 112.018 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.91 139.37 53.73 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.505 0.557 . . . . 61.41 112.505 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.77 88.38 1.71 Allowed Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.352 -0.385 . . . . 45.34 113.792 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.94 116.42 0.45 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.183 0.438 . . . . 64.43 112.183 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -161.11 126.16 3.64 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.836 0.351 . . . . 73.0 111.696 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.74 76.66 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.101 0.477 . . . . 42.34 110.816 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.32 30.29 2.57 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.404 0.621 . . . . 71.33 111.748 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -76.92 71.45 3.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.356 0.598 . . . . 64.55 110.816 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.57 146.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.137 -0.483 . . . . 65.35 112.088 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.6 p -116.39 127.56 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.943 0.401 . . . . 60.0 110.702 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -144.81 93.69 2.44 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.958 0.409 . . . . 61.11 111.229 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -165.47 123.81 1.61 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.556 -0.293 . . . . 72.43 110.532 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.1 tp -165.9 128.26 1.99 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -172.47 134.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.1 -0.5 . . . . 72.04 111.144 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -168.23 45.91 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 72.52 111.852 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -84.39 130.75 34.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.167 -0.333 . . . . 72.4 111.312 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.26 127.17 3.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.366 . . . . 72.12 111.611 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -148.64 159.31 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.652 -0.249 . . . . 73.22 110.972 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -153.27 81.48 1.19 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.783 0.325 . . . . 64.22 111.688 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 123.076 0.55 . . . . 71.01 111.188 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 tpp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.8 0.333 . . . . 63.25 111.291 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.75 159.29 66.66 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.452 -0.34 . . . . 74.35 111.121 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -45.9 -60.06 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.716 2.278 . . . . 74.43 113.892 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -105.49 115.96 31.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.075 -0.39 . . . . 74.05 111.704 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 64.02 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 60.04 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 63.54 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 102' ' ' GLY . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 71.43 112.093 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 53.4 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 73.3 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 72.34 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 73.32 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.594 HD22 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 42.24 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 71.43 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 72.44 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 71.15 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 54.54 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 72.13 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 61.1 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 72.02 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.459 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 50.01 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.664 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 71.21 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 60.22 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 65.31 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.532 HD13 HG12 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 54.22 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 65.55 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 44.55 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 65.04 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.724 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 65.15 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 63.4 112.443 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 63.33 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 71.42 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 70.21 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 62.23 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 63.44 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 71.44 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.42 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 51.42 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 45.43 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 60.14 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG13 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 70.13 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 73.13 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 53.24 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 64.33 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.22 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 44.44 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 64.24 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 74.11 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 13.0 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD22 HH12 ' A' ' 27' ' ' ARG . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 73.04 111.743 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 55.2 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 70.53 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 64.5 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 61.22 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 11' ' ' LYS . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.13 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 73.31 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 64.03 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.01 -23.63 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -56.65 -15.56 4.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.391 0.515 . . . . 70.2 112.391 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -95.42 6.21 49.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.604 0.594 . . . . 60.44 112.604 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 35.2 ptt180 -132.05 -170.88 2.5 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.08 -0.388 . . . . 70.1 111.944 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.61 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 6.2 m 77.01 27.01 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.238 1.57 . . . . 73.1 115.238 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 112' ' ' THR . 60.0 Cg_endo -72.85 134.74 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.831 2.354 . . . . 70.31 112.907 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -158.7 173.37 16.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.55 -0.296 . . . . 35.33 111.319 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.86 88.32 0.28 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.174 -0.536 . . . . 64.34 113.057 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.71 112.88 9.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.691 0.282 . . . . 64.32 111.143 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.09 173.62 12.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.357 0.598 . . . . 64.25 112.589 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.36 173.14 13.37 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.905 -0.589 . . . . 64.35 110.995 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -140.23 127.75 21.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.953 0.406 . . . . 75.25 111.404 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.26 93.36 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.155 0.503 . . . . 64.23 110.944 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.1 104.02 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.536 0.684 . . . . 73.53 112.013 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -154.36 111.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.442 0.639 . . . . 61.23 111.514 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.6 t -155.26 104.44 2.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.005 0.431 . . . . 65.55 110.784 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.15 123.18 21.5 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.18 0.514 . . . . 65.43 110.922 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.529 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -145.88 154.18 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.139 0.495 . . . . 72.12 111.652 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -137.25 131.26 32.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.088 -0.505 . . . . 63.02 110.826 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -126.96 115.25 18.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.073 0.463 . . . . 74.14 111.183 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.75 127.66 19.41 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.293 -0.412 . . . . 75.54 110.878 -175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -163.6 122.37 1.99 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.833 0.349 . . . . 73.23 110.972 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -149.01 26.98 0.87 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.95 0.352 . . . . 73.45 111.95 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -79.99 117.47 20.86 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.964 0.412 . . . . 51.21 111.297 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.326 0.584 . . . . 43.41 111.636 179.358 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.804 0.335 . . . . 74.1 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.31 152.89 96.25 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.985 0.365 . . . . 64.41 111.985 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -58.29 -27.63 81.66 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.831 2.354 . . . . 71.14 113.18 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -126.44 141.78 51.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 63.5 111.798 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.31 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 40.22 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 55.31 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 74.02 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 63.41 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 70.24 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 60.22 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 63.34 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 73.11 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.663 ' NH1' HG22 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 71.5 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 63.12 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 63.32 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.663 HG22 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 71.14 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 74.55 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 72.12 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 72.52 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.34 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 71.2 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 54.24 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 53.14 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.1 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 64.4 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 61.05 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 60.21 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 22' ' ' THR . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 52.32 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 70.12 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.32 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 53.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 63.03 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 72.34 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 62.51 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 65.04 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 60.24 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 62.34 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 73.3 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 72.13 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 71.43 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 44.03 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 61.44 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 73.13 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.3 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 73.11 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 71.41 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.05 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 63.11 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.24 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 33.0 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 73.34 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 63.31 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 60.41 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 52.1 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.85 -40.1 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 63.55 112.34 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.637 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 66.2 mm-40 -69.48 72.2 0.33 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.659 0.743 . . . . 64.31 111.703 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -161.87 -38.61 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.343 -0.844 . . . . 75.14 109.312 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.18 83.41 1.79 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.451 -0.795 . . . . 75.11 110.566 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -109.44 145.85 32.73 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.928 -0.578 . . . . 73.42 112.513 -171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -94.86 15.5 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.4 2.733 . . . . 71.21 112.922 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.66 -178.74 2.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.895 0.702 . . . . 72.4 112.895 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.02 -148.44 20.15 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.853 -0.612 . . . . 43.2 112.307 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.75 108.0 0.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.252 0.834 . . . . 75.15 113.252 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -129.21 125.58 37.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.81 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -99.8 -174.95 2.83 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.034 0.445 . . . . 74.15 111.777 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -153.66 136.51 15.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.899 0.333 . . . . 65.41 111.899 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -79.29 110.29 14.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 110.12 -0.326 . . . . 75.3 110.12 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.8 t -80.96 -27.91 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.709 0.633 . . . . 74.22 112.709 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.09 105.14 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.836 0.351 . . . . 54.03 111.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 t -167.73 14.1 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.933 0.397 . . . . 53.34 111.966 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.3 tpt85 -126.17 122.37 35.45 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.883 0.373 . . . . 75.1 111.562 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -163.52 169.42 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.387 -0.37 . . . . 75.42 111.604 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.47 138.51 21.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.747 0.308 . . . . 75.42 110.846 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -161.48 89.42 0.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.952 0.405 . . . . 72.1 111.878 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -131.87 121.09 23.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.114 0.483 . . . . 73.41 112.181 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -132.32 143.83 50.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.356 -0.384 . . . . 64.44 111.472 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -113.8 -77.55 0.58 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.664 -0.244 . . . . 63.33 110.91 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 55.33 96.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.718 0.636 . . . . 62.51 112.718 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.067 0.461 . . . . 61.11 111.462 178.167 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 23.3 ttt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.479 0.18 . . . . 75.12 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.62 142.17 25.45 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 111.816 0.302 . . . . 74.32 111.816 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.88 -41.83 50.5 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.956 2.437 . . . . 74.11 112.708 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -125.19 133.63 52.69 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 42.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 63.55 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 61.53 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 90' ' ' LEU . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 62.11 110.609 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 61.04 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 73.2 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 73.04 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 65.43 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 61.2 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.586 HG21 HD21 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 54.41 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.1 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 48' ' ' LEU . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 53.23 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 55.35 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 65.41 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 72.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.654 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 64.53 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 63.11 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 72.13 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 25.01 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 55.33 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 71.11 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 72.35 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 72.01 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 63.4 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 71.52 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 26' ' ' VAL . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 73.43 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 53.15 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 72.45 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 64.14 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.03 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 71.02 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.32 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 64.42 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 61.55 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 70.43 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 45.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 64.23 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 65.33 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 73.52 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 74.24 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 72.42 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 72.54 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.23 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 74.3 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 44.24 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.02 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.506 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 33.13 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.666 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 60.31 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 73.14 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 54.51 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 73.01 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 73.23 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HG2' HG21 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 43.33 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 54.52 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 54.23 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 43.13 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.452 HG21 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 54.34 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.24 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -64.04 -30.35 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.15 -6.24 1.92 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.899 -0.591 . . . . 74.23 111.997 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.3 t -111.42 6.41 20.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.173 0.434 . . . . 70.2 112.173 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.49 138.48 54.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.992 0.425 . . . . 72.41 112.02 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.6 p -131.24 150.32 76.17 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.261 -0.427 . . . . 73.54 111.17 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.24 97.15 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.55 2.167 . . . . 52.41 113.118 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.74 150.76 39.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.875 0.369 . . . . 73.24 111.701 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.2 116.27 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.432 -0.413 . . . . 73.45 113.403 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.84 39.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.92 0.391 . . . . 70.23 111.9 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -159.2 149.53 19.34 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.444 -0.344 . . . . 72.33 111.719 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -171.81 -178.39 2.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.064 0.459 . . . . 73.43 112.135 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.8 t80 60.56 53.74 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.634 -0.712 . . . . 75.4 112.072 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -75.89 -28.92 58.29 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.533 0.683 . . . . 73.53 110.197 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.65 143.25 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.419 0.896 . . . . 65.42 113.419 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.44 131.32 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.508 -0.769 . . . . 63.04 110.14 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t -139.29 105.0 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.881 0.697 . . . . 63.33 112.881 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.066 -0.516 . . . . 73.1 110.815 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.3 tp -150.26 99.23 2.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.737 0.304 . . . . 70.32 111.671 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -174.31 99.75 0.1 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 61.24 111.448 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -157.07 88.04 1.01 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.377 -0.374 . . . . 50.22 110.836 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -167.92 114.92 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.572 -0.286 . . . . 73.03 110.941 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -154.02 126.85 8.22 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.973 0.416 . . . . 74.13 111.717 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -132.36 96.9 3.97 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.273 -0.422 . . . . 74.13 111.161 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -112.08 55.77 0.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.277 0.56 . . . . 70.34 111.429 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.83 177.647 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.552 0.215 . . . . 61.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -80.69 153.07 73.03 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 120.642 0.258 . . . . 71.02 111.328 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.31 -43.19 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.162 1.908 . . . . 71.34 111.489 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -149.61 116.88 6.05 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 71.51 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.0 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 62.34 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 65.24 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 63.34 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 63.44 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 60.42 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.02 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 71.21 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 54.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 65.4 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.45 HG21 HD21 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 71.11 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 74.33 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 64.11 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.41 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 61.44 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 32.52 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 63.23 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 63.55 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 54.33 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 54.0 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.545 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 44.22 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.03 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 61.42 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.03 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 62.52 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 72.33 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 71.12 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.608 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 71.43 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 65.23 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 72' ' ' THR . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' HB3' HD23 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.32 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 61.4 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 64.24 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 64.44 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 52.01 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 70.51 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 52.24 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 55.14 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 64.31 111.332 176.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 51.12 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 61.21 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.42 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.02 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 71.01 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.51 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 65.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.31 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 63.12 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 70.03 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 44.24 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 73.53 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 71.23 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 44.12 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -69.68 -23.25 25.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 61.42 110.984 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.02 80.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.46 -0.791 . . . . 74.05 109.688 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 111' ' ' ARG . 38.6 t 176.96 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 75.54 110.13 -169.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 110' ' ' SER . 0.0 OUTLIER -121.08 -1.16 9.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.264 -0.425 . . . . 75.03 111.188 177.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 p 63.96 148.18 0.1 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.158 0.983 . . . . 74.22 111.52 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.51 -64.7 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.531 2.154 . . . . 61.41 113.604 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -178.05 -173.13 0.36 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.367 -0.833 . . . . 75.3 111.419 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.1 -155.92 27.99 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.193 -0.527 . . . . 64.13 112.281 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.63 147.06 32.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.004 0.43 . . . . 73.24 111.76 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -160.68 128.94 4.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.095 -0.502 . . . . 72.23 110.934 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -144.67 179.98 6.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.144 -0.48 . . . . 75.31 110.763 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.46 142.49 25.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.802 0.334 . . . . 74.13 111.19 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -64.46 108.86 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.42 0.629 . . . . 62.42 111.154 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.67 85.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.19 0.519 . . . . 65.41 111.304 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.7 120.69 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.881 -0.6 . . . . 75.44 111.935 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.7 t 176.09 89.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.844 -0.616 . . . . 71.3 110.436 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 124' ' ' ARG . 36.8 ttt180 -138.13 142.17 40.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.997 0.427 . . . . 70.41 112.125 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.36 95.7 2.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.701 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -147.45 130.46 16.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 62.24 111.564 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -146.01 14.25 1.32 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.463 0.542 . . . . 63.4 112.463 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -77.41 109.66 11.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.829 -0.544 . . . . 65.53 110.93 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -161.53 110.94 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.372 -0.376 . . . . 64.51 111.071 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.75 136.18 1.96 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.908 0.336 . . . . 70.12 111.908 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -151.05 97.35 2.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.587 0.588 . . . . 44.33 112.587 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.602 0.239 . . . . 63.33 111.123 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.461 0.172 . . . . 72.31 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.36 155.65 92.58 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.837 0.351 . . . . 75.22 111.73 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.46 -32.89 97.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.574 2.182 . . . . 73.24 112.103 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -121.85 109.61 14.86 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.794 -0.639 . . . . 63.34 111.062 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 65.34 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 72.12 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 64.43 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 72.11 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 72.53 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 71.13 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 71.1 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 32.31 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 65.24 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.677 HD22 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HD13 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 51.32 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.2 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 70.31 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 73.24 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.488 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 60.54 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 71.43 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 73.51 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.747 ' HA ' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 60.21 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.49 ' HB2' HD23 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.677 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 64.23 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 70.13 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 54.12 111.143 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 52.24 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 70.31 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.05 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 34.14 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 71.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 54.24 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.742 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 62.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.742 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 60.12 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 71.01 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 70.14 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 73.12 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 64.31 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 44.25 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 17.8 m80 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 44.22 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 34.32 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 64.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 72.23 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.459 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 15.21 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.427 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.01 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG21 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 54.41 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.802 HG21 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 60.23 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 62.43 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 71.34 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 44.14 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp -73.87 -32.86 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 73.21 111.637 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -71.34 -1.07 11.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.156 -0.475 . . . . 71.44 112.071 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -73.39 -19.03 61.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.792 0.664 . . . . 54.15 112.792 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.95 160.64 41.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.076 0.465 . . . . 72.1 112.162 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -99.23 140.69 21.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 115.854 -0.612 . . . . 70.11 111.832 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.01 122.13 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.93 2.42 . . . . 75.25 113.654 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.59 131.16 2.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.949 -0.568 . . . . 61.31 110.969 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.41 117.74 0.42 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.948 -0.644 . . . . 74.4 113.456 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.13 149.87 12.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.943 0.401 . . . . 65.24 111.695 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -149.11 144.79 26.87 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.32 -0.4 . . . . 65.14 110.722 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -142.1 131.09 23.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.578 0.584 . . . . 74.03 112.578 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -169.06 85.54 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.261 0.553 . . . . 72.42 111.512 170.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -119.83 70.27 0.86 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.425 0.631 . . . . 65.35 109.495 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.4 114.81 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.853 -0.612 . . . . 64.43 111.533 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.7 130.33 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.062 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -150.78 110.87 4.12 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.793 0.294 . . . . 64.22 111.793 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -129.13 137.28 51.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.779 0.323 . . . . 75.11 110.718 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.86 110.18 13.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.734 0.302 . . . . 72.41 111.451 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.64 112.47 8.95 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.52 0.676 . . . . 71.12 112.123 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -136.2 113.05 10.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.322 -0.399 . . . . 62.33 110.345 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -143.96 102.18 3.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.791 0.329 . . . . 65.35 111.085 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -130.98 121.99 26.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.706 0.289 . . . . 74.24 110.977 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -161.51 151.43 16.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.772 0.32 . . . . 72.21 111.554 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.37 152.9 42.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.694 0.283 . . . . 61.53 111.132 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.357 0.599 . . . . 71.41 111.984 -179.215 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 41.1 tpp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.671 0.248 . . . . 62.02 111.671 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 69.42 148.0 0.12 Allowed Pre-proline 0 N--CA 1.476 0.856 0 CA-C-O 121.172 0.51 . . . . 75.31 112.267 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 11.3 Cg_endo -55.7 -37.71 95.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.639 2.226 . . . . 62.41 112.583 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -133.09 131.18 40.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.285 -0.416 . . . . 51.22 111.247 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.411 ' O ' HD12 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.33 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.689 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 72.13 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.573 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 71.32 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.1 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 73.32 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 63.21 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.534 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 73.33 112.414 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 61.11 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 55.52 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 61.54 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 72.32 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 53.41 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 72.43 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 72.04 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 63.23 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' HA ' HD13 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.462 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 54.31 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 64.42 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 62.01 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 72.53 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 51.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 72.41 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.34 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.494 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD22 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 64.4 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 63.14 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 73.03 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 64.32 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 44.04 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.03 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.637 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 53.51 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 61.3 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.34 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 73.43 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 72.31 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 61.03 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 74.43 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 54.5 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 72.21 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 61.55 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 64.5 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 63.12 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 63.24 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 64.53 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG12 HG13 ' A' ' 76' ' ' VAL . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 41.45 110.775 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 62.23 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 65.12 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 62.22 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 52.24 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 72.4 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 12.51 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -70.47 -23.23 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 62.44 111.597 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.36 -12.07 12.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.214 -0.448 . . . . 73.33 112.143 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -89.18 -0.4 57.42 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.256 0.465 . . . . 73.41 112.256 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 9.1 ptm180 -141.75 159.72 41.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.145 0.497 . . . . 71.52 111.968 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.2 p -97.2 132.68 25.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 74.53 111.256 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.5 Cg_exo -75.52 35.75 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.977 2.452 . . . . 63.31 113.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -179.46 154.93 0.65 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.181 0.592 . . . . 75.14 110.733 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.1 132.25 1.35 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.695 -0.764 . . . . 41.34 113.815 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.02 101.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.805 0.669 . . . . 74.44 112.805 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -172.24 127.64 0.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.683 -0.69 . . . . 74.42 110.107 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.09 129.92 12.42 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.114 0.412 . . . . 62.22 112.114 -175.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -118.42 11.14 12.91 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.312 0.577 . . . . 74.14 111.346 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.07 83.83 0.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.319 0.58 . . . . 63.33 111.288 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.97 164.39 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.092 -0.504 . . . . 62.03 111.604 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.41 143.24 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.703 0.287 . . . . 73.4 111.23 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.4 t -154.88 89.97 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.211 0.449 . . . . 72.33 112.211 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -178.28 128.84 0.13 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.855 0.36 . . . . 73.45 111.567 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.8 tp -152.99 127.84 9.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.197 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 13.2 pt-20 -159.54 -147.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.496 0.554 . . . . 70.13 112.496 -170.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 32.8 m170 87.12 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.598 1.159 . . . . 75.21 113.114 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -137.67 113.68 9.89 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.027 -0.533 . . . . 70.03 110.692 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -165.68 128.08 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.716 -0.22 . . . . 74.14 111.397 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -167.64 130.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.978 0.418 . . . . 73.52 111.713 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -162.24 113.2 1.59 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.095 0.474 . . . . 43.3 111.203 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 121.271 0.557 . . . . 71.11 111.336 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.74 0.305 . . . . 71.12 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -89.13 150.72 45.64 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 75.24 112.26 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.23 -39.36 13.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.445 2.097 . . . . 73.44 110.655 168.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -131.43 109.85 10.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.141 -0.936 . . . . 62.21 109.801 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 62.33 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 52.14 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 54.22 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 70.55 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.492 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 72.02 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 31.15 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.34 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 56' ' ' LEU . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 64.42 111.658 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 40.54 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.716 HD21 HD11 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 64.22 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.615 ' NH1' HD22 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.648 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 54.34 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 63.12 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 64.4 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 42.12 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 53.44 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.537 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 63.53 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 61.4 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 73.45 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 65.32 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 64.14 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 62.02 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 63.52 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.692 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 73.03 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 70.32 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 54.43 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 73.15 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 65.22 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 64.14 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 63.04 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 45.11 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 70.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 41.51 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.615 HD22 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 64.02 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 73.33 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 64.22 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 65.43 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 53.54 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 43.24 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 71.13 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.543 HG21 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 54.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 73.04 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 73.03 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.28 -23.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 65.41 112.274 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -53.3 -23.49 9.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 112.197 0.443 . . . . 75.21 112.197 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.2 t -58.11 -32.34 68.01 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.05 0.452 . . . . 71.42 111.303 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.32 100.63 10.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.735 -0.468 . . . . 63.31 109.735 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.0 p -87.6 118.53 69.92 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 113.055 0.761 . . . . 74.23 113.055 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.25 68.77 7.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.106 2.537 . . . . 72.44 111.69 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -91.51 0.77 57.47 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.542 0.571 . . . . 74.4 112.542 -175.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.24 73.02 1.12 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.22 -0.514 . . . . 50.44 113.28 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.54 146.8 29.0 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.636 -0.331 . . . . 62.31 111.434 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.09 -169.24 1.7 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.987 0.422 . . . . 63.3 111.552 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.3 125.33 32.83 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.243 0.46 . . . . 65.35 112.243 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 121' ' ' VAL . 73.2 t80 -74.94 -73.71 0.23 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.984 0.421 . . . . 72.32 109.876 172.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.52 11.58 1.77 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.891 1.071 . . . . 72.04 113.891 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.2 t -88.51 109.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.108 0.48 . . . . 70.11 110.981 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.21 39.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.1 0.476 . . . . 75.34 112.097 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 m -59.37 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.856 0.687 . . . . 34.54 112.856 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 124' ' ' ARG . 19.9 ttm-85 -151.24 105.2 3.18 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.886 -0.597 . . . . 72.42 110.475 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.9 tp -164.35 97.47 0.8 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.917 0.389 . . . . 74.03 111.619 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.8 130.98 16.42 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.386 -0.37 . . . . 63.04 111.032 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -142.79 106.11 4.59 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.433 0.531 . . . . 65.03 112.433 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -147.85 135.53 20.89 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.053 0.541 . . . . 75.14 110.228 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -145.2 149.46 34.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.89 0.376 . . . . 71.32 111.814 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -121.57 141.45 51.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.32 -0.4 . . . . 71.52 111.367 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -80.02 122.93 27.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.682 0.277 . . . . 62.04 111.029 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.01 0.433 . . . . 75.5 111.496 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 25.8 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.64 0.257 . . . . 51.43 110.821 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 44.9 mt-10 -81.18 145.83 57.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.767 0.317 . . . . 42.23 111.781 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 2' ' ' GLU . 37.5 Cg_exo -60.86 -32.93 93.21 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.024 2.482 . . . . 74.53 112.649 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.39 130.92 53.36 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.298 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 64.12 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 64.41 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 73.5 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 70.33 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 72.23 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 34.44 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 72.31 112.298 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 61.34 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 73.43 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 54.1 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 55.21 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 72.44 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.15 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 52.5 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 60.25 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 64.44 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 64.21 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 62.43 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 24' ' ' LEU . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 60.03 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 40.11 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.504 HD13 HG12 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 61.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 62.1 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 70.21 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 72.34 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 61.4 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 71.13 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.13 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 64.31 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 61.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 71.45 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 54.04 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 24.34 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 53.11 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 70.5 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 62.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 73.1 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 63.54 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 73.24 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 53.32 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 60.03 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.02 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 71.25 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.11 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 74.33 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 52.24 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 64.52 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 41.41 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 44.43 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 63.25 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 74.24 111.265 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 104' ' ' THR . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 64.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 8' ' ' HIS . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 73.13 111.518 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 51.22 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.462 HG21 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 63.33 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -79.23 -36.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -72.55 36.74 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 116.037 -0.529 . . . . 74.12 111.927 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.5 t -157.04 19.06 0.3 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.846 0.355 . . . . 75.43 111.777 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 111' ' ' ARG . 9.9 ptp180 -153.18 173.11 15.94 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.432 0.634 . . . . 75.14 112.684 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -120.84 151.12 54.24 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 115.539 -0.755 . . . . 72.23 112.16 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 85.8 Cg_endo -82.79 -129.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 122.859 2.372 . . . . 61.41 111.804 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.428 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 57.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.885 0.698 . . . . 63.23 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -162.53 41.73 0.36 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.572 -0.823 . . . . 62.33 113.39 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -176.28 132.27 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.982 0.364 . . . . 74.4 111.982 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -167.24 117.85 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.428 -0.351 . . . . 72.2 110.075 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -90.84 -176.38 4.65 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.975 0.732 . . . . 71.44 112.975 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -141.77 141.25 33.21 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.857 -0.61 . . . . 74.13 111.106 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.13 118.22 12.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.932 0.396 . . . . 75.22 111.311 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.72 117.12 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.173 0.435 . . . . 72.12 112.173 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -166.76 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.055 -0.52 . . . . 74.35 111.339 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 99.1 p -166.35 123.59 1.36 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -177.15 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.74 -0.663 . . . . 63.24 110.11 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.1 tp -95.13 126.69 40.63 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.172 0.51 . . . . 62.43 112.127 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -120.82 138.88 53.82 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.113 -0.494 . . . . 74.53 111.227 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -167.38 96.98 0.49 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.257 0.551 . . . . 74.22 111.619 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -145.81 121.91 10.78 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.33 -0.395 . . . . 54.34 110.829 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -150.34 128.73 12.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.892 0.377 . . . . 73.34 111.692 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -160.91 136.62 8.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.253 -0.431 . . . . 74.33 110.985 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -159.29 94.7 1.2 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.045 0.45 . . . . 72.44 111.211 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.272 -0.422 . . . . 74.23 111.01 -179.876 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.486 0.184 . . . . 75.04 110.705 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.16 144.7 82.55 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 120.5 0.191 . . . . 61.24 111.247 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.36 -45.78 17.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.262 1.974 . . . . 62.11 112.303 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -121.84 122.15 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 65.42 111.386 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 63.32 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 61.02 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 61.42 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 62.55 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 73.41 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 72.34 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 71.41 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 72.14 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.468 HG21 HD21 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 52.11 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.537 HG11 ' HB1' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 73.43 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 51.44 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 55.23 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' HH22 ' A' ' 27' ' ' ARG . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 64.33 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.566 ' HB2' HD23 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 52.31 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 62.33 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.33 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 65.22 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 43' ' ' MET . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 60.4 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 82' ' ' ALA . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 64.54 111.795 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 64.34 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 64.21 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 55.2 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 63.13 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 52.34 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 63.24 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 73.24 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 61.4 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 64.55 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 62.23 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 76' ' ' VAL . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 41.11 111.412 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 73.15 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 87' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.2 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 71.3 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 64.1 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 44.21 112.085 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 74.43 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 72.11 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 65.42 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 64.22 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 55.03 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 53.52 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.03 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 55.43 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 71.11 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 54.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 50.51 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 72.4 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.13 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.02 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.36 -29.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 72.15 111.649 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.42 -15.98 8.13 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.295 0.569 . . . . 53.2 111.209 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 m -105.7 3.45 29.0 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 73.4 112.664 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 111' ' ' ARG . 43.5 mtp-105 -96.64 128.97 44.08 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.414 0.524 . . . . 54.23 112.414 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 121.14 56.26 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 116.126 -0.488 . . . . 63.35 112.03 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.45 107.32 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.955 2.437 . . . . 63.11 112.127 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.53 145.14 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.058 0.456 . . . . 55.23 112.19 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -106.34 -158.26 21.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.202 -0.523 . . . . 71.03 112.868 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.42 -156.78 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.41 0.284 . . . . 41.24 111.585 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -54.52 160.17 1.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.34 112.501 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -99.4 -157.6 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.995 -0.548 . . . . 75.41 111.426 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.45 -38.08 68.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.201 0.445 . . . . 72.1 112.201 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.8 m120 60.19 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.09 0.556 . . . . 72.32 111.657 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.8 t 55.05 103.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.441 0.696 . . . . 71.1 112.419 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.82 -42.39 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.853 -0.612 . . . . 72.4 112.283 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 t 59.74 -166.09 0.19 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.375 0.27 . . . . 75.53 111.384 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 66.06 -177.32 0.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.399 0.518 . . . . 74.1 112.399 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' ' 127' ' ' HIS . 20.1 tp 59.22 33.5 22.7 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.456 0.646 . . . . 74.11 111.836 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.08 -22.12 64.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.789 0.663 . . . . 63.43 112.789 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 125' ' ' LEU . 40.5 m80 67.05 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.793 1.035 . . . . 73.12 113.793 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.93 113.82 8.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.575 -0.739 . . . . 60.55 109.724 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -63.81 -44.36 93.51 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.54 0.571 . . . . 65.14 112.54 -173.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 65.06 148.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.296 0.85 . . . . 61.15 113.296 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -177.89 -59.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.912 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 122.712 0.405 . . . . 74.14 111.213 -173.789 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 13.0 tmm? . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.156 -0.313 . . . . 64.21 110.156 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.47 148.66 98.16 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 112.522 0.564 . . . . 75.24 112.522 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.56 -26.16 21.58 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.443 2.762 . . . . 62.35 113.848 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.799 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -131.6 173.27 11.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 173.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 21' ' ' PHE . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 73.45 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 72.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 71.11 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.619 HG21 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 70.44 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 72.23 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 53.4 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 61.0 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 HH12 HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 65.44 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 72.24 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 53.34 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 63.12 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.05 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 65.04 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 62.13 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.637 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 72.12 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 53.23 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 62.03 111.99 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.632 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 71.21 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 65.42 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 40.03 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 63.0 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 55.23 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.744 HD11 HD21 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 73.41 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 64.33 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 64.42 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 33.14 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 61.13 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 71.04 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 71.44 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 61.43 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 70.01 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 62.12 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.11 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 71.1 111.796 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.01 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 73.52 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.607 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 51.14 111.604 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.799 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.709 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 63.44 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 21.23 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD22 HH12 ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 65.3 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 72.03 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 32.53 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 33.14 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 62.32 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 1.8 mp -77.67 -39.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -54.02 -34.49 60.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.667 -0.697 . . . . 71.01 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.7 m -61.41 -35.12 76.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.654 -0.703 . . . . 74.21 112.364 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 17.2 ptp180 -105.39 135.76 46.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.356 0.598 . . . . 73.35 111.526 -175.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 5.0 t -130.68 141.18 41.04 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 112.037 0.384 . . . . 71.22 112.037 -175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 8.2 Cg_exo -73.34 136.35 23.97 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.839 2.359 . . . . 64.53 112.305 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.42 160.91 26.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.965 0.412 . . . . 61.43 111.605 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.06 37.07 6.1 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.26 -0.495 . . . . 63.25 113.108 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.15 123.14 36.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.857 0.361 . . . . 61.12 110.996 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -149.2 163.96 36.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.624 -0.262 . . . . 64.43 110.954 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -161.25 161.06 30.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.778 0.323 . . . . 62.2 111.245 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -152.92 135.6 15.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 73.22 111.439 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.39 94.24 0.71 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.319 -0.4 . . . . 62.21 110.964 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.92 67.1 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.745 0.783 . . . . 64.24 112.15 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.54 109.52 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.328 0.585 . . . . 51.32 111.386 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.4 t -159.7 105.13 1.6 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.293 -0.412 . . . . 72.13 111.429 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -159.66 116.18 2.55 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.361 -0.381 . . . . 73.35 110.844 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.622 ' O ' HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -142.46 138.89 31.35 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.712 0.292 . . . . 63.41 111.479 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.0 119.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.772 0.656 . . . . 75.4 112.772 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -163.46 98.98 0.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.693 -0.685 . . . . 74.42 110.354 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -134.4 34.21 3.26 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.105 -0.498 . . . . 73.44 112.148 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -110.52 88.03 2.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.204 0.526 . . . . 63.2 110.3 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -165.37 95.29 0.65 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.986 -0.552 . . . . 73.4 110.614 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -158.92 100.61 1.58 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.908 0.385 . . . . 74.23 111.043 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.738 0.78 . . . . 55.42 110.702 -178.787 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.526 -0.175 . . . . 75.41 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.83 149.99 54.74 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.341 0.256 . . . . 71.53 111.235 -177.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.47 -55.41 4.11 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.088 2.525 . . . . 54.33 113.45 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -121.7 118.2 28.53 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.473 -0.331 . . . . 73.35 110.21 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 52.12 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 62.35 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 61.45 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 54.43 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 52.21 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 72.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.14 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 70.11 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 60.03 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 72.42 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 73.32 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 65.25 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 61.21 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 53.55 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 52.13 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 64.13 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 71.14 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 64.35 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 31.43 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 72.2 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 82' ' ' ALA . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.42 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 31.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 71.32 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 34.1 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.625 HD11 HD21 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 70.42 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 73.3 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 71.33 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 63.41 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 61.21 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 65.34 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 45' ' ' ILE . 22.9 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 63.52 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 71.2 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 54.2 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 72.54 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 32.44 111.653 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 62.01 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 73.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 24.24 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.13 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.56 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 45.42 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 55.12 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 61.31 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -74.31 -33.95 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 61.45 111.506 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.615 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 33.9 mm-40 -58.39 -27.25 64.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.683 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.1 m -63.5 -49.36 73.87 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.044 0.45 . . . . 43.03 110.784 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 2.1 ppt_? -168.32 130.18 1.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.726 -0.67 . . . . 54.42 111.236 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 p -78.63 161.97 67.39 Favored Pre-proline 0 N--CA 1.474 0.76 0 N-CA-C 112.787 0.662 . . . . 70.42 112.787 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.64 -140.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.724 2.282 . . . . 74.22 111.381 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 175.8 -174.75 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.801 0.334 . . . . 75.13 111.739 -172.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.37 111.67 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.036 -0.602 . . . . 54.21 113.502 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.08 99.94 0.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.264 0.226 . . . . 63.3 111.548 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.85 122.24 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.072 0.463 . . . . 72.3 111.505 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.29 168.02 25.28 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.092 -0.504 . . . . 75.03 110.984 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -130.56 142.59 50.47 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.98 0.419 . . . . 74.54 111.402 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.49 100.42 11.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 73.34 110.959 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.0 t -85.59 -30.27 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.162 -0.472 . . . . 74.14 111.992 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 m -62.74 84.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.734 0.778 . . . . 74.14 112.808 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 t -137.22 77.46 1.64 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.57 -0.741 . . . . 62.33 109.747 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -171.15 118.64 0.48 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.241 -0.89 . . . . 71.2 109.21 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.5 tp -128.8 131.01 47.75 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.05 0.759 . . . . 71.12 113.05 -171.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -132.29 138.68 47.94 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.647 -0.706 . . . . 74.52 110.338 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -167.4 102.43 0.51 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.147 0.499 . . . . 73.44 111.228 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -151.64 109.77 3.72 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.87 0.367 . . . . 73.15 110.667 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -148.01 162.6 39.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.967 0.358 . . . . 61.42 111.967 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.2 89.43 0.78 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.095 0.474 . . . . 73.13 112.019 177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -141.57 156.05 45.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.419 -0.355 . . . . 74.22 111.336 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.209 0.528 . . . . 72.42 111.714 178.049 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ppp? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.003 0.43 . . . . 63.14 110.632 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 6.4 mp0 -72.03 146.54 90.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.867 -172.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.64 -24.27 78.04 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.672 2.248 . . . . 70.45 112.03 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.54 120.17 5.15 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.112 -0.949 . . . . 64.1 110.492 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 45.23 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' HG23 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 52.31 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 52.35 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 53.41 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 72.11 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 70.04 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 63.54 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.14 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 54.35 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 73.21 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.659 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 63.21 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 72.42 110.623 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 71.4 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 62.33 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 53.01 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 34.52 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.77 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD13 HG12 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.11 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.77 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 61.2 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 65.53 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 64.43 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 54.22 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 72.14 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 72' ' ' THR . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 72.1 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 65.04 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 23.7 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 73.13 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 64.15 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 72.14 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 60.43 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 43.33 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 65.22 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 53.3 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 64.04 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 62.44 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 52.34 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 53.43 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 73.0 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 52.22 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 71.23 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 55.3 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 65.33 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 65.43 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 53.22 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 62.33 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -33.79 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -60.8 -18.79 57.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.73 -0.668 . . . . 74.43 111.137 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 51.3 m -76.09 -24.54 55.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.199 -0.455 . . . . 62.52 111.441 175.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -157.07 58.51 0.52 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.388 0.613 . . . . 64.25 111.475 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.5 p -53.33 147.99 17.66 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 112.512 0.56 . . . . 74.43 112.512 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.97 -25.07 80.87 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.582 2.188 . . . . 70.44 113.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 52.96 38.23 26.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.618 . . . . 71.5 112.536 175.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.05 -175.49 40.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.18 -0.533 . . . . 74.45 113.1 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -175.59 125.33 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 122.63 0.372 . . . . 52.53 111.42 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -108.29 151.56 25.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.956 0.408 . . . . 61.02 111.722 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.98 176.55 6.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.838 0.351 . . . . 75.21 111.563 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -105.82 -83.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.223 -0.298 . . . . 65.35 111.184 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.8 m120 67.05 -7.68 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.859 1.059 . . . . 71.4 113.859 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.49 132.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 121.996 -0.44 . . . . 72.11 111.729 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.96 144.05 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.6 m -155.41 136.76 14.02 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.249 -0.432 . . . . 63.34 111.278 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -169.41 128.98 1.02 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.67 0.272 . . . . 74.34 110.918 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 126' ' ' GLU . 3.0 tm? -158.4 139.2 12.9 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.189 -0.319 . . . . 62.12 111.334 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.538 ' N ' HD13 ' A' ' 125' ' ' LEU . 7.2 tp10 -165.74 122.06 1.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.566 0.58 . . . . 75.14 112.566 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -169.09 112.78 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.93 0.395 . . . . 74.41 111.647 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -148.62 143.91 26.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.655 0.613 . . . . 54.32 112.655 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -159.41 121.71 3.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 74.4 110.581 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -80.12 -12.46 59.66 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.744 0.275 . . . . 74.53 111.744 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 18.7 t60 74.58 -34.02 0.26 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.958 1.095 . . . . 70.34 113.958 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.037 0.446 . . . . 41.24 112.177 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 25.3 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.397 0.147 . . . . 72.42 111.397 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 1' ' ' MET . 45.3 mm-40 67.45 145.33 0.1 Allowed Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 121.328 0.585 . . . . 64.03 112.269 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 39.8 Cg_endo -69.22 -38.7 8.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.567 2.178 . . . . 75.14 111.809 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -131.82 109.32 10.03 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.752 -0.658 . . . . 75.21 111.117 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 63.2 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.495 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 61.43 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 73.43 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 72.32 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 61.1 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 71.41 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 51.21 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.24 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 20' ' ' ALA . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 62.2 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 72.14 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 64.33 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 53.25 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 62.25 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.43 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 64.44 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 72.03 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 61.24 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 63.34 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.473 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 65.21 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 61.43 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 74.34 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 65.44 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 61.1 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 71.54 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 63.32 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 73.35 111.38 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.57 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 74.33 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 24' ' ' LEU . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 50.11 111.589 -174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.21 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 55.51 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.22 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 73.34 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 29.6 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 52.24 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 51.12 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 72.13 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 64.42 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 71.55 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 53.15 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 61.1 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 63.52 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 61.21 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 43.41 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 65.45 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 44.3 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 71.13 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 63.01 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.522 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 64.33 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.822 HG21 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.468 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 61.22 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.95 -35.19 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 70.31 111.345 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.57 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 64.0 mm-40 -78.2 65.02 3.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.484 0.659 . . . . 71.24 110.357 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.1 t -179.9 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.545 -0.752 . . . . 71.23 111.298 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 111' ' ' ARG . 12.0 ptm85 -75.93 172.14 13.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.202 0.525 . . . . 74.42 112.393 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.4 p -84.82 129.98 54.55 Favored Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.386 0.884 . . . . 42.4 113.386 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -96.32 115.13 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.321 2.68 . . . . 72.32 113.333 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 72.33 172.7 0.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.648 0.981 . . . . 74.23 113.648 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.21 -137.38 2.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.714 -0.676 . . . . 45.42 113.036 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.8 101.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.341 0.571 . . . . 64.41 112.205 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -133.4 129.78 37.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.315 -0.241 . . . . 65.32 111.251 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.69 169.19 24.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.331 0.586 . . . . 73.53 111.862 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . 34.3 t80 -108.98 -58.99 1.95 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.908 -0.587 . . . . 73.52 110.66 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.3 -71.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.57 0.748 . . . . 65.12 112.807 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -30.75 105.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.746 1.218 . . . . 64.15 113.913 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.13 130.37 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.933 -0.576 . . . . 61.24 111.357 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -144.52 131.77 20.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.048 0.452 . . . . 54.21 112.021 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -158.65 -71.18 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.101 -0.5 . . . . 75.34 110.214 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 tt 46.34 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.859 0.864 . . . . 71.53 113.058 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.46 133.43 52.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.09 -0.381 . . . . 44.24 110.181 171.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -153.61 93.51 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.067 0.461 . . . . 71.31 112.089 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -147.39 120.42 8.81 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.838 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -163.7 125.61 2.43 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.04 0.448 . . . . 64.44 111.417 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -98.1 -102.66 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.289 -0.414 . . . . 72.41 111.627 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -150.67 156.22 40.91 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.921 -0.487 . . . . 75.44 111.852 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.216 0.531 . . . . 75.01 110.897 176.072 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 18.4 tmm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.561 0.219 . . . . 74.02 110.618 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 11.1 pt-20 -89.91 159.14 43.57 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -171.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 11.1 Cg_endo -56.22 -37.54 96.5 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.224 2.616 . . . . 71.44 113.543 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.58 99.32 6.12 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.334 -0.394 . . . . 61.01 111.609 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 71.44 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 43.54 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 64.42 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 72.32 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 65.51 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 61.22 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 62.41 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 62.34 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 74.41 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.653 HD22 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 71.43 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 63.24 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 53.02 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 71.25 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 62.44 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 73.21 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 33.33 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 72.35 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.653 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.03 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD13 HG12 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.2 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 52.45 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD11 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 65.51 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.673 ' HG2' ' H ' ' A' ' 59' ' ' SER . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.673 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 72.14 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 73.14 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 53.41 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 50.44 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 61.44 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 63.31 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 54.3 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 73.4 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.41 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 71.23 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 61.33 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 55.44 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 52.13 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 52.31 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 55.33 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 45.41 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD22 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 64.5 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 74.34 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 74.42 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 65.23 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.633 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 35.15 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 74.11 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 111' ' ' ARG . 1.7 mp -67.4 -40.02 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 64.05 112.319 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.78 -14.06 19.09 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 74.35 111.029 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -102.48 1.18 34.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.055 -0.52 . . . . 53.13 111.737 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 108' ' ' ILE . 12.7 mmm180 -87.25 142.66 27.73 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.154 0.502 . . . . 74.05 111.956 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 54.7 p -95.05 142.34 24.47 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.846 -0.615 . . . . 64.43 111.499 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 16.5 Cg_exo -68.42 -75.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.042 2.495 . . . . 61.01 113.514 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 63.11 -171.3 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.929 -0.578 . . . . 70.33 112.294 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.78 108.1 3.27 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.887 -0.673 . . . . 72.51 113.454 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.01 143.54 2.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.616 0.367 . . . . 62.24 111.119 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -158.11 121.87 4.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.625 0.726 . . . . 60.15 111.818 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.78 153.07 50.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 74.05 110.847 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -151.5 145.0 24.87 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.786 0.327 . . . . 71.4 111.845 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.01 80.15 0.66 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.353 0.597 . . . . 74.24 110.978 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.28 -16.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 75.04 112.377 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.33 103.05 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.992 0.425 . . . . 73.5 111.428 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.4 t -132.83 109.5 9.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.314 -0.403 . . . . 70.43 110.799 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.61 123.88 5.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.725 0.298 . . . . 64.42 110.423 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.5 125.63 7.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.663 0.268 . . . . 74.41 111.663 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -153.0 144.65 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.926 0.393 . . . . 62.0 111.187 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.99 29.99 1.18 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.787 0.327 . . . . 65.23 111.804 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.96 114.42 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.891 0.377 . . . . 73.3 111.791 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -142.43 118.17 10.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.032 -0.531 . . . . 75.54 110.026 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -127.0 100.73 6.26 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.131 0.419 . . . . 73.42 112.131 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -155.4 135.43 12.93 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.567 0.347 . . . . 54.22 111.836 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.3 m80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.012 0.434 . . . . 73.31 111.184 173.776 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.637 0.256 . . . . 74.33 110.77 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.58 155.06 89.89 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.487 -0.324 . . . . 60.43 111.573 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.39 -20.58 54.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.585 2.19 . . . . 70.02 112.654 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.32 124.79 35.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 64.12 111.971 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 62.11 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HA ' HD12 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 62.32 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.02 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.406 ' HA ' ' HD1' ' A' ' 16' ' ' TRP . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 63.31 111.184 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 62.2 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HD1' ' HA ' ' A' ' 12' ' ' SER . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 73.25 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 71.25 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 21.4 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 52.11 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 63.41 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 53.34 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 71.24 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 63.13 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.02 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.402 ' O ' HG13 ' A' ' 107' ' ' ILE . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 31' ' ' THR . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 34.21 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 70.02 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.524 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 72.41 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 51.53 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 74.3 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 43.23 112.555 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 62.34 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 63.01 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 63.33 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.2 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 70.31 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 71.32 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.928 HD11 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 54.13 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 74.32 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 63.42 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 63.22 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 72.45 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 73.13 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 64.12 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 63.51 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 42.13 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 63.14 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 71.11 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 64.02 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 63.34 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 50.43 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.14 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 41.43 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 62.04 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 76' ' ' VAL . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 74.11 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 73.03 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 72.11 113.761 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 63.12 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 61.15 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 61.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 54.15 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 33' ' ' ASN . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp -70.73 -28.92 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 65.25 111.13 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.89 78.35 0.63 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.488 -1.233 . . . . 74.25 110.67 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.3 t -176.54 -38.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.041 -0.981 . . . . 60.01 110.596 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 2.5 mpt_? -86.11 120.29 27.33 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.167 -0.47 . . . . 75.33 111.635 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 3.3 t -88.01 130.52 46.08 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-O 120.838 0.351 . . . . 71.43 111.878 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 3.0 Cg_exo -75.64 98.5 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.811 2.341 . . . . 75.04 112.339 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.74 108.81 13.96 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.986 0.422 . . . . 74.43 111.939 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.31 109.02 0.22 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.261 -0.495 . . . . 72.22 112.913 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.8 158.6 9.1 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.877 0.37 . . . . 32.2 111.676 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -135.47 -169.85 2.48 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.768 0.318 . . . . 71.42 111.419 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.29 159.35 44.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.864 0.69 . . . . 74.34 112.864 -173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -161.97 97.1 1.03 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.973 -0.558 . . . . 73.34 111.455 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -158.04 22.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 65.02 111.401 174.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -90.23 129.33 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.723 0.638 . . . . 75.11 112.723 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.5 t 59.64 104.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 113.786 1.032 . . . . 74.53 113.786 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 t -161.12 99.26 1.2 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.987 -0.551 . . . . 41.21 110.894 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -148.6 146.09 28.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.825 0.345 . . . . 64.22 111.181 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -149.94 131.64 14.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.435 -0.348 . . . . 61.3 110.434 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.53 141.86 19.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.849 0.357 . . . . 74.41 111.352 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -165.75 112.5 0.91 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.003 0.43 . . . . 71.42 112.007 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.88 146.5 45.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 44.13 111.292 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.38 99.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.219 0.533 . . . . 74.4 111.924 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -139.62 103.59 4.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.103 0.477 . . . . 75.23 111.16 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -129.97 96.04 4.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 75.31 110.512 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.238 0.461 0 CA-C-N 116.255 -0.429 . . . . 64.42 110.991 -176.631 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 120.742 0.306 . . . . 72.55 111.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 63.32 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 62.32 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 72.53 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.03 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 70.45 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 62.42 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 71.21 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 62.31 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 42.14 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 65.12 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD21 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 64.34 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.439 HG11 ' HB1' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 51.12 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.505 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 72.11 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 74.15 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.32 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 71.13 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.583 ' SD ' HD22 ' A' ' 24' ' ' LEU . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 53.11 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 63.02 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 73.2 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 44.34 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.458 HD22 ' HB1' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 71.34 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 72.0 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 52.44 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 64.31 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 55.43 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.6 HD11 HD21 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 71.31 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 70.32 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 55.51 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.14 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 73.44 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 64.34 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 71.22 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 64.04 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 54.51 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 52.13 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 64.54 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 72.15 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG13 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 62.2 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 71.11 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.01 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.31 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 51.43 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.436 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.14 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.01 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.11 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 61.05 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 30.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 60.35 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.13 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 61.04 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 62.11 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 54.22 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.32 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 51.52 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 71.24 111.789 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 120.801 0.334 . . . . 55.34 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 90' ' ' LEU . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 71.42 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 65.45 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.597 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 71.21 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.549 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 42.33 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 72.3 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 54.22 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HE ' ' HB2' ' A' ' 29' ' ' ARG . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 65.44 110.815 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.435 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 71.12 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 53.55 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 54.11 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 65.12 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 62.2 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 71.25 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.634 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 64.41 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 73.44 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 65.32 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 73.54 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 74.22 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 70.2 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 74.43 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG2' HD22 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 72.42 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 73.44 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 52.4 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 54.0 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 71.23 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 73.45 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.9 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.66 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 70.53 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.625 HH21 HG12 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 72.43 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 54.4 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 63.34 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 74.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 45.31 111.263 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 65.15 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 54.45 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 65.03 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 63.13 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 61.12 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 14.53 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 63.41 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 71.52 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 65.34 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 71.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 61.25 112.149 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.966 0.413 . . . . 74.42 111.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 42.01 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 64.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 64.02 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.05 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 70.23 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 70.33 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 60.42 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 63.3 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 72.14 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 42.3 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 62.13 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 71.51 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.14 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 72.45 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.2 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 61.32 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HD23 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 73.32 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 74.3 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 74.21 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 82' ' ' ALA . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 71.33 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 42.51 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 65.12 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 70.3 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.701 HD11 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.13 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 71.44 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 72.31 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.683 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 71.13 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 72.42 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 65.41 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HB3' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 72.12 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 41.02 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 61.01 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 52.33 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 71.31 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 52' ' ' ALA . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 55.51 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 71.24 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 70.3 111.647 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 51.13 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 64.13 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 64.31 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.81 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 60.43 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 72.01 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 60.0 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.6 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 42.52 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.81 HG21 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 62.41 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.552 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 65.54 110.579 173.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 73.01 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.0 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 62.24 110.133 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 61.0 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 74.31 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 63.45 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HD2' HD12 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 73.24 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 54.35 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 70.4 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 71.43 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 71.51 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.24 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 70.44 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 71.01 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.502 HG11 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 73.02 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 51.42 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.544 HG22 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 72.32 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 63.13 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.454 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 70.53 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 44.34 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 71.41 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.74 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 54.43 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 73.24 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 43' ' ' MET . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 70.41 113.647 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 53.33 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.571 HD11 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 64.13 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 70.35 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 45.31 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 73.22 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 34.24 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 62.41 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 25.33 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.579 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 74.23 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 50.34 111.36 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 44.21 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 64.34 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 51.34 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 63.11 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 53.0 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 41.23 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 72.02 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 54.54 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 64.3 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 71.33 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.782 ' HG2' HG21 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 64.02 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 64.2 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.11 112.693 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.782 HG21 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 72.21 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 64.24 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 108' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.0 111.617 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 64.5 111.963 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 61.33 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 70.45 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 61.03 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 72.01 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 60.44 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 70.15 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 72.33 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 73.45 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 71.31 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 73.13 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 54.53 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 71.32 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 71.24 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.483 ' HA ' HD13 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 63.31 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 34.12 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 62.34 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 42.24 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 43.14 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.464 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 64.11 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.03 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.43 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 64.11 112.13 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 73.4 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 73.33 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 63.05 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 73.34 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 61.5 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.704 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 60' ' ' ARG . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 61.22 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.14 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 72.11 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 52.43 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.12 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 52.43 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 72.32 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 53.15 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.31 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 53.42 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 74.34 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 64.31 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 61.33 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 62.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.704 ' HB3' HG21 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 71.11 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 70.14 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 62.45 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 63.34 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 65.53 112.295 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 65.01 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 71.1 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 63.45 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 64.35 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 60.1 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 63.35 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 71.52 111.736 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 120.837 0.351 . . . . 74.05 111.704 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 64.02 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 60.04 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 63.54 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 102' ' ' GLY . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 71.43 112.093 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 53.4 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 73.3 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 72.34 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 73.32 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.594 HD22 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 42.24 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 71.43 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 72.44 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 71.15 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 54.54 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 72.13 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 61.1 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 72.02 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.459 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 50.01 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.664 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 71.21 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 60.22 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 65.31 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.532 HD13 HG12 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 54.22 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 65.55 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 44.55 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 65.04 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.724 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 65.15 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 63.4 112.443 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 63.33 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 71.42 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 70.21 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 62.23 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 63.44 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 71.44 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.42 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 51.42 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 45.43 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 60.14 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG13 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 70.13 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 73.13 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 53.24 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 64.33 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.22 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 44.44 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 64.24 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 74.11 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 13.0 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD22 HH12 ' A' ' 27' ' ' ARG . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 73.04 111.743 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 55.2 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 70.53 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 64.5 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 61.22 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 11' ' ' LYS . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.13 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 73.31 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 64.03 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 63.5 111.798 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.31 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 40.22 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 55.31 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 74.02 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 63.41 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 70.24 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 60.22 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 63.34 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 73.11 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.663 ' NH1' HG22 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 71.5 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 63.12 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 63.32 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.663 HG22 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 71.14 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 74.55 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 72.12 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 72.52 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.34 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 71.2 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 54.24 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 53.14 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.1 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 64.4 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 61.05 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 60.21 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 22' ' ' THR . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 52.32 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 70.12 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.32 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 53.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 63.03 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 72.34 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 62.51 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 65.04 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 60.24 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 62.34 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 73.3 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 72.13 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 71.43 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 44.03 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 61.44 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 73.13 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.3 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 73.11 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 71.41 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.05 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 63.11 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.24 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 33.0 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 73.34 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 63.31 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 60.41 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 52.1 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm . . . . . 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 63.55 112.34 176.189 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 42.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 63.55 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 61.53 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 90' ' ' LEU . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 62.11 110.609 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 61.04 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 73.2 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 73.04 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 65.43 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 61.2 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.586 HG21 HD21 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 54.41 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.1 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 48' ' ' LEU . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 53.23 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 55.35 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 65.41 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 72.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.654 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 64.53 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 63.11 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 72.13 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 25.01 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 55.33 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 71.11 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 72.35 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 72.01 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 63.4 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 71.52 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 26' ' ' VAL . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 73.43 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 53.15 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 72.45 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 64.14 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.03 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 71.02 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.32 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 64.42 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 61.55 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 70.43 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 45.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 64.23 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 65.33 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 73.52 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 74.24 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 72.42 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 72.54 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.23 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 74.3 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 44.24 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.02 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 33.13 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.666 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 60.31 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 73.14 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 54.51 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 73.01 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 73.23 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HG2' HG21 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 43.33 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 54.52 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 54.23 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 43.13 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.452 HG21 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 54.34 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.24 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 71.51 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.0 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 62.34 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 65.24 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 63.34 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 63.44 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 60.42 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.02 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 71.21 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 54.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 65.4 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.45 HG21 HD21 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 71.11 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 74.33 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 64.11 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.41 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 61.44 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 32.52 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 63.23 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 63.55 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 54.33 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 54.0 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.545 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 44.22 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.03 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 61.42 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.03 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 62.52 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 72.33 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 71.12 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.608 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 71.43 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 65.23 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 72' ' ' THR . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' HB3' HD23 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.32 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 61.4 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 64.24 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 64.44 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 52.01 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 70.51 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 52.24 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 55.14 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 64.31 111.332 176.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 51.12 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 61.21 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.42 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.02 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 71.01 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.51 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 65.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.31 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 63.12 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 70.03 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 44.24 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 73.53 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 71.23 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 44.12 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 61.42 110.984 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.964 0.411 . . . . 63.34 111.062 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 65.34 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 72.12 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 64.43 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 72.11 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 72.53 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 71.13 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 71.1 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 32.31 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 65.24 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.677 HD22 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HD13 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 51.32 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.2 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 70.31 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 73.24 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.488 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 60.54 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 71.43 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 73.51 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.747 ' HA ' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 60.21 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.49 ' HB2' HD23 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.677 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 64.23 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 70.13 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 54.12 111.143 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 52.24 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 70.31 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.05 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 34.14 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 71.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 54.24 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.742 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 62.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.742 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 60.12 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 71.01 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 70.14 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 73.12 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 64.31 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 44.25 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 17.7 m-70 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 44.22 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 34.32 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 64.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 72.23 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.459 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 15.21 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.427 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.01 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG21 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 54.41 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.802 HG21 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 60.23 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 62.43 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 71.34 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 44.14 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 73.21 111.637 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.958 0.409 . . . . 51.22 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.411 ' O ' HD12 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.33 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.689 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 72.13 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 71.32 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.1 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 73.32 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 63.21 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.534 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 73.33 112.414 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 61.11 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 55.52 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 61.54 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 72.32 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 53.41 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 72.43 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 72.04 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 63.23 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' HA ' HD13 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.462 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 54.31 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 64.42 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 62.01 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 72.53 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 51.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 72.41 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.34 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.494 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD22 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 64.4 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 63.14 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 73.03 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 64.32 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 44.04 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.03 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.637 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 53.51 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 61.3 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.34 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 73.43 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 72.31 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 61.03 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 74.43 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 54.5 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 72.21 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 61.55 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 64.5 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 63.12 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 63.24 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 64.53 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG12 HG13 ' A' ' 76' ' ' VAL . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 41.45 110.775 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 62.23 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 65.12 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 62.22 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 52.24 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 72.4 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 12.51 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 62.44 111.597 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.801 -0.444 . . . . 62.21 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 62.33 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 52.14 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 54.22 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 70.55 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.492 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 72.02 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 31.15 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.34 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 56' ' ' LEU . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 64.42 111.658 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 40.54 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.716 HD21 HD11 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 64.22 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.615 ' NH1' HD22 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.648 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 54.34 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 63.12 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 64.4 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 42.12 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 53.44 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.537 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 63.53 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 61.4 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 73.45 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 65.32 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 64.14 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 62.02 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 63.52 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.692 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 73.03 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 70.32 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 54.43 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 73.15 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 65.22 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 64.14 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 63.04 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 45.11 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 70.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 41.51 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.615 HD22 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 64.02 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 73.33 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 64.22 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 65.43 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 53.54 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 43.24 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 71.13 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.543 HG21 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 54.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 73.04 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 73.03 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 65.41 112.274 -179.843 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.755 0.312 . . . . 70.23 111.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 64.12 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 64.41 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 73.5 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 70.33 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 72.23 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 34.44 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 72.31 112.298 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 61.34 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 73.43 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 54.1 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 55.21 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 72.44 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.15 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 52.5 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 60.25 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 64.44 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 64.21 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 62.43 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 24' ' ' LEU . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 60.03 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 40.11 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.504 HD13 HG12 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 61.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 62.1 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 70.21 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 72.34 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 61.4 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 71.13 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.13 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 64.31 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 61.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 71.45 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 54.04 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 24.34 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 53.11 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 70.5 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 62.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 73.1 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 63.54 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 73.24 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 53.32 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 60.03 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.02 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 71.25 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.11 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 74.33 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 52.24 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 64.52 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 41.41 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 44.43 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 63.25 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 74.24 111.265 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 104' ' ' THR . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 64.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 8' ' ' HIS . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 73.13 111.518 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 51.22 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.462 HG21 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 63.33 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 65.42 111.386 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 63.32 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 61.02 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 61.42 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 62.55 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 73.41 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 72.34 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 71.41 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 72.14 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.468 HG21 HD21 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 52.11 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.537 HG11 ' HB1' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 73.43 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 51.44 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 55.23 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' HH22 ' A' ' 27' ' ' ARG . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 64.33 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.566 ' HB2' HD23 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 52.31 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 62.33 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.33 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 65.22 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 43' ' ' MET . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 60.4 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 82' ' ' ALA . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 64.54 111.795 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 64.34 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 64.21 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 55.2 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 63.13 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 52.34 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 63.24 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 73.24 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 61.4 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 64.55 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 62.23 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 76' ' ' VAL . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 41.11 111.412 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 73.15 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 87' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.2 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 71.3 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 64.1 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 44.21 112.085 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 74.43 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 72.11 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 65.42 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 64.22 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 55.03 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 53.52 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.03 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 55.43 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 71.11 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 54.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 50.51 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 72.4 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.13 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.02 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 72.15 111.649 179.104 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.799 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 21' ' ' PHE . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 73.45 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 72.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 71.11 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.619 HG21 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 70.44 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 72.23 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 53.4 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 61.0 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 HH12 HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 65.44 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 72.24 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 53.34 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 63.12 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.05 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 65.04 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 62.13 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.637 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 72.12 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 53.23 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 62.03 111.99 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.632 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 71.21 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 65.42 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 40.03 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 63.0 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 55.23 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.744 HD11 HD21 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 73.41 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 64.33 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 64.42 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 33.14 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 61.13 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 71.04 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 71.44 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 61.43 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 70.01 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 62.12 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.11 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 71.1 111.796 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.01 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 73.52 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 51.14 111.604 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.799 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.709 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 63.44 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 21.23 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.509 HD22 HH12 ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 65.3 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 72.03 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 32.53 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 33.14 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 62.32 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 110.21 -0.293 . . . . 73.35 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 52.12 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 62.35 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 61.45 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 54.43 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 52.21 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 72.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.14 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 70.11 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 60.03 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 72.42 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 73.32 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 65.25 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 61.21 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 53.55 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.549 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 52.13 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 64.13 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 71.14 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 64.35 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 31.43 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 72.2 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 82' ' ' ALA . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.42 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 31.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 71.32 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 34.1 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.625 HD11 HD21 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 70.42 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 73.3 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 71.33 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 63.41 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 61.21 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 65.34 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 45' ' ' ILE . 3.3 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 63.52 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 71.2 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 54.2 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 72.54 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 32.44 111.653 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 62.01 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 73.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 24.24 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.13 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.56 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 45.42 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 55.12 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 61.31 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 61.45 111.506 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.237 0.442 0 CA-C-O 120.53 0.205 . . . . 64.1 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 45.23 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' HG23 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 52.31 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 52.35 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 53.41 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 72.11 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 70.04 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 63.54 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.14 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 54.35 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 73.21 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.659 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 63.21 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 72.42 110.623 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 71.4 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 62.33 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 53.01 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 34.52 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.77 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD13 HG12 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.11 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.77 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 61.2 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 65.53 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 64.43 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 54.22 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 72.14 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 72' ' ' THR . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 72.1 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 65.04 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.8 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 73.13 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 64.15 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 72.14 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 60.43 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 43.33 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 65.22 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 53.3 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 64.04 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 62.44 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 52.34 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 53.43 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 73.0 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 52.22 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 71.23 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 55.3 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 65.33 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 65.43 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 53.22 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 62.33 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.77 0.319 . . . . 75.21 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 63.2 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.495 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 61.43 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 73.43 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 72.32 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 61.1 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 71.41 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 51.21 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.24 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 20' ' ' ALA . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 62.2 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 72.14 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 64.33 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 53.25 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 62.25 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.43 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 64.44 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 72.03 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 61.24 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 63.34 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.473 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 65.21 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 61.43 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 74.34 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 65.44 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 61.1 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 71.54 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 63.32 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 73.35 111.38 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.57 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 74.33 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 24' ' ' LEU . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 50.11 111.589 -174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.21 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 55.51 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.22 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 73.34 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 4.4 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 52.24 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 51.12 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 72.13 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 64.42 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 71.55 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 53.15 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 61.1 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 63.52 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 61.21 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 43.41 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 65.45 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 44.3 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 71.13 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 63.01 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.522 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 64.33 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.822 HG21 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.468 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 61.22 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 70.31 111.345 174.494 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.81 0.338 . . . . 61.01 111.609 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 71.44 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 43.54 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 64.42 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 72.32 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 65.51 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 61.22 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 62.41 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 62.34 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 74.41 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.653 HD22 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 71.43 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 63.24 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 53.02 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 71.25 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 62.44 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 73.21 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 33.33 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 72.35 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.653 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.03 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.55 HD13 HG12 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.2 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 52.45 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD11 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 65.51 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.673 ' HG2' ' H ' ' A' ' 59' ' ' SER . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.673 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 72.14 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 73.14 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 53.41 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 50.44 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 61.44 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 63.31 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 54.3 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 73.4 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.41 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 71.23 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 61.33 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 55.44 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 52.13 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.504 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 52.31 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 55.33 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 45.41 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD22 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 64.5 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 74.34 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 74.42 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 65.23 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.633 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 35.15 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 74.11 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 34' ' ' ASP . 1.7 mp . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 64.05 112.319 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 64.12 111.971 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 62.11 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HA ' HD12 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 62.32 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.02 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.406 ' HA ' ' HD1' ' A' ' 16' ' ' TRP . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 63.31 111.184 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 62.2 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HD1' ' HA ' ' A' ' 12' ' ' SER . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 73.25 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 71.25 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 21.4 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 52.11 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 63.41 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 53.34 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 71.24 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 63.13 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.02 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.402 ' O ' HG13 ' A' ' 107' ' ' ILE . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 31' ' ' THR . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 34.21 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 70.02 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.524 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 72.41 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 51.53 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 74.3 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 43.23 112.555 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 62.34 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 63.01 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 63.33 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.2 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 70.31 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 71.32 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.928 HD11 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 54.13 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 74.32 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 63.42 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 63.22 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 72.45 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 73.13 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 64.12 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 63.51 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 42.13 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 63.14 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 71.11 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 64.02 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 63.34 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 50.43 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.14 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 41.43 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 62.04 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 76' ' ' VAL . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 74.11 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 73.03 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 72.11 113.761 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 63.12 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 61.15 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 61.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 54.15 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 33' ' ' ASN . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 65.25 111.13 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.971 0.415 . . . . 64.33 111.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.72 154.43 45.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.28 -0.418 . . . . 71.24 111.669 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.66 -26.84 13.72 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 123.38 2.72 . . . . 73.42 115.066 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -129.07 115.19 17.37 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.023 -0.423 . . . . 72.55 111.704 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -117.61 134.11 55.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.766 0.317 . . . . 63.32 111.517 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.5 t70 -71.69 158.41 36.21 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.948 0.404 . . . . 75.12 110.64 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.654 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.03 -51.13 67.25 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.784 0.661 . . . . 71.24 112.784 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.6 p-80 -73.63 -25.53 60.34 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.692 0.627 . . . . 62.32 112.692 -176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 6' ' ' ASP . 95.6 t -57.53 -50.21 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.039 0.447 . . . . 73.13 110.214 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -67.24 -42.61 83.69 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.157 -0.474 . . . . 73.22 111.064 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.6 tttt -57.28 -44.7 84.22 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.055 0.455 . . . . 72.53 111.743 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 m -73.05 -39.69 65.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.356 0.598 . . . . 75.55 110.086 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -63.27 -27.52 69.4 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.691 -0.686 . . . . 74.03 111.314 174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.7 tp -76.7 -52.36 9.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.828 0.347 . . . . 70.45 111.548 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.64 -51.42 7.76 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.12 0.486 . . . . 62.42 112.204 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -88.31 -37.91 15.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.62 0.6 . . . . 74.13 112.62 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.85 -162.97 36.09 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.044 -0.598 . . . . 71.24 113.495 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 5.0 mp0 -92.14 136.37 25.95 Favored Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 122.554 0.342 . . . . 71.21 110.949 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.3 Cg_exo -64.54 -88.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.219 1.946 . . . . 62.31 112.483 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 48.77 22.2 0.51 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.785 0.661 . . . . 71.01 112.785 -177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -131.65 159.1 39.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.239 0.542 . . . . 42.14 112.109 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -123.11 119.84 31.49 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.84 -0.618 . . . . 75.11 110.807 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.61 123.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 120.642 0.258 . . . . 65.12 111.222 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD21 HD11 ' A' ' 56' ' ' LEU . 63.1 mt -107.09 130.2 54.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.947 0.403 . . . . 64.34 111.764 -178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -88.98 104.36 16.9 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.04 -0.527 . . . . 73.43 110.456 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.439 HG11 ' HB1' ' A' ' 75' ' ' ALA . 33.9 m -102.17 5.14 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 111.9 0.333 . . . . 51.12 111.9 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.505 ' NH1' HG22 ' A' ' 31' ' ' THR . 69.7 mtm180 -64.62 -69.26 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 72.11 110.94 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -171.32 154.48 3.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.459 -0.791 . . . . 75.55 110.07 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 tpt85 -58.24 -47.21 84.25 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-O 121.559 0.695 . . . . 74.15 110.828 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -67.12 -47.67 70.42 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.803 -0.635 . . . . 75.24 110.66 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.505 HG22 ' NH1' ' A' ' 27' ' ' ARG . 27.9 m -60.22 -32.23 70.91 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.196 -0.456 . . . . 64.12 111.512 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -57.09 -50.43 72.79 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.095 0.474 . . . . 73.32 110.204 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -64.17 -42.1 96.85 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.361 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.546 ' HA ' HD13 ' A' ' 108' ' ' ILE . 15.8 t70 -53.49 -48.9 68.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.141 0.576 . . . . 71.43 111.519 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . 179.81 118.08 0.57 Allowed Glycine 0 C--O 1.22 -0.725 0 C-N-CA 120.573 -0.822 . . . . 71.54 112.986 174.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -128.81 170.63 13.13 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.357 0.579 . . . . 71.13 111.86 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.8 mt -66.2 142.6 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.684 0.278 . . . . 74.25 110.867 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.7 ttm -62.27 111.68 2.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.863 0.364 . . . . 63.35 111.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.67 48.7 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.239 -0.505 . . . . 72.22 113.613 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.12 145.76 54.77 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.2 ptm -110.08 152.09 26.4 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 75.53 112.071 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.8 109.72 13.3 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.282 0.845 . . . . 74.43 113.282 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.583 ' SD ' HD22 ' A' ' 24' ' ' LEU . 56.1 mtt -143.19 86.35 9.17 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.085 -0.507 . . . . 53.11 110.276 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -64.52 135.85 47.69 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.656 2.237 . . . . 63.02 110.6 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.8 tt -44.82 -33.34 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 114.338 1.236 . . . . 73.2 114.338 -166.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.08 -37.11 61.66 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.819 -0.551 . . . . 44.34 111.826 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -91.5 -9.49 44.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.147 0.499 . . . . 72.4 110.839 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.458 HD22 ' HB1' ' A' ' 75' ' ' ALA . 63.9 tp -44.93 -58.14 3.34 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.742 1.016 . . . . 75.3 113.742 -175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.9 t -55.59 -53.18 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.042 0.449 . . . . 71.34 111.866 -175.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.65 -48.98 79.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.022 -0.536 . . . . 73.34 112.02 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 14.6 mmt180 -53.5 -53.89 45.0 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.186 0.517 . . . . 72.0 111.731 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.25 77.0 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.034 -0.53 . . . . 52.44 111.717 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -56.0 -33.7 65.12 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.233 0.539 . . . . 64.31 111.529 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -78.23 -15.58 58.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.773 0.657 . . . . 73.41 112.773 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -131.99 -60.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.626 0.602 . . . . 55.43 112.626 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.6 HD11 HD21 ' A' ' 24' ' ' LEU . 66.0 mt -79.67 148.22 31.68 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.383 0.512 . . . . 71.31 112.383 -173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -90.28 168.42 11.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.995 0.426 . . . . 74.22 110.646 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 29.7 mmtp -74.55 -23.23 58.76 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.031 0.443 . . . . 70.32 111.74 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.0 p -95.19 4.27 53.76 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.106 0.41 . . . . 55.51 112.106 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 9.0 tpp180 -69.64 126.64 30.34 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 122.375 -0.203 . . . . 71.14 110.71 175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 95.25 0.36 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.608 0.718 . . . . 73.44 110.398 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.3 mt -101.31 124.77 55.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.682 -0.69 . . . . 64.34 112.25 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -107.79 117.15 33.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.363 0.602 . . . . 75.04 110.27 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.2 t -104.78 136.79 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.878 -0.601 . . . . 70.13 111.132 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -137.65 131.02 30.88 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.595 0.712 . . . . 71.22 111.885 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -114.66 -170.34 16.57 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.198 -0.91 . . . . 64.04 112.234 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.07 -45.28 92.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.1 0.476 . . . . 54.51 110.926 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -130.53 173.91 19.91 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.864 -0.607 . . . . 70.41 112.143 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.09 -33.43 72.08 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.37 0.507 . . . . 73.25 112.37 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.76 -53.26 59.99 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.858 0.361 . . . . 52.13 111.767 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -62.89 -41.41 99.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.254 0.55 . . . . 75.31 110.736 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 35.5 m -59.79 -54.3 47.88 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.556 -0.747 . . . . 72.52 111.369 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -63.85 -40.57 96.9 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.802 -0.635 . . . . 64.54 112.063 -177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -64.55 -43.21 94.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.899 0.381 . . . . 72.31 111.1 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.531 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.84 -47.74 84.52 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.258 0.552 . . . . 72.15 111.004 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG13 HG12 ' A' ' 87' ' ' VAL . 79.2 t -52.43 -45.15 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.76 -0.655 . . . . 62.24 111.46 173.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -54.9 -50.57 68.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.462 0.649 . . . . 62.2 111.006 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 75' ' ' ALA . 37.6 mt -58.51 -36.82 74.4 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.324 -0.853 . . . . 65.45 112.312 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 65.2 mt -70.2 -53.43 17.12 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.876 0.324 . . . . 75.03 111.876 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 9.6 ptp180 -65.75 -22.86 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.489 -0.485 . . . . 71.11 111.189 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.9 t -64.12 -36.39 83.88 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.053 0.454 . . . . 73.01 110.646 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.468 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.34 4.58 20.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.0 -0.546 . . . . 73.31 112.134 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 107.77 -19.88 32.54 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.981 -0.628 . . . . 51.43 114.052 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.436 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -55.2 120.18 6.63 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.431 0.634 . . . . 71.14 112.286 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.42 -56.45 4.32 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.639 -0.709 . . . . 73.25 111.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 21.4 m170 -88.16 82.34 7.15 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.834 0.35 . . . . 75.52 111.387 -173.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 76' ' ' VAL . 25.0 t -132.84 119.87 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.687 0.28 . . . . 73.05 111.083 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.0 t -120.16 142.51 48.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.257 -0.429 . . . . 70.01 111.977 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -88.55 122.57 32.15 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.081 0.467 . . . . 64.11 111.025 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.4 tp -74.94 89.49 2.38 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.267 0.556 . . . . 72.23 110.04 175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -60.0 125.31 23.15 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.856 -0.611 . . . . 61.05 112.279 -173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 107.9 -24.87 22.38 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.817 -0.628 . . . . 62.14 112.914 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.67 -168.3 54.79 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.199 -0.524 . . . . 30.1 113.574 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HD3' ' A' ' 98' ' ' LYS . 58.4 tp -62.15 -43.68 98.3 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.547 -0.384 . . . . 60.35 111.928 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.96 44.02 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.246 0.462 . . . . 74.13 112.246 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.96 -49.52 36.69 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.953 0.406 . . . . 71.12 110.811 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -50.18 -42.54 51.4 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.411 0.624 . . . . 70.41 111.076 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 94' ' ' LEU . 42.1 mtpt -78.12 -34.81 49.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.842 -0.617 . . . . 74.51 111.919 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.24 -28.71 68.94 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 111.945 0.35 . . . . 61.04 111.945 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.9 pt -89.56 4.61 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.049 0.452 . . . . 74.04 111.142 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 44.06 46.65 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.455 -0.402 . . . . 62.11 113.749 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -84.84 152.44 27.26 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.447 -0.406 . . . . 73.12 113.624 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.83 122.29 10.31 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.828 2.352 . . . . 74.52 112.709 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.421 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.5 p -127.5 165.62 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.73 0.776 . . . . 54.22 112.829 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.0 174.47 10.59 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.96 -1.018 . . . . 72.32 110.229 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.533 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 142.93 -178.16 21.42 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.657 -0.782 . . . . 51.52 113.556 177.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.5 mt -93.72 -50.66 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 120.838 0.352 . . . . 72.33 110.696 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.38 -27.79 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.286 0.565 . . . . 71.24 111.789 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -57.67 -17.22 13.61 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.289 0.566 . . . . 61.55 110.641 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.1 m -99.81 -59.67 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.705 -0.68 . . . . 75.34 111.003 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -92.67 127.93 38.34 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.21 0.529 . . . . 41.2 111.755 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.9 p -123.27 151.39 62.3 Favored Pre-proline 0 N--CA 1.474 0.767 0 CA-C-N 116.269 -0.423 . . . . 73.4 111.625 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.43 97.46 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.527 2.151 . . . . 64.33 112.552 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.69 159.42 44.01 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.95 -0.568 . . . . 25.41 111.55 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.63 90.65 0.8 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.33 -0.462 . . . . 65.12 112.732 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.29 122.55 1.52 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.552 0.575 . . . . 71.44 112.552 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -168.05 121.48 0.9 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.092 0.557 . . . . 65.12 109.922 173.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -143.98 108.74 4.91 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.651 0.611 . . . . 72.12 112.651 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -150.76 86.4 1.38 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.23 0.538 . . . . 74.22 110.916 168.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -120.34 75.83 1.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.227 0.537 . . . . 75.0 110.098 174.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.4 t -136.6 115.84 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.908 -0.587 . . . . 74.54 111.344 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 25.9 m -101.61 125.93 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 116.293 -0.412 . . . . 73.35 110.794 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.0 t -110.37 101.16 9.91 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.002 0.371 . . . . 34.35 112.002 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -167.56 111.46 0.67 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.397 -0.365 . . . . 72.21 110.365 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 24.5 tp -110.88 159.66 17.49 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.728 -0.214 . . . . 71.1 110.819 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -135.98 133.56 37.66 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 122.305 -0.247 . . . . 74.43 110.807 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -138.87 69.66 1.37 Allowed 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.366 0.603 . . . . 70.21 112.51 -175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -69.53 144.43 53.13 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.598 0.592 . . . . 75.13 112.598 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -145.1 179.69 7.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.016 -0.538 . . . . 71.14 110.798 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 67.88 102.56 0.05 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.61 0.596 . . . . 72.33 112.61 176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -148.0 151.84 36.45 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.92 0.39 . . . . 64.51 111.24 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.391 0.615 . . . . 75.34 110.745 177.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 22.8 ptp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.531 0.205 . . . . 73.02 110.906 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -65.41 143.04 98.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-O 120.743 0.306 . . . . 63.43 111.741 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.8 -60.43 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.888 2.392 . . . . 43.43 112.977 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.1 110.96 21.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.373 -0.376 . . . . 55.34 110.833 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 90' ' ' LEU . 61.4 p -92.07 137.88 32.0 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.909 0.385 . . . . 75.43 111.191 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.7 t70 -84.68 156.21 21.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.908 0.385 . . . . 72.14 111.06 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.49 -51.18 65.89 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.759 0.652 . . . . 73.14 112.759 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -74.14 -25.68 59.89 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.73 -0.606 . . . . 71.42 112.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG23 ' HB3' ' A' ' 6' ' ' ASP . 76.0 t -60.75 -50.41 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.094 0.473 . . . . 65.45 110.293 171.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.35 -46.87 81.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.318 -0.401 . . . . 71.44 111.223 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.69 -48.45 75.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.855 0.36 . . . . 75.52 111.652 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.7 p -62.41 -34.55 76.97 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.504 -0.316 . . . . 72.01 111.737 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.597 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 46.6 mtp180 -73.89 -33.33 63.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.948 0.404 . . . . 71.21 111.511 176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 53.6 tp -65.66 -44.88 84.95 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.354 -0.384 . . . . 73.44 111.578 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 77.6 mt-10 -87.62 -52.7 5.18 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.288 0.566 . . . . 73.34 111.899 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.549 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 18.3 m95 -98.03 -37.07 9.91 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.092 -0.503 . . . . 75.15 112.171 -171.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.38 -129.1 0.32 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.429 -0.351 . . . . 42.33 113.264 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -112.77 109.11 53.17 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 122.332 -0.511 . . . . 72.14 111.177 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.04 14.83 0.51 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 123.399 2.733 . . . . 74.31 113.493 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.26 6.03 24.38 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.709 0.633 . . . . 74.32 112.709 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 5.4 p90 -93.05 158.85 15.57 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.7 0.286 . . . . 74.32 110.737 177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 t -103.25 142.37 34.3 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.762 0.315 . . . . 70.43 111.257 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.8 mt -113.12 119.09 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.253 -0.277 . . . . 72.3 110.253 176.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 HD11 ' A' ' 56' ' ' LEU . 49.0 mt -106.52 123.54 48.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 63.04 112.272 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -83.94 121.87 27.97 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.686 -0.688 . . . . 54.22 110.365 170.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG11 ' HB1' ' A' ' 75' ' ' ALA . 27.0 m -115.05 17.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.13 0.418 . . . . 73.43 112.13 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 58.3 mtm180 -71.91 -69.59 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.644 0.259 . . . . 70.1 110.868 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -174.5 157.38 2.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.424 -0.353 . . . . 73.22 110.953 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HE ' ' HB2' ' A' ' 29' ' ' ARG . 7.8 tpp180 -50.08 -49.41 51.55 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 122.081 0.943 . . . . 65.44 110.815 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -70.3 -39.6 74.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.725 -1.125 . . . . 74.4 111.316 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.435 HG22 ' NH1' ' A' ' 27' ' ' ARG . 20.9 m -67.76 -31.21 70.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.048 -0.523 . . . . 75.14 111.183 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HB2' ' OD2' ' A' ' 25' ' ' ASP . 72.1 t80 -59.38 -53.31 59.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.293 0.568 . . . . 71.12 110.281 171.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.491 ' HB3' HD12 ' A' ' 107' ' ' ILE . 91.6 m-20 -61.27 -35.82 78.34 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.626 -0.715 . . . . 53.55 111.618 177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HA ' HG12 ' A' ' 108' ' ' ILE . 12.8 t70 -63.83 -47.13 82.04 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.004 0.43 . . . . 65.51 111.202 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.46 147.51 10.3 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.156 -0.545 . . . . 54.11 112.391 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -160.57 162.03 32.78 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 117.794 0.797 . . . . 74.41 112.089 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -62.58 140.27 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.638 -0.256 . . . . 75.11 110.445 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -58.07 123.69 16.78 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.021 0.438 . . . . 74.4 111.557 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 20.78 76.28 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.187 -0.53 . . . . 54.42 113.446 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.94 19.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.331 0.586 . . . . 65.12 111.957 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mmm -98.56 158.89 15.31 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.676 -0.693 . . . . 62.2 111.629 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.79 97.72 8.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.948 0.404 . . . . 71.25 111.483 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.634 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 46.0 mtt -139.37 82.56 18.66 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-O 121.576 0.703 . . . . 64.41 111.269 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -68.68 142.34 52.7 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.423 2.082 . . . . 73.44 111.841 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.5 tt -47.28 -29.52 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 114.59 1.33 . . . . 74.52 114.59 -166.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.44 -29.34 21.5 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.703 -0.623 . . . . 63.22 112.539 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -95.35 -5.96 42.18 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.365 0.603 . . . . 74.43 110.859 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.442 HD22 ' HB1' ' A' ' 75' ' ' ALA . 60.4 tp -50.87 -64.36 0.84 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.089 1.144 . . . . 65.32 114.089 -173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.74 -52.97 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.46 0.541 . . . . 74.11 112.46 -174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -60.06 -48.98 79.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.784 0.326 . . . . 73.54 111.421 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.82 -55.51 22.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.157 0.503 . . . . 74.22 111.761 177.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.65 95.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.205 -0.452 . . . . 75.34 111.414 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 t -64.51 -19.49 65.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.857 0.36 . . . . 74.12 111.831 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.2 t -95.12 -45.84 7.04 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.047 0.388 . . . . 72.32 112.047 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m -91.57 -40.05 11.56 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.861 0.689 . . . . 74.34 112.861 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 24' ' ' LEU . 84.5 mt -106.44 155.74 19.25 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.524 0.564 . . . . 70.2 112.524 -171.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -87.39 179.89 6.5 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.444 0.64 . . . . 74.35 111.425 174.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.92 -34.12 19.47 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.023 0.916 . . . . 75.24 109.606 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -84.28 -3.44 58.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.144 -0.935 . . . . 74.43 111.733 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HG2' HD22 ' A' ' 56' ' ' LEU . 21.8 tpp180 -67.47 128.49 36.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.392 -0.367 . . . . 73.23 111.07 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.35 107.19 3.2 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.38 0.609 . . . . 72.42 111.076 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 60' ' ' ARG . 72.0 mt -115.02 126.09 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.654 . . . . 73.44 112.64 -173.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -112.67 121.88 46.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.248 -0.433 . . . . 75.51 110.322 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 79' ' ' LEU . 92.2 t -111.42 141.36 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.385 0.513 . . . . 74.03 112.385 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -138.69 130.02 27.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.548 0.69 . . . . 75.2 111.748 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.75 -164.03 23.3 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.69 -0.686 . . . . 65.13 112.175 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.9 -31.06 31.61 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.275 -0.544 . . . . 52.4 110.689 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.58 175.09 22.26 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.652 -0.704 . . . . 73.12 112.74 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.13 -51.39 64.4 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.56 0.578 . . . . 54.0 112.56 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -56.95 -52.11 66.51 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.951 0.405 . . . . 71.23 111.657 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 60.0 tt0 -59.63 -42.99 93.99 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.077 0.465 . . . . 73.22 111.163 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 76' ' ' VAL . 59.4 m -65.34 -55.19 19.62 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.956 -0.566 . . . . 73.45 111.821 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.8 m -64.97 -41.06 95.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.268 -0.424 . . . . 74.53 112.107 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.9 tt0 -63.63 -45.06 91.97 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.769 0.318 . . . . 71.04 111.237 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.558 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.41 -50.53 72.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.191 0.519 . . . . 70.42 111.145 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.66 HG13 HG12 ' A' ' 87' ' ' VAL . 77.9 t -58.31 -33.44 47.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.934 -0.576 . . . . 75.42 111.576 174.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 9.4 t30 -63.05 -45.7 90.98 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.507 0.67 . . . . 71.53 110.394 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.0 mt -63.51 -41.29 98.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 70.53 111.469 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 64' ' ' VAL . 64.3 mt -67.33 -49.24 64.92 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.008 0.373 . . . . 74.51 112.008 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.625 HH21 HG12 ' A' ' 76' ' ' VAL . 14.1 ptp180 -60.8 -37.68 82.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.12 0.486 . . . . 72.43 110.142 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.2 t -65.74 -29.47 70.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.965 0.412 . . . . 54.4 110.831 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.98 22.53 0.93 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.347 -0.388 . . . . 63.23 111.856 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.66 -23.64 12.53 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.049 -0.596 . . . . 74.43 114.247 171.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -50.63 108.27 0.22 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.456 0.646 . . . . 63.34 112.646 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.8 mt-10 -62.74 -54.1 44.31 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.434 -0.803 . . . . 74.11 111.917 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 11.9 m-70 -96.7 86.27 4.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.243 0.46 . . . . 75.45 112.243 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.66 HG12 HG13 ' A' ' 76' ' ' VAL . 19.6 t -135.7 131.07 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.917 0.389 . . . . 73.21 111.52 176.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.432 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 44.2 t -124.96 150.27 46.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.97 0.414 . . . . 45.31 111.263 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.543 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -102.73 126.01 49.68 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.035 0.445 . . . . 74.0 111.348 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 7' ' ' ALA . 38.5 tp -82.62 136.11 34.88 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.4 0.619 . . . . 65.15 111.999 -176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.7 mmpt? -88.05 147.78 24.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.99 -0.55 . . . . 70.13 111.238 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.86 -57.14 4.95 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.402 -0.428 . . . . 54.45 113.064 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.76 -160.1 21.69 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.17 -0.538 . . . . 70.14 112.906 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -57.56 -50.82 71.86 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.149 0.425 . . . . 65.03 112.149 -177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.57 -42.78 64.78 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.568 0.581 . . . . 73.12 112.568 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.35 72.51 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.886 0.374 . . . . 63.13 111.112 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -49.73 -41.89 44.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.691 0.758 . . . . 74.52 110.719 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -77.58 -32.73 53.89 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.342 -0.844 . . . . 61.12 112.117 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.71 -36.66 81.03 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.889 0.376 . . . . 14.53 111.616 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.5 pt -79.4 -1.13 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.006 0.431 . . . . 63.41 111.525 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.13 41.24 8.68 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.462 -0.399 . . . . 43.44 113.524 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -88.44 158.98 29.25 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.415 -0.421 . . . . 71.52 113.342 175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.89 130.23 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.121 2.547 . . . . 65.34 113.062 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.2 p -135.61 159.75 40.63 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.569 0.581 . . . . 71.33 112.569 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -141.25 157.82 44.73 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.789 -0.642 . . . . 73.01 110.966 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.66 156.8 9.85 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.956 -0.64 . . . . 43.31 113.606 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 33' ' ' ASN . 48.4 mt -60.34 -38.7 78.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.909 0.385 . . . . 75.2 110.845 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.528 HG12 ' HA ' ' A' ' 34' ' ' ASP . 35.5 mm -85.11 -36.67 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.003 0.43 . . . . 61.25 112.149 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.46 86.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.441 0.639 . . . . 73.15 111.005 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.5 t -159.35 -58.76 0.07 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.652 -0.703 . . . . 64.3 111.631 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.645 ' HD3' ' H ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -104.6 151.71 23.32 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.961 0.41 . . . . 62.45 111.453 -177.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 8.1 m -140.3 35.17 0.22 Allowed Pre-proline 0 CA--C 1.567 1.62 0 N-CA-C 113.25 0.833 . . . . 74.12 113.25 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 112' ' ' THR . 32.0 Cg_endo -65.03 83.99 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.247 2.631 . . . . 71.21 113.532 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.6 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.868 -0.605 . . . . 53.03 110.823 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 141.62 -13.73 2.7 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.74 -0.743 . . . . 63.12 113.899 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.78 116.64 15.72 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.098 0.449 . . . . 71.12 111.297 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -175.11 124.6 0.25 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.613 0.227 . . . . 74.11 111.613 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -166.33 146.64 6.19 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.325 0.584 . . . . 73.14 112.482 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 12.3 t80 179.36 90.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.163 -0.926 . . . . 75.13 110.047 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -133.15 11.94 4.23 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.049 -0.523 . . . . 71.12 111.666 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.9 110.87 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.001 0.429 . . . . 64.15 111.704 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.92 144.58 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.163 -0.471 . . . . 73.11 110.865 176.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 t -128.49 110.02 11.92 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.77 0.319 . . . . 73.02 111.766 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.99 155.73 28.06 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.837 0.351 . . . . 63.15 110.936 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.8 tp -145.83 144.45 30.26 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.749 0.309 . . . . 73.21 111.219 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -151.13 137.18 18.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.63 0.252 . . . . 65.41 111.622 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.34 115.21 1.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.989 0.423 . . . . 74.34 111.449 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -145.36 110.46 5.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.338 0.59 . . . . 71.23 111.352 174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -166.44 119.96 1.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.914 -0.585 . . . . 62.41 110.607 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -146.96 21.33 1.25 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.036 0.384 . . . . 74.41 112.036 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -73.55 82.95 1.51 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.13 0.491 . . . . 71.43 110.825 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.1 t60 . . . . . 0 C--O 1.236 0.388 0 CA-C-O 121.137 0.494 . . . . 75.45 111.067 -178.101 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 110.642 -0.133 . . . . 53.25 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -60.38 147.79 81.44 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 112.098 0.407 . . . . 70.15 112.098 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.61 -53.59 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.841 2.361 . . . . 73.54 112.206 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -121.07 118.76 30.58 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.222 -0.445 . . . . 74.42 111.719 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.2 t -98.12 129.78 44.92 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.444 -0.344 . . . . 73.11 111.057 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -69.73 141.92 53.38 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.673 0.273 . . . . 74.52 110.92 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.39 -44.76 72.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.981 0.42 . . . . 70.22 111.723 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' ILE . 26.9 t60 -63.88 -46.11 86.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.243 -0.435 . . . . 73.43 111.463 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.11 -38.43 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 120.668 0.271 . . . . 42.01 111.383 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.32 -41.01 86.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.726 0.298 . . . . 64.44 110.988 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.6 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 75.3 tttt -59.15 -43.97 92.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.042 0.449 . . . . 64.02 111.135 176.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -69.4 -39.03 78.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.538 0.685 . . . . 74.05 110.131 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 63' ' ' TYR . 17.6 ttm180 -66.19 -27.1 67.74 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.533 -0.758 . . . . 74.32 111.647 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -77.9 -58.05 3.47 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 122.274 -0.266 . . . . 74.34 111.377 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -77.29 -36.94 53.73 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.606 0.595 . . . . 70.23 112.606 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -104.13 3.82 33.47 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.049 0.388 . . . . 70.33 112.049 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -120.1 -114.77 2.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.723 -0.751 . . . . 72.3 113.497 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 14.2 tp10 -155.53 118.08 2.37 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.797 -0.237 . . . . 74.3 110.874 -175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 10.2 Cg_exo -73.01 46.5 1.11 Allowed 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.386 2.724 . . . . 60.42 114.059 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 -9.46 59.44 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.204 0.526 . . . . 63.3 111.494 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -94.19 158.51 15.57 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.801 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.7 m -114.26 120.1 39.26 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.353 -0.385 . . . . 72.14 111.723 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.21 129.93 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.648 0.261 . . . . 73.04 111.543 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 56' ' ' LEU . 63.5 mt -111.68 130.91 55.62 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.037 0.446 . . . . 74.12 112.028 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -93.07 103.3 15.61 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.895 -0.593 . . . . 42.3 110.38 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 75' ' ' ALA . 32.5 m -98.63 8.82 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.837 0.68 . . . . 62.13 112.837 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 60.8 mtm180 -67.78 -62.62 1.32 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.06 0.457 . . . . 71.51 110.275 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -179.42 156.77 0.75 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.555 -0.748 . . . . 74.3 111.019 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -62.38 -42.49 99.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.152 0.501 . . . . 75.14 111.034 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.1 m -80.76 -41.95 22.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.234 -0.439 . . . . 63.35 110.714 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 ' NH1' ' A' ' 27' ' ' ARG . 31.7 m -58.48 -36.75 74.21 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.982 0.42 . . . . 72.54 110.627 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 60.6 t80 -55.69 -49.99 71.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.908 0.385 . . . . 70.44 110.289 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -58.78 -45.8 88.97 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.373 -0.376 . . . . 63.12 111.38 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG13 ' A' ' 108' ' ' ILE . 75.7 m-20 -58.53 -48.43 80.86 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.498 0.555 . . . . 73.14 112.498 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -163.76 130.56 2.24 Favored Glycine 0 C--O 1.215 -1.07 0 C-N-CA 120.472 -0.871 . . . . 62.53 112.13 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 47.9 p-80 -153.2 163.87 39.1 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.975 0.887 . . . . 73.4 112.09 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.4 mt -63.97 141.83 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.837 0.351 . . . . 72.45 110.539 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.8 ttm -60.75 117.63 5.63 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.321 0.489 . . . . 75.2 112.321 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.21 28.49 58.09 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.94 -0.573 . . . . 71.43 114.176 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.05 179.25 7.01 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.224 0.535 . . . . 61.32 112.022 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.551 ' HB2' HD23 ' A' ' 24' ' ' LEU . 73.0 mmm -104.72 144.66 31.43 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.077 -0.51 . . . . 70.32 111.774 175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.28 94.39 8.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.33 -0.395 . . . . 70.33 111.319 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.435 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 48.1 mtt -132.67 91.7 29.22 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-O 121.256 0.55 . . . . 74.33 111.614 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.15 132.7 28.56 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.502 2.135 . . . . 75.21 111.092 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -44.56 -31.06 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 114.099 1.148 . . . . 73.32 114.099 -168.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -76.5 -38.22 55.55 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.126 0.417 . . . . 60.13 112.126 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.44 -9.69 43.66 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 122.281 -0.262 . . . . 74.3 111.621 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -44.02 -54.99 4.98 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.089 0.774 . . . . 74.21 113.089 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 82' ' ' ALA . 81.6 t -54.28 -52.7 36.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 111.997 0.369 . . . . 74.42 111.997 -177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.12 -47.16 78.13 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.61 0.243 . . . . 71.33 111.554 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 10.3 mmp_? -52.4 -55.77 19.44 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.62 0.724 . . . . 75.33 111.304 178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB1' ' CZ ' ' A' ' 84' ' ' PHE . . . -66.86 -47.51 71.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.546 -0.752 . . . . 42.51 111.742 -176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -57.92 -31.92 67.27 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.111 0.482 . . . . 65.12 111.917 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -86.9 -13.76 43.86 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.319 0.489 . . . . 70.3 112.319 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 m -125.97 -58.59 1.38 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.12 0.785 . . . . 60.14 113.12 -171.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.701 HD11 HD21 ' A' ' 24' ' ' LEU . 90.9 mt -83.63 155.04 23.4 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.258 0.836 . . . . 64.13 113.258 -171.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 59' ' ' SER . 40.8 tt0 -86.93 140.13 29.92 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.586 -0.734 . . . . 71.44 111.351 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' HA ' ' CD1' ' A' ' 84' ' ' PHE . 33.3 mmtp -61.98 -25.7 67.78 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.985 0.421 . . . . 72.31 111.955 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.683 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.5 p -98.52 -2.1 39.58 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.496 0.554 . . . . 62.53 112.496 -177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 15.1 tpp180 -69.19 127.83 34.46 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.544 -0.097 . . . . 71.13 111.011 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.475 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 26.9 m-20 -66.87 103.2 1.08 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.424 0.631 . . . . 72.42 111.276 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 60' ' ' ARG . 86.1 mt -107.09 139.94 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.758 -0.655 . . . . 65.41 112.327 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 77.6 m-85 -115.48 121.13 41.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.382 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 79' ' ' LEU . 71.4 t -108.12 135.84 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.457 -0.338 . . . . 73.24 111.886 -176.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HB3' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -137.16 131.16 32.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.496 0.665 . . . . 72.12 111.997 177.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.01 -165.39 21.4 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.678 -0.692 . . . . 62.51 112.34 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.13 -15.42 57.13 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.083 0.468 . . . . 41.02 110.87 174.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.26 162.36 30.96 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.164 -0.471 . . . . 61.42 113.124 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.2 -48.68 34.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.363 0.665 . . . . 74.23 112.48 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.0 -48.15 81.6 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.433 -0.349 . . . . 75.52 111.855 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -58.55 -44.87 89.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.964 0.412 . . . . 73.53 110.896 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 76' ' ' VAL . 97.3 m -56.88 -54.07 50.76 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.175 -0.466 . . . . 72.3 111.049 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.2 t -56.06 -49.27 74.23 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 116.063 -0.517 . . . . 74.44 112.374 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -65.56 -43.12 90.85 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.248 -0.433 . . . . 62.43 111.354 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.0 -49.38 77.67 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.995 0.426 . . . . 61.01 111.526 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.65 HG21 ' HG2' ' A' ' 89' ' ' GLU . 80.6 t -54.86 -36.69 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.126 -0.488 . . . . 75.31 111.537 175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.65 -46.73 84.33 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.289 0.566 . . . . 74.21 110.725 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.629 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.3 mt -57.58 -40.83 79.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 52.33 112.054 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HD12 ' A' ' 24' ' ' LEU . 69.5 mt -65.23 -52.81 52.3 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.009 0.374 . . . . 72.33 112.009 176.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 19.6 ptp180 -62.04 -32.42 72.92 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.012 0.434 . . . . 75.32 110.601 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.941 0.401 . . . . 71.31 110.791 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.71 3.42 33.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.176 -0.466 . . . . 70.11 111.722 176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.62 -20.08 23.09 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.961 -0.638 . . . . 72.4 114.191 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.492 ' CZ ' ' HB1' ' A' ' 52' ' ' ALA . 96.6 m-85 -60.04 110.74 1.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.31 0.576 . . . . 73.42 112.481 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.66 -40.65 61.31 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.699 -0.682 . . . . 73.13 111.735 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 30.2 m-70 -103.43 85.9 2.55 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 55.51 112.471 -173.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.474 HG12 HG13 ' A' ' 76' ' ' VAL . 47.3 t -138.49 119.12 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.407 -0.36 . . . . 71.24 111.094 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 t -108.99 150.92 27.04 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.287 0.565 . . . . 70.3 111.647 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.0 mt-10 -93.53 115.79 28.3 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.542 -0.754 . . . . 75.12 111.11 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.4 tp -80.25 119.54 23.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.991 0.424 . . . . 73.22 111.076 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -62.62 136.87 58.1 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.712 0.634 . . . . 75.5 112.712 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.15 -61.73 3.03 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.91 -0.586 . . . . 71.24 113.584 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -143.46 17.93 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.361 -0.447 . . . . 51.13 112.837 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 tp -65.34 -49.6 68.77 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.172 0.434 . . . . 64.13 112.172 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -34.9 71.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.649 0.262 . . . . 75.11 111.556 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.03 -49.59 67.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.101 0.477 . . . . 64.31 110.762 174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -54.2 -36.83 63.86 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.794 -0.639 . . . . 73.11 111.174 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.81 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.5 mtmt -78.68 -33.85 46.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.2 -0.455 . . . . 75.54 111.825 177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.08 -29.05 70.04 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.024 0.44 . . . . 60.43 111.712 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 8' ' ' HIS . 26.9 pt -91.92 10.76 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.178 -0.465 . . . . 72.01 111.817 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.12 44.98 96.99 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.183 -0.532 . . . . 60.0 113.375 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.6 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.67 168.6 47.86 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.353 -0.451 . . . . 73.31 113.619 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 115.46 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.653 2.235 . . . . 42.52 112.232 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.81 HG21 ' HG2' ' A' ' 98' ' ' LYS . 70.1 p -129.76 151.79 49.96 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.363 0.601 . . . . 62.41 112.275 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 42.6 mt-10 -126.16 174.3 8.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.218 -0.901 . . . . 73.23 109.933 175.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.552 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 148.7 158.44 8.02 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.154 -1.022 . . . . 65.15 115.077 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.437 ' O ' ' HB3' ' A' ' 110' ' ' SER . 60.8 mt -73.29 -43.83 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.155 -0.522 . . . . 74.4 111.006 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ASP . 1.6 pp -70.92 -33.6 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.937 0.875 . . . . 65.54 110.579 173.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -71.15 -5.98 35.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.486 -1.234 . . . . 54.14 111.269 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 16.4 t -67.99 -37.71 81.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.752 -0.658 . . . . 70.12 111.981 177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -160.12 151.32 19.36 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.068 0.461 . . . . 74.43 111.972 -177.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 18.6 p -120.7 167.45 12.87 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 115.843 -0.617 . . . . 75.42 111.329 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.452 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 6.7 Cg_exo -75.24 -125.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.592 2.194 . . . . 73.44 111.032 170.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.452 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 176.47 160.62 0.35 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 111.992 0.368 . . . . 74.24 111.992 -175.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.83 122.68 0.69 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.873 -0.68 . . . . 62.31 113.389 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.4 148.28 33.17 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.55 -0.382 . . . . 74.2 111.49 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -155.67 157.77 37.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 120.993 0.425 . . . . 75.4 111.622 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -131.56 139.89 49.33 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.923 0.392 . . . . 74.22 111.505 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -90.03 127.68 36.11 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.902 0.382 . . . . 63.44 111.001 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.78 90.75 0.6 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.017 0.437 . . . . 72.22 111.591 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 m -76.27 75.28 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.476 0.655 . . . . 71.01 112.244 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.06 104.66 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.655 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.7 t -174.44 104.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.831 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.86 113.24 1.93 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.8 0.333 . . . . 74.23 111.352 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.08 157.6 39.23 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.027 0.442 . . . . 65.52 111.882 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -146.28 150.01 34.95 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.086 0.469 . . . . 44.45 112.228 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -131.68 83.43 2.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.329 -0.396 . . . . 61.13 111.227 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -124.0 120.13 31.54 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.75 0.309 . . . . 75.55 111.285 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -153.86 104.24 2.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.473 -0.33 . . . . 71.23 111.025 177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -125.73 12.64 7.96 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.92 0.39 . . . . 74.23 111.803 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -62.97 116.74 5.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.655 0.264 . . . . 75.22 111.375 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 120.987 0.422 . . . . 72.41 111.848 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 ttp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.451 0.167 . . . . 70.24 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 68.07 153.33 0.13 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 123.097 0.559 . . . . 65.42 112.282 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.35 -54.46 2.14 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.91 2.406 . . . . 71.25 113.687 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -118.53 124.31 47.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.042 0.449 . . . . 63.51 112.06 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -122.53 140.93 52.22 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.96 0.409 . . . . 60.0 111.49 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.96 157.77 37.22 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.452 -0.34 . . . . 64.13 110.785 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.68 -51.04 66.77 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.023 0.749 . . . . 73.01 113.023 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.9 p-80 -73.26 -25.98 60.91 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.555 -0.716 . . . . 65.0 112.392 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -60.73 -41.79 89.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.146 0.498 . . . . 62.24 110.133 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 13' ' ' ARG . 28.0 tp -73.8 -41.52 62.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.066 -0.515 . . . . 61.0 110.878 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 75.0 tttt -55.88 -43.88 77.6 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.988 0.423 . . . . 74.31 111.652 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.5 m -74.12 -38.2 63.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.9 0.857 . . . . 63.45 109.392 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' HD2' HD12 ' A' ' 10' ' ' LEU . 27.7 ttm180 -60.87 -31.14 70.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.876 -1.056 . . . . 73.24 111.43 173.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.05 -56.66 4.51 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 54.35 110.852 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -71.07 -52.34 19.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.332 0.587 . . . . 70.4 112.11 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -89.79 -40.63 12.35 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.816 -0.629 . . . . 75.42 112.252 -174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.86 -104.48 0.12 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.091 -0.576 . . . . 71.43 113.845 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.8 tt0 -160.62 124.11 1.94 Allowed Pre-proline 0 CA--C 1.542 0.668 0 O-C-N 122.68 -0.306 . . . . 74.42 111.424 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -75.12 36.65 0.45 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.199 2.6 . . . . 73.12 113.897 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.32 5.44 23.27 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 73.54 112.064 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -103.23 158.9 16.0 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.43 -0.35 . . . . 71.51 110.957 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -116.64 117.36 29.6 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.855 0.36 . . . . 75.24 111.563 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.6 mt -90.7 127.87 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.773 0.32 . . . . 70.44 111.215 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 HD22 ' SD ' ' A' ' 43' ' ' MET . 44.5 mt -108.78 130.39 55.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.235 0.541 . . . . 71.01 111.537 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.55 101.87 14.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.503 -0.771 . . . . 73.14 110.427 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.502 HG11 ' HB1' ' A' ' 75' ' ' ALA . 30.1 m -98.89 6.72 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.139 0.422 . . . . 74.33 112.139 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' ' 32' ' ' TYR . 71.4 mtm180 -63.43 -71.33 0.17 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.266 0.555 . . . . 73.02 111.377 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -173.27 149.92 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.56 -0.745 . . . . 72.33 109.976 -176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -54.96 -47.08 74.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.099 0.476 . . . . 73.23 111.375 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.7 t -70.78 -49.8 42.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.498 -0.319 . . . . 51.42 110.557 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.544 HG22 ' NH1' ' A' ' 27' ' ' ARG . 29.8 m -55.67 -32.1 62.96 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 73.5 111.217 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 75.4 t80 -61.29 -50.57 72.47 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.013 0.435 . . . . 73.21 110.407 172.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -43.16 99.41 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.239 -0.437 . . . . 72.32 111.782 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -59.15 -48.33 82.0 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.048 0.388 . . . . 75.43 112.048 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -167.91 136.97 4.35 Favored Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.59 -0.814 . . . . 63.13 112.519 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -158.68 159.12 34.96 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 117.807 0.803 . . . . 71.2 112.297 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.5 mt -60.14 131.25 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 116.256 -0.429 . . . . 62.41 110.7 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.454 ' HA ' ' OE1' ' A' ' 105' ' ' GLU . 40.9 ttp -63.11 112.93 2.84 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.093 0.473 . . . . 70.53 111.251 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.11 -9.01 27.11 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.993 -0.549 . . . . 44.34 113.313 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.82 150.85 42.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.27 0.557 . . . . 71.41 112.368 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.7 mmm -94.97 149.77 20.88 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.822 -0.626 . . . . 71.33 111.832 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.77 82.51 8.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.358 0.599 . . . . 65.33 111.205 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.74 ' HG2' ' HB3' ' A' ' 51' ' ' ARG . 50.8 mtt -130.12 83.47 63.17 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 73.12 110.871 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 15.0 Cg_exo -63.41 138.31 64.98 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.84 2.36 . . . . 54.43 110.84 -175.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 20.0 tt -43.61 -38.85 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 114.426 1.269 . . . . 73.24 114.426 -168.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.94 -32.54 63.54 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.294 0.569 . . . . 71.44 111.928 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 28.4 t0 -95.6 -5.85 41.6 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.789 -0.641 . . . . 75.51 110.686 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 43' ' ' MET . 62.9 tp -53.1 -56.16 18.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.647 0.98 . . . . 70.41 113.647 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 82' ' ' ALA . 69.9 t -55.15 -53.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.943 0.402 . . . . 71.3 111.905 -175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -62.34 -49.14 76.76 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.159 -0.473 . . . . 74.21 111.471 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.74 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 6.6 mmt180 -54.11 -54.08 44.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.077 0.465 . . . . 73.21 111.977 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.97 -53.71 24.05 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.94 -0.573 . . . . 73.05 112.292 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t -62.77 -25.96 68.47 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.019 0.377 . . . . 63.43 112.019 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 t -90.34 1.51 56.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.101 0.408 . . . . 75.1 112.101 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -135.26 -58.81 0.79 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.13 0.491 . . . . 53.33 111.69 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.571 HD11 HD21 ' A' ' 24' ' ' LEU . 72.7 mt -80.66 160.18 25.1 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.024 -0.535 . . . . 64.13 111.825 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -89.79 174.16 7.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 70.35 111.158 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -85.64 -25.57 26.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.572 0.701 . . . . 72.1 110.724 -177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.0 m -87.76 -2.67 58.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.75 -0.659 . . . . 45.31 111.872 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 86' ' ' HIS . 14.4 tpp180 -64.77 130.43 43.49 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.284 0.233 . . . . 74.21 111.319 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -72.66 98.11 2.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.984 0.421 . . . . 72.44 110.94 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -104.32 135.33 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 113.369 0.877 . . . . 74.42 113.369 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -116.15 132.27 56.71 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.586 -0.734 . . . . 73.22 110.722 170.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.55 134.2 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.292 -0.413 . . . . 70.43 111.705 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -137.34 130.2 30.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.612 0.72 . . . . 75.03 111.81 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.45 -171.26 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.43 -0.804 . . . . 34.24 112.417 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.48 -4.43 55.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.316 0.579 . . . . 62.41 111.1 175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.47 33.89 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.023 -0.535 . . . . 25.33 112.757 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -51.42 -49.37 61.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.068 0.461 . . . . 72.55 111.57 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -56.79 -52.01 66.7 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.928 -0.578 . . . . 74.4 111.885 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.579 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 36.1 tt0 -58.72 -49.71 76.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.173 0.511 . . . . 74.23 111.433 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 40.0 m -55.45 -52.52 63.34 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.646 -0.707 . . . . 50.34 111.36 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' HG3' ' A' ' 126' ' ' GLU . 19.3 m -57.89 -39.32 77.59 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.817 -0.629 . . . . 73.12 112.245 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -68.72 -46.59 68.54 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.863 0.363 . . . . 44.21 111.205 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.25 -45.9 83.53 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.094 0.473 . . . . 64.34 111.527 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 89' ' ' GLU . 86.6 t -52.92 -42.58 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 115.982 -0.554 . . . . 51.34 111.473 174.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -62.94 -45.05 94.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.347 0.594 . . . . 75.21 110.993 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 75' ' ' ALA . 46.9 mt -60.04 -42.5 94.55 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.5 -0.773 . . . . 75.33 111.855 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 24' ' ' LEU . 75.5 mt -62.77 -52.67 62.29 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.876 0.325 . . . . 63.11 111.876 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -64.93 -28.64 69.67 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.926 -0.484 . . . . 75.34 111.16 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -65.21 -31.29 72.38 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.016 0.436 . . . . 72.44 110.862 170.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.99 2.0 41.06 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.153 0.427 . . . . 72.13 112.153 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.31 -17.17 37.56 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.917 -0.659 . . . . 53.0 114.357 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 79' ' ' LEU . 93.5 m-85 -55.43 113.78 1.56 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.317 0.58 . . . . 72.21 112.245 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 50.2 mt-10 -67.69 -49.59 61.93 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.656 -0.702 . . . . 73.34 111.526 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 11.5 m-70 -97.97 88.8 4.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.892 0.377 . . . . 63.25 111.931 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 76' ' ' VAL . 50.3 t -133.12 122.07 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.956 0.408 . . . . 41.23 111.616 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.6 p -131.47 172.43 12.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.874 -0.603 . . . . 73.52 110.812 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.655 ' HB3' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -124.67 162.86 23.25 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.31 0.576 . . . . 74.2 112.398 -175.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.7 tp -117.31 120.33 37.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.793 -0.639 . . . . 72.02 111.551 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.5 mmpt? -80.8 141.18 34.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.427 0.632 . . . . 74.42 112.257 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.7 -23.15 27.14 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.769 -0.651 . . . . 54.54 113.226 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.32 -161.37 48.16 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.207 -0.521 . . . . 72.23 113.682 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.0 -40.93 97.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.097 0.406 . . . . 64.3 112.097 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.42 90.81 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.031 0.382 . . . . 72.14 112.031 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.4 -45.72 86.42 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.015 0.436 . . . . 72.2 110.865 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -51.07 -38.65 52.87 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.357 0.599 . . . . 71.33 110.905 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.782 ' HG2' HG21 ' A' ' 104' ' ' THR . 53.6 mtmt -78.79 -39.97 34.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.055 -0.52 . . . . 64.02 112.224 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.12 73.91 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.104 0.478 . . . . 71.43 111.583 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 8' ' ' HIS . 19.2 pt -81.81 -1.99 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.006 -0.543 . . . . 71.3 111.307 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.9 44.16 20.26 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.452 -0.404 . . . . 64.2 113.188 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -85.62 161.4 35.16 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 122.457 -0.437 . . . . 73.35 113.877 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.95 118.43 5.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.886 2.391 . . . . 72.11 112.693 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.782 HG21 ' HG2' ' A' ' 98' ' ' LYS . 78.1 p -124.28 161.82 25.03 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.319 0.859 . . . . 72.21 113.319 -172.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' HA ' ' A' ' 38' ' ' MET . 49.4 mt-10 -137.32 174.52 10.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.321 -0.854 . . . . 64.24 110.976 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.5 142.83 4.37 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.625 -0.798 . . . . 73.34 113.654 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.0 mt -57.66 -39.28 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.977 0.418 . . . . 73.23 110.572 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 108' ' ' ILE . 1.9 mp -91.83 -43.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.531 0.682 . . . . 74.0 111.617 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.97 -5.39 34.56 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.4 -0.818 . . . . 61.55 112.572 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.1 t -53.35 -30.89 41.88 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.51 . . . . 64.02 110.869 173.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.606 ' N ' ' HD3' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -149.77 106.68 3.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.359 0.6 . . . . 73.41 110.368 177.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -85.52 124.14 71.82 Favored Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 122.017 -0.427 . . . . 54.1 111.329 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -85.34 -4.53 9.39 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.612 2.208 . . . . 73.22 113.301 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -156.68 128.56 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.38 0.511 . . . . 41.2 112.38 -176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.86 80.9 0.71 Allowed Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.255 -0.738 . . . . 64.31 111.255 171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.91 145.44 24.62 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.019 0.748 . . . . 74.32 113.019 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.13 141.9 28.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.872 -0.603 . . . . 75.03 110.546 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -94.87 158.74 15.36 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.314 0.578 . . . . 73.03 112.102 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -54.35 -34.34 60.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.524 -0.762 . . . . 73.03 110.287 167.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 46.07 63.58 1.79 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.826 -1.079 . . . . 62.41 112.16 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.48 127.36 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.334 -0.394 . . . . 71.3 110.606 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.87 89.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 121.281 0.562 . . . . 74.22 111.043 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 77.5 p -71.52 -75.68 0.12 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.795 -0.639 . . . . 71.33 110.673 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 124' ' ' ARG . 1.7 tmm_? 58.42 103.25 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.249 0.547 . . . . 62.24 112.115 174.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 tp -115.6 6.18 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.912 0.863 . . . . 75.04 109.815 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HG3' ' OG ' ' A' ' 73' ' ' SER . 4.4 mp0 -74.98 112.24 11.01 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.037 -0.983 . . . . 71.22 112.039 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -67.55 134.22 50.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.809 -0.812 . . . . 74.45 108.809 165.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -55.38 166.66 0.58 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.17 0.804 . . . . 71.02 113.17 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -47.98 145.9 2.78 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.793 1.034 . . . . 74.14 113.793 -170.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -93.93 -156.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.406 -0.815 . . . . 74.51 109.739 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -75.69 163.16 27.58 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 122.143 -0.348 . . . . 63.33 110.552 173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 N--CA 1.471 0.625 0 N-CA-C 112.092 0.404 . . . . 62.51 112.092 -173.556 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 ttp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.822 0.344 . . . . 61.52 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.09 154.12 86.51 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.377 -0.374 . . . . 74.4 111.498 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.61 -57.13 2.36 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.743 2.295 . . . . 75.22 112.849 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -104.34 130.04 52.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.179 0.514 . . . . 64.5 111.963 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.479 ' O ' HD12 ' A' ' 90' ' ' LEU . 47.4 t -101.8 142.22 33.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.079 -0.509 . . . . 71.24 110.572 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HB3' HG23 ' A' ' 9' ' ' VAL . 14.0 t70 -86.12 161.14 19.03 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.944 0.402 . . . . 74.54 110.671 175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.75 -51.27 70.67 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.304 0.483 . . . . 73.45 112.304 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -26.65 60.71 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.816 -0.552 . . . . 74.41 112.27 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG23 ' HB3' ' A' ' 6' ' ' ASP . 99.1 t -60.8 -49.57 84.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.074 0.464 . . . . 74.41 110.427 173.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.8 tp -67.58 -39.8 84.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.398 -0.365 . . . . 61.33 110.968 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 81.4 tttt -58.53 -45.99 87.73 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.927 0.394 . . . . 70.45 111.349 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -63.42 -31.92 73.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.909 0.385 . . . . 61.03 110.434 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.5 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 97.5 mtt180 -71.13 -29.76 65.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.691 0.282 . . . . 72.01 111.515 175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.29 -53.21 15.05 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 60.44 110.429 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -75.55 -52.68 10.06 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.108 -0.496 . . . . 71.45 112.264 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -98.96 -28.55 13.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.454 0.538 . . . . 73.55 112.454 -174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -75.77 -165.0 16.72 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.382 -0.372 . . . . 70.54 113.7 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.21 139.54 20.83 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 122.633 -0.333 . . . . 74.32 111.33 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.15 37.91 0.46 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.941 2.428 . . . . 73.12 113.817 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.67 5.22 52.51 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.271 0.471 . . . . 70.15 112.271 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 8.4 p90 -112.52 159.02 19.21 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.931 0.395 . . . . 72.33 111.865 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.3 m -122.57 124.03 42.57 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.347 -0.388 . . . . 73.45 111.641 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -100.01 137.74 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 122.249 -0.282 . . . . 71.31 110.975 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 41' ' ' MET . 50.3 mt -123.39 143.28 50.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.963 0.411 . . . . 74.33 111.881 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -103.5 106.84 17.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.83 0.452 . . . . 73.13 111.261 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 26.8 m -101.15 4.44 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 112.937 0.717 . . . . 73.14 112.937 -174.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' OE1' ' A' ' 71' ' ' GLN . 87.0 mtm180 -61.54 -64.76 0.84 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.513 0.673 . . . . 54.53 111.805 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.5 t70 -174.28 154.03 2.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.196 -0.911 . . . . 71.32 109.862 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 29' ' ' ARG . 9.6 tpt180 -59.81 -47.08 87.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.311 0.577 . . . . 73.52 111.273 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 m -79.41 -33.87 42.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.248 -0.433 . . . . 75.21 111.726 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 73.2 m -66.11 -32.84 74.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 71.24 110.665 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 43.3 t80 -56.67 -49.25 75.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.092 0.472 . . . . 75.23 110.306 170.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.536 ' O ' HG12 ' A' ' 107' ' ' ILE . 86.4 m-20 -59.24 -44.77 92.34 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.473 -0.33 . . . . 73.44 111.131 173.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.483 ' HA ' HD13 ' A' ' 108' ' ' ILE . 10.2 t70 -51.54 -48.4 63.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.989 0.516 . . . . 63.31 111.265 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.28 144.79 8.9 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 121.098 -0.572 . . . . 34.12 112.015 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -159.16 159.43 34.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.452 0.626 . . . . 62.34 111.904 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.72 137.99 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.522 -0.308 . . . . 74.2 111.353 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 ttm -64.64 112.23 3.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.959 0.409 . . . . 42.24 111.537 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.6 -3.99 57.9 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.265 -0.425 . . . . 63.12 113.313 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.19 153.41 28.61 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.014 0.435 . . . . 43.14 112.041 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.464 ' HB2' ' CD2' ' A' ' 24' ' ' LEU . 58.0 mtp -90.37 164.99 14.11 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.103 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -106.63 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.745 0.307 . . . . 64.11 111.181 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.631 ' HG2' ' CB ' ' A' ' 51' ' ' ARG . 37.7 mtt 60.96 75.17 0.47 Allowed Pre-proline 0 N--CA 1.471 0.609 0 CA-C-O 121.398 0.618 . . . . 74.03 112.072 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -70.82 149.65 60.48 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.086 2.524 . . . . 73.51 111.709 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.43 HD12 ' HG3' ' A' ' 71' ' ' GLN . 20.4 tt -46.96 -30.31 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 114.111 1.152 . . . . 72.14 114.111 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -79.7 -41.37 26.92 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.949 -0.47 . . . . 64.11 112.13 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 51' ' ' ARG . 35.3 m-20 -85.49 -14.91 44.57 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.14 0.422 . . . . 62.44 112.14 176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 75' ' ' ALA . 59.1 tp -39.76 -61.1 0.88 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.946 1.091 . . . . 73.43 113.946 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -54.68 -52.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 121.094 0.473 . . . . 73.45 111.981 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.79 -52.66 64.17 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.794 -0.639 . . . . 74.02 111.436 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 21.7 mmt180 -56.14 -55.11 37.02 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.385 0.612 . . . . 73.4 111.852 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.83 72.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.63 -0.714 . . . . 74.0 111.843 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.2 t -63.54 -21.93 66.61 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.047 0.451 . . . . 73.33 111.262 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -88.04 -23.88 23.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.638 0.607 . . . . 74.33 112.638 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.3 m -142.54 15.49 1.99 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.939 1.089 . . . . 63.05 113.939 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.7 mt -140.15 157.91 44.88 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.418 0.628 . . . . 73.34 112.562 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.704 ' HG2' ' H ' ' A' ' 59' ' ' SER . 36.8 tt0 -93.54 135.64 34.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 73.3 110.576 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 93.4 mttt -70.34 -18.5 63.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.265 0.555 . . . . 61.5 111.496 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.704 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 50.6 m -86.22 -15.18 41.65 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.244 -0.434 . . . . 74.25 111.006 175.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 60' ' ' ARG . 9.8 tpp180 -65.51 128.71 37.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.425 -0.352 . . . . 72.23 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 4.8 m-20 -67.45 95.71 0.47 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.409 0.623 . . . . 61.22 111.214 176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -102.66 128.6 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.612 -0.722 . . . . 62.14 112.122 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 96.8 m-85 -106.45 118.69 37.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.131 0.491 . . . . 74.04 110.601 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.21 131.23 57.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.29 -0.414 . . . . 72.11 111.681 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -125.86 131.23 52.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.67 0.748 . . . . 72.22 111.809 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.49 -160.21 13.85 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.225 -0.898 . . . . 60.04 112.773 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.45 -9.13 39.57 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.808 0.337 . . . . 52.43 111.762 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.7 168.14 41.08 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.418 -0.42 . . . . 73.12 112.961 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.92 -40.26 66.56 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.637 0.606 . . . . 73.3 112.637 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 28.8 tt0 -56.99 -52.47 65.11 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.902 0.382 . . . . 71.24 110.61 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 27' ' ' ARG . 35.3 tt0 -65.08 -37.44 87.52 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.992 -0.549 . . . . 64.45 112.163 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 37.8 p -65.79 -56.08 13.83 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.934 0.397 . . . . 52.43 110.912 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.4 t -56.75 -44.06 81.35 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.816 -0.629 . . . . 71.11 111.25 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -64.78 -54.01 38.05 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.863 -0.608 . . . . 72.32 111.662 -178.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -62.77 -50.42 71.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.919 0.39 . . . . 53.15 111.817 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 89' ' ' GLU . 85.5 t -60.84 -36.2 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 116.568 -0.287 . . . . 61.33 111.048 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 6.8 t30 -51.26 -48.25 62.23 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.492 0.663 . . . . 74.32 110.423 170.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 75' ' ' ALA . 27.2 mt -63.31 -35.9 81.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.962 -1.017 . . . . 73.31 111.856 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 mt -72.2 -52.79 14.88 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.111 0.411 . . . . 53.42 112.111 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 4.9 ptp180 -61.79 -29.82 70.4 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.863 -0.523 . . . . 74.34 110.479 177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.7 t -67.03 -37.69 84.56 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.062 0.458 . . . . 75.45 110.91 170.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.79 2.96 5.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.696 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.2 59.64 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.173 -0.537 . . . . 75.14 113.675 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.559 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.4 m-85 -71.66 118.32 14.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.253 0.549 . . . . 75.14 111.273 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.89 -56.35 5.87 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.702 -0.681 . . . . 64.31 111.837 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 22.2 m-70 -99.36 90.14 4.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.285 0.476 . . . . 75.04 112.285 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 ' CG1' HG13 ' A' ' 76' ' ' VAL . 23.3 t -137.38 139.23 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.237 -0.289 . . . . 61.33 111.126 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.2 t -132.86 133.74 43.7 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.75 0.31 . . . . 62.23 111.159 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.704 ' HB3' HG21 ' A' ' 76' ' ' VAL . 2.1 pm0 -90.2 131.61 35.94 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.347 0.594 . . . . 73.35 111.448 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 5' ' ' SER . 22.6 tp -86.71 136.01 33.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.338 -0.392 . . . . 71.11 111.966 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -77.06 134.14 38.87 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.537 -0.302 . . . . 70.14 111.696 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.47 -25.73 4.31 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 114.677 0.631 . . . . 73.23 114.677 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.81 -153.84 47.7 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.064 -0.589 . . . . 64.21 113.515 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.56 -40.99 96.57 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.243 0.46 . . . . 62.45 112.243 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.81 63.15 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.127 0.418 . . . . 61.42 112.127 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.1 -49.8 58.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.177 0.513 . . . . 61.43 110.784 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -49.24 -41.35 37.16 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.562 -0.745 . . . . 63.34 110.917 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -78.41 -36.56 45.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.719 -0.673 . . . . 65.53 112.295 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -34.02 74.43 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.253 0.549 . . . . 65.01 111.607 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.61 -6.37 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 121.111 0.482 . . . . 71.1 111.277 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.05 40.1 10.81 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.454 -0.403 . . . . 63.45 113.199 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -78.95 153.88 38.62 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.408 -0.425 . . . . 64.35 113.508 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.1 120.05 7.11 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.565 2.177 . . . . 74.13 112.51 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 58.7 p -123.91 150.98 44.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.75 0.786 . . . . 60.1 112.703 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -113.73 173.95 6.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.987 -1.006 . . . . 64.12 109.818 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.82 25.63 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.612 -0.804 . . . . 63.35 113.783 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 33' ' ' ASN . 26.6 mm -98.18 -49.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.19 0.519 . . . . 74.44 110.106 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -72.4 -30.53 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.14 0.495 . . . . 71.52 111.736 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -59.93 -4.95 0.83 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.891 -0.595 . . . . 73.23 112.53 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.8 t -88.33 -4.99 58.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.729 0.64 . . . . 63.53 112.729 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 151.73 41.0 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.213 0.53 . . . . 75.11 112.222 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.6 p -105.89 144.47 28.96 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 115.787 -0.642 . . . . 75.0 112.022 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.3 Cg_exo -80.52 105.55 1.74 Allowed 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.03 2.487 . . . . 72.32 112.018 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.91 139.37 53.73 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.505 0.557 . . . . 61.41 112.505 -177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.77 88.38 1.71 Allowed Glycine 0 CA--C 1.529 0.915 0 CA-C-N 116.352 -0.385 . . . . 45.34 113.792 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.94 116.42 0.45 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.183 0.438 . . . . 64.43 112.183 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -161.11 126.16 3.64 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.836 0.351 . . . . 73.0 111.696 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -133.74 76.66 1.67 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.101 0.477 . . . . 42.34 110.816 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.32 30.29 2.57 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.404 0.621 . . . . 71.33 111.748 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -76.92 71.45 3.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.356 0.598 . . . . 64.55 110.816 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.57 146.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.137 -0.483 . . . . 65.35 112.088 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.6 p -116.39 127.56 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.943 0.401 . . . . 60.0 110.702 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -144.81 93.69 2.44 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.958 0.409 . . . . 61.11 111.229 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -165.47 123.81 1.61 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.556 -0.293 . . . . 72.43 110.532 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 48.1 tp -165.9 128.26 1.99 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.073 0.397 . . . . 74.14 112.073 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -172.47 134.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.1 -0.5 . . . . 72.04 111.144 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -168.23 45.91 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.889 0.376 . . . . 72.52 111.852 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -84.39 130.75 34.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.167 -0.333 . . . . 72.4 111.312 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.26 127.17 3.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.366 . . . . 72.12 111.611 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -148.64 159.31 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.652 -0.249 . . . . 73.22 110.972 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -153.27 81.48 1.19 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.783 0.325 . . . . 64.22 111.688 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 123.076 0.55 . . . . 71.01 111.188 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 tpp . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.8 0.333 . . . . 63.25 111.291 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -81.75 159.29 66.66 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 116.452 -0.34 . . . . 74.35 111.121 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -45.9 -60.06 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.716 2.278 . . . . 74.43 113.892 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -105.49 115.96 31.13 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 122.075 -0.39 . . . . 74.05 111.704 -174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.4 m -109.2 140.09 43.26 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.028 0.442 . . . . 71.12 111.605 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.463 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 34.2 t70 -78.44 142.6 37.41 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.312 0.486 . . . . 64.02 112.312 -176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.95 -43.26 95.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.239 -0.437 . . . . 60.04 112.155 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 100' ' ' ILE . 13.4 t60 -65.93 -38.45 88.69 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.944 0.402 . . . . 63.54 111.682 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.86 -39.24 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.868 0.366 . . . . 73.03 110.767 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.33 -46.79 81.96 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.467 -0.333 . . . . 72.34 111.092 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HE2' ' HA2' ' A' ' 102' ' ' GLY . 57.8 tttm -52.85 -46.19 67.73 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.364 0.602 . . . . 71.43 112.093 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.9 p -73.72 -42.92 60.52 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.916 -0.583 . . . . 53.4 110.426 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -60.03 -27.5 66.97 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.954 -0.566 . . . . 73.41 111.383 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 49.4 tp -77.14 -56.68 4.36 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.862 0.363 . . . . 73.3 111.677 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.57 -50.61 24.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.087 0.47 . . . . 71.43 111.67 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -82.59 -52.89 6.4 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.367 -0.378 . . . . 72.34 111.405 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.83 -109.73 0.06 OUTLIER Glycine 0 CA--C 1.531 1.032 0 N-CA-C 114.857 0.703 . . . . 75.04 114.857 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -148.02 126.09 5.93 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 111.797 0.295 . . . . 74.32 111.797 -171.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -82.23 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.052 2.502 . . . . 74.52 113.807 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.03 10.94 8.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.208 0.447 . . . . 72.23 112.208 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HZ ' ' HB2' ' A' ' 14' ' ' LEU . 28.4 p90 -110.53 158.41 18.57 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.09 0.471 . . . . 73.32 111.707 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.3 m -117.29 126.07 52.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.261 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -93.12 133.89 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 120.419 0.152 . . . . 73.3 110.905 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.594 HD22 ' SD ' ' A' ' 43' ' ' MET . 53.8 mt -115.82 125.49 52.76 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.163 0.506 . . . . 65.32 111.801 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -89.74 101.41 14.1 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.699 -0.682 . . . . 42.24 110.501 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD13 ' A' ' 48' ' ' LEU . 31.7 m -98.59 5.98 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.197 0.443 . . . . 71.43 112.197 -173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 88.0 mtm180 -63.24 -68.92 0.3 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.126 0.489 . . . . 72.44 110.937 177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -177.02 158.34 1.53 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 72.43 109.166 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NH1' ' OD1' ' A' ' 33' ' ' ASN . 51.2 tpt85 -66.72 -31.0 71.37 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.312 0.577 . . . . 75.02 110.505 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.9 p -73.45 -54.58 7.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.678 -0.692 . . . . 71.15 110.35 176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.3 m -55.21 -36.13 65.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 54.54 111.083 176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -55.29 -45.0 76.24 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.939 -0.573 . . . . 72.13 110.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 91.4 m-20 -64.4 -43.07 95.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.255 -0.43 . . . . 71.01 111.738 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' HA ' HD13 ' A' ' 108' ' ' ILE . 8.5 m-20 -56.32 -47.91 77.79 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.305 -0.247 . . . . 64.22 111.283 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.2 128.34 1.35 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 120.671 -0.776 . . . . 64.3 112.937 175.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -138.18 157.55 46.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.113 0.456 . . . . 61.1 111.536 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.7 mt -60.09 140.9 17.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.654 0.264 . . . . 72.02 111.26 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.3 ttm -62.37 101.9 0.27 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.233 0.54 . . . . 75.02 111.652 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.34 15.07 18.57 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.056 -0.52 . . . . 54.45 113.445 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.29 152.55 21.86 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.427 0.632 . . . . 54.42 112.351 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.459 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 56.8 mmm -97.1 151.18 20.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 74.11 111.455 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.85 77.07 7.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 50.01 111.587 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.664 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -113.07 87.86 11.28 Favored Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.172 -0.467 . . . . 70.43 110.997 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.6 136.91 40.83 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 121.764 1.643 . . . . 71.44 110.891 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 74' ' ' GLN . 19.4 tt -50.52 -25.68 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 112.632 0.605 . . . . 71.21 112.632 -174.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -64.4 -41.11 96.83 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.009 0.433 . . . . 60.22 111.623 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -111.96 6.52 19.47 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.921 -0.581 . . . . 65.31 111.796 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.532 HD13 HG12 ' A' ' 26' ' ' VAL . 65.5 tp -46.36 -55.91 6.63 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.888 1.07 . . . . 54.22 113.888 -169.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.1 t -54.09 -53.09 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 112.089 0.403 . . . . 74.42 112.089 -175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -66.41 -45.27 80.5 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.723 0.297 . . . . 65.55 111.622 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 9.3 mmt180 -54.65 -51.38 65.61 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.312 0.577 . . . . 75.11 111.591 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.3 -54.21 8.94 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 72.32 112.282 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.7 t -59.64 -26.62 65.65 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.438 0.533 . . . . 44.55 112.438 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.8 t -84.74 -23.38 29.29 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.757 0.651 . . . . 71.5 112.757 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.9 m -125.33 1.04 7.75 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 65.04 113.078 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD11 HD21 ' A' ' 24' ' ' LEU . 96.3 mt -132.46 151.95 51.7 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.019 0.437 . . . . 65.04 111.52 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.724 ' HG3' ' H ' ' A' ' 59' ' ' SER . 14.1 tp10 -91.69 148.12 22.49 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.082 0.467 . . . . 71.31 110.803 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -67.88 -22.08 65.12 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.216 0.532 . . . . 65.15 111.249 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.724 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 66.6 m -94.09 2.8 55.95 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.487 0.551 . . . . 73.4 112.487 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 62' ' ' ILE . 19.9 tpp180 -79.69 124.23 28.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.429 0.157 . . . . 74.43 110.839 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 10.8 m-20 -63.88 108.8 1.56 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.208 0.528 . . . . 71.43 111.159 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 60' ' ' ARG . 82.4 mt -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.303 0.573 . . . . 63.4 112.443 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -106.04 116.54 32.11 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.72 -0.673 . . . . 63.33 110.465 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 79' ' ' LEU . 91.6 t -104.92 134.17 47.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.306 -0.407 . . . . 71.42 111.529 -176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -132.41 129.61 39.53 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.665 0.745 . . . . 75.51 111.777 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.0 -168.87 19.86 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 115.282 -0.872 . . . . 70.21 111.957 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.16 -40.1 68.23 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.246 0.546 . . . . 62.23 111.205 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -136.91 178.79 18.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.051 -0.522 . . . . 63.44 112.65 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -58.01 -43.24 86.55 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.149 0.426 . . . . 72.25 112.149 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.1 -53.51 57.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.462 -0.336 . . . . 71.44 111.487 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 44.9 tt0 -65.39 -43.82 89.47 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.069 0.461 . . . . 75.42 111.568 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 65.8 m -57.66 -52.22 66.33 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.881 -0.599 . . . . 73.51 111.476 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -66.81 -45.42 78.39 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.441 0.534 . . . . 51.42 112.441 -176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 21.0 pt20 -63.34 -36.64 84.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.16 0.505 . . . . 45.43 111.493 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.21 -50.31 73.62 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.096 0.474 . . . . 60.14 110.888 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG13 HG12 ' A' ' 87' ' ' VAL . 99.2 t -54.63 -40.82 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.916 0.389 . . . . 72.53 111.068 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.2 t30 -52.15 -50.28 62.11 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.424 0.631 . . . . 70.13 110.729 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 75' ' ' ALA . 44.2 mt -58.76 -40.87 85.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.181 -0.918 . . . . 73.13 111.994 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 24' ' ' LEU . 83.2 mt -68.0 -52.49 35.1 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.068 0.396 . . . . 52.22 112.068 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -61.96 -32.47 72.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.897 0.38 . . . . 74.12 110.67 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.0 t -71.03 -27.33 63.59 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.819 0.342 . . . . 53.24 110.869 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.11 -1.03 34.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.04 0.385 . . . . 64.33 112.04 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.47 -15.18 29.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.887 -0.673 . . . . 74.22 113.939 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -60.88 121.46 12.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.633 0.73 . . . . 44.44 111.917 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -84.17 -41.04 17.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.152 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 15.1 m-70 -103.14 83.06 2.15 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.442 -0.345 . . . . 74.31 111.742 -176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 76' ' ' VAL . 26.6 t -138.34 129.84 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.058 -0.401 . . . . 72.33 111.391 176.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.9 t -126.55 137.48 53.36 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.318 -0.401 . . . . 64.24 111.571 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 76' ' ' VAL . 1.2 pm0 -79.0 122.01 25.64 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.337 0.589 . . . . 71.3 111.29 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 ' HA ' ' A' ' 7' ' ' ALA . 27.5 tp -77.61 129.49 35.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.899 -0.591 . . . . 74.13 111.302 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 7.8 mmpt? -85.29 118.8 25.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.213 0.53 . . . . 74.11 112.11 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.04 -23.82 24.55 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 115.744 -0.662 . . . . 73.41 114.177 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.25 -156.61 51.5 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.712 -0.756 . . . . 13.0 113.66 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD22 HH12 ' A' ' 27' ' ' ARG . 49.0 tp -67.67 -44.62 77.38 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.675 -0.309 . . . . 73.04 111.743 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.67 -44.15 62.96 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.513 0.56 . . . . 71.42 112.513 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.96 -48.99 76.48 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.033 0.444 . . . . 55.2 111.169 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -52.58 -39.4 61.52 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.293 0.568 . . . . 70.53 110.868 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.567 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.6 mtpt -77.68 -34.24 53.01 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.383 0.512 . . . . 64.5 112.383 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.29 79.77 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.252 0.548 . . . . 72.1 111.546 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 8' ' ' HIS . 15.9 pt -84.59 -0.79 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.105 -0.498 . . . . 61.22 111.639 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 34.81 20.92 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.351 -0.452 . . . . 70.43 113.461 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' HA2' ' HE2' ' A' ' 11' ' ' LYS . . . -73.93 145.89 35.8 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.433 -0.413 . . . . 74.22 113.759 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.27 124.81 15.95 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.801 2.334 . . . . 74.13 112.524 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 98' ' ' LYS . 55.6 p -128.03 152.71 47.61 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.017 0.747 . . . . 71.14 113.017 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -119.98 173.4 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.049 -0.978 . . . . 73.31 110.046 171.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.53 176.38 14.54 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.575 -0.822 . . . . 74.44 113.808 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 46.7 mt -95.67 -51.69 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 121.151 0.5 . . . . 64.03 110.829 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -71.01 -23.63 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.12 0.486 . . . . 74.24 112.306 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -56.65 -15.56 4.71 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.391 0.515 . . . . 70.2 112.391 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.7 m -95.42 6.21 49.59 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.604 0.594 . . . . 60.44 112.604 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 35.2 ptt180 -132.05 -170.88 2.5 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.08 -0.388 . . . . 70.1 111.944 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.61 ' N ' ' CD ' ' A' ' 113' ' ' PRO . 6.2 m 77.01 27.01 0.02 OUTLIER Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 115.238 1.57 . . . . 73.1 115.238 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 112' ' ' THR . 60.0 Cg_endo -72.85 134.74 22.26 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.831 2.354 . . . . 70.31 112.907 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -158.7 173.37 16.67 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.55 -0.296 . . . . 35.33 111.319 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.86 88.32 0.28 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.174 -0.536 . . . . 64.34 113.057 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.71 112.88 9.79 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.691 0.282 . . . . 64.32 111.143 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -81.09 173.62 12.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.357 0.598 . . . . 64.25 112.589 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.36 173.14 13.37 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.905 -0.589 . . . . 64.35 110.995 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -140.23 127.75 21.51 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.953 0.406 . . . . 75.25 111.404 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.26 93.36 2.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.155 0.503 . . . . 64.23 110.944 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.4 m -68.1 104.02 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.536 0.684 . . . . 73.53 112.013 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.2 p -154.36 111.45 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.442 0.639 . . . . 61.23 111.514 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.6 t -155.26 104.44 2.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.005 0.431 . . . . 65.55 110.784 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.15 123.18 21.5 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.18 0.514 . . . . 65.43 110.922 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.529 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -145.88 154.18 41.68 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.139 0.495 . . . . 72.12 111.652 178.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -137.25 131.26 32.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.088 -0.505 . . . . 63.02 110.826 177.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -126.96 115.25 18.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.073 0.463 . . . . 74.14 111.183 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.75 127.66 19.41 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.293 -0.412 . . . . 75.54 110.878 -175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -163.6 122.37 1.99 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.833 0.349 . . . . 73.23 110.972 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -149.01 26.98 0.87 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.95 0.352 . . . . 73.45 111.95 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -79.99 117.47 20.86 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.964 0.412 . . . . 51.21 111.297 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.239 0.502 0 CA-C-O 121.326 0.584 . . . . 43.41 111.636 179.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.804 0.335 . . . . 74.1 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -68.31 152.89 96.25 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 111.985 0.365 . . . . 64.41 111.985 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -58.29 -27.63 81.66 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.831 2.354 . . . . 71.14 113.18 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -126.44 141.78 51.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.072 0.463 . . . . 63.5 111.798 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.9 m -129.82 132.69 46.57 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.967 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 9' ' ' VAL . 11.6 t70 -76.11 154.1 35.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.957 0.408 . . . . 62.2 110.984 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -62.18 -52.05 65.35 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.739 0.644 . . . . 73.34 112.739 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -74.2 -25.75 59.87 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.898 -0.501 . . . . 75.31 112.096 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 6' ' ' ASP . 75.4 t -60.0 -47.66 90.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.76 0.314 . . . . 74.34 110.344 171.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.8 tp -68.81 -46.89 67.48 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.72 0.295 . . . . 40.22 111.408 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -55.73 -47.33 77.12 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.196 0.443 . . . . 73.22 112.196 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.5 p -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.278 0.561 . . . . 55.31 109.908 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 21.2 ttt85 -63.31 -27.0 69.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.897 -0.592 . . . . 73.35 111.327 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tt -78.11 -57.0 4.02 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.773 0.321 . . . . 74.03 111.382 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.29 -39.85 28.02 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.462 0.542 . . . . 71.22 112.462 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.8 m95 -105.18 -9.2 17.88 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.56 0.578 . . . . 71.53 112.56 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.01 -111.44 3.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.821 -0.705 . . . . 74.02 114.305 -173.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.07 104.42 2.81 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 111.829 0.307 . . . . 75.04 111.829 -173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.35 103.42 0.65 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.671 2.247 . . . . 63.41 112.934 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.1 18.5 0.36 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.483 0.659 . . . . 70.24 110.88 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -129.13 158.97 37.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.834 -0.621 . . . . 74.13 111.968 -172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 m -111.75 133.22 54.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.235 -0.439 . . . . 74.3 111.898 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -109.39 129.58 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.034 -0.358 . . . . 60.22 110.034 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.699 HD22 ' SD ' ' A' ' 43' ' ' MET . 24.9 mt -112.88 131.6 55.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.311 0.576 . . . . 63.34 112.167 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -91.19 112.55 24.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.449 -0.796 . . . . 75.33 110.399 178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG12 HD13 ' A' ' 48' ' ' LEU . 34.5 m -107.51 10.4 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 112.798 0.666 . . . . 73.11 112.798 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.663 ' NH1' HG22 ' A' ' 31' ' ' THR . 64.1 mtm180 -67.84 -73.52 0.14 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.892 0.377 . . . . 71.5 111.251 -178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -172.06 159.4 4.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.024 -0.535 . . . . 63.12 109.931 178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -59.04 -39.77 83.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.272 0.558 . . . . 73.21 110.838 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.3 p -70.61 -53.64 15.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.755 -0.657 . . . . 63.32 110.611 179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.663 HG22 ' NH1' ' A' ' 27' ' ' ARG . 2.7 m -55.55 -36.03 66.35 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.437 -0.802 . . . . 71.14 111.43 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 76.5 t80 -59.71 -50.2 74.77 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.43 . . . . 74.55 110.504 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.92 -41.75 92.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.117 -0.492 . . . . 72.12 111.478 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -60.18 -47.59 85.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.991 0.367 . . . . 74.35 111.991 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.637 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -174.09 122.8 0.92 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 119.65 -1.262 . . . . 72.52 114.068 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 p-80 -134.8 158.21 44.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.982 0.391 . . . . 73.34 111.349 -176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.99 140.41 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.713 0.292 . . . . 75.3 111.337 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.9 ttm -62.12 102.61 0.3 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.012 0.434 . . . . 71.2 111.441 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.76 0.18 27.41 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.135 -0.484 . . . . 54.24 113.264 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.76 142.58 35.26 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.516 0.561 . . . . 73.15 112.516 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 72.2 mtp -89.29 144.3 26.19 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.167 -0.47 . . . . 55.43 110.929 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.84 102.86 7.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.385 . . . . 71.2 111.834 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.699 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -133.9 77.6 62.32 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-O 120.79 0.329 . . . . 75.13 111.707 174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.36 131.4 45.01 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.408 2.072 . . . . 53.14 110.941 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -46.09 -27.27 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 113.687 0.995 . . . . 75.42 113.687 -169.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.34 -43.6 55.91 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.074 0.464 . . . . 72.23 111.563 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -88.76 -6.6 57.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.729 0.412 . . . . 75.35 111.573 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG12 ' A' ' 26' ' ' VAL . 59.0 tp -45.79 -66.16 0.44 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.618 1.34 . . . . 74.25 114.618 -171.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.11 -53.32 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.208 0.447 . . . . 65.1 112.208 -172.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -58.75 -49.59 77.08 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.151 0.501 . . . . 74.34 111.246 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.692 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 15.7 mmm180 -51.62 -55.5 18.96 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.777 -0.647 . . . . 64.4 112.335 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.48 75.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 61.05 111.603 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 t -56.0 -35.84 67.24 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.948 0.404 . . . . 60.21 111.897 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 m -88.83 2.53 53.47 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.53 0.567 . . . . 72.4 112.53 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.8 m -134.25 -23.77 1.67 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.01 0.744 . . . . 55.5 113.01 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 22' ' ' THR . 88.0 mt -132.89 157.44 45.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.146 0.498 . . . . 74.11 111.86 -173.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -88.55 176.71 7.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.498 0.666 . . . . 74.01 111.577 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 83' ' ' GLY . 32.1 mmtp -84.21 -27.3 28.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 52.32 111.231 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.2 m -85.23 -9.17 58.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.34 -0.391 . . . . 70.12 111.661 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -66.07 126.39 28.48 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.82 0.304 . . . . 75.32 111.82 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.91 106.87 2.03 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.414 0.626 . . . . 53.32 111.466 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 ' HG ' ' A' ' 24' ' ' LEU . 79.1 mt -113.24 126.77 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.519 -0.764 . . . . 63.03 112.132 -176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.68 117.0 33.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.169 -0.469 . . . . 72.34 109.964 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.09 135.56 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.653 -0.248 . . . . 62.51 111.494 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -139.01 132.38 30.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.614 0.721 . . . . 65.04 112.187 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.65 -177.63 21.76 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.214 -0.903 . . . . 60.24 112.236 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -75.14 -35.7 61.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.532 0.682 . . . . 62.34 110.282 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.79 156.95 15.28 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.511 -0.768 . . . . 74.11 111.999 172.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -61.57 -38.7 88.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.137 0.494 . . . . 65.22 110.691 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.34 -50.9 71.79 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.982 -0.553 . . . . 73.3 111.307 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 65.1 tt0 -55.97 -41.22 74.41 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.374 0.607 . . . . 74.4 110.726 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 76' ' ' VAL . 70.8 m -58.2 -54.81 42.72 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.442 -0.799 . . . . 74.02 111.59 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 m -65.12 -37.36 87.2 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.909 0.385 . . . . 72.13 112.001 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -64.96 -46.95 79.4 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.005 0.431 . . . . 72.12 111.31 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.601 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.78 -44.18 94.02 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.973 0.416 . . . . 72.52 111.517 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.4 t -54.51 -42.31 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.438 -0.346 . . . . 71.43 111.406 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -56.73 -46.28 81.43 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.396 0.617 . . . . 64.3 110.821 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -62.53 -40.35 96.47 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.222 -0.899 . . . . 44.03 112.035 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 64' ' ' VAL . 56.7 mt -68.74 -51.59 39.73 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.014 0.376 . . . . 74.03 112.014 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -60.91 -32.99 72.45 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.09 -0.381 . . . . 61.44 110.594 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.8 t -65.63 -31.45 72.49 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.87 0.367 . . . . 73.4 110.955 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.16 3.17 18.49 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.943 0.402 . . . . 73.13 111.777 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.425 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 108.64 -19.62 30.78 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.233 -0.508 . . . . 34.05 113.941 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -55.46 108.48 0.43 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.414 0.626 . . . . 73.3 112.237 -176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -66.09 -57.33 7.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.333 -0.849 . . . . 73.11 112.208 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -94.28 79.03 3.95 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.348 -0.387 . . . . 71.41 112.019 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 76' ' ' VAL . 59.3 t -124.41 131.94 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 O-C-N 122.232 -0.293 . . . . 72.25 111.021 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.9 p -128.91 141.58 51.23 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.846 0.355 . . . . 72.41 111.277 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.9 pt-20 -88.4 127.93 35.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.943 0.401 . . . . 74.05 111.176 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.3 tp -78.49 103.44 8.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.906 0.384 . . . . 63.11 110.434 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.726 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 8.0 mmpt? -55.63 121.19 8.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.422 0.629 . . . . 73.24 112.298 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 97.58 -27.62 17.98 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.605 -0.725 . . . . 71.44 113.569 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.05 -154.47 37.3 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.143 -0.551 . . . . 74.54 113.607 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD22 ' NH1' ' A' ' 27' ' ' ARG . 57.4 tp -63.38 -43.23 98.2 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.542 -0.387 . . . . 64.24 111.851 -177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.14 60.03 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.733 0.272 . . . . 53.41 111.733 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.2 -47.67 70.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.097 0.475 . . . . 55.41 110.772 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.6 t-105 -55.76 -39.87 71.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.468 0.651 . . . . 75.44 111.086 176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.7 mtpt -77.67 -39.17 45.81 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.863 -0.608 . . . . 73.32 111.963 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.39 -39.42 90.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.145 0.498 . . . . 74.55 111.367 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.9 pt -79.14 4.3 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 116.198 -0.455 . . . . 74.1 111.672 178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.98 46.66 43.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.469 -0.396 . . . . 33.0 113.553 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.79 158.03 29.13 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.432 -0.413 . . . . 73.34 113.41 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.63 117.43 4.86 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.794 2.329 . . . . 63.31 112.773 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 98' ' ' LYS . 81.2 p -119.13 147.05 44.61 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.585 0.707 . . . . 60.41 112.448 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -114.75 174.25 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.274 -0.876 . . . . 75.11 110.5 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.522 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.78 175.01 13.72 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.869 -0.682 . . . . 70.45 113.481 177.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.9 mt -83.28 -38.08 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 52.1 109.719 174.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.85 -40.1 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.931 -0.577 . . . . 63.55 112.34 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.637 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 66.2 mm-40 -69.48 72.2 0.33 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.659 0.743 . . . . 64.31 111.703 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -161.87 -38.61 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.343 -0.844 . . . . 75.14 109.312 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.18 83.41 1.79 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.451 -0.795 . . . . 75.11 110.566 173.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.1 t -109.44 145.85 32.73 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.928 -0.578 . . . . 73.42 112.513 -171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -94.86 15.5 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.4 2.733 . . . . 71.21 112.922 176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.66 -178.74 2.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.895 0.702 . . . . 72.4 112.895 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.02 -148.44 20.15 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.853 -0.612 . . . . 43.2 112.307 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.75 108.0 0.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.252 0.834 . . . . 75.15 113.252 175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -129.21 125.58 37.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.016 -0.538 . . . . 74.21 110.81 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -99.8 -174.95 2.83 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.034 0.445 . . . . 74.15 111.777 -178.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -153.66 136.51 15.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.899 0.333 . . . . 65.41 111.899 -174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -79.29 110.29 14.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 110.12 -0.326 . . . . 75.3 110.12 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.8 t -80.96 -27.91 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.709 0.633 . . . . 74.22 112.709 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.8 t -89.09 105.14 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.836 0.351 . . . . 54.03 111.887 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 t -167.73 14.1 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 120.933 0.397 . . . . 53.34 111.966 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.3 tpt85 -126.17 122.37 35.45 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.883 0.373 . . . . 75.1 111.562 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -163.52 169.42 18.78 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.387 -0.37 . . . . 75.42 111.604 179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -149.47 138.51 21.24 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.747 0.308 . . . . 75.42 110.846 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -161.48 89.42 0.76 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.952 0.405 . . . . 72.1 111.878 -175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -131.87 121.09 23.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.114 0.483 . . . . 73.41 112.181 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -132.32 143.83 50.14 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.356 -0.384 . . . . 64.44 111.472 175.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -113.8 -77.55 0.58 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.664 -0.244 . . . . 63.33 110.91 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 85.3 t60 55.33 96.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.718 0.636 . . . . 62.51 112.718 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.067 0.461 . . . . 61.11 111.462 178.167 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 23.3 ttt . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.479 0.18 . . . . 75.12 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.62 142.17 25.45 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 111.816 0.302 . . . . 74.32 111.816 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.88 -41.83 50.5 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.956 2.437 . . . . 74.11 112.708 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -125.19 133.63 52.69 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.069 0.461 . . . . 75.55 110.874 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.7 p -118.59 139.62 51.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.977 0.417 . . . . 72.12 111.223 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 17.5 t70 -81.12 138.9 35.89 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 116.572 -0.286 . . . . 70.14 111.189 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.23 -41.41 65.39 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.029 0.442 . . . . 42.13 111.879 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.56 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.9 t60 -65.18 -43.29 92.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.364 -0.38 . . . . 63.55 111.775 177.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.09 -41.95 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.934 0.397 . . . . 61.53 111.383 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.424 HD22 HD13 ' A' ' 90' ' ' LEU . 43.0 tp -63.56 -41.89 98.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.977 0.418 . . . . 62.11 110.609 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HA ' ' CH2' ' A' ' 97' ' ' TRP . 75.5 tttt -57.45 -45.07 85.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.836 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 m -64.47 -32.38 73.99 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.136 -0.484 . . . . 74.51 110.758 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.493 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 97.1 mtt180 -72.26 -33.14 67.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.778 0.323 . . . . 74.41 111.523 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.7 -50.01 64.23 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.888 0.375 . . . . 70.34 110.404 176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.99 -52.96 6.86 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.094 0.473 . . . . 61.04 112.159 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -95.46 -42.09 8.64 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.46 0.541 . . . . 73.2 112.46 -174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -71.46 -166.59 7.65 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 114.396 0.519 . . . . 73.04 114.396 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -90.83 138.02 26.54 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 120.87 0.367 . . . . 74.42 111.33 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -86.25 45.57 1.45 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.957 2.438 . . . . 44.23 113.24 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.28 -11.75 29.52 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.411 -0.359 . . . . 65.43 111.827 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -94.23 158.74 15.45 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.222 0.534 . . . . 61.2 112.152 -175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.586 HG21 HD21 ' A' ' 56' ' ' LEU . 86.4 m -128.21 133.57 48.88 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.246 -0.433 . . . . 74.52 111.07 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 37' ' ' ILE . 69.3 mt -103.43 132.36 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.072 0.397 . . . . 72.05 112.072 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.78 HD21 HD11 ' A' ' 56' ' ' LEU . 19.4 mt -112.98 131.56 55.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.27 0.47 . . . . 54.41 112.27 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -93.02 97.5 10.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.114 -0.494 . . . . 72.1 110.876 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 48' ' ' LEU . 34.4 m -95.42 8.69 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.63 0.604 . . . . 53.23 112.63 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.5 mtm180 -65.08 -66.42 0.55 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.238 0.542 . . . . 55.35 110.146 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 177.05 156.61 0.3 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.087 -0.96 . . . . 74.13 109.087 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.33 -34.84 79.07 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 65.41 110.89 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 80.2 p -69.56 -46.47 66.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.222 0.534 . . . . 71.31 110.758 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.455 HG22 ' NH1' ' A' ' 27' ' ' ARG . 7.7 m -66.78 -30.61 70.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.008 -0.542 . . . . 72.23 110.884 177.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -59.16 -52.17 66.86 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.975 0.417 . . . . 71.42 110.082 172.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -62.35 -32.29 73.05 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.486 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.688 ' HA ' HD13 ' A' ' 108' ' ' ILE . 9.6 t70 -61.1 -49.6 76.65 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.772 0.32 . . . . 71.14 111.31 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.654 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -179.94 128.01 1.18 Allowed Glycine 0 C--O 1.221 -0.701 0 C-N-CA 120.956 -0.64 . . . . 64.53 112.092 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -145.15 172.86 12.5 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.478 0.639 . . . . 63.11 111.653 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 23' ' ' ILE . 70.6 mt -66.59 141.46 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-O 120.857 0.36 . . . . 72.13 111.291 175.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.6 tpp -59.17 118.42 5.86 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.833 0.349 . . . . 61.02 111.502 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.58 64.49 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.186 -0.53 . . . . 74.43 113.845 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.6 166.32 20.32 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.509 0.671 . . . . 25.01 112.264 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 87.5 mmm -102.31 146.35 28.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.681 -0.691 . . . . 55.33 111.823 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.78 68.09 7.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.13 0.49 . . . . 71.11 111.657 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.684 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.7 mpt? -108.1 88.87 5.06 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.322 -0.399 . . . . 74.4 111.19 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 51' ' ' ARG . 93.6 Cg_endo -75.67 140.88 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.566 2.177 . . . . 72.35 111.676 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.9 tt -49.41 -25.81 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.867 1.062 . . . . 72.01 113.867 -170.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -71.92 -49.68 35.64 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.332 0.587 . . . . 63.4 111.077 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.63 4.47 51.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.93 -0.577 . . . . 71.52 111.662 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 26' ' ' VAL . 66.5 tp -44.72 -55.21 5.48 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.574 0.953 . . . . 73.43 113.574 -173.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.71 -52.86 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.15 0.5 . . . . 74.02 111.619 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -53.63 55.8 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.811 -0.631 . . . . 53.15 112.045 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.634 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.2 mmt180 -58.41 -49.64 76.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.048 -0.524 . . . . 72.45 112.084 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.12 -46.38 84.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.221 -0.445 . . . . 63.5 111.583 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -58.06 -23.17 53.52 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.831 0.348 . . . . 64.14 111.539 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.6 t -82.31 -62.75 1.53 Allowed 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.627 0.603 . . . . 74.03 112.627 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 m -93.72 1.03 56.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.036 0.754 . . . . 71.02 113.036 -172.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.78 HD11 HD21 ' A' ' 24' ' ' LEU . 89.5 mt -135.59 159.9 40.16 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.5 0.666 . . . . 75.03 112.424 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.5 mp0 -96.97 176.68 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.657 -0.701 . . . . 72.23 111.281 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 95.8 mttt -92.91 -27.34 17.15 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.2 -0.909 . . . . 75.32 110.598 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.9 m -88.27 -2.96 58.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.111 -0.495 . . . . 64.42 111.272 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 15.0 tpp180 -67.59 134.34 51.04 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.651 0.38 . . . . 70.41 110.766 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.97 96.0 0.41 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.138 0.494 . . . . 64.53 110.899 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.85 132.98 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.858 0.688 . . . . 64.42 112.858 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -120.36 132.87 55.47 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.772 -0.649 . . . . 61.55 110.581 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.77 135.45 58.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 111.973 0.36 . . . . 74.14 111.973 -174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -134.27 128.97 34.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.609 0.719 . . . . 74.22 111.829 174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.52 -173.84 21.61 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.553 -0.749 . . . . 70.43 112.385 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.45 24.18 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.273 0.559 . . . . 74.41 110.408 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.28 152.67 17.05 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.611 -0.722 . . . . 45.52 112.557 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -49.1 -42.54 39.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.935 0.494 . . . . 72.43 111.963 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.92 -37.84 79.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 116.242 -0.435 . . . . 65.14 111.946 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 48.4 tt0 -58.65 -45.05 90.18 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.578 0.704 . . . . 73.14 109.846 172.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 36.4 m -56.8 -52.58 64.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.843 -1.071 . . . . 64.23 111.558 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -61.0 -40.92 95.35 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.434 0.531 . . . . 65.33 112.434 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -64.88 -45.92 83.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.933 0.397 . . . . 74.34 111.156 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.59 -50.33 70.39 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.111 0.481 . . . . 73.52 111.405 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 89' ' ' GLU . 72.2 t -53.66 -44.06 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.265 -0.425 . . . . 74.03 111.73 174.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -56.31 -42.03 76.96 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.385 0.612 . . . . 73.33 111.181 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 75' ' ' ALA . 35.3 mt -65.7 -35.97 82.28 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.464 -0.789 . . . . 74.24 111.803 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.8 mt -71.72 -51.9 20.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.003 0.371 . . . . 72.42 112.003 177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -58.86 -32.97 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.671 -0.412 . . . . 72.54 110.465 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -63.56 -38.67 92.01 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.938 0.399 . . . . 53.23 111.134 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 -9.71 58.5 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.441 . . . . 74.3 111.794 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.68 -2.8 29.05 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.214 -0.517 . . . . 44.24 113.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 73.1 m-85 -65.56 120.83 13.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.071 0.463 . . . . 74.02 111.948 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -79.92 -48.29 13.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.823 -0.626 . . . . 74.24 112.233 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.506 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 47.9 m-70 -101.82 82.64 2.28 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.246 0.461 . . . . 74.45 112.246 -175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.42 124.66 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.66 0.267 . . . . 33.13 111.039 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.0 t -120.53 141.69 50.01 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.732 0.301 . . . . 65.55 111.483 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.666 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.9 pt-20 -92.15 128.93 38.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.222 0.534 . . . . 75.21 111.394 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.5 tp -81.83 121.86 26.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.048 -0.523 . . . . 73.31 111.52 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 11.2 mmpt? -75.25 150.55 38.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.494 . . . . 74.11 111.093 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.79 -52.02 4.37 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.252 -0.499 . . . . 73.45 113.702 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.45 -170.8 24.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.077 -0.582 . . . . 60.31 112.905 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.56 -40.75 92.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 122.53 -0.394 . . . . 73.14 111.568 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.21 -39.45 60.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 111.748 0.277 . . . . 54.51 111.748 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.81 -46.33 68.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.029 0.442 . . . . 73.01 110.64 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.7 t-105 -52.08 -40.78 61.7 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.709 0.766 . . . . 73.23 111.054 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.452 ' HG2' HG21 ' A' ' 104' ' ' THR . 39.3 mtpt -78.51 -32.1 47.96 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.421 -0.808 . . . . 71.54 111.974 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.12 72.1 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.998 0.428 . . . . 43.33 111.809 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.7 pt -84.84 -1.07 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.368 -0.378 . . . . 54.52 111.485 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.32 57.45 9.28 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.384 -0.436 . . . . 54.23 113.143 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.87 169.0 30.67 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.917 -0.658 . . . . 43.13 113.293 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.54 116.96 3.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.566 2.177 . . . . 75.11 112.114 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.452 HG21 ' HG2' ' A' ' 98' ' ' LYS . 67.7 p -119.02 169.25 10.07 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.905 0.86 . . . . 75.11 112.925 -173.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -148.11 171.8 15.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.917 -1.038 . . . . 73.41 109.848 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.3 160.89 9.82 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.129 -1.034 . . . . 54.34 114.668 175.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.18 -54.87 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.248 0.619 . . . . 74.24 111.389 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.688 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -64.04 -30.35 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.072 0.463 . . . . 74.05 111.671 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.15 -6.24 1.92 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.899 -0.591 . . . . 74.23 111.997 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.3 t -111.42 6.41 20.29 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.173 0.434 . . . . 70.2 112.173 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -122.49 138.48 54.54 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.992 0.425 . . . . 72.41 112.02 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.6 p -131.24 150.32 76.17 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.261 -0.427 . . . . 73.54 111.17 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.24 97.15 1.13 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.55 2.167 . . . . 52.41 113.118 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.74 150.76 39.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.875 0.369 . . . . 73.24 111.701 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 111.2 116.27 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.432 -0.413 . . . . 73.45 113.403 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -150.99 155.84 39.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.92 0.391 . . . . 70.23 111.9 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -159.2 149.53 19.34 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.444 -0.344 . . . . 72.33 111.719 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -171.81 -178.39 2.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.064 0.459 . . . . 73.43 112.135 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 32.8 t80 60.56 53.74 4.0 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.634 -0.712 . . . . 75.4 112.072 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -75.89 -28.92 58.29 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.533 0.683 . . . . 73.53 110.197 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 32.8 m -55.65 143.25 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.419 0.896 . . . . 65.42 113.419 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.44 131.32 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.508 -0.769 . . . . 63.04 110.14 174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t -139.29 105.0 5.12 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.881 0.697 . . . . 63.33 112.881 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -143.26 136.82 28.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.066 -0.516 . . . . 73.1 110.815 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.3 tp -150.26 99.23 2.77 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.737 0.304 . . . . 70.32 111.671 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -174.31 99.75 0.1 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 61.24 111.448 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -157.07 88.04 1.01 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.377 -0.374 . . . . 50.22 110.836 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -167.92 114.92 0.72 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.572 -0.286 . . . . 73.03 110.941 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -154.02 126.85 8.22 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.973 0.416 . . . . 74.13 111.717 -176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -132.36 96.9 3.97 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.273 -0.422 . . . . 74.13 111.161 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -112.08 55.77 0.67 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.277 0.56 . . . . 70.34 111.429 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.83 177.647 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.552 0.215 . . . . 61.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -80.69 153.07 73.03 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-O 120.642 0.258 . . . . 71.02 111.328 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.31 -43.19 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.162 1.908 . . . . 71.34 111.489 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.591 ' HB2' ' HB2' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -149.61 116.88 6.05 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.402 0.62 . . . . 63.33 110.584 172.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.401 ' OG ' ' HE1' ' A' ' 63' ' ' TYR . 30.1 m -95.32 138.36 33.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.354 0.597 . . . . 72.52 112.434 -172.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 16.9 t70 -72.7 139.55 47.29 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.708 -0.678 . . . . 72.22 111.393 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -56.32 -42.99 78.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.984 0.421 . . . . 71.51 111.914 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.605 ' HB2' HG21 ' A' ' 100' ' ' ILE . 12.9 t60 -62.7 -39.18 93.19 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.301 -0.409 . . . . 72.0 111.692 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.91 -38.83 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.052 0.454 . . . . 75.55 111.082 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.6 tp -65.04 -42.72 94.03 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.523 -0.308 . . . . 62.34 111.443 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.5 tttt -60.17 -43.55 95.74 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.771 0.319 . . . . 65.24 111.451 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -64.14 -30.63 71.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.007 0.432 . . . . 63.34 110.573 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' HB3' ' HE2' ' A' ' 21' ' ' PHE . 98.2 mtt180 -72.78 -27.11 61.8 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.206 -0.309 . . . . 73.12 111.723 174.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.8 -47.24 54.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.959 0.409 . . . . 63.44 110.585 174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -80.4 -53.14 6.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.125 0.488 . . . . 71.35 112.133 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -94.07 -40.39 10.09 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.117 -0.492 . . . . 60.42 112.249 -174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.91 -110.5 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 121.617 -0.325 . . . . 71.53 113.72 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.7 pt-20 -171.91 148.3 2.09 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 122.554 -0.38 . . . . 74.02 111.405 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 8.2 Cg_exo -74.02 32.58 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.249 2.633 . . . . 71.21 114.272 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.44 -4.89 47.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.239 0.542 . . . . 54.14 111.582 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' HE2' ' HB3' ' A' ' 13' ' ' ARG . 4.1 p90 -105.48 159.96 15.53 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 65.4 112.12 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.45 HG21 HD21 ' A' ' 56' ' ' LEU . 56.4 m -124.77 125.52 44.16 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.255 -0.43 . . . . 71.11 111.442 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.3 mp -96.85 132.04 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 120.655 0.264 . . . . 74.33 111.141 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 56' ' ' LEU . 48.7 mt -112.67 126.73 55.7 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.116 0.413 . . . . 64.11 112.116 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.37 98.15 11.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.028 -0.533 . . . . 74.14 110.356 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.7 m -96.01 10.67 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 112.231 0.456 . . . . 73.21 112.231 -174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' A' ' 67' ' ' ALA . 84.5 mtm180 -67.81 -68.03 0.42 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.956 0.408 . . . . 73.15 110.476 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -179.25 157.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.664 -0.698 . . . . 74.33 110.093 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -55.72 -41.14 73.42 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.083 0.468 . . . . 74.41 111.142 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.0 p -71.69 -49.63 37.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.246 -0.434 . . . . 74.1 110.841 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.2 m -60.56 -32.16 71.25 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.002 -0.544 . . . . 61.44 111.208 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -57.37 -54.51 46.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.208 -0.451 . . . . 73.55 110.272 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -62.25 -34.07 75.81 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.033 -0.53 . . . . 72.11 111.315 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.8 t70 -58.14 -49.59 76.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.594 0.358 . . . . 71.23 111.277 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -178.36 113.29 0.41 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.517 -0.849 . . . . 32.52 112.81 176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -131.85 166.43 21.62 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.171 0.485 . . . . 63.23 112.124 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.81 137.87 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.828 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.7 ttm -62.56 112.02 2.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.915 0.388 . . . . 63.55 111.406 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.72 22.62 35.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.234 -0.508 . . . . 54.33 113.666 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.28 158.86 16.33 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.317 -0.52 . . . . 63.42 111.296 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.8 mmm -89.54 142.67 27.46 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.17 0.509 . . . . 74.35 112.141 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.59 81.56 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 54.0 109.755 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.545 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 28.4 ttm -132.6 79.67 64.07 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.142 -0.481 . . . . 44.22 110.409 -172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.08 145.05 59.76 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.627 2.218 . . . . 74.03 112.224 -172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.4 tt -53.9 -28.67 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.737 0.643 . . . . 61.42 112.737 -171.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -72.28 -28.23 62.97 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.913 0.387 . . . . 73.13 111.837 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.31 2.97 15.71 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.767 0.317 . . . . 73.03 111.06 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 75' ' ' ALA . 57.2 tp -47.81 -54.42 12.44 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.203 0.816 . . . . 73.44 113.203 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.8 t -54.82 -49.19 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.99 0.424 . . . . 62.52 111.854 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.21 -50.47 63.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.279 -0.419 . . . . 72.21 111.731 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 27.5 mmt180 -57.09 -54.7 43.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.105 0.478 . . . . 72.33 111.859 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.14 -49.95 75.61 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.903 -0.59 . . . . 54.33 112.085 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.7 p -58.29 -26.8 63.42 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.975 0.417 . . . . 73.15 111.639 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -88.38 -18.22 28.85 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.768 0.655 . . . . 72.32 112.768 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.0 m -128.02 -10.83 5.38 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.775 1.028 . . . . 72.35 113.775 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 24' ' ' LEU . 93.2 mt -132.23 167.21 20.21 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.694 0.627 . . . . 73.24 112.694 -172.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 59' ' ' SER . 11.0 tp10 -107.67 153.2 23.27 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.588 -0.733 . . . . 74.12 110.771 175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 45.7 mmtm -62.71 -30.73 71.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.207 0.527 . . . . 71.12 111.516 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.608 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 93.0 p -86.36 -10.51 54.22 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.213 -0.449 . . . . 73.34 112.005 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 62' ' ' ILE . 22.7 tpp180 -63.44 125.28 23.69 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.699 0.285 . . . . 71.43 111.457 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.13 98.85 0.82 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.536 0.684 . . . . 65.55 111.027 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 60' ' ' ARG . 85.3 mt -101.67 129.07 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 115.744 -0.662 . . . . 72.54 112.525 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 89.2 m-85 -109.47 117.52 34.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.221 -0.445 . . . . 65.23 110.42 174.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 72' ' ' THR . 81.6 t -104.9 135.32 43.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.185 -0.461 . . . . 63.42 111.553 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' HB3' HD23 ' A' ' 90' ' ' LEU . 4.8 p90 -137.81 128.57 26.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.666 0.746 . . . . 74.32 111.802 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.87 -172.21 24.45 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.466 -0.788 . . . . 63.14 111.594 173.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' N ' ' HG2' ' A' ' 27' ' ' ARG . . . -72.35 -19.77 61.58 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.182 -0.599 . . . . 74.14 111.034 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -146.41 154.34 25.9 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 115.572 -0.74 . . . . 61.4 111.955 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.04 -40.85 15.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 64.24 112.371 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -60.25 -51.46 69.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.041 0.385 . . . . 64.44 112.041 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -61.28 -36.17 79.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.171 0.51 . . . . 62.42 110.579 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 76' ' ' VAL . 86.9 m -58.61 -54.67 44.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.75 -0.659 . . . . 75.43 110.904 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 t -57.45 -43.45 83.97 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.749 -0.66 . . . . 52.01 112.202 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -64.9 -45.22 86.82 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.952 0.406 . . . . 70.51 111.352 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -61.99 -44.97 95.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.089 0.471 . . . . 52.24 111.599 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 89' ' ' GLU . 71.3 t -52.64 -46.83 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.091 -0.504 . . . . 74.51 111.135 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -54.46 -49.08 70.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.346 0.593 . . . . 55.14 111.029 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 75' ' ' ALA . 43.4 mt -59.75 -33.44 71.67 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.467 -0.788 . . . . 71.45 112.221 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 24' ' ' LEU . 54.6 mt -68.14 -53.04 28.08 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.955 0.354 . . . . 64.4 111.955 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -66.57 -25.03 66.44 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.927 -0.483 . . . . 64.31 111.332 176.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.2 t -68.18 -31.52 71.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.183 0.516 . . . . 51.12 110.53 168.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.89 2.95 31.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 116.307 -0.406 . . . . 75.34 111.356 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' C ' ' HD2' ' A' ' 58' ' ' LYS . . . 109.04 -30.75 8.33 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.347 -0.454 . . . . 61.21 113.916 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 99.2 m-85 -49.14 115.39 1.28 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.94 0.719 . . . . 71.42 112.94 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.26 -55.57 5.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 65.25 112.096 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -90.66 88.02 6.94 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.892 0.377 . . . . 75.02 111.833 -172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.458 HG12 HG13 ' A' ' 76' ' ' VAL . 39.1 t -134.69 140.7 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 O-C-N 122.331 -0.231 . . . . 71.41 110.699 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.3 t -134.98 148.09 49.9 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.379 0.511 . . . . 74.12 112.379 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 26.2 mt-10 -84.35 113.47 21.18 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 73.02 110.738 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.573 HD11 ' HA ' ' A' ' 7' ' ' ALA . 25.4 tp -73.69 103.97 4.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.339 0.59 . . . . 74.23 111.139 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.475 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 60.6 mtpt -63.67 135.66 56.89 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.713 -0.676 . . . . 71.01 112.507 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.33 -25.01 13.71 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.047 -0.524 . . . . 61.51 114.164 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.42 -156.76 51.44 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.791 -0.719 . . . . 61.2 113.679 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.1 -41.01 91.21 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.887 0.375 . . . . 65.41 111.647 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.85 76.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.364 -0.38 . . . . 72.31 111.94 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.01 0.433 . . . . 63.12 111.204 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -54.87 -38.9 68.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.244 0.545 . . . . 74.23 110.907 176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -74.88 -38.35 61.93 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.287 -0.415 . . . . 72.24 111.982 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.33 -31.03 67.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.072 0.463 . . . . 64.22 112.007 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.605 HG21 ' HB2' ' A' ' 8' ' ' HIS . 22.7 pt -92.9 11.95 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.104 -0.498 . . . . 70.03 111.634 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.9 34.27 76.76 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.372 -0.442 . . . . 44.24 113.699 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.489 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.07 149.38 44.23 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.13 -0.557 . . . . 75.0 113.358 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 129.37 20.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.704 2.269 . . . . 72.33 112.519 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.8 p -129.48 150.79 50.68 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.266 0.555 . . . . 73.53 112.131 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -124.32 159.99 29.06 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.784 -0.644 . . . . 62.55 110.484 174.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.8 -178.45 29.93 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.228 -0.987 . . . . 71.23 114.527 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 28.4 mt -97.1 -49.86 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.051 0.54 . . . . 44.12 110.96 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.501 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -69.68 -23.25 25.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.356 0.598 . . . . 61.42 110.984 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -59.02 80.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.46 -0.791 . . . . 74.05 109.688 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 111' ' ' ARG . 38.6 t 176.96 -45.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.057 -0.974 . . . . 75.54 110.13 -169.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HD3' ' HB3' ' A' ' 110' ' ' SER . 0.0 OUTLIER -121.08 -1.16 9.85 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.264 -0.425 . . . . 75.03 111.188 177.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.2 p 63.96 148.18 0.1 Allowed Pre-proline 0 N--CA 1.484 1.252 0 C-N-CA 124.158 0.983 . . . . 74.22 111.52 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -56.51 -64.7 0.12 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.531 2.154 . . . . 61.41 113.604 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -178.05 -173.13 0.36 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.367 -0.833 . . . . 75.3 111.419 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.1 -155.92 27.99 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.193 -0.527 . . . . 64.13 112.281 175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.63 147.06 32.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.004 0.43 . . . . 73.24 111.76 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -160.68 128.94 4.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.095 -0.502 . . . . 72.23 110.934 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -144.67 179.98 6.95 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.144 -0.48 . . . . 75.31 110.763 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -148.46 142.49 25.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.802 0.334 . . . . 74.13 111.19 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.553 HD22 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -64.46 108.86 1.76 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.42 0.629 . . . . 62.42 111.154 175.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.67 85.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.19 0.519 . . . . 65.41 111.304 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.7 120.69 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.881 -0.6 . . . . 75.44 111.935 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.7 t 176.09 89.24 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.844 -0.616 . . . . 71.3 110.436 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 124' ' ' ARG . 36.8 ttt180 -138.13 142.17 40.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.997 0.427 . . . . 70.41 112.125 -176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -152.36 95.7 2.07 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.701 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -147.45 130.46 16.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 62.24 111.564 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -146.01 14.25 1.32 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.463 0.542 . . . . 63.4 112.463 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -77.41 109.66 11.51 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.829 -0.544 . . . . 65.53 110.93 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 -161.53 110.94 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.372 -0.376 . . . . 64.51 111.071 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -168.75 136.18 1.96 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.908 0.336 . . . . 70.12 111.908 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -151.05 97.35 2.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.587 0.588 . . . . 44.33 112.587 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.4 p80 . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.602 0.239 . . . . 63.33 111.123 170.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.461 0.172 . . . . 72.31 111.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.36 155.65 92.58 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.837 0.351 . . . . 75.22 111.73 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.46 -32.89 97.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.574 2.182 . . . . 73.24 112.103 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -121.85 109.61 14.86 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.794 -0.639 . . . . 63.34 111.062 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -93.12 137.91 32.04 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.883 0.373 . . . . 65.34 111.461 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 9' ' ' VAL . 12.8 t70 -77.3 154.73 32.6 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.415 -0.357 . . . . 74.11 110.9 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.682 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.99 -52.0 65.78 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.892 0.701 . . . . 72.12 112.892 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 100' ' ' ILE . 3.4 p-80 -73.88 -24.89 59.79 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.681 -0.637 . . . . 74.03 112.157 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HB3' ' A' ' 6' ' ' ASP . 66.5 t -56.07 -51.03 66.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.885 0.374 . . . . 65.25 110.453 171.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.64 -44.82 80.94 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.391 -0.368 . . . . 64.43 111.496 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HB3' ' HA ' ' A' ' 8' ' ' HIS . 74.0 tttt -56.19 -48.97 75.36 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.106 0.479 . . . . 72.11 112.119 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -75.75 -30.97 59.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.396 0.617 . . . . 72.53 110.058 -175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -64.26 -34.76 78.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.894 -0.594 . . . . 74.43 110.657 171.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tt -65.01 -56.12 15.0 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.042 0.449 . . . . 73.03 110.792 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.451 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 27.6 mt-10 -77.43 -54.08 6.87 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.404 0.621 . . . . 71.13 111.87 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 49.2 m95 -94.9 -37.29 11.25 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.007 0.743 . . . . 71.1 113.007 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.67 -109.52 0.84 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 114.722 0.649 . . . . 62.13 114.722 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 37.6 tt0 -137.76 126.48 14.64 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 122.738 0.415 . . . . 75.41 111.301 -170.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.95 21.98 0.96 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 123.06 2.507 . . . . 32.31 114.006 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 18' ' ' GLU . . . -83.32 55.97 3.37 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.017 0.437 . . . . 65.24 112.102 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -154.88 159.88 40.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.409 . . . . 74.35 111.619 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' CG2' HG12 ' A' ' 62' ' ' ILE . 14.9 t -117.46 146.81 43.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.681 0.277 . . . . 75.51 110.673 173.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.3 mt -113.93 122.01 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.824 -0.171 . . . . 75.21 110.888 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.677 HD22 ' SD ' ' A' ' 43' ' ' MET . 49.7 mt -110.6 123.25 49.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.113 0.483 . . . . 73.41 112.081 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -88.54 100.58 13.18 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.968 -0.56 . . . . 74.52 110.576 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HD13 ' A' ' 48' ' ' LEU . 30.6 m -95.72 12.06 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.775 0.657 . . . . 51.32 112.775 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.0 mtm180 -71.46 -66.6 0.6 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.991 0.424 . . . . 71.2 110.595 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 178.44 158.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.491 -0.777 . . . . 70.31 109.984 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 14.1 tpt180 -65.12 -38.18 89.81 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 120.893 0.378 . . . . 74.33 111.43 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.6 t -76.46 -49.95 15.31 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.031 0.443 . . . . 73.24 110.364 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.488 HG22 ' NH1' ' A' ' 27' ' ' ARG . 30.1 m -56.33 -32.14 64.39 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.019 -0.537 . . . . 60.54 110.658 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.501 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 58.2 t80 -57.51 -51.73 68.29 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.046 -0.525 . . . . 71.43 110.362 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -59.47 -41.94 90.91 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.349 -0.387 . . . . 73.51 111.901 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.747 ' HA ' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -54.2 -48.9 70.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.32 0.489 . . . . 70.52 112.32 178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.496 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -169.47 136.63 4.12 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.705 -0.76 . . . . 71.3 112.212 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.443 ' NE2' ' HB3' ' A' ' 105' ' ' GLU . 48.1 p-80 -160.27 178.78 9.27 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.66 0.73 . . . . 72.33 112.132 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -77.5 139.89 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.246 -0.434 . . . . 75.23 111.85 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 44.3 tpp -53.96 116.03 2.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.402 0.519 . . . . 74.22 112.402 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.33 45.91 58.93 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.198 -0.525 . . . . 64.22 113.842 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.24 172.89 6.72 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.282 -0.54 . . . . 60.21 111.754 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.49 ' HB2' HD23 ' A' ' 24' ' ' LEU . 95.2 mmm -99.48 144.14 28.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.127 -0.488 . . . . 74.3 111.086 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.46 74.38 1.9 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 53.21 111.763 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.677 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.0 mpt? -104.62 93.73 6.38 Favored Pre-proline 0 N--CA 1.468 0.458 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.848 173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.86 135.32 23.27 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.893 1.729 . . . . 75.13 110.988 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 48' ' ' LEU . 18.2 tt -47.11 -25.83 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.096 0.776 . . . . 64.23 113.096 -171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -72.77 -43.32 62.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 70.13 111.613 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -98.47 0.34 44.99 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.208 -0.451 . . . . 54.12 111.143 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD13 HG12 ' A' ' 26' ' ' VAL . 64.0 tp -40.35 -67.37 0.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.566 1.321 . . . . 52.24 114.566 -168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -55.06 -51.37 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.371 0.605 . . . . 70.31 111.604 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.31 -32.42 73.17 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.611 -0.722 . . . . 64.34 112.361 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 12.4 mmt180 -70.88 -55.41 8.51 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.272 0.558 . . . . 72.05 111.159 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.15 84.73 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.754 -0.657 . . . . 74.53 112.046 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -56.73 -25.43 54.63 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.153 0.427 . . . . 34.14 112.153 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.1 t -84.41 -23.56 29.98 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.945 0.721 . . . . 71.31 112.945 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.4 t -132.97 -4.36 3.14 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.437 0.903 . . . . 74.12 113.437 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 24' ' ' LEU . 88.5 mt -124.66 168.25 13.42 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.689 0.757 . . . . 54.24 112.739 -175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.742 ' HG2' ' H ' ' A' ' 59' ' ' SER . 30.5 tt0 -108.84 141.45 40.87 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.179 -0.919 . . . . 73.15 110.822 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . 61.7 mmtt -60.23 -32.07 70.78 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.302 0.572 . . . . 62.41 111.199 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.742 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 49.4 m -91.48 -5.33 54.41 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.125 -0.489 . . . . 55.53 112.13 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 20.5 tpp180 -68.0 132.91 48.15 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.237 0.215 . . . . 75.54 111.519 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.98 97.9 0.19 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.458 0.647 . . . . 74.13 110.867 175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 60' ' ' ARG . 66.6 mt -104.08 132.39 50.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.886 -0.597 . . . . 60.12 112.479 -175.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -117.11 121.6 41.75 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.276 0.56 . . . . 75.41 110.754 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.8 t -109.38 138.5 36.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.87 -0.605 . . . . 74.45 111.675 -175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -137.45 127.24 25.49 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.638 0.732 . . . . 71.01 112.121 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.95 -162.69 23.94 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.471 -0.786 . . . . 73.4 111.947 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.1 -36.97 39.88 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.057 0.456 . . . . 75.4 110.894 173.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.71 -179.48 18.83 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 115.921 -0.581 . . . . 75.45 113.444 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -53.95 -51.86 62.49 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.04 0.756 . . . . 73.11 113.04 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.62 -50.05 72.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.934 0.346 . . . . 70.14 111.934 -174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.6 tt0 -58.36 -47.05 85.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.171 0.51 . . . . 74.11 111.024 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 89' ' ' GLU . 59.3 m -61.87 -54.02 47.72 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.778 -0.646 . . . . 65.11 111.477 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -65.17 -40.43 94.29 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.133 -0.485 . . . . 73.12 112.2 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -63.6 -45.31 90.94 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.715 0.293 . . . . 72.41 111.16 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.0 -48.2 79.04 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.154 0.502 . . . . 72.45 111.143 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.0 t -53.05 -45.35 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.992 -0.549 . . . . 74.43 111.929 174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -57.53 -48.99 77.78 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.354 0.597 . . . . 73.11 111.017 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 75' ' ' ALA . 31.2 mt -59.02 -41.97 89.02 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.443 -0.798 . . . . 64.31 111.97 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HG ' HD21 ' A' ' 48' ' ' LEU . 54.6 mt -65.2 -49.28 70.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.049 0.389 . . . . 74.41 112.049 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 13.1 ptp180 -67.7 -29.33 68.56 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.91 -0.494 . . . . 74.42 111.092 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -69.34 -23.04 63.72 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.021 0.439 . . . . 75.31 110.676 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.61 17.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.071 -0.513 . . . . 74.45 111.49 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.18 -21.19 47.29 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.194 -0.527 . . . . 44.25 113.856 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' LYS . 97.0 m-85 -59.09 101.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.582 0.706 . . . . 63.43 111.83 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 48.4 mt-10 -68.3 -42.32 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.179 -0.919 . . . . 72.24 112.492 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' ARG . 17.7 m-70 -102.97 88.01 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.997 0.369 . . . . 75.14 111.997 -175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 76' ' ' VAL . 47.5 t -137.74 120.0 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.829 0.347 . . . . 71.02 111.402 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.1 t -118.43 143.33 46.76 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.687 0.28 . . . . 44.22 111.562 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.614 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.7 pt-20 -88.75 127.55 35.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.162 0.506 . . . . 72.53 111.538 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 7' ' ' ALA . 36.0 tp -79.52 100.67 7.85 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.291 0.567 . . . . 72.23 110.783 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 6.8 mmpt? -58.94 115.58 3.22 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.505 0.669 . . . . 70.3 112.694 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.08 -21.93 32.53 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.563 -0.744 . . . . 34.32 113.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.79 -152.42 51.72 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.094 -0.574 . . . . 63.02 113.427 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.74 -49.17 78.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.633 0.605 . . . . 64.4 112.633 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.45 -39.18 56.91 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.306 0.484 . . . . 72.23 112.306 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.459 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -68.28 -46.99 68.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.811 0.339 . . . . 15.21 111.169 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.427 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 56.4 t-105 -52.11 -38.96 59.07 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.677 0.751 . . . . 74.01 110.78 175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.802 ' HG2' HG21 ' A' ' 104' ' ' THR . 24.5 mtpt -78.2 -39.62 40.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.354 -0.839 . . . . 74.12 111.876 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.71 74.14 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.019 0.437 . . . . 54.41 111.806 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' HIS . 28.5 pt -84.16 2.45 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.488 . . . . 73.15 111.448 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.4 48.13 25.57 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.355 -0.45 . . . . 74.1 113.742 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -92.05 167.34 30.43 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.048 -0.596 . . . . 52.01 113.291 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.65 120.86 7.6 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.677 2.251 . . . . 73.42 112.511 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.802 HG21 ' HG2' ' A' ' 98' ' ' LYS . 21.2 p -121.04 169.38 10.55 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.567 -0.288 . . . . 60.23 110.958 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 2.2 tt0 -161.09 144.31 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.972 0.415 . . . . 62.43 112.072 -173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.57 158.22 9.14 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 119.968 -1.11 . . . . 71.34 114.663 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.29 -47.59 89.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.077 0.465 . . . . 44.14 110.96 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.6 mp -73.87 -32.86 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.13 0.491 . . . . 73.21 111.637 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -71.34 -1.07 11.65 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.156 -0.475 . . . . 71.44 112.071 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -73.39 -19.03 61.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.792 0.664 . . . . 54.15 112.792 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.95 160.64 41.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.076 0.465 . . . . 72.1 112.162 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -99.23 140.69 21.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 115.854 -0.612 . . . . 70.11 111.832 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.01 122.13 3.74 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.93 2.42 . . . . 75.25 113.654 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -164.59 131.16 2.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.949 -0.568 . . . . 61.31 110.969 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.41 117.74 0.42 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.948 -0.644 . . . . 74.4 113.456 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -163.13 149.87 12.55 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.943 0.401 . . . . 65.24 111.695 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -149.11 144.79 26.87 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.32 -0.4 . . . . 65.14 110.722 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -142.1 131.09 23.12 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.578 0.584 . . . . 74.03 112.578 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -169.06 85.54 0.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.261 0.553 . . . . 72.42 111.512 170.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -119.83 70.27 0.86 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.425 0.631 . . . . 65.35 109.495 173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.4 114.81 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.853 -0.612 . . . . 64.43 111.533 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.7 130.33 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.406 -0.361 . . . . 74.52 111.062 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.6 t -150.78 110.87 4.12 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.793 0.294 . . . . 64.22 111.793 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -129.13 137.28 51.12 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.779 0.323 . . . . 75.11 110.718 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.4 mt -125.86 110.18 13.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.734 0.302 . . . . 72.41 111.451 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.64 112.47 8.95 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.52 0.676 . . . . 71.12 112.123 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -136.2 113.05 10.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.322 -0.399 . . . . 62.33 110.345 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -143.96 102.18 3.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.791 0.329 . . . . 65.35 111.085 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -130.98 121.99 26.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.706 0.289 . . . . 74.24 110.977 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -161.51 151.43 16.97 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.772 0.32 . . . . 72.21 111.554 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.37 152.9 42.62 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.694 0.283 . . . . 61.53 111.132 175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.7 p80 . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.357 0.599 . . . . 71.41 111.984 -179.215 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 41.1 tpp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 111.671 0.248 . . . . 62.02 111.671 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 69.42 148.0 0.12 Allowed Pre-proline 0 N--CA 1.476 0.856 0 CA-C-O 121.172 0.51 . . . . 75.31 112.267 -176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 11.3 Cg_endo -55.7 -37.71 95.14 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.639 2.226 . . . . 62.41 112.583 176.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -133.09 131.18 40.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.285 -0.416 . . . . 51.22 111.247 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.411 ' O ' HD12 ' A' ' 90' ' ' LEU . 67.7 m -119.4 135.58 54.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.388 -0.369 . . . . 73.14 111.426 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 16.7 t70 -77.31 147.92 35.95 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.492 -0.322 . . . . 73.33 110.676 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.689 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -52.51 -43.73 65.27 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.036 0.446 . . . . 72.13 111.83 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.573 ' HA ' HD12 ' A' ' 100' ' ' ILE . 25.0 t60 -61.1 -34.75 75.43 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.063 0.459 . . . . 73.31 111.826 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 85.9 t -72.42 -36.41 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.17 0.51 . . . . 71.32 111.152 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 54.6 tp -69.15 -41.65 77.0 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.338 -0.392 . . . . 75.1 110.958 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.1 tttt -58.09 -46.78 84.92 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.907 0.384 . . . . 73.32 111.298 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -66.22 -30.51 70.97 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.368 -0.378 . . . . 75.43 110.584 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 35.3 mtt85 -72.62 -33.03 66.39 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.646 0.61 . . . . 63.21 112.646 176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.534 HD12 ' CH2' ' A' ' 97' ' ' TRP . 13.6 mt -68.08 -51.39 47.07 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.905 -0.497 . . . . 75.21 111.502 174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 42.6 mt-10 -83.54 -39.86 19.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.414 0.524 . . . . 73.33 112.414 -176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 54.2 m95 -115.59 -3.23 12.34 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.18 0.807 . . . . 74.22 113.18 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -109.78 -130.87 6.03 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 120.621 -0.8 . . . . 64.22 114.721 -174.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -126.52 129.03 24.22 Favored Pre-proline 0 N--CA 1.47 0.569 0 C-N-CA 122.802 0.441 . . . . 73.33 110.643 -175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.54 28.01 0.55 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.622 2.214 . . . . 61.11 113.09 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.64 -2.0 40.71 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.977 0.362 . . . . 55.52 111.977 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 13' ' ' ARG . 21.8 p90 -112.1 152.33 28.39 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.984 0.421 . . . . 73.1 111.931 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 HG22 HG12 ' A' ' 62' ' ' ILE . 14.5 t -107.82 140.78 40.39 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.334 -0.394 . . . . 61.54 111.5 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.6 mp -99.44 124.8 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 110.198 -0.297 . . . . 75.04 110.198 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.686 HD22 ' SD ' ' A' ' 43' ' ' MET . 46.4 mt -110.72 125.61 53.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.323 0.49 . . . . 75.44 112.323 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -89.45 103.24 15.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.732 -0.667 . . . . 72.32 110.16 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 ' HB1' ' A' ' 75' ' ' ALA . 35.3 m -101.83 10.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.427 0.529 . . . . 53.41 112.427 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 80.6 mtm180 -65.5 -70.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.289 0.566 . . . . 74.51 110.837 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -171.29 157.83 5.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.708 -0.678 . . . . 71.3 109.874 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -57.28 -48.11 79.74 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.577 0.703 . . . . 74.34 110.036 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -56.78 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.483 -0.78 . . . . 72.12 111.08 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.6 m -55.07 -33.79 63.05 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.346 -0.388 . . . . 72.43 111.789 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -55.54 -50.11 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.779 -0.452 . . . . 72.04 109.779 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -62.35 -42.53 99.47 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.41 -0.359 . . . . 63.23 111.524 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' HA ' HD13 ' A' ' 108' ' ' ILE . 1.3 m-20 -53.11 -48.92 67.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.242 0.46 . . . . 73.14 112.242 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -177.62 119.29 0.67 Allowed Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.092 -1.051 . . . . 65.23 113.179 177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -129.11 164.15 23.94 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.366 0.506 . . . . 75.53 112.366 -175.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.22 141.27 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.335 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.462 ' HA ' ' CG ' ' A' ' 105' ' ' GLU . 44.2 ttm -57.62 107.28 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.103 0.408 . . . . 74.55 112.103 -176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 11.61 54.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.228 -0.51 . . . . 64.54 114.303 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.46 155.45 36.23 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 117.579 0.689 . . . . 54.31 112.749 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.2 mmm -91.26 150.42 21.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.545 -0.752 . . . . 64.42 111.817 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.85 88.21 6.55 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.242 -0.436 . . . . 62.01 111.95 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.686 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.5 81.88 59.31 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.335 -0.393 . . . . 72.53 111.171 174.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -57.97 129.83 35.2 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.359 2.039 . . . . 51.14 110.982 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 19.8 tt -42.17 -33.87 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 113.917 1.08 . . . . 72.41 113.917 -170.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.65 -40.11 56.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.14 -0.35 . . . . 71.34 111.863 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.494 ' HB3' ' HE ' ' A' ' 51' ' ' ARG . 1.7 m-20 -80.84 -15.2 56.99 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 122.673 0.389 . . . . 73.04 111.913 174.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD22 ' HB1' ' A' ' 75' ' ' ALA . 65.0 tp -39.83 -67.2 0.24 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.227 1.195 . . . . 74.32 114.227 -170.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.9 t -47.63 -48.55 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.18 0.514 . . . . 72.45 111.9 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -63.28 -51.12 67.39 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.821 -0.627 . . . . 64.4 111.596 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HE ' ' HB3' ' A' ' 47' ' ' ASP . 29.1 mmt180 -59.12 -52.32 66.25 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.201 0.524 . . . . 63.14 111.699 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.97 -49.87 73.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.742 -0.663 . . . . 71.02 111.584 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.4 t -56.06 -26.9 51.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.172 0.51 . . . . 73.03 111.481 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.8 t -84.58 -47.6 10.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.638 0.607 . . . . 64.32 112.638 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.2 m -111.79 8.5 20.58 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.092 1.145 . . . . 44.04 114.092 -170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD11 HD21 ' A' ' 24' ' ' LEU . 95.8 mt -135.25 148.99 49.74 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.952 -0.467 . . . . 74.03 111.722 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.637 ' HG2' ' H ' ' A' ' 59' ' ' SER . 37.8 tt0 -94.32 138.56 32.16 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.762 0.315 . . . . 75.1 110.593 173.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 95.3 mttt -64.15 -18.8 64.8 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.158 0.504 . . . . 74.42 111.943 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.637 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 29.2 t -89.99 -12.88 37.38 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.227 -0.442 . . . . 53.51 111.919 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -78.26 131.79 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 110.201 -0.296 . . . . 71.41 110.201 -178.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 17.0 m-20 -62.91 128.29 35.2 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.066 0.46 . . . . 61.3 111.883 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 60' ' ' ARG . 67.2 mt -128.44 133.46 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.314 0.487 . . . . 74.13 112.314 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -115.51 119.98 37.99 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.775 0.43 . . . . 73.25 110.197 171.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.1 t -106.83 136.73 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 116.507 -0.315 . . . . 74.34 111.793 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -134.95 132.29 38.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.531 0.681 . . . . 73.43 111.733 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.23 -171.2 19.23 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.414 -0.812 . . . . 72.31 111.99 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.7 -27.94 63.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.213 0.53 . . . . 61.03 110.897 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.3 175.57 24.79 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 115.907 -0.588 . . . . 71.52 113.334 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -56.0 -50.74 70.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 122.886 0.474 . . . . 65.55 112.225 -178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -57.23 -52.65 64.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 111.954 0.353 . . . . 74.43 111.954 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 62.1 tt0 -58.72 -47.22 85.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 75.34 111.201 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' LEU . 91.7 m -56.85 -54.18 49.35 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.717 -0.674 . . . . 71.44 111.746 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.3 t -68.22 -38.21 81.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.256 0.465 . . . . 54.5 112.256 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -62.88 -45.51 92.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.938 0.399 . . . . 72.21 111.118 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.24 -48.74 78.06 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.367 0.603 . . . . 71.3 111.289 177.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.5 t -53.5 -39.58 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.039 -0.528 . . . . 61.55 111.644 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -60.42 -48.72 80.53 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.242 0.544 . . . . 74.13 110.491 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 75' ' ' ALA . 39.8 mt -58.32 -36.69 73.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.262 -0.881 . . . . 74.12 112.01 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.4 mt -66.19 -52.64 46.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.835 0.309 . . . . 73.52 111.835 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -68.53 -25.45 64.94 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.856 -0.528 . . . . 64.5 111.666 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.6 p -72.4 -22.56 61.1 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.859 0.362 . . . . 63.12 110.822 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.2 -8.39 59.48 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.144 0.497 . . . . 73.35 111.017 172.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.13 -4.36 28.56 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.193 -0.458 . . . . 52.01 114.016 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 78.9 m-85 -65.55 113.35 4.12 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 117.307 0.553 . . . . 74.11 112.212 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 42.5 mt-10 -74.67 -52.01 12.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.774 -0.648 . . . . 63.24 111.878 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 12.7 m-70 -92.84 81.96 4.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.333 0.494 . . . . 64.53 112.333 -172.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG12 HG13 ' A' ' 76' ' ' VAL . 32.8 t -137.01 133.68 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 120.574 0.226 . . . . 75.53 111.34 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 29.7 t -127.2 141.93 51.61 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.747 0.308 . . . . 41.45 110.775 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.651 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.3 pt-20 -92.26 126.36 37.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.197 0.522 . . . . 74.33 111.653 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 7' ' ' ALA . 22.0 tp -81.68 123.11 28.44 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.176 -0.465 . . . . 74.15 111.568 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 43.2 mtpt -75.06 148.12 40.06 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.893 0.378 . . . . 74.32 111.368 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.9 -68.94 3.4 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.186 -0.53 . . . . 71.01 113.124 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.2 -151.31 18.08 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.218 -0.515 . . . . 62.23 113.315 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.5 tp -67.76 -47.33 69.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.364 0.505 . . . . 65.12 112.364 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -36.14 74.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.284 -0.26 . . . . 62.22 111.614 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.52 -43.76 84.34 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.141 0.496 . . . . 52.24 110.669 173.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CH2' HD12 ' A' ' 14' ' ' LEU . 61.8 t-105 -54.81 -37.19 65.8 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.911 -0.586 . . . . 73.43 110.918 174.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -77.27 -34.09 55.73 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.277 -0.419 . . . . 72.4 111.321 176.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.0 69.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.937 0.399 . . . . 65.31 111.963 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.3 pt -92.32 6.05 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.561 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.2 43.59 79.57 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.334 -0.46 . . . . 43.11 113.055 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -83.65 149.91 26.26 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.4 -0.429 . . . . 71.52 113.302 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HB2' ' HE3' ' A' ' 38' ' ' MET . 59.7 Cg_endo -71.13 134.93 26.13 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.73 2.287 . . . . 70.54 113.01 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.1 p -139.11 165.98 25.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.271 0.558 . . . . 74.13 110.943 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' CG ' ' HA ' ' A' ' 38' ' ' MET . 0.2 OUTLIER -155.12 162.58 40.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 71.34 111.074 177.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 155.03 -178.18 31.86 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.925 -0.655 . . . . 12.51 113.423 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.6 mt -79.43 -53.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.042 0.449 . . . . 75.01 111.084 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -70.47 -23.23 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.268 0.556 . . . . 62.44 111.597 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.36 -12.07 12.58 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.214 -0.448 . . . . 73.33 112.143 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.1 m -89.18 -0.4 57.42 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.256 0.465 . . . . 73.41 112.256 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 9.1 ptm180 -141.75 159.72 41.64 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.145 0.497 . . . . 71.52 111.968 -176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 69.2 p -97.2 132.68 25.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.25 -0.432 . . . . 74.53 111.256 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 5.5 Cg_exo -75.52 35.75 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.977 2.452 . . . . 63.31 113.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -179.46 154.93 0.65 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.181 0.592 . . . . 75.14 110.733 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.1 132.25 1.35 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.695 -0.764 . . . . 41.34 113.815 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 64.02 101.38 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.805 0.669 . . . . 74.44 112.805 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -172.24 127.64 0.56 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.683 -0.69 . . . . 74.42 110.107 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.09 129.92 12.42 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.114 0.412 . . . . 62.22 112.114 -175.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -118.42 11.14 12.91 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.312 0.577 . . . . 74.14 111.346 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.07 83.83 0.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.319 0.58 . . . . 63.33 111.288 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.97 164.39 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.092 -0.504 . . . . 62.03 111.604 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -91.41 143.24 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.703 0.287 . . . . 73.4 111.23 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.4 t -154.88 89.97 1.27 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.211 0.449 . . . . 72.33 112.211 -178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -178.28 128.84 0.13 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.855 0.36 . . . . 73.45 111.567 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 59.8 tp -152.99 127.84 9.56 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.115 -0.493 . . . . 74.22 110.197 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 13.2 pt-20 -159.54 -147.81 0.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.496 0.554 . . . . 70.13 112.496 -170.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 126' ' ' GLU . 32.8 m170 87.12 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.598 1.159 . . . . 75.21 113.114 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -137.67 113.68 9.89 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.027 -0.533 . . . . 70.03 110.692 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -165.68 128.08 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.716 -0.22 . . . . 74.14 111.397 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -167.64 130.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.978 0.418 . . . . 73.52 111.713 175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -162.24 113.2 1.59 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.095 0.474 . . . . 43.3 111.203 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.238 0.47 0 CA-C-O 121.271 0.557 . . . . 71.11 111.336 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 tpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.74 0.305 . . . . 71.12 110.81 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -89.13 150.72 45.64 Favored Pre-proline 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 75.24 112.26 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.23 -39.36 13.32 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.445 2.097 . . . . 73.44 110.655 168.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -131.43 109.85 10.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.141 -0.936 . . . . 62.21 109.801 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -92.94 145.27 24.5 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.923 0.392 . . . . 62.33 111.987 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.715 ' HB2' HG23 ' A' ' 9' ' ' VAL . 6.8 m-20 -82.41 146.82 29.12 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.865 0.364 . . . . 52.14 110.836 174.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -50.84 -48.75 59.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.068 0.395 . . . . 54.22 112.068 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.3 p-80 -68.87 -25.85 64.84 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.007 0.743 . . . . 70.2 113.007 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 6' ' ' ASP . 70.5 t -61.58 -49.9 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.403 0.62 . . . . 72.12 110.268 174.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.2 tp -65.54 -42.85 91.45 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.737 -0.665 . . . . 75.24 110.983 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.548 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 72.6 tttt -57.45 -49.93 74.65 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.395 -0.366 . . . . 74.22 111.894 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.3 m -65.54 -32.71 74.45 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.62 0.248 . . . . 70.55 110.923 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.595 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 7.0 mtt85 -69.32 -29.01 66.75 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.744 0.307 . . . . 75.52 111.391 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HA ' ' HZ ' ' A' ' 21' ' ' PHE . 56.3 tp -77.32 -43.72 32.1 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.06 0.457 . . . . 74.22 111.504 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.492 ' HB2' ' HD1' ' A' ' 16' ' ' TRP . 33.8 mt-10 -85.37 -50.26 7.46 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.182 0.515 . . . . 74.2 111.956 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.492 ' HD1' ' HB2' ' A' ' 15' ' ' GLU . 47.1 m95 -103.04 -27.19 12.74 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.777 0.658 . . . . 72.02 112.777 -172.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -76.1 -120.89 0.15 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 114.923 0.729 . . . . 31.15 114.923 -169.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 45.3 tt0 -153.98 125.77 3.76 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 122.655 -0.321 . . . . 72.35 111.351 -171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 16.6 Cg_exo -67.27 92.31 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.681 2.254 . . . . 75.23 113.367 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.31 -9.46 0.86 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.945 173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.549 ' HZ ' ' HA ' ' A' ' 14' ' ' LEU . 33.6 p90 -96.83 159.15 15.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.863 -0.608 . . . . 74.34 112.318 -172.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 56' ' ' LEU . 87.3 m -126.23 124.23 39.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.267 -0.424 . . . . 64.42 111.658 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.5 mp -97.03 130.68 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 122.43 -0.169 . . . . 40.54 110.822 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.716 HD21 HD11 ' A' ' 56' ' ' LEU . 52.2 mt -114.47 125.88 54.32 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.047 0.451 . . . . 75.12 112.158 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.89 99.13 12.22 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.894 -0.594 . . . . 64.22 110.381 177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 34.4 m -95.64 10.83 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.707 0.632 . . . . 73.52 112.707 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.615 ' NH1' HD22 ' A' ' 94' ' ' LEU . 88.6 mtm180 -68.94 -69.7 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.807 0.337 . . . . 75.3 110.98 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -172.95 160.73 4.33 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.078 0.466 . . . . 63.13 110.937 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.648 HH21 ' HD2' ' A' ' 32' ' ' TYR . 1.7 tpm_? -56.14 -46.92 79.05 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.23 0.538 . . . . 54.34 110.773 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 86.5 p -65.96 -54.93 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.747 -0.66 . . . . 63.12 111.024 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.3 m -55.77 -34.79 65.57 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.229 -0.441 . . . . 71.45 111.968 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD2' HH21 ' A' ' 29' ' ' ARG . 84.9 t80 -57.01 -48.46 78.43 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.966 0.412 . . . . 75.35 109.998 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -38.78 92.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.432 -0.349 . . . . 64.4 111.2 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -62.34 -47.14 85.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.467 0.544 . . . . 42.12 112.467 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.595 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -172.09 104.6 0.2 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.272 -0.966 . . . . 74.41 113.611 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' HH22 ' A' ' 27' ' ' ARG . 51.3 p-80 -124.88 159.25 31.54 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.1 0.45 . . . . 53.44 112.107 -173.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.76 142.67 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 120.764 0.316 . . . . 73.34 111.326 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.89 114.52 2.59 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.078 0.466 . . . . 74.43 111.939 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.75 18.16 58.72 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.241 0.457 . . . . 62.32 114.241 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.71 165.75 21.67 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.441 0.639 . . . . 63.21 112.265 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.537 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 84.3 mmm -102.9 149.47 24.48 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.849 -0.614 . . . . 72.44 111.77 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.59 9.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.092 0.472 . . . . 74.15 111.603 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.633 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -121.32 84.63 41.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 116.401 -0.363 . . . . 63.53 111.382 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.84 139.95 44.89 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.345 2.03 . . . . 61.4 111.733 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.3 tt -50.96 -26.66 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 113.228 0.825 . . . . 72.12 113.228 -171.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 47' ' ' ASP . 9.3 pt-20 -70.91 -43.75 67.64 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.245 0.545 . . . . 73.12 111.73 175.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -101.15 0.73 38.23 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.847 -0.615 . . . . 73.13 110.903 -174.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' A' ' 43' ' ' MET . 68.2 tp -46.9 -56.37 6.46 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.75 1.019 . . . . 73.45 113.75 -172.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -55.51 -53.23 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.161 0.505 . . . . 75.35 111.652 -175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.26 -44.67 87.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.971 -0.559 . . . . 65.32 111.815 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 13.5 mmt180 -57.12 -55.22 37.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.049 0.452 . . . . 64.14 111.939 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.96 99.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.199 -0.455 . . . . 62.02 111.694 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.7 t -60.54 -27.05 67.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.342 0.497 . . . . 74.23 112.342 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -75.36 -20.32 59.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.589 0.588 . . . . 75.53 112.589 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.6 m -133.05 -54.63 0.92 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.701 0.63 . . . . 65.43 112.701 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 HD21 ' A' ' 24' ' ' LEU . 92.8 mt -70.54 152.73 43.65 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.712 1.004 . . . . 63.52 113.712 -168.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.692 ' HG3' ' H ' ' A' ' 59' ' ' SER . 16.3 tp10 -85.46 150.06 24.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.475 -0.784 . . . . 75.51 110.997 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -70.52 -33.06 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.355 0.598 . . . . 74.55 110.72 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.692 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -91.65 1.23 57.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.065 -0.516 . . . . 75.03 111.735 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 14.5 tpp180 -75.56 129.5 37.31 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.948 0.404 . . . . 74.13 111.566 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.56 107.37 1.13 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.805 0.812 . . . . 74.33 111.503 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.5 mt -113.57 128.96 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.653 -0.703 . . . . 72.13 112.118 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.18 116.33 32.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.142 0.496 . . . . 73.12 110.616 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.17 136.09 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.281 -0.418 . . . . 72.41 111.789 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -135.38 130.45 34.94 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.358 0.599 . . . . 74.24 111.816 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.15 -167.13 17.73 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.619 -0.718 . . . . 72.21 112.11 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.08 -48.43 44.15 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.229 0.537 . . . . 73.03 110.994 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -124.18 174.91 16.97 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.892 -0.594 . . . . 42.44 112.508 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.47 -42.97 75.07 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.891 0.376 . . . . 54.32 111.41 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -56.29 -54.35 46.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.258 -0.428 . . . . 70.32 111.845 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.0 tt0 -63.93 -39.91 95.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.288 0.566 . . . . 74.44 111.386 -177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.0 m -62.57 -54.44 39.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.812 -0.631 . . . . 72.31 111.704 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.1 t -69.11 -38.42 78.92 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.003 0.371 . . . . 54.43 112.003 -176.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 4.9 tt0 -66.42 -38.6 87.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.675 0.39 . . . . 73.15 111.364 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.579 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -63.02 -45.43 92.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.991 0.424 . . . . 65.41 111.236 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 89' ' ' GLU . 79.1 t -53.31 -41.49 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.226 173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 61.9 t30 -54.53 -50.98 66.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.453 0.644 . . . . 65.22 110.769 174.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.6 mt -58.33 -41.76 85.32 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.235 -0.893 . . . . 64.14 111.791 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.528 HD11 HD12 ' A' ' 24' ' ' LEU . 63.5 mt -64.64 -51.07 64.52 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.991 0.367 . . . . 63.04 111.991 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -65.91 -29.2 69.58 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 120.457 -0.497 . . . . 73.34 111.001 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -68.35 -25.51 65.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.805 0.336 . . . . 72.02 110.96 171.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.27 -1.29 55.03 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.872 0.368 . . . . 45.11 111.554 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.74 -16.31 40.28 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.229 -0.51 . . . . 70.11 113.894 177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -54.98 105.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.648 0.737 . . . . 72.41 111.842 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -64.03 -53.01 56.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.958 -1.019 . . . . 72.43 112.414 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -102.41 87.93 3.15 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.508 0.559 . . . . 70.24 112.508 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.3 t -132.35 136.93 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.147 -0.346 . . . . 74.22 111.173 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 t -128.96 144.46 51.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.967 0.413 . . . . 74.23 111.676 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HB3' HG21 ' A' ' 76' ' ' VAL . 10.3 pt-20 -93.11 128.76 39.15 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.188 0.518 . . . . 75.34 110.832 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 7' ' ' ALA . 24.4 tp -79.36 108.83 13.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.24 -0.436 . . . . 75.42 111.444 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -58.1 127.08 30.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.46 . . . . 72.34 111.657 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.9 -70.96 0.49 Allowed Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.374 -0.441 . . . . 41.51 113.235 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.71 -157.36 15.18 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 122.489 -0.418 . . . . 72.32 113.054 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.615 HD22 ' NH1' ' A' ' 27' ' ' ARG . 40.4 tp -62.26 -52.78 62.36 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.905 0.335 . . . . 64.02 111.905 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.68 -35.9 56.09 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 111.651 0.241 . . . . 73.33 111.651 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -49.28 69.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.956 0.407 . . . . 64.22 111.357 175.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.416 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.8 t-105 -53.9 -38.69 65.07 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.44 0.638 . . . . 72.31 110.882 174.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.543 ' HG2' HG21 ' A' ' 104' ' ' THR . 41.0 mtpt -77.62 -37.14 50.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.769 -0.651 . . . . 65.43 111.86 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.76 84.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.02 0.438 . . . . 53.54 111.569 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.81 5.45 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.325 -0.398 . . . . 71.21 111.176 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.1 38.45 47.47 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.413 -0.422 . . . . 43.24 113.556 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.548 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -82.25 149.0 27.25 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.462 -0.399 . . . . 62.54 113.577 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 13.6 Cg_exo -68.68 124.28 11.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.995 2.463 . . . . 71.13 112.464 178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.543 HG21 ' HG2' ' A' ' 98' ' ' LYS . 68.9 p -124.74 149.78 46.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.503 0.668 . . . . 54.41 112.664 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.92 174.11 6.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.2 -0.909 . . . . 64.32 110.056 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.98 166.87 10.75 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.626 -0.797 . . . . 73.04 113.881 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mt -95.68 -44.65 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.354 0.597 . . . . 73.03 110.822 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.28 -23.77 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.07 -0.514 . . . . 65.41 112.274 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -53.3 -23.49 9.29 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 112.197 0.443 . . . . 75.21 112.197 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.2 t -58.11 -32.34 68.01 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.05 0.452 . . . . 71.42 111.303 174.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.32 100.63 10.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 109.735 -0.468 . . . . 63.31 109.735 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 75.0 p -87.6 118.53 69.92 Favored Pre-proline 0 N--CA 1.474 0.733 0 N-CA-C 113.055 0.761 . . . . 74.23 113.055 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.25 68.77 7.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.106 2.537 . . . . 72.44 111.69 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -91.51 0.77 57.47 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.542 0.571 . . . . 74.4 112.542 -175.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -73.24 73.02 1.12 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.22 -0.514 . . . . 50.44 113.28 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.54 146.8 29.0 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.636 -0.331 . . . . 62.31 111.434 177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -100.09 -169.24 1.7 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.987 0.422 . . . . 63.3 111.552 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.3 125.33 32.83 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.243 0.46 . . . . 65.35 112.243 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.419 ' O ' HG23 ' A' ' 121' ' ' VAL . 73.2 t80 -74.94 -73.71 0.23 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.984 0.421 . . . . 72.32 109.876 172.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 58.52 11.58 1.77 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.891 1.071 . . . . 72.04 113.891 171.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.2 t -88.51 109.03 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 121.108 0.48 . . . . 70.11 110.981 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.21 39.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.1 0.476 . . . . 75.34 112.097 -175.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 58.4 m -59.37 87.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.856 0.687 . . . . 34.54 112.856 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 124' ' ' ARG . 19.9 ttm-85 -151.24 105.2 3.18 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.886 -0.597 . . . . 72.42 110.475 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.9 tp -164.35 97.47 0.8 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.917 0.389 . . . . 74.03 111.619 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.8 130.98 16.42 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.386 -0.37 . . . . 63.04 111.032 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -142.79 106.11 4.59 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.433 0.531 . . . . 65.03 112.433 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -147.85 135.53 20.89 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.053 0.541 . . . . 75.14 110.228 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -145.2 149.46 34.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.89 0.376 . . . . 71.32 111.814 -174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -121.57 141.45 51.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.32 -0.4 . . . . 71.52 111.367 175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -80.02 122.93 27.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.682 0.277 . . . . 62.04 111.029 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.01 0.433 . . . . 75.5 111.496 -179.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.568 ' SD ' ' HB3' ' A' ' 86' ' ' HIS . 25.8 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.64 0.257 . . . . 51.43 110.821 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 44.9 mt-10 -81.18 145.83 57.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-O 120.767 0.317 . . . . 42.23 111.781 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 2' ' ' GLU . 37.5 Cg_exo -60.86 -32.93 93.21 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.024 2.482 . . . . 74.53 112.649 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.39 130.92 53.36 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.163 -0.471 . . . . 70.23 111.298 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.4 t -114.26 133.54 55.57 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.852 0.358 . . . . 50.14 111.337 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.67 155.93 33.0 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.933 0.397 . . . . 75.44 110.776 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.82 -52.24 63.92 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.565 0.58 . . . . 73.11 112.565 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 3.0 p-80 -74.96 -26.64 59.75 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.876 -0.515 . . . . 73.42 112.336 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.68 -49.11 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.885 0.374 . . . . 64.12 110.385 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.57 -43.45 84.97 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.856 0.36 . . . . 73.14 111.095 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 67.1 tttt -55.58 -43.64 76.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.276 0.56 . . . . 64.41 111.576 177.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.0 m -74.49 -35.94 63.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.737 0.78 . . . . 74.13 109.737 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -64.88 -27.68 69.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.183 -0.917 . . . . 73.5 111.377 174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 tt -77.51 -56.92 4.13 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.261 -0.427 . . . . 70.33 111.396 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.8 -36.6 42.48 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.748 0.648 . . . . 72.23 112.748 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -100.29 -43.97 6.09 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.004 0.372 . . . . 75.44 112.004 -177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.46 -117.45 0.14 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 114.54 0.576 . . . . 74.54 114.54 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -136.72 123.3 13.8 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 111.991 0.367 . . . . 72.34 111.991 -174.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.67 16.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.779 2.986 . . . . 34.44 114.954 176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.36 48.74 1.05 Allowed 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.572 -0.705 . . . . 72.31 112.298 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -155.15 158.47 39.02 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.877 0.37 . . . . 72.54 111.575 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.0 m -122.26 134.99 54.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.466 -0.333 . . . . 61.34 111.369 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.6 mp -108.57 133.95 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 120.589 0.233 . . . . 73.43 110.892 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.63 HD21 HD11 ' A' ' 56' ' ' LEU . 73.5 mt -117.94 129.94 55.92 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.768 0.655 . . . . 54.1 112.768 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -83.41 92.64 7.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.909 -0.587 . . . . 72.15 111.164 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 48' ' ' LEU . 33.2 m -84.6 -9.38 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.033 0.444 . . . . 55.21 110.944 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 9.5 ptp180 -57.57 -70.31 0.14 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.88 -0.6 . . . . 73.4 111.332 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 29.8 t70 173.1 154.09 0.09 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.429 0.692 . . . . 72.33 109.345 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HA ' ' HB3' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.32 -29.01 68.46 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.027 0.38 . . . . 72.22 112.027 -178.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.5 p -67.61 -52.89 33.04 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.219 0.533 . . . . 72.44 110.3 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 84.8 m -62.7 -38.5 90.66 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.531 -0.759 . . . . 72.15 110.975 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -59.94 -45.6 92.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.067 -0.515 . . . . 75.2 111.249 176.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -63.07 -43.93 97.2 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.312 -0.243 . . . . 52.5 110.694 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.474 ' HA ' HD13 ' A' ' 108' ' ' ILE . 11.5 t70 -53.23 -47.24 69.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.984 0.514 . . . . 60.25 110.873 174.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.75 135.8 3.67 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.006 -0.543 . . . . 73.43 112.945 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -159.29 175.49 13.32 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.991 0.424 . . . . 73.34 111.591 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.3 mt -70.3 138.66 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.374 -0.376 . . . . 64.44 111.079 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.6 ttm -64.33 116.06 5.69 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.936 0.398 . . . . 64.21 110.957 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.82 -5.94 54.18 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.244 -0.503 . . . . 73.55 113.105 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.36 156.94 29.26 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.808 0.337 . . . . 62.43 111.357 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ptm -128.13 149.89 50.22 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.652 0.612 . . . . 70.12 112.652 -174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . . . -73.34 105.64 4.82 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.773 0.657 . . . . 74.02 112.773 -175.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.502 ' SD ' HD22 ' A' ' 24' ' ' LEU . 49.8 mtt -136.47 81.54 36.11 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.825 -0.625 . . . . 55.11 109.927 169.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -61.43 139.86 84.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.41 2.073 . . . . 60.03 111.033 -176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 tt -47.24 -24.12 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.02 0.438 . . . . 40.11 112.147 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.2 -51.21 70.54 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.996 0.427 . . . . 63.1 111.673 175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.6 -1.51 21.13 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.115 -0.493 . . . . 72.43 111.685 -173.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.504 HD13 HG12 ' A' ' 26' ' ' VAL . 64.1 tp -39.98 -56.15 1.89 Allowed 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.368 0.877 . . . . 61.31 113.368 -175.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.5 t -56.09 -52.72 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 120.817 0.341 . . . . 62.1 111.84 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.54 -51.35 68.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.027 0.441 . . . . 60.5 111.67 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 1.6 mmt180 -53.02 -55.89 20.21 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.402 0.62 . . . . 70.21 111.678 177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.17 51.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.518 -0.764 . . . . 72.34 112.003 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t -61.37 -17.09 52.35 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.984 0.421 . . . . 72.41 111.708 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.3 t -85.19 -62.98 1.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.035 0.445 . . . . 74.3 111.795 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -96.1 -8.12 34.22 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.215 0.82 . . . . 61.4 113.215 -171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 24' ' ' LEU . 90.6 mt -117.09 141.1 48.68 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.985 0.422 . . . . 71.13 111.648 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 5.1 mp0 -72.23 171.36 12.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.714 0.769 . . . . 73.13 111.703 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -89.32 -29.88 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.077 -0.965 . . . . 71.05 109.847 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.5 t -83.49 -11.87 56.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.543 -0.753 . . . . 64.31 111.177 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 23.9 tpp180 -59.24 124.03 18.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.596 0.358 . . . . 75.34 111.288 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 7.7 m-20 -65.66 96.64 0.28 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.133 0.492 . . . . 61.14 111.163 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 77.7 mt -102.96 124.5 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.46 0.648 . . . . 71.43 112.317 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -104.51 119.08 38.17 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.741 -0.663 . . . . 73.54 110.229 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 79' ' ' LEU . 97.5 t -105.88 133.17 51.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.912 -0.585 . . . . 72.32 112.248 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.2 p90 -143.22 131.73 22.32 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.743 0.782 . . . . 73.33 111.89 171.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.14 -162.29 31.89 Favored Glycine 0 CA--C 1.517 0.193 0 CA-C-N 115.473 -0.785 . . . . 71.45 111.707 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' N ' ' HB3' ' A' ' 27' ' ' ARG . . . -77.24 -50.68 12.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.0 -0.706 . . . . 54.04 109.817 174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -110.49 165.4 12.24 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 115.673 -0.694 . . . . 24.34 112.485 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -56.63 -38.39 72.06 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.944 0.402 . . . . 71.25 111.951 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -56.62 -53.7 54.59 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.009 0.433 . . . . 74.13 111.79 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' CD ' ' HA ' ' A' ' 27' ' ' ARG . 63.7 tt0 -61.25 -39.58 90.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.11 0.481 . . . . 75.32 111.316 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 65' ' ' TYR . 36.1 m -56.63 -47.66 79.2 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.946 -0.57 . . . . 53.11 111.116 177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.28 -54.96 33.09 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.921 -0.581 . . . . 71.41 112.329 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.57 -38.57 85.0 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.11 0.411 . . . . 75.54 112.11 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.47 -43.87 93.15 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.93 0.395 . . . . 75.22 111.636 176.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 89' ' ' GLU . 73.2 t -54.66 -45.32 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.317 -0.402 . . . . 70.5 111.033 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.86 -47.59 70.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.409 0.623 . . . . 62.25 111.125 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 75' ' ' ALA . 36.4 mt -62.63 -36.95 84.45 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.445 -0.798 . . . . 73.1 112.262 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.464 HD12 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -71.39 -47.26 57.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.187 0.44 . . . . 63.54 112.187 178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -65.27 -30.65 71.54 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.691 -0.631 . . . . 73.24 110.684 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.8 t -64.38 -27.65 69.15 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.117 0.484 . . . . 72.34 110.933 170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.67 0.94 53.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.345 0.498 . . . . 53.32 112.345 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.21 -8.29 55.28 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 114.868 0.707 . . . . 61.32 114.868 173.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -59.9 121.08 10.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.957 0.725 . . . . 60.03 112.957 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -70.07 -50.05 44.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.769 -0.65 . . . . 74.53 111.724 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.568 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 25.4 m-70 -100.62 92.58 5.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.428 0.529 . . . . 70.02 112.428 -173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.87 119.21 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.26 -0.427 . . . . 71.25 110.675 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.5 t -125.6 138.34 53.93 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.809 0.338 . . . . 73.11 111.159 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 76' ' ' VAL . 7.6 pt-20 -85.25 135.78 33.79 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.043 0.449 . . . . 74.33 111.488 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -79.68 117.15 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.959 0.409 . . . . 52.24 110.192 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -75.97 130.46 38.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.165 0.507 . . . . 64.52 112.013 -177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.76 -33.62 5.59 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 116.085 -0.507 . . . . 41.41 114.19 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.95 -170.9 30.92 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 120.789 -0.72 . . . . 44.43 112.98 -177.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.2 -36.02 82.69 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.409 -0.465 . . . . 74.32 111.078 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.49 -40.69 62.65 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.544 -0.298 . . . . 75.34 111.512 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.24 71.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.945 0.402 . . . . 63.25 110.944 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -55.33 -37.11 67.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.501 0.667 . . . . 74.24 111.265 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 104' ' ' THR . 23.5 mtpp -77.46 -41.25 40.37 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.929 -0.578 . . . . 74.01 112.062 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.31 72.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.056 0.455 . . . . 64.44 111.937 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 8' ' ' HIS . 27.7 pt -83.28 2.89 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.047 0.451 . . . . 73.13 111.518 178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.74 49.42 49.42 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.113 -0.565 . . . . 65.32 112.925 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.47 164.04 30.32 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.245 -0.503 . . . . 63.4 113.524 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.83 115.1 4.1 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.546 2.164 . . . . 51.22 112.234 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.462 HG21 ' HG2' ' A' ' 98' ' ' LYS . 44.7 p -121.35 149.89 42.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.353 0.597 . . . . 72.22 112.268 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -122.82 152.91 40.24 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.946 -0.57 . . . . 72.1 110.726 173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 160.04 156.54 8.2 Favored Glycine 0 C--N 1.315 -0.585 0 C-N-CA 120.307 -0.949 . . . . 72.41 113.658 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.8 mt -63.9 -42.97 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.681 0.392 . . . . 63.33 110.497 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.7 mp -79.23 -36.73 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.143 0.496 . . . . 75.41 111.469 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -72.55 36.74 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 116.037 -0.529 . . . . 74.12 111.927 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.5 t -157.04 19.06 0.3 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.846 0.355 . . . . 75.43 111.777 -175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 111' ' ' ARG . 9.9 ptp180 -153.18 173.11 15.94 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.432 0.634 . . . . 75.14 112.684 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.5 p -120.84 151.12 54.24 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 115.539 -0.755 . . . . 72.23 112.16 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 114' ' ' ALA . 85.8 Cg_endo -82.79 -129.48 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 122.859 2.372 . . . . 61.41 111.804 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.428 ' H ' ' HB2' ' A' ' 113' ' ' PRO . . . 57.59 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.885 0.698 . . . . 63.23 112.885 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -162.53 41.73 0.36 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.572 -0.823 . . . . 62.33 113.39 178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -176.28 132.27 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 111.982 0.364 . . . . 74.4 111.982 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -167.24 117.85 0.87 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.428 -0.351 . . . . 72.2 110.075 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -90.84 -176.38 4.65 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.975 0.732 . . . . 71.44 112.975 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -141.77 141.25 33.21 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.857 -0.61 . . . . 74.13 111.106 -178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.13 118.22 12.69 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.932 0.396 . . . . 75.22 111.311 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 55.8 t -98.72 117.12 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.173 0.435 . . . . 72.12 112.173 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -166.76 109.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.055 -0.52 . . . . 74.35 111.339 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 99.1 p -166.35 123.59 1.36 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.502 0.556 . . . . 74.43 112.502 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -177.15 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.74 -0.663 . . . . 63.24 110.11 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 45.1 tp -95.13 126.69 40.63 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.172 0.51 . . . . 62.43 112.127 -174.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -120.82 138.88 53.82 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.113 -0.494 . . . . 74.53 111.227 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -167.38 96.98 0.49 Allowed 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.257 0.551 . . . . 74.22 111.619 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -145.81 121.91 10.78 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.33 -0.395 . . . . 54.34 110.829 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -150.34 128.73 12.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.892 0.377 . . . . 73.34 111.692 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.1 p-80 -160.91 136.62 8.07 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.253 -0.431 . . . . 74.33 110.985 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -159.29 94.7 1.2 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.045 0.45 . . . . 72.44 111.211 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 . . . . . 0 CA--C 1.535 0.397 0 CA-C-N 116.272 -0.422 . . . . 74.23 111.01 -179.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.486 0.184 . . . . 75.04 110.705 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.16 144.7 82.55 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 120.5 0.191 . . . . 61.24 111.247 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.36 -45.78 17.27 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.262 1.974 . . . . 62.11 112.303 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -121.84 122.15 38.8 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.923 0.392 . . . . 65.42 111.386 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.92 0.391 . . . . 63.32 111.912 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' HB2' HG23 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -68.95 147.59 51.42 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.002 0.43 . . . . 53.45 111.711 177.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -64.98 -48.99 72.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.319 -0.401 . . . . 61.02 111.746 177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -27.42 67.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.858 0.688 . . . . 73.23 112.858 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 6' ' ' ASP . 80.6 t -65.36 -44.98 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.258 0.551 . . . . 65.24 110.111 173.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.7 tp -63.44 -41.41 98.66 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.871 -0.604 . . . . 61.42 110.629 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 76.3 tttt -63.19 -48.04 80.06 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.797 -0.638 . . . . 62.55 112.276 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 87.1 p -64.21 -38.04 89.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.0 0.429 . . . . 73.33 110.921 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' GLU . 74.5 mtp180 -70.83 -35.39 72.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.384 -0.371 . . . . 73.41 111.445 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.11 -49.66 73.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.881 0.372 . . . . 74.23 111.104 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.69 -52.33 6.16 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.351 0.5 . . . . 72.34 112.351 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -90.31 -59.53 2.16 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.802 0.334 . . . . 71.41 111.692 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.59 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.922 -0.581 . . . . 72.41 114.142 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 13' ' ' ARG . 31.0 tt0 -169.39 118.6 0.57 Allowed Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 122.665 0.386 . . . . 73.41 110.76 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -77.83 49.17 2.86 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.796 2.331 . . . . 72.14 113.58 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.06 -2.65 57.09 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.119 0.485 . . . . 73.52 111.15 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -93.47 159.43 15.24 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.957 -0.565 . . . . 63.01 111.165 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.468 HG21 HD21 ' A' ' 56' ' ' LEU . 84.3 m -113.14 124.4 52.47 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.397 0.518 . . . . 54.03 112.397 -176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.02 136.96 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.364 -0.38 . . . . 75.42 110.624 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.566 HD23 ' HB2' ' A' ' 41' ' ' MET . 65.5 mt -121.3 125.57 47.37 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.972 0.73 . . . . 52.11 112.972 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.11 98.0 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.635 173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.537 HG11 ' HB1' ' A' ' 75' ' ' ALA . 26.9 m -93.82 1.23 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.636 -0.426 . . . . 71.3 112.037 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 82.5 mtm180 -58.85 -68.49 0.26 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.28 -0.418 . . . . 73.43 111.46 176.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -174.81 157.49 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.003 -0.544 . . . . 74.43 109.64 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 15.0 tpt85 -63.9 -39.45 94.2 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.258 0.551 . . . . 75.11 110.504 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 95.7 p -71.15 -49.03 48.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 72.2 110.375 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.1 m -56.67 -34.08 67.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.938 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 67.0 t80 -55.28 -52.07 64.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.301 -0.409 . . . . 51.44 110.039 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -59.32 -44.7 92.57 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.264 -0.425 . . . . 55.23 111.387 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -53.65 -47.28 70.48 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.154 0.428 . . . . 72.53 112.154 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -175.67 122.32 0.86 Allowed Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.595 -0.812 . . . . 70.44 112.981 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' HH22 ' A' ' 27' ' ' ARG . 48.7 p-80 -142.36 162.83 34.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.755 0.312 . . . . 74.35 111.5 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.68 140.61 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.957 0.408 . . . . 74.02 111.022 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 42.6 ttm -63.42 112.63 2.83 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.912 0.387 . . . . 64.33 111.343 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.06 2.81 59.2 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.217 -0.447 . . . . 74.13 113.778 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.37 170.05 13.99 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.409 0.522 . . . . 63.23 112.409 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.566 ' HB2' HD23 ' A' ' 24' ' ' LEU . 80.2 mmm -109.87 146.45 35.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.307 0.575 . . . . 72.1 112.159 -177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.45 71.17 10.48 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.809 -0.632 . . . . 52.31 111.53 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 24' ' ' LEU . 1.5 mpt? -111.02 92.48 15.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.024 -0.535 . . . . 62.33 110.739 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.075 1.85 . . . . 71.33 111.88 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.7 tt -48.88 -25.89 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.787 0.662 . . . . 75.42 112.787 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -68.71 -50.05 53.91 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.23 0.538 . . . . 74.04 111.646 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -102.07 4.1 39.36 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.976 -0.556 . . . . 65.22 111.639 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 43' ' ' MET . 63.5 tp -44.39 -60.72 1.81 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.085 1.143 . . . . 60.4 114.085 -171.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 82' ' ' ALA . 74.4 t -54.82 -52.99 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-O 121.079 0.466 . . . . 64.54 111.795 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -59.61 -47.05 87.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.878 -0.601 . . . . 64.34 111.954 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 14.5 mmt180 -57.57 -53.82 53.86 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.196 0.522 . . . . 75.13 111.54 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.86 95.12 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.085 -0.507 . . . . 64.21 111.564 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.7 t -59.81 -22.75 62.62 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.937 0.399 . . . . 73.11 111.959 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -92.08 -62.6 1.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.048 0.452 . . . . 55.2 112.081 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 m -81.2 -11.62 59.36 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.035 0.754 . . . . 72.02 113.035 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 22' ' ' THR . 85.2 mt -127.7 157.94 38.95 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.224 0.535 . . . . 64.44 112.293 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.48 177.86 6.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.64 0.733 . . . . 74.31 111.413 171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 92.9 mttt -98.52 -21.61 16.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.019 -0.991 . . . . 63.13 110.094 176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 p -80.96 -17.94 48.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.169 -0.923 . . . . 52.34 110.546 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -58.93 129.19 40.94 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.557 -0.747 . . . . 74.14 111.58 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -70.67 97.65 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.371 0.605 . . . . 74.43 110.917 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.9 mt -105.38 134.29 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.449 0.642 . . . . 63.24 112.076 -176.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -122.34 115.57 22.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.83 -0.623 . . . . 73.53 110.161 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 76' ' ' VAL . 85.3 t -105.33 139.48 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.93 -0.577 . . . . 73.24 112.229 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 90' ' ' LEU . 2.1 p90 -140.2 135.24 32.19 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.778 0.799 . . . . 73.34 112.022 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.56 -159.86 22.98 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.066 -0.97 . . . . 61.4 111.902 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.61 -42.39 42.6 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.537 -0.39 . . . . 61.13 111.034 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -129.7 -176.95 14.63 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.005 -0.543 . . . . 74.43 112.809 175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.23 -50.88 68.29 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.428 0.529 . . . . 64.55 112.428 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.33 -52.14 66.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.223 0.453 . . . . 62.23 112.223 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.47 -42.7 92.65 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.951 0.405 . . . . 64.3 111.223 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 76' ' ' VAL . 90.6 m -56.56 -54.5 45.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.057 -0.52 . . . . 41.11 111.412 177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -65.79 -38.64 89.56 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.205 -0.452 . . . . 65.44 112.039 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 13.2 tt0 -64.72 -46.32 82.77 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.984 0.421 . . . . 73.15 111.228 -178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.85 -47.46 86.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.904 0.383 . . . . 75.11 111.497 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 HG12 ' A' ' 87' ' ' VAL . 74.7 t -56.19 -39.14 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.37 -0.377 . . . . 73.2 111.081 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 64.1 t30 -55.55 -44.5 76.83 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.57 0.7 . . . . 72.35 110.648 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 75' ' ' ALA . 34.6 mt -63.82 -36.65 84.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.342 -0.845 . . . . 71.3 112.123 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 64' ' ' VAL . 61.3 mt -74.24 -49.24 24.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 111.881 0.326 . . . . 63.41 111.881 177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -61.1 -31.58 71.26 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.094 -0.379 . . . . 64.1 110.358 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.5 t -65.53 -30.64 71.42 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.744 0.307 . . . . 74.12 111.581 172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -81.42 -1.79 47.03 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.048 0.451 . . . . 44.21 112.085 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.5 8.23 58.64 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.064 -0.588 . . . . 72.31 113.858 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 56.6 m-85 -67.02 111.53 3.89 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 117.153 0.476 . . . . 74.43 111.095 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 46.8 mt-10 -61.62 -54.41 43.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.214 0.531 . . . . 72.11 112.133 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 19.0 m-70 -100.4 85.58 3.0 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.208 -0.451 . . . . 75.42 112.096 -173.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 76' ' ' VAL . 21.9 t -132.89 129.44 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.763 0.316 . . . . 75.22 110.826 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -130.33 142.77 50.52 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.3 0.571 . . . . 65.42 112.146 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -79.24 119.27 22.07 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.33 -0.85 . . . . 64.22 111.192 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 7' ' ' ALA . 37.2 tp -76.95 114.72 16.05 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.172 0.51 . . . . 55.03 111.655 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -71.3 116.78 12.02 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.453 0.538 . . . . 74.41 112.453 -176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 106.13 -17.37 41.14 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 114.284 0.473 . . . . 65.34 114.284 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.51 -155.68 53.06 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.877 -0.678 . . . . 65.4 113.38 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.2 tp -69.81 -41.75 74.62 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.647 -0.325 . . . . 74.3 111.587 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.88 -39.65 59.33 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.07 0.396 . . . . 72.42 112.07 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.463 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -67.18 -50.9 59.35 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.874 0.369 . . . . 53.52 111.102 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 59.1 t-105 -50.47 -41.43 53.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.555 0.693 . . . . 74.03 111.038 175.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -77.69 -37.2 50.14 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.6 -0.727 . . . . 55.43 112.292 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.31 97.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.123 0.487 . . . . 71.11 111.448 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.3 pt -76.32 1.64 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.977 0.418 . . . . 54.14 111.427 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.49 42.6 21.91 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.516 -0.373 . . . . 50.51 113.627 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -88.02 154.07 25.18 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.174 -0.536 . . . . 72.51 113.144 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.06 132.96 20.56 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.605 2.203 . . . . 70.13 112.854 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.5 p -131.67 160.47 35.32 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.494 0.664 . . . . 72.4 112.602 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.32 169.56 13.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.295 -0.866 . . . . 73.13 110.132 173.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.77 -177.61 21.7 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.146 -1.026 . . . . 73.0 114.214 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.9 mt -97.07 -53.18 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.032 0.444 . . . . 73.02 110.918 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.36 -29.66 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.129 0.49 . . . . 72.15 111.649 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -57.42 -15.98 8.13 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.295 0.569 . . . . 53.2 111.209 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.8 m -105.7 3.45 29.0 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 73.4 112.664 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 111' ' ' ARG . 43.5 mtp-105 -96.64 128.97 44.08 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.414 0.524 . . . . 54.23 112.414 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 64.9 p -99.26 121.14 56.26 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 116.126 -0.488 . . . . 63.35 112.03 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.45 107.32 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.955 2.437 . . . . 63.11 112.127 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.53 145.14 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.058 0.456 . . . . 55.23 112.19 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -106.34 -158.26 21.9 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.202 -0.523 . . . . 71.03 112.868 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.42 -156.78 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.41 0.284 . . . . 41.24 111.585 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.6 ' HB3' HD21 ' A' ' 120' ' ' ASN . 2.5 m-20 -54.52 160.17 1.85 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.485 0.66 . . . . 74.34 112.501 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -99.4 -157.6 0.61 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.995 -0.548 . . . . 75.41 111.426 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -55.45 -38.08 68.56 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.201 0.445 . . . . 72.1 112.201 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.6 HD21 ' HB3' ' A' ' 117' ' ' ASP . 48.3 m-80 60.19 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.09 0.556 . . . . 72.32 111.657 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.8 t 55.05 103.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.441 0.696 . . . . 71.1 112.419 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.82 -42.39 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 115.853 -0.612 . . . . 72.4 112.283 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 t 59.74 -166.09 0.19 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.375 0.27 . . . . 75.53 111.384 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 66.06 -177.32 0.19 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.399 0.518 . . . . 74.1 112.399 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.403 ' HG ' ' CE1' ' A' ' 127' ' ' HIS . 20.1 tp 59.22 33.5 22.7 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.456 0.646 . . . . 74.11 111.836 176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.08 -22.12 64.02 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.789 0.663 . . . . 63.43 112.789 -175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' A' ' 125' ' ' LEU . 40.5 m80 67.05 133.99 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.793 1.035 . . . . 73.12 113.793 175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -140.93 113.82 8.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.575 -0.739 . . . . 60.55 109.724 169.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -63.81 -44.36 93.51 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 112.54 0.571 . . . . 65.14 112.54 -173.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 65.06 148.97 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.296 0.85 . . . . 61.15 113.296 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -177.89 -59.92 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.912 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 122.712 0.405 . . . . 74.14 111.213 -173.789 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 13.0 tmm? . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.156 -0.313 . . . . 64.21 110.156 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -68.47 148.66 98.16 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 112.522 0.564 . . . . 75.24 112.522 -172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.56 -26.16 21.58 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 123.443 2.762 . . . . 62.35 113.848 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.799 ' HB3' ' HG3' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -131.6 173.27 11.29 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.334 0.588 . . . . 73.32 111.569 173.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.3 t -154.19 152.72 30.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.729 -0.669 . . . . 62.41 111.017 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 9' ' ' VAL . 10.3 t70 -80.16 155.39 27.46 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.863 177.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -58.06 -51.07 71.2 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.445 0.535 . . . . 72.12 112.445 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 5.1 p-80 -74.23 -26.4 60.22 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.724 0.639 . . . . 75.52 112.724 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 6' ' ' ASP . 90.0 t -60.89 -45.8 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.078 0.466 . . . . 73.44 110.257 172.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.427 HD11 ' CE2' ' A' ' 21' ' ' PHE . 48.9 tp -67.98 -46.34 71.61 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.027 -0.533 . . . . 73.05 111.002 175.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.3 tttt -53.94 -40.89 67.16 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.377 0.608 . . . . 73.45 111.505 177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 66.0 m -75.78 -40.42 55.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.13 109.595 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -60.78 -28.92 69.1 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.654 -0.703 . . . . 72.52 110.903 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.32 -55.14 5.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.97 0.414 . . . . 74.31 112.101 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.75 -18.61 34.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.037 0.754 . . . . 74.31 113.037 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' SER . 53.1 m95 -124.06 -46.6 1.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.203 0.446 . . . . 74.51 112.203 -177.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.67 -146.36 4.63 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 114.778 0.671 . . . . 75.23 114.778 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 32.2 tt0 -93.34 108.93 37.01 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 120.945 0.402 . . . . 74.05 111.896 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 3.2 Cg_exo -76.61 24.08 0.47 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.503 2.802 . . . . 71.03 114.032 -176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.87 43.0 0.48 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.098 -0.376 . . . . 71.11 111.974 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 19' ' ' PRO . 55.8 p90 -141.59 159.26 42.58 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.808 0.337 . . . . 73.3 111.7 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.619 HG21 HD21 ' A' ' 56' ' ' LEU . 28.6 m -123.36 136.95 54.9 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.579 -0.282 . . . . 70.44 111.189 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.8 mp -101.36 131.24 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 122.287 -0.258 . . . . 72.23 111.241 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.744 HD21 HD11 ' A' ' 56' ' ' LEU . 33.6 mt -112.48 131.24 55.68 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.349 0.5 . . . . 74.34 112.349 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -93.17 97.65 10.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.008 -0.542 . . . . 53.4 110.241 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 48' ' ' LEU . 35.1 m -94.04 4.86 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 112.852 0.686 . . . . 61.0 112.852 -172.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 HH12 HD22 ' A' ' 94' ' ' LEU . 89.5 mtm180 -65.23 -69.07 0.32 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.957 0.408 . . . . 72.15 110.565 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -177.9 159.95 1.42 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.797 -0.638 . . . . 73.43 110.164 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -58.55 -37.75 76.36 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.209 0.528 . . . . 73.15 111.445 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.8 p -70.2 -52.96 19.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.053 -0.522 . . . . 74.5 110.848 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.415 HG21 ' HD2' ' A' ' 27' ' ' ARG . 22.2 m -59.77 -29.98 68.56 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.945 -0.57 . . . . 65.44 111.354 177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -57.57 -54.05 51.27 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.138 0.494 . . . . 72.24 110.14 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.94 -36.9 82.77 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.03 -0.532 . . . . 55.23 111.296 176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.14 -47.37 83.53 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.415 -0.357 . . . . 72.22 111.744 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' ' 106' ' ' GLY . . . -176.82 106.59 0.22 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.356 -0.926 . . . . 53.34 113.267 176.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -124.37 153.77 41.36 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 117.072 0.436 . . . . 75.24 111.749 -175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.8 mt -57.1 142.36 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 120.915 0.388 . . . . 63.12 111.216 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.5 ttm -62.3 104.95 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.979 0.419 . . . . 74.05 111.59 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.59 22.33 11.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 116.094 -0.503 . . . . 72.51 113.398 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.09 168.07 13.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.38 0.61 . . . . 65.04 112.075 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 84.4 mmm -109.88 146.3 35.36 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.107 -0.497 . . . . 74.13 111.979 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -81.57 72.83 8.62 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.024 -0.534 . . . . 62.13 111.106 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.637 ' SD ' HD22 ' A' ' 24' ' ' LEU . 24.9 mtt -123.0 88.47 50.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.356 0.598 . . . . 73.13 111.087 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -77.91 140.27 18.1 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.05 2.5 . . . . 72.13 111.916 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 15.5 tt -49.24 -25.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.058 0.762 . . . . 72.12 113.058 -171.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -67.88 -50.21 57.66 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.259 0.552 . . . . 74.54 111.634 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -101.88 3.17 38.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.033 -0.53 . . . . 72.53 111.844 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 43' ' ' MET . 60.5 tp -45.51 -61.62 1.61 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.797 1.036 . . . . 53.23 113.797 -172.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 82' ' ' ALA . 64.8 t -54.48 -53.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 121.137 0.494 . . . . 62.03 111.99 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.08 -38.79 80.33 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.867 -0.606 . . . . 71.23 111.85 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.632 ' HB3' ' HG2' ' A' ' 43' ' ' MET . 27.9 mmt180 -66.86 -51.75 51.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.154 0.502 . . . . 71.21 111.821 178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.5 79.05 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.048 -0.524 . . . . 65.42 112.102 -176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -59.04 -24.79 63.15 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.865 0.364 . . . . 40.03 111.806 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -75.56 -33.86 60.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.477 0.547 . . . . 63.0 112.477 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.2 m -118.83 -43.89 2.65 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.045 0.757 . . . . 55.23 113.045 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.744 HD11 HD21 ' A' ' 24' ' ' LEU . 92.1 mt -84.66 151.37 24.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.065 0.765 . . . . 74.34 113.065 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 60' ' ' ARG . 3.0 mp0 -79.17 174.79 11.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 73.04 110.985 167.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -100.37 -22.3 15.11 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.358 -0.837 . . . . 73.41 110.68 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.1 t -89.65 -4.88 57.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.865 -0.607 . . . . 74.32 110.967 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB2' ' HB2' ' A' ' 57' ' ' GLU . 13.9 tpp180 -70.28 131.31 43.98 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.79 -0.641 . . . . 75.54 111.269 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.79 96.63 0.3 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.265 0.555 . . . . 62.25 110.655 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.2 mt -101.12 114.97 41.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.998 0.428 . . . . 75.31 111.93 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -99.7 122.74 43.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.253 0.549 . . . . 74.5 111.265 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.0 t -105.31 140.44 23.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 64.33 111.415 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -138.08 129.03 27.1 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.445 0.64 . . . . 64.42 111.56 173.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.74 -167.69 18.23 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.611 -0.722 . . . . 73.51 112.385 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -26.03 61.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.177 0.513 . . . . 75.34 110.881 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -144.46 167.47 27.0 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.807 -0.633 . . . . 33.14 112.337 176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.59 -38.81 69.9 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.14 0.422 . . . . 61.13 112.14 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -64.07 -52.38 59.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.831 0.308 . . . . 71.04 111.831 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -56.43 -43.26 79.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.379 0.609 . . . . 75.35 110.63 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 76' ' ' VAL . 39.3 m -58.26 -53.59 56.58 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.421 -0.809 . . . . 74.24 111.286 177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.1 t -62.73 -44.23 96.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.033 -0.531 . . . . 63.2 112.183 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.24 -44.46 96.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.9 0.381 . . . . 74.25 111.458 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -57.59 -47.64 81.57 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.167 0.508 . . . . 71.44 110.991 175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HB3' ' A' ' 89' ' ' GLU . 75.2 t -53.47 -43.91 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.727 -0.669 . . . . 61.43 111.714 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -55.26 -48.69 73.62 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.504 0.668 . . . . 74.21 110.695 176.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 75' ' ' ALA . 32.9 mt -60.43 -36.36 77.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.232 -0.894 . . . . 70.01 111.977 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 24' ' ' LEU . 86.6 mt -71.97 -52.6 16.3 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 111.81 0.3 . . . . 62.12 111.81 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -61.1 -28.83 69.37 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.788 -0.57 . . . . 72.42 110.747 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -68.29 -29.49 68.28 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 120.9 0.381 . . . . 74.11 111.38 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -77.87 -2.25 35.71 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.047 0.451 . . . . 71.1 111.796 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 0.66 52.02 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.16 -0.543 . . . . 71.01 113.316 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 96.6 m-85 -70.76 105.99 3.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 117.16 0.48 . . . . 72.01 111.033 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 86' ' ' HIS . 44.4 mt-10 -61.03 -53.41 57.52 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.976 -0.557 . . . . 72.13 112.188 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.415 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 15.8 m-70 -98.04 88.84 4.34 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.914 0.388 . . . . 72.05 111.955 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 76' ' ' VAL . 23.7 t -134.47 120.02 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.809 0.338 . . . . 73.52 111.027 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.607 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.2 t -117.85 140.2 50.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.269 -0.423 . . . . 51.14 111.604 -176.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.799 ' HG3' ' HB3' ' A' ' 4' ' ' GLN . 10.0 pt-20 -91.74 123.58 35.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.131 0.491 . . . . 73.5 111.604 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.628 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.5 tp -74.94 119.97 19.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.912 0.387 . . . . 74.31 110.807 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.709 ' HA ' ' HE2' ' A' ' 91' ' ' LYS . 10.8 mmpt? -70.44 135.28 48.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.326 0.584 . . . . 63.44 111.865 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.89 -74.41 1.88 Allowed Glycine 0 CA--C 1.529 0.946 0 CA-C-N 115.942 -0.572 . . . . 75.44 113.33 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.54 -154.59 20.46 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.241 -0.504 . . . . 21.23 113.392 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.509 HD22 HH12 ' A' ' 27' ' ' ARG . 48.4 tp -64.74 -49.41 70.91 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.695 -0.297 . . . . 65.3 111.678 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.88 57.28 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.756 0.28 . . . . 75.41 111.756 176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.47 -48.18 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.051 0.453 . . . . 74.01 110.968 175.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.1 t-105 -56.2 -40.42 73.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.007 -0.542 . . . . 72.03 111.178 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mtpt -77.88 -38.01 46.81 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.29 0.478 . . . . 74.31 112.29 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.21 -33.71 73.92 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.053 0.454 . . . . 75.23 111.716 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.1 pt -84.3 7.38 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 116.239 -0.437 . . . . 75.0 111.672 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.2 32.42 52.27 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.538 -0.363 . . . . 32.53 113.538 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -75.53 153.25 44.11 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 121.262 -0.494 . . . . 63.53 113.431 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.7 125.44 9.49 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.558 2.172 . . . . 75.43 113.004 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.4 p -133.33 163.54 29.11 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.557 0.694 . . . . 33.14 112.853 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.64 174.57 10.42 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.974 -1.012 . . . . 51.12 110.545 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 141.14 142.57 4.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.767 -0.73 . . . . 62.32 113.718 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.3 mt -54.21 -51.06 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.884 0.474 . . . . 75.54 111.211 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 1.8 mp -77.67 -39.26 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.22 0.533 . . . . 73.24 111.55 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -54.02 -34.49 60.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.667 -0.697 . . . . 71.01 110.943 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.7 m -61.41 -35.12 76.65 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.654 -0.703 . . . . 74.21 112.364 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 17.2 ptp180 -105.39 135.76 46.18 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.356 0.598 . . . . 73.35 111.526 -175.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 5.0 t -130.68 141.18 41.04 Favored Pre-proline 0 N--CA 1.473 0.724 0 N-CA-C 112.037 0.384 . . . . 71.22 112.037 -175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 8.2 Cg_exo -73.34 136.35 23.97 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.839 2.359 . . . . 64.53 112.305 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -162.42 160.91 26.95 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.965 0.412 . . . . 61.43 111.605 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.06 37.07 6.1 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.26 -0.495 . . . . 63.25 113.108 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.15 123.14 36.05 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.857 0.361 . . . . 61.12 110.996 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -149.2 163.96 36.15 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.624 -0.262 . . . . 64.43 110.954 -175.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -161.25 161.06 30.62 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.778 0.323 . . . . 62.2 111.245 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -152.92 135.6 15.29 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.947 0.403 . . . . 73.22 111.439 178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.39 94.24 0.71 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.319 -0.4 . . . . 62.21 110.964 178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.7 m -78.92 67.1 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.745 0.783 . . . . 64.24 112.15 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.54 109.52 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 121.328 0.585 . . . . 51.32 111.386 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.4 t -159.7 105.13 1.6 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.293 -0.412 . . . . 72.13 111.429 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -159.66 116.18 2.55 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.361 -0.381 . . . . 73.35 110.844 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.622 ' O ' HD22 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -142.46 138.89 31.35 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.712 0.292 . . . . 63.41 111.479 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.0 119.86 0.35 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.772 0.656 . . . . 75.4 112.772 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -163.46 98.98 0.91 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.693 -0.685 . . . . 74.42 110.354 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -134.4 34.21 3.26 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.105 -0.498 . . . . 73.44 112.148 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -110.52 88.03 2.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.204 0.526 . . . . 63.2 110.3 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -165.37 95.29 0.65 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.986 -0.552 . . . . 73.4 110.614 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -158.92 100.61 1.58 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.908 0.385 . . . . 74.23 111.043 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.738 0.78 . . . . 55.42 110.702 -178.787 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 110.526 -0.175 . . . . 75.41 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.83 149.99 54.74 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 122.341 0.256 . . . . 71.53 111.235 -177.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.47 -55.41 4.11 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.088 2.525 . . . . 54.33 113.45 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -121.7 118.2 28.53 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.473 -0.331 . . . . 73.35 110.21 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.7 t -113.7 144.25 43.26 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.058 0.456 . . . . 52.12 112.086 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.15 145.27 35.75 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.333 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -53.04 -36.54 60.68 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.921 0.391 . . . . 72.33 111.666 178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.423 ' HA ' HD12 ' A' ' 100' ' ' ILE . 32.6 t60 -63.56 -39.0 93.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.242 -0.435 . . . . 62.35 111.724 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -73.61 -40.34 54.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.905 0.384 . . . . 52.41 111.223 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.32 -46.79 87.15 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.93 0.395 . . . . 75.11 111.143 175.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.56 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 74.6 tttt -59.21 -40.6 86.3 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.954 0.407 . . . . 61.45 111.805 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.1 p -74.77 -40.87 60.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.306 0.574 . . . . 72.03 110.063 -177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -60.24 -28.64 68.19 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.715 -0.675 . . . . 74.35 111.349 172.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HZ ' ' A' ' 21' ' ' PHE . 54.1 tp -77.43 -53.18 7.96 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.014 0.435 . . . . 73.44 111.662 177.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -75.04 -45.57 40.72 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.476 0.547 . . . . 73.41 112.476 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.4 m95 -97.61 -36.37 10.3 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.235 0.457 . . . . 74.52 112.235 -176.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.76 -118.43 0.82 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.27 -0.49 . . . . 55.0 114.014 -176.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -141.44 142.16 25.49 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 120.865 0.364 . . . . 72.22 111.395 -176.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 70.8 Cg_endo -94.53 42.03 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.761 2.974 . . . . 54.43 113.239 -175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.97 15.36 3.43 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.086 0.47 . . . . 52.21 111.915 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' HE1' HD11 ' A' ' 23' ' ' ILE . 29.2 p90 -117.44 158.54 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.301 -0.409 . . . . 72.31 111.711 -177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.7 m -119.06 127.72 53.68 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.559 -0.291 . . . . 63.14 111.652 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HE1' ' A' ' 21' ' ' PHE . 3.5 mp -96.07 126.83 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 122.417 -0.177 . . . . 70.11 111.156 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' SD ' ' A' ' 43' ' ' MET . 41.3 mt -111.27 127.68 55.7 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.836 0.351 . . . . 60.03 111.612 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -88.87 104.06 16.58 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.909 0.385 . . . . 73.45 110.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 33.5 m -96.96 9.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.935 0.717 . . . . 72.42 112.935 -173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.536 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 68.2 mtm180 -66.73 -71.59 0.19 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.132 -0.355 . . . . 73.13 110.263 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -178.39 158.39 1.11 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.705 0.402 . . . . 73.32 110.561 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.6 tpt85 -56.69 -36.6 69.82 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.883 0.373 . . . . 72.24 111.398 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.8 p -68.12 -49.24 62.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.366 0.603 . . . . 65.25 110.143 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.508 HG21 ' HD2' ' A' ' 27' ' ' ARG . 7.9 m -63.58 -25.62 68.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.496 -0.775 . . . . 61.21 111.337 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -62.39 -44.89 95.39 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.131 0.491 . . . . 53.55 110.088 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -63.33 -41.27 98.89 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.559 172.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.645 ' HA ' HD13 ' A' ' 108' ' ' ILE . 6.2 t70 -52.64 -48.72 66.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.767 0.427 . . . . 74.2 111.748 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -179.06 115.67 0.49 Allowed Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.273 -0.965 . . . . 52.13 113.489 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -125.46 150.67 47.13 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.6 -0.353 . . . . 73.32 111.409 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 40' ' ' ALA . 69.2 mt -57.18 142.68 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.479 0.181 . . . . 64.13 110.699 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.5 ttm -59.53 106.9 0.51 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.138 0.494 . . . . 71.14 111.855 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.22 11.48 58.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.24 -0.505 . . . . 54.14 113.644 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . . . -72.33 171.87 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.246 0.546 . . . . 64.35 111.999 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 88.7 mmm -107.48 145.04 33.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.147 0.499 . . . . 75.14 112.114 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.63 83.12 7.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.842 -0.617 . . . . 31.43 110.968 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.691 ' SD ' HD22 ' A' ' 24' ' ' LEU . 6.6 mtt -131.12 87.41 48.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.404 0.621 . . . . 72.31 111.107 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.91 140.24 28.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.618 2.212 . . . . 65.52 111.691 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.3 tt -48.68 -26.53 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 112.395 0.517 . . . . 74.35 112.395 -174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.18 -42.14 60.34 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.011 -0.541 . . . . 72.2 112.047 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -97.5 -4.69 37.47 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 122.167 -0.333 . . . . 75.52 111.585 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.4 tp -43.5 -57.39 3.13 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.14 1.163 . . . . 71.34 114.14 -168.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 82' ' ' ALA . 58.9 t -54.46 -53.52 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.317 0.488 . . . . 74.43 112.317 -173.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.53 -50.37 71.65 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.757 0.313 . . . . 74.52 111.662 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' CB ' ' HG2' ' A' ' 43' ' ' MET . 36.3 mmt180 -51.58 -55.27 20.12 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.474 0.654 . . . . 74.42 111.409 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 -49.3 71.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.566 -0.743 . . . . 31.35 111.819 -176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 t -55.59 -28.05 52.88 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.106 0.479 . . . . 71.32 111.505 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -77.9 -55.13 5.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.14 112.391 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.8 m -107.63 -2.59 20.08 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 113.977 1.103 . . . . 34.1 113.977 -170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.625 HD11 HD21 ' A' ' 24' ' ' LEU . 91.0 mt -117.4 155.9 28.84 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.771 0.656 . . . . 65.53 112.771 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 59' ' ' SER . 83.4 tt0 -97.31 138.89 34.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.675 . . . . 70.42 110.54 174.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 96.8 mttt -67.4 -21.56 65.59 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.186 0.439 . . . . 74.2 112.186 -176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 79.4 p -90.25 -12.13 38.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.915 -0.491 . . . . 73.02 111.313 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -61.24 133.15 55.61 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.282 -0.417 . . . . 73.3 111.375 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -67.07 96.08 0.43 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.292 0.567 . . . . 74.43 110.411 175.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.2 mt -100.94 122.73 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-O 121.246 0.545 . . . . 74.54 112.434 -175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -97.5 118.83 34.88 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.725 -0.67 . . . . 74.41 110.785 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 73.6 t -104.88 125.46 59.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.44 111.044 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -128.04 130.95 49.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.509 0.671 . . . . 71.33 111.686 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.91 -160.68 12.48 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 115.515 -0.766 . . . . 71.12 111.947 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.88 -29.25 22.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.238 0.542 . . . . 74.31 111.084 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -140.5 171.05 24.18 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 116.061 -0.518 . . . . 63.41 113.038 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.71 -26.88 66.38 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.674 0.62 . . . . 74.25 112.674 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -36.15 63.79 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.965 -0.46 . . . . 61.21 110.928 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 57.7 tt0 -67.91 -39.05 83.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.413 -0.358 . . . . 54.41 111.101 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.667 ' HB ' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -63.98 -55.94 18.8 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.784 0.29 . . . . 74.34 111.784 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.8 m -57.91 -39.18 77.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 111.921 0.341 . . . . 65.34 111.921 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 45' ' ' ILE . 3.3 tt0 -66.77 -48.48 68.93 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.786 0.327 . . . . 75.42 111.479 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.8 -47.67 85.28 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.26 0.553 . . . . 63.52 111.168 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 89' ' ' GLU . 59.8 t -52.9 -43.28 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.851 -0.613 . . . . 63.52 111.105 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' HG2' ' A' ' 80' ' ' ARG . 65.1 t30 -57.96 -49.37 77.01 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.213 0.53 . . . . 71.2 110.928 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 75' ' ' ALA . 47.1 mt -59.43 -43.15 93.15 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.642 -0.708 . . . . 54.2 112.079 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -65.65 -53.01 47.21 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 77' ' ' ASN . 5.3 ptm180 -64.17 -27.44 69.07 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.918 0.389 . . . . 72.54 110.581 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 t -66.45 -36.89 83.9 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.752 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -73.82 2.33 8.65 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.026 0.441 . . . . 32.44 111.653 176.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.77 1.57 57.44 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.238 -0.506 . . . . 73.33 113.73 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 62.6 m-85 -67.11 126.57 29.59 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 117.431 0.616 . . . . 70.14 111.321 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.95 -62.79 1.59 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.497 -0.774 . . . . 74.15 111.854 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -92.73 85.02 5.1 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.965 0.412 . . . . 62.01 111.983 -172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.83 120.98 62.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.216 0.532 . . . . 72.55 111.418 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.9 t -122.07 159.17 27.65 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.146 -0.479 . . . . 75.54 111.006 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.667 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 13.1 pt-20 -117.14 137.26 52.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.255 0.55 . . . . 73.1 111.402 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 7' ' ' ALA . 18.6 tp -84.13 101.92 12.18 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.903 -0.59 . . . . 75.12 111.283 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -62.75 111.83 2.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.076 0.465 . . . . 73.22 111.743 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 111.99 -13.65 26.6 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.851 -0.613 . . . . 24.24 113.019 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 60.97 -151.54 41.54 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.442 -0.409 . . . . 72.13 114.114 177.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 41.4 tp -66.26 -42.71 88.1 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.647 0.26 . . . . 63.34 111.612 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.17 -46.04 65.33 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.23 0.455 . . . . 70.25 112.23 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.47 -46.05 87.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.923 0.392 . . . . 74.11 111.276 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -54.71 -38.75 67.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.326 0.584 . . . . 74.42 110.781 175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -77.54 -33.76 54.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.922 -0.581 . . . . 75.2 111.932 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.22 -37.28 82.45 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.937 0.399 . . . . 74.24 111.667 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 8' ' ' HIS . 22.2 pt -84.75 7.45 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.813 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.56 37.35 68.47 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.153 -0.546 . . . . 51.5 112.924 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.56 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -72.51 148.04 41.45 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.376 -0.44 . . . . 45.42 113.256 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HA2' ' A' ' 102' ' ' GLY . 24.7 Cg_exo -64.59 117.94 4.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.784 2.323 . . . . 75.24 112.545 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.6 p -125.62 165.06 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.702 0.763 . . . . 61.34 112.617 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -136.45 171.07 15.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.967 -1.015 . . . . 55.12 109.722 174.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.549 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 132.64 155.56 7.92 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.46 -0.876 . . . . 65.22 114.014 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.4 mt -63.06 -52.41 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.685 0.278 . . . . 61.31 111.396 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 34' ' ' ASP . 1.8 mp -74.31 -33.95 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.052 0.453 . . . . 61.45 111.506 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.615 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 33.9 mm-40 -58.39 -27.25 64.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.683 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.1 m -63.5 -49.36 73.87 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.044 0.45 . . . . 43.03 110.784 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 111' ' ' ARG . 2.1 ppt_? -168.32 130.18 1.39 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.726 -0.67 . . . . 54.42 111.236 176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.3 p -78.63 161.97 67.39 Favored Pre-proline 0 N--CA 1.474 0.76 0 N-CA-C 112.787 0.662 . . . . 70.42 112.787 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.64 -140.1 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.724 2.282 . . . . 74.22 111.381 171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 175.8 -174.75 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.801 0.334 . . . . 75.13 111.739 -172.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.37 111.67 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.036 -0.602 . . . . 54.21 113.502 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.08 99.94 0.29 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.264 0.226 . . . . 63.3 111.548 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -174.85 122.24 0.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.072 0.463 . . . . 72.3 111.505 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -150.29 168.02 25.28 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.092 -0.504 . . . . 75.03 110.984 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -130.56 142.59 50.47 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.98 0.419 . . . . 74.54 111.402 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.49 100.42 11.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 73.34 110.959 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.0 t -85.59 -30.27 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.162 -0.472 . . . . 74.14 111.992 -175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 m -62.74 84.12 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 121.734 0.778 . . . . 74.14 112.808 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 t -137.22 77.46 1.64 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.57 -0.741 . . . . 62.33 109.747 174.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -171.15 118.64 0.48 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.241 -0.89 . . . . 71.2 109.21 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 51.5 tp -128.8 131.01 47.75 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.05 0.759 . . . . 71.12 113.05 -171.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -132.29 138.68 47.94 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.647 -0.706 . . . . 74.52 110.338 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -167.4 102.43 0.51 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.147 0.499 . . . . 73.44 111.228 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -151.64 109.77 3.72 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.87 0.367 . . . . 73.15 110.667 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -148.01 162.6 39.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.967 0.358 . . . . 61.42 111.967 -173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -161.2 89.43 0.78 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.095 0.474 . . . . 73.13 112.019 177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -141.57 156.05 45.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.419 -0.355 . . . . 74.22 111.336 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.209 0.528 . . . . 72.42 111.714 178.049 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ppp? . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.003 0.43 . . . . 63.14 110.632 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 6.4 mp0 -72.03 146.54 90.21 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.192 -0.458 . . . . 72.44 111.867 -172.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.64 -24.27 78.04 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 122.672 2.248 . . . . 70.45 112.03 174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -154.54 120.17 5.15 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.112 -0.949 . . . . 64.1 110.492 -172.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.8 m -135.07 137.41 42.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.714 0.292 . . . . 45.23 110.987 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' HB2' HG23 ' A' ' 9' ' ' VAL . 5.4 m-20 -66.18 159.83 25.49 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.02 0.438 . . . . 72.22 111.469 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -54.19 -50.44 67.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.135 0.42 . . . . 52.31 112.135 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.609 ' HA ' HD12 ' A' ' 100' ' ' ILE . 1.2 p-80 -66.9 -25.89 66.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.047 0.758 . . . . 52.35 113.047 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 6' ' ' ASP . 89.6 t -60.0 -53.3 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.269 0.557 . . . . 53.41 110.03 172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.3 -41.16 98.29 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.991 -0.549 . . . . 72.11 110.958 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 73.4 tttt -57.48 -44.05 84.59 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.891 0.377 . . . . 70.04 111.224 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.8 m -62.53 -31.77 72.61 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.607 -0.27 . . . . 64.53 110.523 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 73.5 mtt180 -72.71 -34.4 67.09 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 111.973 0.36 . . . . 73.42 111.973 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tt -64.6 -51.86 60.53 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.924 0.392 . . . . 63.54 110.652 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . 38.5 mt-10 -82.2 -52.84 6.57 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.049 0.452 . . . . 74.14 112.114 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 15' ' ' GLU . 29.8 m95 -97.2 -37.85 9.93 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -171.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -82.87 -150.08 8.9 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 113.914 0.325 . . . . 54.35 113.914 -172.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.4 153.01 42.28 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 122.548 0.339 . . . . 74.11 111.18 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -86.71 24.5 0.74 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.916 2.411 . . . . 72.43 113.489 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.72 52.61 1.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.899 0.38 . . . . 61.13 112.008 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -155.27 158.74 39.28 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.376 -0.375 . . . . 73.21 111.407 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.659 HG21 HD21 ' A' ' 56' ' ' LEU . 91.0 m -128.46 127.86 43.29 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.697 0.285 . . . . 63.21 111.182 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -98.83 132.23 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 111.957 0.355 . . . . 74.11 111.957 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 ' SD ' ' A' ' 43' ' ' MET . 61.7 mt -118.64 125.6 50.11 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 111.75 0.278 . . . . 73.14 111.75 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -95.02 111.15 22.98 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.061 0.458 . . . . 72.42 110.623 175.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 48' ' ' LEU . 28.3 m -104.88 7.99 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 113.266 0.839 . . . . 71.4 113.266 -170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.59 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 14.3 ptp180 -73.51 -55.36 6.43 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.233 0.457 . . . . 75.03 112.233 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 36.9 t70 -172.06 153.76 3.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.458 0.17 . . . . 62.33 110.841 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 7.9 tpt180 -64.21 -45.21 89.3 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.073 0.464 . . . . 73.44 111.663 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 75.7 m -78.54 -40.93 33.56 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.953 -0.467 . . . . 72.55 111.255 -178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 87.2 m -61.59 -32.72 72.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.075 -0.25 . . . . 53.01 110.754 174.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 44.2 t80 -55.18 -52.91 61.81 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.906 0.384 . . . . 34.52 110.23 170.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' HG13 ' A' ' 107' ' ' ILE . 46.0 m-80 -58.8 -40.82 85.19 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.477 -0.329 . . . . 71.44 111.195 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.44 -45.08 92.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.886 0.328 . . . . 74.33 111.886 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.57 130.58 2.22 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.12 -0.562 . . . . 62.15 113.064 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -158.98 164.56 35.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.902 0.382 . . . . 72.51 111.226 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.31 143.35 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.851 0.358 . . . . 74.21 111.413 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.573 ' SD ' ' HG3' ' A' ' 105' ' ' GLU . 41.8 tpp -53.83 108.0 0.31 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.645 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.89 26.3 38.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.137 0.415 . . . . 65.0 114.137 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.14 161.26 21.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.325 0.563 . . . . 73.24 111.685 177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.495 ' HB2' HD23 ' A' ' 24' ' ' LEU . 77.1 mmm -97.34 149.01 22.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.195 0.521 . . . . 65.51 112.253 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.2 88.22 7.21 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.764 -0.653 . . . . 74.32 111.602 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.77 ' HG3' ' HB3' ' A' ' 51' ' ' ARG . 1.8 mpt? -130.31 84.65 59.11 Favored Pre-proline 0 N--CA 1.47 0.543 0 CA-C-N 116.091 -0.504 . . . . 75.13 110.919 176.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.26 143.1 42.9 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.953 1.769 . . . . 73.0 111.334 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.1 tt -48.95 -25.02 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 112.566 0.58 . . . . 74.25 112.566 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -68.47 -50.65 50.87 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.159 0.504 . . . . 74.33 111.729 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -103.08 2.78 35.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.369 . . . . 74.51 111.789 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD13 HG12 ' A' ' 26' ' ' VAL . 60.5 tp -44.95 -50.38 10.59 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.562 0.949 . . . . 75.54 113.562 -174.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.5 t -58.59 -53.3 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 120.753 0.311 . . . . 75.11 111.642 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.13 -52.78 61.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.162 0.506 . . . . 65.35 111.515 178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.77 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 19.1 mmt180 -50.56 -55.25 17.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.917 -0.583 . . . . 61.2 112.331 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.49 86.6 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.405 -0.361 . . . . 63.24 111.77 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.6 t -62.72 -32.56 73.69 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.029 0.442 . . . . 65.53 111.941 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 t -78.69 -51.12 10.29 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.242 0.46 . . . . 64.43 112.242 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -84.51 -35.26 23.03 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.857 0.688 . . . . 54.22 112.857 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 22' ' ' THR . 82.1 mt -109.11 164.99 11.94 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.214 0.82 . . . . 74.53 113.214 -171.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -86.52 179.61 6.8 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.148 -0.933 . . . . 75.31 110.903 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 84' ' ' PHE . 90.2 mttt -102.62 -24.57 13.76 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.358 -0.837 . . . . 75.23 111.129 178.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 m -88.77 -4.93 58.38 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.264 -0.426 . . . . 63.14 110.823 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -68.73 135.04 50.66 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.067 -0.515 . . . . 73.25 111.833 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.78 96.48 0.29 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.141 0.496 . . . . 63.43 111.023 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.21 132.34 54.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.296 0.48 . . . . 72.14 112.296 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' OH ' ' NH1' ' A' ' 13' ' ' ARG . 52.1 m-85 -112.74 118.13 34.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.151 0.501 . . . . 72.24 110.635 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 79.0 t -105.34 140.02 24.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.848 -0.615 . . . . 73.12 111.866 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.491 ' HA ' HG23 ' A' ' 72' ' ' THR . 2.4 p90 -145.12 131.77 19.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.252 0.548 . . . . 74.32 111.369 174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.56 -162.79 26.16 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.675 -0.57 . . . . 73.44 111.675 173.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 27' ' ' ARG . . . -71.09 -40.82 71.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.285 0.564 . . . . 75.14 110.401 174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -117.47 165.68 12.55 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.654 -0.703 . . . . 63.12 112.802 176.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 72' ' ' THR . 10.7 t70 -58.8 -44.4 90.75 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.994 0.426 . . . . 65.14 111.835 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -60.16 -49.61 76.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.348 -0.387 . . . . 72.1 111.793 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 61.8 tt0 -55.28 -42.47 73.62 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.673 0.749 . . . . 74.42 110.434 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 65' ' ' TYR . 84.8 m -55.99 -54.17 48.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.013 -0.994 . . . . 73.43 111.598 177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.5 t -65.08 -37.1 86.44 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.111 -0.495 . . . . 65.04 112.286 -176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' O ' ' HB3' ' A' ' 77' ' ' ASN . 2.8 tt0 -67.86 -44.95 75.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.97 0.414 . . . . 74.54 111.313 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.62 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.9 -46.26 82.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.322 0.582 . . . . 74.14 111.066 176.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 87' ' ' VAL . 73.1 t -52.91 -42.19 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.696 -0.684 . . . . 73.13 111.429 172.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 12.3 t30 -58.79 -47.5 84.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.154 0.502 . . . . 64.15 111.02 176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 75' ' ' ALA . 24.6 mt -61.48 -40.12 93.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.664 -0.698 . . . . 72.14 112.045 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' HG ' HD21 ' A' ' 48' ' ' LEU . 43.9 mt -65.58 -53.19 45.31 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.091 0.404 . . . . 60.43 112.091 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 13.9 ptp180 -63.13 -27.92 69.71 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.904 -0.497 . . . . 71.22 110.707 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.6 t -63.8 -38.43 91.07 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.899 0.381 . . . . 72.5 110.987 170.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.23 -3.89 35.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.055 0.455 . . . . 43.33 111.692 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.06 -3.21 35.41 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.333 -0.461 . . . . 64.14 113.792 176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 58' ' ' LYS . 61.2 m-85 -63.33 109.48 1.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.249 0.524 . . . . 74.31 111.515 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.31 -54.9 29.8 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.594 -0.73 . . . . 65.22 112.526 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -101.89 86.2 2.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.154 0.427 . . . . 53.3 112.154 -172.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 76' ' ' VAL . 58.7 t -132.9 119.03 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.961 0.41 . . . . 75.02 111.395 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 45.5 t -111.62 151.45 28.77 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.004 -0.544 . . . . 72.42 111.525 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 76' ' ' VAL . 8.7 pt-20 -95.97 123.75 39.7 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.089 0.471 . . . . 75.04 111.3 177.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.651 HD11 ' HA ' ' A' ' 7' ' ' ALA . 23.8 tp -76.0 92.0 3.12 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.124 0.488 . . . . 72.43 110.805 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -64.93 116.19 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.653 0.74 . . . . 75.1 112.221 -176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.29 -32.49 4.32 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 114.931 -1.031 . . . . 74.21 113.321 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.0 -174.57 55.06 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.991 -0.623 . . . . 64.04 113.141 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.6 tp -68.08 -38.96 82.98 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 122.307 -0.525 . . . . 62.44 111.675 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.95 71.76 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.774 0.321 . . . . 71.21 111.4 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -67.25 -44.95 78.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.842 0.354 . . . . 52.34 110.483 174.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -52.14 -36.78 52.35 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.267 0.556 . . . . 53.43 111.015 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -78.01 -40.78 37.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.238 -0.437 . . . . 73.0 111.973 176.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.66 -29.36 70.36 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.074 0.464 . . . . 61.34 111.896 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 8' ' ' HIS . 20.6 pt -83.71 2.56 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.051 0.453 . . . . 52.22 110.906 176.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.01 43.36 40.88 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.256 -0.429 . . . . 71.23 113.515 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.445 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -90.71 154.53 23.28 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 121.288 -0.482 . . . . 55.3 113.392 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.36 126.24 10.84 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.758 2.306 . . . . 65.33 112.714 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.9 p -128.28 147.4 50.6 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.278 0.561 . . . . 75.23 112.133 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.573 ' HG3' ' SD ' ' A' ' 38' ' ' MET . 33.0 mt-10 -113.87 144.92 42.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.843 -0.617 . . . . 65.43 110.18 171.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 166.68 166.0 25.02 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.004 -1.093 . . . . 53.22 114.828 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 33' ' ' ASN . 34.4 mt -80.89 -49.45 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.151 0.58 . . . . 62.33 110.856 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -33.79 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.077 0.465 . . . . 75.14 110.623 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -60.8 -18.79 57.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.73 -0.668 . . . . 74.43 111.137 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 51.3 m -76.09 -24.54 55.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.199 -0.455 . . . . 62.52 111.441 175.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -157.07 58.51 0.52 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.388 0.613 . . . . 64.25 111.475 -179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 47.5 p -53.33 147.99 17.66 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 112.512 0.56 . . . . 74.43 112.512 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.97 -25.07 80.87 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.582 2.188 . . . . 70.44 113.009 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 52.96 38.23 26.59 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.839 -0.618 . . . . 71.5 112.536 175.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.05 -175.49 40.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.18 -0.533 . . . . 74.45 113.1 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -175.59 125.33 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 122.63 0.372 . . . . 52.53 111.42 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -108.29 151.56 25.81 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.956 0.408 . . . . 61.02 111.722 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -93.98 176.55 6.29 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.838 0.351 . . . . 75.21 111.563 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -105.82 -83.82 0.51 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.223 -0.298 . . . . 65.35 111.184 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.8 m120 67.05 -7.68 0.48 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.859 1.059 . . . . 71.4 113.859 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.9 t -73.49 132.09 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 121.996 -0.44 . . . . 72.11 111.729 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 32.7 m -87.96 144.05 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 112.472 0.545 . . . . 71.12 112.472 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.6 m -155.41 136.76 14.02 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.249 -0.432 . . . . 63.34 111.278 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -169.41 128.98 1.02 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.67 0.272 . . . . 74.34 110.918 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 126' ' ' GLU . 3.0 tm? -158.4 139.2 12.9 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 122.189 -0.319 . . . . 62.12 111.334 -174.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.538 ' N ' HD13 ' A' ' 125' ' ' LEU . 7.2 tp10 -165.74 122.06 1.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.566 0.58 . . . . 75.14 112.566 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -169.09 112.78 0.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.93 0.395 . . . . 74.41 111.647 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -148.62 143.91 26.86 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 112.655 0.613 . . . . 54.32 112.655 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -159.41 121.71 3.46 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 74.4 110.581 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -80.12 -12.46 59.66 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.744 0.275 . . . . 74.53 111.744 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 18.7 t60 74.58 -34.02 0.26 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.958 1.095 . . . . 70.34 113.958 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 p80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.037 0.446 . . . . 41.24 112.177 -175.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 25.3 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.397 0.147 . . . . 72.42 111.397 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 1' ' ' MET . 45.3 mm-40 67.45 145.33 0.1 Allowed Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 121.328 0.585 . . . . 64.03 112.269 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 39.8 Cg_endo -69.22 -38.7 8.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.567 2.178 . . . . 75.14 111.809 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -131.82 109.32 10.03 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.752 -0.658 . . . . 75.21 111.117 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 t -87.47 142.43 27.87 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.032 0.444 . . . . 63.2 111.587 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.45 138.75 35.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.448 -0.342 . . . . 71.21 111.046 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.742 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -55.61 -40.84 72.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.231 0.539 . . . . 73.15 111.504 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.495 ' HA ' HD12 ' A' ' 100' ' ' ILE . 41.7 t60 -66.81 -35.94 81.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.826 -0.624 . . . . 73.24 112.007 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.9 t -75.81 -37.56 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.253 0.549 . . . . 74.52 111.554 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.4 tp -65.82 -41.32 91.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.084 0.468 . . . . 61.43 110.368 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 77.7 tttt -62.63 -44.36 96.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.236 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' TRP . 93.6 p -60.59 -42.18 96.23 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 120.835 0.35 . . . . 73.43 110.096 -178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 96.4 mtt180 -65.39 -40.59 93.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.187 0.44 . . . . 72.32 112.187 177.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.77 -55.29 36.15 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.857 0.361 . . . . 61.1 111.053 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -87.33 -46.22 9.87 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.304 0.483 . . . . 71.41 112.304 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' SER . 33.9 m95 -96.48 -36.02 10.93 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.542 0.571 . . . . 75.11 112.542 -171.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -83.16 -127.65 1.24 Allowed Glycine 0 CA--C 1.525 0.658 0 CA-C-N 116.367 -0.378 . . . . 51.21 112.769 -177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -144.35 110.36 4.98 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.578 -0.527 . . . . 73.24 109.578 172.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HB2' ' H ' ' A' ' 20' ' ' ALA . 37.0 Cg_exo -56.81 -91.0 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.843 2.362 . . . . 75.24 114.175 -172.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' H ' ' HB2' ' A' ' 19' ' ' PRO . . . 51.9 12.09 0.17 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.993 0.738 . . . . 73.2 112.993 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.16 149.96 30.15 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.196 0.522 . . . . 62.2 111.444 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.7 m -101.19 116.76 33.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.972 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -91.37 124.04 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.61 0.243 . . . . 72.14 111.029 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 56' ' ' LEU . 60.2 mt -111.55 126.17 54.7 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.053 0.454 . . . . 64.33 112.16 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -89.05 97.82 11.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.974 -0.557 . . . . 71.4 110.537 177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 33.0 m -96.35 7.78 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.534 0.568 . . . . 62.23 112.534 -174.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' A' ' 35' ' ' GLY . 76.5 mtm180 -67.98 -64.22 0.9 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.344 0.592 . . . . 74.41 110.795 178.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' HB3' ' CB ' ' A' ' 31' ' ' THR . 27.0 t70 -177.79 156.06 1.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.364 -0.834 . . . . 53.25 110.102 -176.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 44.0 tpt85 -65.08 -43.99 90.38 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.023 0.44 . . . . 62.25 111.061 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.4 m -75.54 -38.85 59.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.572 -0.286 . . . . 61.43 111.077 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.423 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 44.3 m -63.06 -32.81 74.27 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.009 0.433 . . . . 64.44 110.614 174.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 75.3 t80 -55.46 -48.38 74.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.121 0.486 . . . . 72.22 110.074 170.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.51 -41.89 99.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.889 -0.596 . . . . 75.41 111.546 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.011 0.524 . . . . 73.32 111.187 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 109' ' ' GLU . . . -177.34 121.69 0.79 Allowed Glycine 0 C--O 1.219 -0.832 0 C-N-CA 120.783 -0.722 . . . . 64.22 112.398 174.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -134.86 165.42 25.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 117.391 0.596 . . . . 73.1 112.004 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.65 142.72 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.497 -0.319 . . . . 74.24 110.87 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 37.0 tpp -49.82 109.39 0.28 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.328 0.492 . . . . 72.03 112.328 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.92 22.74 73.74 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 114.34 0.496 . . . . 61.24 114.34 176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.66 160.62 31.32 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.417 0.609 . . . . 63.34 111.616 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 91.4 mmm -83.7 140.43 32.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.003 0.43 . . . . 75.21 112.035 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.55 67.85 6.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.928 -0.578 . . . . 73.13 109.842 175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.473 ' HG3' ' CB ' ' A' ' 51' ' ' ARG . 35.7 ttm -121.83 80.57 41.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 115.829 -0.623 . . . . 65.21 110.504 -172.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.71 144.83 50.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.587 2.191 . . . . 61.43 112.291 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.526 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 17.9 tt -50.53 -25.7 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 112.957 0.725 . . . . 74.34 112.957 -172.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -67.91 -49.17 63.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.091 0.472 . . . . 65.44 111.617 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.54 1.43 43.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.852 0.358 . . . . 60.01 111.353 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 43' ' ' MET . 53.0 tp -45.41 -56.85 4.55 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.423 0.897 . . . . 73.53 113.423 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 82' ' ' ALA . 89.3 t -52.65 -52.02 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.858 0.361 . . . . 64.14 111.785 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.74 -53.35 52.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.955 0.407 . . . . 72.13 111.681 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.3 OUTLIER -53.12 -54.08 40.92 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.221 0.534 . . . . 61.1 111.806 179.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB2' ' SD ' ' A' ' 43' ' ' MET . . . -64.98 -45.41 85.75 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.956 -0.566 . . . . 75.15 112.068 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.4 t -63.7 -27.29 69.11 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.031 0.443 . . . . 71.54 111.543 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.3 t -86.75 -41.57 14.02 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.286 0.476 . . . . 63.32 112.286 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.0 m -99.48 -22.56 15.45 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.176 0.806 . . . . 74.43 113.176 -173.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 24' ' ' LEU . 88.0 mt -116.11 162.11 17.92 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.406 0.622 . . . . 72.33 112.627 -173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG2' ' H ' ' A' ' 59' ' ' SER . 39.7 tt0 -97.37 146.1 25.5 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.019 -0.537 . . . . 72.23 110.586 175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 84' ' ' PHE . 31.1 mmtp -62.98 -24.24 67.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.393 0.616 . . . . 73.35 111.38 -179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.57 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 70.5 m -93.21 0.49 57.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.377 0.51 . . . . 73.14 112.377 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 4.5 tpm_? -72.2 123.89 23.88 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.324 -0.235 . . . . 74.44 111.094 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 86' ' ' HIS . 21.8 m-20 -62.14 99.98 0.15 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.263 0.554 . . . . 74.33 111.466 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' ARG . 83.0 mt -106.33 130.25 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.89 -0.595 . . . . 64.25 112.595 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 85.6 m-85 -112.45 118.98 36.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.304 0.573 . . . . 64.43 110.489 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG22 ' HB2' ' A' ' 24' ' ' LEU . 74.9 t -104.99 140.01 24.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 50.11 111.589 -174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -134.24 129.57 35.86 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.725 0.774 . . . . 70.21 112.054 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 72' ' ' THR . . . -109.81 -172.57 20.5 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.279 -0.873 . . . . 55.51 112.382 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.35 -11.26 59.36 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.273 0.559 . . . . 60.31 110.989 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.58 165.52 31.49 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 115.64 -0.709 . . . . 72.14 112.184 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 72' ' ' THR . 3.6 m-20 -56.84 -46.24 81.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.941 0.4 . . . . 75.21 111.602 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -62.5 -45.42 93.07 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.48 -0.327 . . . . 73.24 111.788 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.52 -49.29 78.12 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.888 0.375 . . . . 72.22 111.53 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 89' ' ' GLU . 5.3 t -64.76 -45.18 87.48 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.321 0.582 . . . . 75.32 111.285 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -61.17 -44.09 97.85 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.334 -0.848 . . . . 73.34 111.66 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 4.4 tt0 -62.25 -42.44 99.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.042 0.449 . . . . 52.24 110.82 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 26' ' ' VAL . . . -58.66 -49.84 76.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.23 0.538 . . . . 51.12 111.125 175.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 89' ' ' GLU . 69.1 t -53.09 -41.34 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.918 -0.583 . . . . 72.13 111.623 173.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 57.7 t30 -57.82 -48.33 80.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.549 0.69 . . . . 64.42 111.02 174.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' GLN . 54.7 mt -63.36 -37.6 87.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.318 -0.855 . . . . 73.32 112.1 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.7 mt -65.58 -51.39 60.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.709 0.29 . . . . 74.21 111.754 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -65.62 -29.33 69.9 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.9 -0.5 . . . . 74.43 110.927 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.1 t -64.37 -32.28 73.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.421 . . . . 73.12 110.753 170.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -83.12 -2.12 54.6 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.323 0.49 . . . . 74.12 112.323 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.23 -12.27 26.37 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.981 -0.628 . . . . 45.42 114.469 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 58' ' ' LYS . 83.8 m-85 -60.96 117.44 5.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 117.474 0.637 . . . . 75.13 112.247 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -75.62 -46.15 33.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.006 -0.543 . . . . 74.03 111.579 176.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.572 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . 41.9 m-70 -99.06 89.27 4.21 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.449 0.537 . . . . 72.43 112.449 -173.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.18 136.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.669 0.271 . . . . 71.55 111.596 177.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.0 t -137.57 147.34 45.02 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.286 0.235 . . . . 53.15 111.315 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.531 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.4 pt-20 -93.22 139.48 30.57 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.054 0.454 . . . . 61.1 111.465 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.4 tp -90.33 106.82 18.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.07 0.462 . . . . 75.31 111.817 -177.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -62.38 134.1 55.99 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.108 -0.496 . . . . 63.52 111.67 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.83 -13.89 59.88 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.298 -0.477 . . . . 73.21 113.643 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 59.28 -156.31 26.03 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 121.226 -0.511 . . . . 61.21 113.811 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.0 tp -64.4 -37.3 87.03 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.54 -0.388 . . . . 72.53 111.966 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.07 87.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.731 0.271 . . . . 43.41 111.731 -177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.81 96.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.996 0.427 . . . . 75.54 110.864 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -54.89 -39.96 69.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.287 0.565 . . . . 65.45 111.087 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.822 ' HG2' HG21 ' A' ' 104' ' ' THR . 49.0 mtmt -77.27 -38.32 51.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.998 -0.546 . . . . 44.3 111.735 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.22 79.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.001 0.429 . . . . 71.13 111.634 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 8' ' ' HIS . 23.7 pt -80.26 9.53 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.152 -0.477 . . . . 63.01 111.876 178.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.64 38.89 90.51 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.393 -0.432 . . . . 71.52 113.156 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.522 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -74.46 153.66 46.44 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.232 -0.509 . . . . 61.55 113.408 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.91 114.78 2.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.457 2.105 . . . . 64.33 112.212 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.822 HG21 ' HG2' ' A' ' 98' ' ' LYS . 82.2 p -127.33 160.62 30.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.566 0.698 . . . . 73.25 112.682 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -139.8 174.52 10.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.887 -1.051 . . . . 71.24 110.15 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.468 ' HA3' ' HA2' ' A' ' 35' ' ' GLY . . . 138.91 -179.64 18.33 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 61.22 114.106 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 32.2 mt -89.94 -44.23 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.017 0.437 . . . . 75.45 110.568 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.95 -35.19 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.041 0.448 . . . . 70.31 111.345 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.57 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 64.0 mm-40 -78.2 65.02 3.47 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.484 0.659 . . . . 71.24 110.357 174.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.1 t -179.9 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.545 -0.752 . . . . 71.23 111.298 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 111' ' ' ARG . 12.0 ptm85 -75.93 172.14 13.23 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.202 0.525 . . . . 74.42 112.393 -177.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.4 p -84.82 129.98 54.55 Favored Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 113.386 0.884 . . . . 42.4 113.386 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -96.32 115.13 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 123.321 2.68 . . . . 72.32 113.333 172.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 72.33 172.7 0.31 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.648 0.981 . . . . 74.23 113.648 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -148.21 -137.38 2.87 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.714 -0.676 . . . . 45.42 113.036 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.8 101.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.341 0.571 . . . . 64.41 112.205 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -133.4 129.78 37.83 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.315 -0.241 . . . . 65.32 111.251 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.69 169.19 24.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.331 0.586 . . . . 73.53 111.862 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.439 ' O ' HG23 ' A' ' 121' ' ' VAL . 34.3 t80 -108.98 -58.99 1.95 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.908 -0.587 . . . . 73.52 110.66 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 21.5 m120 64.3 -71.15 0.07 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.57 0.748 . . . . 65.12 112.807 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -30.75 105.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.746 1.218 . . . . 64.15 113.913 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.13 130.37 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.933 -0.576 . . . . 61.24 111.357 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -144.52 131.77 20.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.048 0.452 . . . . 54.21 112.021 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -158.65 -71.18 0.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.101 -0.5 . . . . 75.34 110.214 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.8 tt 46.34 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.859 0.864 . . . . 71.53 113.058 174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.46 133.43 52.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.09 -0.381 . . . . 44.24 110.181 171.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -153.61 93.51 1.69 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.067 0.461 . . . . 71.31 112.089 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -147.39 120.42 8.81 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.838 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -163.7 125.61 2.43 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.04 0.448 . . . . 64.44 111.417 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -98.1 -102.66 0.2 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.289 -0.414 . . . . 72.41 111.627 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -150.67 156.22 40.91 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.921 -0.487 . . . . 75.44 111.852 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.216 0.531 . . . . 75.01 110.897 176.072 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.702 ' SD ' ' HB2' ' A' ' 88' ' ' SER . 18.4 tmm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.561 0.219 . . . . 74.02 110.618 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 11.1 pt-20 -89.91 159.14 43.57 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -171.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 11.1 Cg_endo -56.22 -37.54 96.5 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.224 2.616 . . . . 71.44 113.543 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -124.58 99.32 6.12 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.334 -0.394 . . . . 61.01 111.609 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.8 p -64.45 138.69 58.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.066 0.46 . . . . 71.44 111.837 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 9.9 t0 -81.01 147.7 30.07 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.036 0.445 . . . . 73.24 110.978 178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -61.44 -51.88 66.88 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.759 0.652 . . . . 43.54 112.759 -176.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' LYS . 1.8 p-80 -74.0 -25.13 59.73 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.789 -0.57 . . . . 64.42 112.275 -178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' A' ' 6' ' ' ASP . 64.1 t -61.7 -44.18 98.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.083 0.468 . . . . 74.51 110.618 172.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 63' ' ' TYR . 46.4 tp -68.74 -44.95 72.73 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.014 0.435 . . . . 72.32 111.006 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.633 ' HE3' ' HA2' ' A' ' 102' ' ' GLY . 78.3 tttt -56.7 -44.97 82.07 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.087 0.47 . . . . 65.51 111.715 178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -65.58 -37.9 87.97 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.162 -0.472 . . . . 61.22 110.808 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 99.3 mtt180 -64.0 -33.09 74.95 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.736 0.303 . . . . 73.14 111.668 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -68.25 -54.03 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.06 0.457 . . . . 62.41 111.008 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -87.49 -18.92 28.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.289 0.848 . . . . 74.44 113.289 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -127.16 -45.7 1.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.005 0.372 . . . . 71.51 112.005 -175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -74.98 -168.99 23.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 114.411 0.524 . . . . 74.13 114.411 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -96.23 141.9 23.79 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 120.805 0.336 . . . . 75.42 111.826 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.73 52.65 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.168 2.579 . . . . 62.34 113.737 -175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 9.69 34.99 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.94 0.4 . . . . 52.11 111.577 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -112.57 158.61 19.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.193 -0.458 . . . . 65.01 111.526 -177.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' HG12 ' A' ' 62' ' ' ILE . 63.2 m -127.86 114.66 17.49 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.811 0.339 . . . . 65.44 111.391 177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.9 mt -88.54 125.93 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.844 0.354 . . . . 74.41 111.874 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.653 HD22 ' SD ' ' A' ' 43' ' ' MET . 47.3 mt -114.8 126.86 55.31 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.95 0.405 . . . . 61.44 111.984 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -90.44 112.76 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.065 -0.516 . . . . 73.4 109.862 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 48' ' ' LEU . 27.4 m -108.5 4.76 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 112.671 0.619 . . . . 71.43 112.671 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.553 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 76.5 mtm180 -61.95 -68.69 0.3 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.29 0.567 . . . . 74.32 111.245 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 31' ' ' THR . 33.3 t70 -173.28 157.57 3.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.489 -0.778 . . . . 63.24 109.851 -177.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 32' ' ' TYR . 8.8 tpt180 -57.43 -50.91 71.49 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.571 0.7 . . . . 73.53 110.891 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.3 m -75.65 -42.14 52.23 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.119 -0.491 . . . . 53.02 111.391 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 28' ' ' ASP . 86.5 m -60.38 -33.19 72.11 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.986 0.422 . . . . 75.42 110.987 175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.479 ' HA ' ' NH2' ' A' ' 27' ' ' ARG . 59.2 t80 -55.29 -54.18 46.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.838 0.351 . . . . 71.54 110.127 171.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -60.84 -38.25 84.85 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.399 -0.364 . . . . 71.25 111.96 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' ILE . 9.5 t70 -51.45 -48.68 62.69 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.694 0.398 . . . . 71.03 111.245 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' NH2' ' A' ' 27' ' ' ARG . . . -176.45 125.43 1.04 Allowed Glycine 0 C--O 1.221 -0.716 0 C-N-CA 120.98 -0.629 . . . . 62.44 111.951 176.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -143.91 169.2 18.24 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 117.536 0.668 . . . . 73.21 112.316 -172.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -63.94 140.63 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 115.897 -0.592 . . . . 73.4 110.572 174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 ttt -58.1 100.3 0.06 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.363 0.505 . . . . 73.24 112.363 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 20.48 33.48 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.197 -0.525 . . . . 33.33 114.36 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.14 156.19 25.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 117.451 0.626 . . . . 60.41 112.445 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.0 mmm -81.23 150.93 28.39 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.896 -0.593 . . . . 72.35 111.908 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.23 96.6 7.57 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.939 0.4 . . . . 74.31 111.522 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.653 ' SD ' HD22 ' A' ' 24' ' ' LEU . 2.1 mpt? -124.87 88.19 54.19 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 116.589 -0.278 . . . . 65.33 111.074 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.57 128.82 28.46 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 121.98 1.787 . . . . 74.03 110.969 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 18.7 tt -44.55 -28.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 114.694 1.368 . . . . 74.04 114.694 -166.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -78.2 -44.68 25.08 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.754 -0.591 . . . . 74.54 111.427 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.521 ' HB3' ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -77.64 -10.85 59.74 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.821 0.448 . . . . 73.33 111.725 176.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD13 HG12 ' A' ' 26' ' ' VAL . 68.1 tp -39.52 -57.7 1.4 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.19 1.181 . . . . 75.2 114.19 -172.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.7 t -52.31 -53.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.532 0.567 . . . . 71.43 112.532 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.46 -46.34 73.31 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.4 -0.364 . . . . 71.1 111.758 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 25.3 mmt180 -57.62 -42.85 84.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.853 0.359 . . . . 74.23 111.538 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.76 -54.4 11.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.294 -0.412 . . . . 72.32 111.691 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 p -55.45 -31.9 62.31 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.246 0.461 . . . . 52.45 112.246 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 p -63.15 -46.84 85.3 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.519 0.563 . . . . 52.22 112.519 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -123.39 10.31 9.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.746 0.647 . . . . 71.14 112.746 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD11 HD21 ' A' ' 24' ' ' LEU . 99.2 mt -128.0 169.23 14.25 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.479 0.657 . . . . 65.51 112.061 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.673 ' HG2' ' H ' ' A' ' 59' ' ' SER . 34.5 tt0 -118.96 139.52 51.54 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.614 -0.721 . . . . 75.4 111.216 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -60.85 -28.81 69.11 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.298 0.571 . . . . 73.32 111.069 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.673 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 41.2 t -87.44 -20.13 27.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.849 -0.614 . . . . 74.33 111.889 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' A' ' 57' ' ' GLU . 4.3 tpm_? -61.01 130.54 46.94 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.664 0.386 . . . . 73.33 111.794 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.85 110.78 1.64 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.041 0.448 . . . . 61.22 110.435 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.42 HG12 ' HB ' ' A' ' 22' ' ' THR . 78.6 mt -123.75 133.41 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.001 0.429 . . . . 74.41 112.126 -175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 88' ' ' SER . 23.8 m-85 -119.31 121.71 40.23 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.188 0.518 . . . . 73.44 110.783 175.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 24' ' ' LEU . 86.1 t -105.31 141.48 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.019 -0.537 . . . . 72.14 111.737 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -136.89 130.47 31.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.702 0.763 . . . . 73.14 112.116 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.93 -163.62 21.31 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.232 -0.894 . . . . 71.14 112.19 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.32 -18.41 57.49 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.169 0.509 . . . . 53.41 111.586 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.22 -177.93 34.74 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.079 -0.51 . . . . 50.44 112.758 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.74 -45.27 78.05 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.093 0.405 . . . . 64.2 112.093 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -62.05 -53.97 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.452 0.538 . . . . 64.3 112.452 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 63.5 tt0 -65.04 -40.59 95.04 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.92 0.39 . . . . 74.41 111.11 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 89' ' ' GLU . 60.7 m -59.61 -53.18 61.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.11 -0.495 . . . . 61.44 111.065 178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.6 t -66.78 -35.95 81.27 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.042 -0.526 . . . . 63.31 111.946 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.39 -48.31 70.53 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.762 0.425 . . . . 54.3 111.442 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -58.76 -45.42 89.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.008 0.432 . . . . 71.35 111.829 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG21 ' HB3' ' A' ' 89' ' ' GLU . 87.2 t -53.05 -43.81 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 116.27 -0.423 . . . . 64.5 111.55 175.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -53.8 -47.36 70.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.509 0.671 . . . . 70.14 110.592 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 75' ' ' ALA . 48.7 mt -60.44 -37.43 80.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.075 -0.966 . . . . 73.4 111.983 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.6 mt -66.69 -52.3 46.32 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.815 0.302 . . . . 72.41 111.815 177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -65.77 -25.23 67.17 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.789 -0.57 . . . . 71.23 111.341 176.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 t -69.89 -22.39 63.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.914 0.388 . . . . 72.01 110.74 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.62 2.94 56.43 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.86 0.362 . . . . 61.33 111.554 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.6 -18.59 32.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 114.309 0.483 . . . . 55.44 114.309 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -56.98 110.81 0.88 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.462 0.649 . . . . 72.24 112.716 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -73.45 -59.21 2.82 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.75 -0.659 . . . . 74.12 112.009 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -89.77 79.07 6.79 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.135 0.493 . . . . 73.55 111.95 -172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG12 HG13 ' A' ' 76' ' ' VAL . 60.6 t -133.87 133.22 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 120.921 0.391 . . . . 52.13 111.313 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.702 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 40.3 t -128.97 157.82 40.57 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.124 0.488 . . . . 71.52 111.06 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.653 ' HB3' HG21 ' A' ' 76' ' ' VAL . 9.8 pt-20 -101.46 133.65 45.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.392 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HA ' ' A' ' 7' ' ' ALA . 28.8 tp -77.99 107.45 10.55 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.111 0.481 . . . . 52.31 110.996 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -54.08 108.77 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.599 0.592 . . . . 74.23 112.599 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 96' ' ' ALA . . . 103.47 -21.08 40.26 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.213 -0.449 . . . . 55.33 113.877 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.86 -152.82 47.92 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.032 -0.604 . . . . 45.41 113.225 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD22 ' NH1' ' A' ' 27' ' ' ARG . 51.7 tp -60.91 -47.25 87.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.077 0.399 . . . . 73.24 112.077 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.5 -33.08 29.96 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.529 0.566 . . . . 64.5 112.529 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . . . -73.62 -47.38 40.61 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.035 0.445 . . . . 74.34 110.903 175.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.436 ' CH2' ' HA ' ' A' ' 11' ' ' LYS . 55.9 t-105 -52.9 -41.42 64.38 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.633 0.73 . . . . 73.53 110.977 175.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' HG21 ' A' ' 104' ' ' THR . 37.8 mtpt -77.87 -34.33 51.7 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.705 -0.679 . . . . 74.42 111.779 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.55 -36.71 81.38 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.997 0.427 . . . . 65.23 111.534 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.3 pt -84.12 5.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 116.178 -0.464 . . . . 73.51 111.279 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.89 49.65 66.42 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.589 -0.338 . . . . 72.34 113.408 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.633 ' HA2' ' HE3' ' A' ' 11' ' ' LYS . . . -86.45 161.18 33.72 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.265 -0.493 . . . . 35.15 113.501 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.31 125.35 15.53 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.73 2.287 . . . . 73.21 112.285 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.442 HG21 ' HG2' ' A' ' 98' ' ' LYS . 61.1 p -133.51 153.54 51.55 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.052 0.453 . . . . 73.04 111.262 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -143.96 172.57 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.591 -0.731 . . . . 74.4 110.655 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.49 -162.82 27.62 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.199 -1.001 . . . . 62.14 114.265 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.47 -57.56 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 122.901 0.48 . . . . 74.11 110.361 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.47 ' HA ' ' HG2' ' A' ' 111' ' ' ARG . 1.7 mp -67.4 -40.02 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 112.319 0.488 . . . . 64.05 112.319 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.78 -14.06 19.09 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 74.35 111.029 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -102.48 1.18 34.8 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.055 -0.52 . . . . 53.13 111.737 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 108' ' ' ILE . 12.7 mmm180 -87.25 142.66 27.73 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.154 0.502 . . . . 74.05 111.956 -177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 54.7 p -95.05 142.34 24.47 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.846 -0.615 . . . . 64.43 111.499 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 16.5 Cg_exo -68.42 -75.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.042 2.495 . . . . 61.01 113.514 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . 63.11 -171.3 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.929 -0.578 . . . . 70.33 112.294 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.78 108.1 3.27 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.887 -0.673 . . . . 72.51 113.454 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.01 143.54 2.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.616 0.367 . . . . 62.24 111.119 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -158.11 121.87 4.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.625 0.726 . . . . 60.15 111.818 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.78 153.07 50.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 74.05 110.847 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -151.5 145.0 24.87 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.786 0.327 . . . . 71.4 111.845 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.01 80.15 0.66 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.353 0.597 . . . . 74.24 110.978 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.1 m -71.28 -16.13 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.856 -0.611 . . . . 75.04 112.377 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.33 103.05 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.992 0.425 . . . . 73.5 111.428 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.4 t -132.83 109.5 9.67 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.314 -0.403 . . . . 70.43 110.799 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.61 123.88 5.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.725 0.298 . . . . 64.42 110.423 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.5 125.63 7.27 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.663 0.268 . . . . 74.41 111.663 -176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -153.0 144.65 23.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.926 0.393 . . . . 62.0 111.187 175.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -144.99 29.99 1.18 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.787 0.327 . . . . 65.23 111.804 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -99.96 114.42 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.891 0.377 . . . . 73.3 111.791 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -142.43 118.17 10.46 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.032 -0.531 . . . . 75.54 110.026 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -127.0 100.73 6.26 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.131 0.419 . . . . 73.42 112.131 -172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -155.4 135.43 12.93 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.567 0.347 . . . . 54.22 111.836 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.3 m80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.012 0.434 . . . . 73.31 111.184 173.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.637 0.256 . . . . 74.33 110.77 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -66.58 155.06 89.89 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.487 -0.324 . . . . 60.43 111.573 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.39 -20.58 54.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.585 2.19 . . . . 70.02 112.654 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -129.32 124.79 35.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.966 0.412 . . . . 64.12 111.971 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.1 p -109.29 129.92 55.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.848 0.356 . . . . 73.22 111.766 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 8' ' ' HIS . 30.9 t70 -62.17 136.65 58.03 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.157 0.429 . . . . 62.11 112.157 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.781 ' HA ' HD11 ' A' ' 90' ' ' LEU . . . -59.18 -43.51 92.16 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.004 0.43 . . . . 71.41 111.897 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HA ' HD12 ' A' ' 100' ' ' ILE . 12.3 t60 -60.9 -45.28 95.24 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.305 -0.407 . . . . 62.32 111.533 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.41 -41.95 86.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.8 0.333 . . . . 74.12 111.212 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.8 tp -57.93 -47.78 81.86 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.038 0.447 . . . . 73.02 110.996 175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -55.85 -48.44 75.51 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.107 -0.497 . . . . 75.22 111.62 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.406 ' HA ' ' HD1' ' A' ' 16' ' ' TRP . 63.8 m -62.55 -29.82 70.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.795 0.331 . . . . 63.31 111.184 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.462 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 83.8 mtt180 -76.0 -27.39 57.4 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.002 -0.436 . . . . 75.02 111.793 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.4 tt -71.38 -44.44 64.97 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.427 0.632 . . . . 62.2 110.496 173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.65 -52.55 5.47 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.034 -0.53 . . . . 73.24 112.305 -176.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.406 ' HD1' ' HA ' ' A' ' 12' ' ' SER . 25.8 m95 -96.44 -30.07 13.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 13' ' ' ARG . . . -84.77 -177.1 51.05 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 114.508 0.563 . . . . 64.45 114.508 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 3.2 mp0 -90.72 137.37 27.06 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 122.794 0.438 . . . . 73.25 111.563 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 3.0 Cg_exo -75.9 59.7 5.86 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 123.234 2.623 . . . . 71.25 113.458 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.91 18.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.19 0.519 . . . . 21.4 111.315 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -94.04 158.81 15.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.762 -0.654 . . . . 55.25 111.538 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 78.0 m -135.65 131.0 35.21 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.426 -0.352 . . . . 74.43 111.85 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 23' ' ' ILE . 3.4 mp -95.81 135.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 120.665 0.269 . . . . 52.11 111.582 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 56' ' ' LEU . 58.3 mt -114.25 129.57 56.63 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.304 0.483 . . . . 63.41 112.304 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -91.68 95.94 10.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.059 -0.519 . . . . 65.14 110.483 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 35.3 m -94.67 7.08 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.331 0.493 . . . . 53.34 112.331 -174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.593 ' HA ' ' NE2' ' A' ' 71' ' ' GLN . 87.9 mtm180 -65.45 -59.29 4.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.083 0.468 . . . . 71.24 110.904 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.5 t70 177.37 161.91 0.49 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.607 -0.724 . . . . 63.13 109.882 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -64.73 -42.15 95.44 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.899 0.381 . . . . 74.03 111.493 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.2 t -76.68 -33.42 58.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.042 0.449 . . . . 73.02 110.684 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.559 ' HA ' ' OD2' ' A' ' 34' ' ' ASP . 94.8 m -70.23 -33.93 72.26 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.333 0.587 . . . . 73.44 110.549 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' ND1' ' A' ' 36' ' ' HIS . 29.8 t80 -57.89 -38.71 76.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.277 0.56 . . . . 75.13 109.631 169.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.402 ' O ' HG13 ' A' ' 107' ' ' ILE . 93.2 m-20 -69.73 -46.55 65.66 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.132 -0.486 . . . . 70.31 112.109 177.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 31' ' ' THR . 7.5 p30 -66.88 -46.24 75.58 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.501 0.926 . . . . 62.5 113.501 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.34 98.86 0.17 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 119.881 -1.152 . . . . 34.21 113.741 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 32' ' ' TYR . 57.3 p-80 -122.3 163.97 18.74 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.152 0.476 . . . . 74.03 112.07 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.8 140.18 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 120.637 0.256 . . . . 64.22 110.699 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.416 ' SD ' ' CG ' ' A' ' 105' ' ' GLU . 40.4 tpp -53.74 110.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.019 0.378 . . . . 65.32 112.019 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.51 71.0 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.398 0.519 . . . . 65.51 114.398 176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 159.84 28.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.519 0.659 . . . . 70.02 112.159 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.524 ' HB3' ' SD ' ' A' ' 43' ' ' MET . 89.3 mmm -89.99 145.64 24.95 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.874 -0.603 . . . . 72.41 112.346 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.77 73.66 9.79 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.96 -0.564 . . . . 75.03 110.776 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 41' ' ' MET . 0.9 OUTLIER -113.51 80.95 5.04 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.926 -0.579 . . . . 51.53 110.956 178.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 47' ' ' ASP . 3.0 Cg_exo -67.53 138.7 46.63 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.714 1.609 . . . . 74.33 110.708 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 26' ' ' VAL . 16.7 tt -45.86 -29.07 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 113.674 0.99 . . . . 74.3 113.674 -171.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -87.04 -28.85 22.34 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.555 0.576 . . . . 43.23 112.555 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' HB3' ' HD2' ' A' ' 44' ' ' PRO . 4.3 t0 -99.45 0.35 42.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.464 0.65 . . . . 54.45 110.654 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.5 tp -51.29 -57.16 9.6 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.787 1.032 . . . . 62.34 113.787 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 82' ' ' ALA . 70.7 t -57.88 -53.51 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.024 0.44 . . . . 72.22 111.703 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.04 -45.97 89.4 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.022 -0.535 . . . . 63.01 112.078 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 2.7 mmp_? -57.31 -51.35 69.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.301 0.572 . . . . 63.33 111.261 176.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -52.05 60.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.764 -0.653 . . . . 63.2 112.408 -174.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.1 t -57.97 -33.33 68.75 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.003 0.43 . . . . 70.31 111.753 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.6 m -89.64 2.15 55.11 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.573 0.583 . . . . 71.32 112.573 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.6 m -137.22 -57.06 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.168 0.508 . . . . 72.51 112.108 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.928 HD11 HD21 ' A' ' 24' ' ' LEU . 80.2 mt -87.17 163.67 16.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.395 0.617 . . . . 73.52 112.636 -176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -101.42 174.27 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.484 -0.78 . . . . 70.43 111.049 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -98.23 -28.61 13.63 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.277 -0.874 . . . . 75.34 111.112 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -84.5 -20.55 31.48 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.008 -0.542 . . . . 54.13 111.807 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -77.71 134.69 38.05 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.6 0.238 . . . . 74.32 111.332 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.15 117.15 7.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.381 0.61 . . . . 63.42 112.354 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 56' ' ' LEU . 75.2 mt -117.98 131.92 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.894 -0.594 . . . . 63.22 111.445 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.67 120.32 42.04 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.12 0.486 . . . . 72.45 111.067 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.0 t -105.22 131.49 54.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.088 -0.506 . . . . 73.13 111.394 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -129.07 130.37 46.44 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.884 0.85 . . . . 75.54 112.042 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.24 177.82 16.62 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 114.846 -1.07 . . . . 64.35 111.291 175.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.59 -26.0 60.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.254 0.527 . . . . 74.11 111.753 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -139.72 164.36 26.06 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.158 -0.544 . . . . 64.12 113.842 -177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -61.82 -34.33 75.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.255 0.55 . . . . 63.51 111.659 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.51 -44.8 77.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.065 0.46 . . . . 75.14 111.087 175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.593 ' NE2' ' HA ' ' A' ' 27' ' ' ARG . 55.6 tt0 -63.17 -43.64 97.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.302 -0.408 . . . . 75.23 111.22 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -60.57 -54.05 50.1 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.582 -0.281 . . . . 73.13 110.751 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 t -50.6 -49.29 56.92 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.064 -0.516 . . . . 42.13 112.122 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -66.7 -45.65 78.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.611 0.243 . . . . 65.0 111.601 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -60.87 -49.54 77.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.917 0.389 . . . . 63.14 111.668 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 89' ' ' GLU . 76.0 t -53.32 -47.38 57.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.256 -0.429 . . . . 71.11 110.836 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -51.72 -48.98 63.38 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.303 0.573 . . . . 64.02 111.267 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.615 HD12 ' HA ' ' A' ' 75' ' ' ALA . 38.6 mt -57.04 -39.93 75.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.374 -0.83 . . . . 63.34 112.169 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 mt -67.63 -45.29 75.79 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.777 0.288 . . . . 50.43 111.777 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 80' ' ' ARG . 1.6 mtp85 -64.42 -32.01 73.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.281 0.562 . . . . 73.14 109.674 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 t -62.24 -32.82 73.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.781 -0.645 . . . . 41.43 110.995 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' A' ' 49' ' ' VAL . . . -82.56 -5.19 58.63 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.364 -0.38 . . . . 62.41 111.361 175.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.78 1.28 55.19 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 114.203 0.441 . . . . 64.4 114.203 176.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -64.32 112.63 3.16 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.59 0.695 . . . . 74.21 111.732 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -70.52 -55.9 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.664 -0.698 . . . . 75.44 112.275 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -92.15 81.49 5.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.265 -0.425 . . . . 62.04 111.821 -174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 76' ' ' VAL . 58.3 t -127.07 119.89 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.99 0.424 . . . . 72.21 111.167 178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.0 t -129.68 136.45 49.72 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.301 -0.408 . . . . 71.13 111.578 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 76' ' ' VAL . 12.6 pt-20 -86.05 145.58 27.01 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.196 0.522 . . . . 74.11 111.096 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.781 HD11 ' HA ' ' A' ' 7' ' ' ALA . 21.3 tp -80.57 122.65 27.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.275 -0.421 . . . . 74.5 111.921 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.25 125.74 28.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.553 -0.294 . . . . 73.03 111.25 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.56 67.97 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.395 -0.431 . . . . 72.11 113.761 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 63.52 -154.54 45.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.324 -0.465 . . . . 70.23 114.081 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.1 tp -66.22 -35.0 79.29 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.998 0.428 . . . . 63.12 111.501 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -42.69 87.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.474 -0.33 . . . . 61.15 111.548 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.11 87.88 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.823 0.345 . . . . 75.03 111.001 175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -52.97 -43.58 66.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.288 0.566 . . . . 72.45 111.059 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -71.43 -39.57 70.98 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.075 -0.511 . . . . 72.42 111.964 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.74 83.27 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.332 0.493 . . . . 73.35 112.332 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 8' ' ' HIS . 18.4 pt -81.61 5.25 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.152 0.427 . . . . 74.54 112.152 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.32 19.35 52.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.396 -0.43 . . . . 74.1 113.633 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.3 138.38 36.39 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.415 -0.421 . . . . 70.51 113.643 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.57 130.56 16.15 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.557 2.172 . . . . 61.22 112.389 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 69.8 p -125.04 155.1 40.27 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.53 0.681 . . . . 74.43 112.266 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' CG ' ' SD ' ' A' ' 38' ' ' MET . 48.7 mt-10 -114.17 175.0 5.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.271 -0.877 . . . . 74.51 110.011 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 156.14 171.38 22.42 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.115 -1.04 . . . . 54.15 114.426 176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 33' ' ' ASN . 41.3 mt -91.07 -41.69 13.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.892 0.377 . . . . 54.12 110.241 173.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 34' ' ' ASP . 1.7 pp -70.73 -28.92 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 121.734 0.778 . . . . 65.25 111.13 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.89 78.35 0.63 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.488 -1.233 . . . . 74.25 110.67 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.3 t -176.54 -38.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.041 -0.981 . . . . 60.01 110.596 -172.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 111' ' ' ARG . 2.5 mpt_? -86.11 120.29 27.33 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.167 -0.47 . . . . 75.33 111.635 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 3.3 t -88.01 130.52 46.08 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-O 120.838 0.351 . . . . 71.43 111.878 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 112' ' ' THR . 3.0 Cg_exo -75.64 98.5 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.811 2.341 . . . . 75.04 112.339 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.74 108.81 13.96 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.986 0.422 . . . . 74.43 111.939 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 170.31 109.02 0.22 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.261 -0.495 . . . . 72.22 112.913 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.8 158.6 9.1 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.877 0.37 . . . . 32.2 111.676 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -135.47 -169.85 2.48 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.768 0.318 . . . . 71.42 111.419 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -151.29 159.35 44.38 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.864 0.69 . . . . 74.34 112.864 -173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -161.97 97.1 1.03 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.973 -0.558 . . . . 73.34 111.455 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -158.04 22.92 0.26 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 65.02 111.401 174.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.9 m -90.23 129.33 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.723 0.638 . . . . 75.11 112.723 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.5 t 59.64 104.27 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 113.786 1.032 . . . . 74.53 113.786 170.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 t -161.12 99.26 1.2 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.987 -0.551 . . . . 41.21 110.894 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -148.6 146.09 28.08 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.825 0.345 . . . . 64.22 111.181 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -149.94 131.64 14.98 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.435 -0.348 . . . . 61.3 110.434 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.53 141.86 19.58 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.849 0.357 . . . . 74.41 111.352 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -165.75 112.5 0.91 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.003 0.43 . . . . 71.42 112.007 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -136.88 146.5 45.63 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.386 -0.37 . . . . 44.13 111.292 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -162.38 99.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.219 0.533 . . . . 74.4 111.924 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -139.62 103.59 4.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.103 0.477 . . . . 75.23 111.16 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -129.97 96.04 4.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.054 0.454 . . . . 75.31 110.512 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 . . . . . 0 C--O 1.238 0.461 0 CA-C-N 116.255 -0.429 . . . . 64.42 110.991 -176.631 . . . . . . . . 0 0 . 1 stop_ save_